Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3009508	u-krea	mmol/l (mmol/l)	101438	304935	0.03%
3009508	u-krea	— (—)	33026	84699	100.00%	Distribution not available
3009508	u-kreatiniini	mmol/l (mmol/l)	3974	4580	0.00%
3009508	u-krea	umol/l (mmol/l)	2781	4283	0.00%
3009508	u-kreat	mmol/l (mmol/l)	1047	1142	0.00%
3009508	kreatiniini,virtsasta(huumeseulonnanyhteydessä)	mmol/l (—)	756	874	100.00%	Distribution not available
3009508	u-kreintp	mmol/l (mmol/l)	562	841	0.00%
3009508	u-kreatiniini,virtsasta(huumeseulonnanyhteydessä)	mmol/l (mmol/l)	263	283	0.00%
3009508	kreatiniini(u-maniposat.)	mmol/l (—)	148	368	100.00%	Distribution not available
3009508	u-kreahuu	mmol/l (mmol/l)	84	213	0.00%
3009508	u-kreintp	— (—)	67	69	100.00%	Distribution not available
3009508	u-krealb	mmol/l (mmol/l)	62	79	0.00%
3009508	u-kreaetg	mmol/l (mmol/l)	30	89	0.00%
3009508	u-kreat	— (—)	21	23	100.00%	Distribution not available
3009508	u-kreahuu	— (—)	16	30	100.00%	Distribution not available
3009508	u-kreint	mmol/l (mmol/l)	9	9	0.00%	Distribution not available
3009508	u-kreatiniini	— (—)	7	7	100.00%	Distribution not available
3009508	u-kreaetg	— (—)	6	8	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Asthma, excluding more controls

15022

58850

1.51

323.31

3.3

3.1

7.54

8.24

mmol/l

2.28

12965

50080

Use of hypnotics and sedatives

20201

90160

1.42

321.39

3.5

3.2

7.42

8.01

mmol/l

3.31

16952

76227

Pre-eclampsia

3380

18010

2.38

321.37

4.1

3.0

11.25

7.08

mmol/l

0.49

2965

15340

Hypothyroidism, strict autoimmune, 3 medication purchases required

15286

77595

1.49

320.64

3.5

3.1

7.20

7.68

mmol/l

1.86

12776

65296

Asthma, unspecified (mode), excluding more controls

9839

53592

1.65

320.35

3.3

3.0

7.22

8.11

mmol/l

2.83

8339

45364

Coronary revascularization (ANGIO or CABG)

8966

43135

1.75

318.52

3.5

3.2

7.26

7.73

mmol/l

21.73

7553

35557

Gonarthrosis [arthrosis of knee](FG)

14693

63987

1.52

317.30

3.1

7.56

7.73

mmol/l

4.32

12275

53594

Major coronary heart disease event

13426

66150

1.56

315.95

3.4

3.2

7.21

7.60

mmol/l

20.29

11259

54939

11303

72715

1.59

314.92

4.1

3.2

8.72

8.29

mmol/l

0.13

9586

61599

Cholelithiasis, broad definition with cholecystitis

15833

81734

1.48

310.44

3.3

3.1

7.37

7.52

mmol/l

3.82

13124

68517

Extracorporeal dialysis

1441

5910

5.20

308.30

10.6

3.3

5.35

7.99

mmol/l

166.90

1393

4972

Dental caries 3

15946

60851

1.48

307.81

3.4

3.1

7.61

7.69

mmol/l

0.98

13453

51094

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

9301

18116

32.72

307.65

4.6

2.5

7.41

8.12

mmol/l

37.24

7987

15520

Benzodiazepine use

19085

100529

1.51

307.65

3.6

3.2

7.17

7.98

mmol/l

7.08

15707

85244

Autoimmune diseases

24627

80923

1.82

307.65

4.1

2.9

7.83

7.98

mmol/l

4.76

21281

68058

Heart failure,strict

9857

49178

1.73

307.65

3.9

3.0

6.65

7.64

mmol/l

109.79

8213

40520

Sleep apnoea

21266

83787

2.22

307.65

3.5

3.2

8.27

7.58

mmol/l

76.50

17486

71094

Glomerular diseases

4833

19695

4.89

307.65

9.7

3.0

6.26

7.96

mmol/l

176.16

4548

16488

Glomerular disorders in diseases classified elsewhere

3307

11933

7.21

307.65

9.8

3.0

6.02

7.98

mmol/l

166.68

3111

10009

Dental pulpitis 1

21189

82880

1.47

307.65

3.5

3.1

7.70

7.94

mmol/l

0.73

17849

70118

Mood disorders

21257

94384

1.72

307.65

3.5

3.2

7.75

7.97

mmol/l

0.78

17956

80029

Other anxiety disorders

8464

44098

2.05

307.65

3.6

3.2

7.90

8.41

mmol/l

0.88

7254

38113

Hypothyroidism, strict autoimmune

13953

64581

1.62

307.65

3.5

2.9

7.32

7.67

mmol/l

15.35

11704

53961

Dental pulpitis 4, only avohilmo

21534

85181

1.46

307.65

3.4

3.2

7.74

7.92

mmol/l

0.51

18148

72066

Chronic periodontitis, including avohilmo

17308

92674

1.58

307.65

3.7

3.2

7.46

7.72

mmol/l

10.84

14412

78211

Type 2 diabetes, strict (exclude DM1)

38661

47631

12.73

307.65

3.7

2.2

7.50

7.97

mmol/l

45.22

32186

40525

Parodontitis

17376

92699

1.58

307.65

3.7

3.2

7.46

7.72

mmol/l

11.27

14463

78244

Gout, unspecified

3970

22994

2.43

307.65

4.6

3.2

7.11

7.83

mmol/l

24.94

3358

18938

Chronic kidney disease

8042

32124

4.81

307.65

7.3

2.9

5.97

7.65

mmol/l

307.65

7393

26106

Hypertensive diseases (excluding secondary)

14928

30640

4.32

307.65

4.1

2.8

7.79

8.49

mmol/l

45.80

13157

26102

Diseases of pulp and periapical tissues, including avohilmo

21163

82739

1.47

307.65

3.5

3.1

7.70

7.94

mmol/l

0.73

17821

70003

Statin medication

18830

35613

4.37

307.65

3.9

2.6

8.56

8.19

mmol/l

0.21

16421

30035

Type 1 diabetes, strict (exclude DM2)

4092

6060

39.10

307.65

5.5

3.0

12.03

8.92

mmol/l

0.46

3752

5328

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

1770

4492

3.81

307.65

3.6

1.8

7.15

8.07

mmol/l

13.08

1483

3785

Disorders of lipoprotein metabolism and other lipidaemias

20571

69341

2.54

307.65

3.8

3.0

8.09

7.78

mmol/l

0.18

17532

57853

Dental caries 3 and operation codes

17656

67543

1.49

307.65

3.4

3.1

7.65

7.73

mmol/l

1.16

14917

56739

Glomerulonephritis

2232

10148

3.67

307.65

10.0

3.2

6.64

7.87

mmol/l

41.63

2120

8596

Viral hepatitis, IBD co-morbidity

1240

2364

8.95

307.65

10.7

1.8

7.14

9.17

mmol/l

26.22

1096

2093

Infections, IBD-co-morbidities

2708

6633

3.80

307.65

4.5

1.8

6.94

8.34

mmol/l

33.93

2349

5698

Dental caries 1 and operation codes

16871

64573

1.48

307.65

3.4

3.1

7.62

7.72

mmol/l

1.73

14234

54114

ILD medications

21841

92557

1.42

307.65

4.1

3.0

7.44

8.11

mmol/l

4.39

18760

78072

ILD medications: prednisolone, methylprednisolone, prednisone

21224

91174

1.45

307.65

4.1

3.0

7.37

8.09

mmol/l

4.87

18168

76841

Anxiety disorders

16668

86551

1.53

307.65

3.5

3.2

7.85

7.99

mmol/l

0.37

14162

73723

Tramadol

17152

68241

1.95

307.65

3.7

3.1

7.48

8.03

mmol/l

1.95

14406

57655

Hyperkinetic disorders

2038

8219

3.43

307.65

4.2

3.7

8.73

8.91

mmol/l

0.56

1788

7330

Schizophrenia or delusion

6085

36126

2.10

307.65

4.1

3.2

7.20

8.15

mmol/l

28.14

5187

30912

Gingivitis and periodontal diseases

17823

68914

1.48

307.65

3.5

3.1

7.63

8.05

mmol/l

1.29

14930

58214

Codeine or tramadol medication

24440

90910

1.73

307.65

3.4

3.2

7.59

7.97

mmol/l

1.72

20622

76800

Dental pulpitis 4

21182

82859

1.47

307.65

3.5

3.1

7.70

7.94

mmol/l

0.73

17844

70101

Atrial fibrillation and flutter with reimbursement

5669

16315

3.05

307.65

3.4

2.6

7.31

8.23

mmol/l

42.34

4815

13516

Other bacterial diseases

18831

91036

1.65

307.65

4.2

3.1

6.95

7.86

mmol/l

144.18

15999

76609

Erysipelas

10539

67267

1.68

307.65

4.1

3.1

7.08

7.82

mmol/l

59.71

8934

56054

Personality disorders

5495

28178

2.60

307.65

4.4

3.2

7.51

8.23

mmol/l

18.04

4726

24318

Acute renal failure

4165

21946

2.73

307.65

5.3

2.9

6.31

7.72

mmol/l

99.90

3649

17938

Autoimmune diseases excluding thyroid diseases

22911

80535

1.86

307.65

4.3

2.9

8.35

7.98

mmol/l

0.25

19984

67725

Type 1 diabetes, strict definition, subgroup 1

3425

4461

87.98

307.65

5.6

3.2

12.96

9.19

mmol/l

0.47

3148

3945

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

19568

88318

1.76

307.65

4.2

3.0

7.08

8.05

mmol/l

7.95

16521

74840

Hypothyroidism, drug reimbursement

2752

4745

5.58

307.65

3.9

1.8

7.31

8.61

mmol/l

29.16

2368

4081

Hypertensive Heart Disease

4340

17208

2.74

307.65

3.8

2.6

6.82

7.71

mmol/l

37.44

3439

13928

L04AD Calcineurin inhibitors

2588

10599

4.68

307.65

10.7

3.1

5.99

8.14

mmol/l

140.64

2511

9066

Care involving dialysis

2191

8076

7.00

307.65

11.3

3.2

5.31

8.05

mmol/l

271.31

2135

6789

Type 1 diabetes, strict definition

3555

4759

68.93

307.65

5.5

3.2

12.78

9.15

mmol/l

0.47

3267

4212

Used for control exclusion in common control thyroid runs

23169

76290

1.79

307.65

4.0

2.9

7.88

8.02

mmol/l

3.98

20002

64189

Hypertensive diseases

21256

48036

3.63

307.65

3.9

2.8

7.65

8.16

mmol/l

39.11

18544

40479

Other nutritional deficiencies

15263

75374

2.76

307.65

3.7

3.2

7.93

7.91

mmol/l

0.04

12911

64065

Gout

5798

29439

2.46

307.65

4.5

3.1

7.11

7.83

mmol/l

36.17

4930

24266

Schizophrenia or delusion, excluding more controls

6085

32533

2.37

307.65

4.1

3.1

7.20

8.16

mmol/l

28.69

5187

27899

Type 2 diabetes, definitions combined

38559

47301

12.79

307.65

3.7

2.2

7.50

7.97

mmol/l

46.02

32095

40248

Secondary hypertension

2195

5950

8.06

307.65

9.5

2.8

6.16

8.36

mmol/l

108.87

2056

4954

Bipolar affective disorders

3751

18017

2.81

307.65

3.6

3.1

7.44

8.17

mmol/l

9.30

3188

15542

Emotionally unstable personality disorder

2477

10406

3.43

307.65

4.6

3.1

7.38

8.30

mmol/l

11.85

2146

9100

Selective serotonin reuptake inhibitors

20395

78329

1.53

307.65

3.4

3.2

7.85

8.06

mmol/l

0.56

17037

66557

Finngen Rheumatological endpoints

18495

79025

1.47

307.65

3.5

3.2

7.70

8.16

mmol/l

1.80

15721

66964

Disturbance of activity and attention

1958

7446

3.72

307.65

4.2

3.6

8.74

8.93

mmol/l

0.59

1718

6639

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

18891

96285

1.60

307.65

4.2

3.1

6.96

7.97

mmol/l

9.74

16008

81130

Examination and observation for other reasons

11409

45944

1.72

307.65

3.7

2.9

7.58

8.08

mmol/l

21.58

9976

38770

Hypertension, essential

20375

46781

3.59

307.65

3.7

2.7

7.61

8.15

mmol/l

42.07

17630

39329

Gout, idiopatic and unspecified

4902

28617

2.39

307.65

4.5

3.2

7.14

7.82

mmol/l

28.31

4176

23582

Persons encountering health services for other counselling and medical advice, not elsewhere classified

21894

92288

1.51

307.65

3.6

3.1

7.54

8.02

mmol/l

2.45

19086

77625

Ischemic heart diseases

16002

67620

1.78

307.65

3.5

3.1

7.23

7.65

mmol/l

28.15

13530

56459

Cardiovascular diseases (excluding rheumatic etc)

13998

38810

2.60

307.65

4.0

2.9

7.91

8.94

mmol/l

2.21

12271

33348

Personality disorders, excluding more controls

5495

24707

3.06

307.65

4.4

3.1

7.51

8.30

mmol/l

21.77

4726

21439

Hypertensive heart and/or renal disease

5092

18424

2.92

307.65

4.2

2.6

6.68

7.77

mmol/l

65.56

4140

14975

Other special examinations and investigations of persons without complaint or reported diagnosis

14623

46299

1.86

307.65

3.6

2.9

7.85

8.09

mmol/l

6.03

12721

39059

Medical observation and evaluation for suspected diseases and conditions

14250

46296

1.82

307.65

3.9

2.9

7.78

8.09

mmol/l

8.80

11648

39059

Obesity

14803

72378

2.88

307.65

3.7

3.2

7.94

7.92

mmol/l

0.03

12503

61542

Preparatory care for dialysis

1158

4169

8.98

307.65

12.4

3.2

5.09

7.90

mmol/l

169.84

1138

3500

General examination and investigation of persons without complaint and reported diagnosis

13782

46257

1.84

307.65

3.6

2.9

7.78

8.09

mmol/l

8.81

12082

39030

Special screening examination for other diseases and disorders

2056

7896

4.22

307.65

5.0

2.8

14.78

8.05

mmol/l

0.43

1671

6653

Persons encountering health services for specific procedures and health care

21289

95157

1.56

307.65

4.0

3.1

7.27

8.09

mmol/l

6.52

18310

80319

Nerve, nerve root and plexus disorders

21679

93339

1.69

307.65

3.6

3.1

7.45

7.91

mmol/l

2.30

18543

78320

Non-invasive ventilation

4306

12095

4.79

307.65

3.4

2.1

7.26

8.20

mmol/l

30.60

3958

10306

All anxiety disorders

11502

59023

1.83

307.65

3.6

3.2

7.96

8.28

mmol/l

0.70

9833

50862

Atrial fibrillation and flutter

6376

20343

2.61

307.65

3.4

2.7

7.40

8.37

mmol/l

48.53

5445

17069

Persons encountering health services for examination and investigation

13471

46299

1.63

307.65

3.5

2.9

7.81

8.09

mmol/l

7.22

11483

39059

Any mental disorder

22181

83330

1.47

307.65

3.4

3.2

7.63

7.80

mmol/l

5.08

18619

70682

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

1367

3048

28.79

307.65

6.7

2.9

6.71

8.65

mmol/l

42.67

1245

2685

Polyarthropathies

13385

60085

1.71

307.65

3.9

3.1

7.27

7.91

mmol/l

48.90

11413

50831

Substance abuse, excluding more controls

11114

62557

1.85

307.65

4.5

3.2

8.76

8.22

mmol/l

0.16

9387

53290

Dental pulpitis 1, only avohilmo

21599

85409

1.46

307.65

3.4

3.2

7.75

7.92

mmol/l

0.47

18191

72265

Insulin, fast-acting

14252

38857

14.35

307.65

5.6

2.9

8.30

8.09

mmol/l

0.08

12600

32548

Insulin medication

23379

41428

14.34

307.65

5.1

2.3

7.80

8.09

mmol/l

0.20

20223

35171

Gestational diabetes (for exclusion)

5269

21657

2.00

307.65

3.3

3.1

10.50

7.65

mmol/l

0.54

4634

18963

Nephropathy related operations

3078

13036

4.73

307.65

9.6

3.2

5.59

8.04

mmol/l

262.91

2932

10958

Hyperkinetic disorders, excluding more controls

2030

5968

4.89

307.65

4.2

3.2

8.74

9.24

mmol/l

2.52

1780

5384

Other intervertebral disc disorders

15982

72488

1.50

307.65

3.2

7.74

7.97

mmol/l

0.57

13641

61058

Insulin, fast-acting (human)

5498

12793

16.27

307.65

6.1

2.8

9.96

8.41

mmol/l

0.27

4990

10869

Carpal tunnel syndrome

11253

70510

1.68

307.65

3.7

3.1

7.37

7.46

mmol/l

1.24

9646

59015

Parodontitis or operation codes

17404

92712

1.58

307.65

3.7

3.2

7.46

7.72

mmol/l

11.39

14478

78260

Hard cardiovascular diseases

15256

70377

1.62

307.65

3.4

3.2

7.23

7.66

mmol/l

26.88

12816

58911

Cardiac arrhythmias

11276

30392

3.06

307.65

3.3

2.3

7.53

8.34

mmol/l

47.17

9624

26076

Neurological diseases, wide definition

6214

11416

3.34

307.65

3.6

1.9

8.29

8.53

mmol/l

2.08

5374

9936

Insulin, intermediate and long-acting

22032

63327

12.44

307.65

5.1

2.9

7.85

8.00

mmol/l

0.09

19085

52806

Insulin, fast-acting or short human

14310

42006

11.93

307.65

5.6

3.0

8.29

7.99

mmol/l

0.12

12652

35117

Heart failure, not strict

17448

69351

2.32

307.65

4.6

3.0

6.78

7.74

mmol/l

160.96

14840

57763

Persons encountering health services in other circumstances, wide

24361

92654

1.52

307.65

3.7

3.1

7.55

8.02

mmol/l

2.40

20988

77903

Other antidepressants

22005

78046

1.69

307.65

3.4

3.2

7.83

8.05

mmol/l

0.63

18489

66289

Hypothyroidism, levothyroxine purchases

5398

7746

5.25

307.65

3.7

1.9

8.12

8.91

mmol/l

16.39

4699

6796

Diabetes, insulin treatment (Kela reimbursement)

45902

57466

16.26

307.65

4.2

2.4

7.79

7.99

mmol/l

0.28

38814

48729

Cardiovascular diseases

12276

35662

2.23

307.65

3.9

2.9

8.03

9.06

mmol/l

1.92

10745

30787

Diabetes mellitus in pregnancy

5324

16757

2.53

307.65

3.9

2.9

7.77

7.76

mmol/l

0.03

4767

14646

Insulin, combination of fast acting with intermediate-acting or long-acting

23387

67557

8.54

307.65

5.1

2.9

7.80

7.97

mmol/l

0.11

20230

56317

Pre-eclampsia or eclampsia

3666

19856

2.33

307.65

4.1

3.0

10.88

7.02

mmol/l

0.49

3211

16898

Senile cataract

12323

53596

1.68

307.65

3.8

3.1

6.99

7.65

mmol/l

54.43

10129

44830

Other heart diseases, wide

17568

79197

1.54

307.65

3.5

3.2

7.40

8.22

mmol/l

4.94

14928

67484

Obesity, other/unspecified

7197

35049

2.87

307.65

3.5

3.1

8.02

7.69

mmol/l

6.60

6155

29905

Parasetamol

17208

55581

1.82

307.65

3.5

3.0

7.90

8.58

mmol/l

1.96

14731

47362

Hypothyroidism (congenital or acquired)

5457

7780

5.29

307.65

3.8

1.9

8.13

8.92

mmol/l

16.25

4750

6829

Dorsalgia

19250

78495

1.46

307.65

3.4

3.2

7.79

8.06

mmol/l

0.76

16269

66447

Renal failure

11005

47560

3.40

307.65

6.3

2.9

6.18

7.68

mmol/l

321.64

9893

38871

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

5243

26472

2.51

307.65

4.3

3.1

7.27

8.18

mmol/l

28.37

4477

22963

Other heart diseases

9383

31301

2.43

307.65

3.7

2.8

7.47

8.52

mmol/l

73.14

8086

26731

Dialysis

1089

3634

8.50

307.65

12.7

3.2

5.25

8.22

mmol/l

148.77

1078

3047

Codeine

20666

73671

1.80

307.65

3.5

3.1

7.63

8.10

mmol/l

1.69

17487

62495

Angina pectoris

11888

55156

1.75

307.65

3.4

3.1

7.24

7.58

mmol/l

14.29

9953

45605

Anaemias

4895

7051

6.48

307.65

4.9

1.9

7.16

8.85

mmol/l

57.42

4317

6186

Anxiety (asthma-related co-morbidities)

11327

54616

1.93

307.65

3.6

3.1

7.95

8.08

mmol/l

1.36

9683

47096

Obesity related asthma

6847

39557

2.30

307.65

3.4

3.2

7.76

7.70

mmol/l

0.46

5806

33257

Other blood glucose lowering drugs, excl. Insulins

4850

12220

10.25

307.65

4.7

2.3

6.76

7.53

mmol/l

29.65

4095

10274

Other soft tissue disorders, not elsewhere classified

17917

77873

1.61

307.65

3.5

3.2

7.55

8.05

mmol/l

2.06

15030

65863

STROKE

10575

47590

1.82

307.65

3.4

2.8

7.24

7.89

mmol/l

39.51

8870

39699

Renal tubulo-interstitial diseases

19113

87504

2.10

307.65

5.0

2.9

6.62

7.78

mmol/l

261.24

16569

73068

Dyspnoea

16957

92970

1.59

307.65

3.4

3.2

7.27

7.84

mmol/l

3.29

14206

78193

Recurrent or chronic depression

7981

34285

2.00

307.65

3.3

3.1

8.08

8.00

mmol/l

0.66

6779

29670

Substance use, excluding alcohol

4080

20412

2.78

307.65

6.9

3.1

7.26

8.42

mmol/l

33.87

3433

17545

Pain in limb

14907

74988

1.64

307.65

3.6

3.2

7.39

8.00

mmol/l

2.57

12469

63331

Sleep disorders (combined)

22993

87711

2.18

307.65

3.5

3.2

8.18

7.79

mmol/l

1.65

19010

74549

Spondylopathies

15520

68028

1.57

307.65

3.2

7.48

7.69

mmol/l

6.58

13006

57117

Abnormalities of breathing

18732

73666

1.74

307.65

3.4

3.2

7.71

8.16

mmol/l

1.56

15785

62739

Diseases of the eye and adnexa

16176

58632

1.52

307.65

3.7

3.0

7.91

8.58

mmol/l

2.10

13917

50269

Shoulder lesions

15106

67313

1.56

307.65

3.4

3.1

7.71

mmol/l

0.02

12954

56489

Pain in throat and chest

17104

70928

1.69

307.65

3.3

3.2

7.65

8.15

mmol/l

1.76

14352

60315

Unspecified mental disorder

8044

48317

2.06

307.65

3.9

3.2

7.28

8.06

mmol/l

27.18

6827

41222

Mental and behavioural disorders due to psychoactive substance use

11443

74178

1.70

307.65

4.5

3.2

8.74

8.29

mmol/l

0.14

9650

62955

Obesity due to excess calories

11084

52146

3.15

307.65

3.8

3.2

7.95

7.74

mmol/l

4.59

9288

44391

Coronary atherosclerosis

13960

60081

1.83

307.65

3.6

3.1

7.18

7.64

mmol/l

28.67

11760

49916

Specific personality disorders

4736

23851

2.66

307.65

4.4

3.2

7.45

8.20

mmol/l

16.92

4091

20603

Symptoms and signs involving the circulatory and respiratory systems

20032

74040

1.49

307.65

3.4

3.2

7.81

8.18

mmol/l

1.18

17002

63078

Autoimmune diseases excluding thyroid diseases, strict definition

22372

78695

1.87

307.65

4.3

2.9

8.38

8.00

mmol/l

0.26

19521

66210

Anxiety disorders, excluding more controls

15741

73793

1.60

307.65

3.5

3.1

7.82

mmol/l

0.04

13347

62863

Hyperlipidaemia, other/unspecified

7862

45183

2.14

307.65

3.9

3.0

7.24

7.59

mmol/l

10.94

6451

37188

Diseases of arteries, arterioles and capillaries (FINNGEN)

5081

15939

3.04

307.65

4.1

2.7

6.77

8.33

mmol/l

107.38

4332

13272

Cerebrovascular diseases (FINNGEN)

5954

21379

2.50

307.65

3.5

2.7

7.35

8.29

mmol/l

40.68

5040

17956

Ischaemic heart disease, wide definition

15924

66686

1.81

307.65

3.5

3.1

7.23

7.65

mmol/l

27.67

13422

55676

Biguanides

40273

54630

13.20

307.65

3.8

2.5

7.45

7.86

mmol/l

41.34

33458

46688

Any reimbursement code in KELA

13634

24204

3.66

307.65

3.8

2.0

8.14

8.74

mmol/l

22.88

11904

20651

Other disorders of glucose regulation and pancreatic internal secretion

1844

7912

3.83

307.65

5.2

3.3

7.05

7.79

mmol/l

9.36

1613

6705

Disorders of adult personality and behaviour

5806

29764

2.59

307.65

4.3

3.2

7.54

8.25

mmol/l

18.17

4997

25708

Kela-code for severe mental illness

7293

43256

2.10

307.65

3.9

3.2

7.21

8.06

mmol/l

28.33

6168

36841

Pregnancy hypertension

6776

36951

1.96

307.65

3.6

3.0

9.29

7.06

mmol/l

0.55

5993

31480

Continuous positive airway pressure

4113

10028

5.41

307.65

4.0

2.2

8.13

8.31

mmol/l

1.26

3105

8522

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

3530

14886

2.78

307.65

4.3

3.4

8.57

8.88

mmol/l

1.96

3107

13220

Psychiatric diseases

21924

81411

1.50

307.65

3.4

3.2

7.64

7.82

mmol/l

4.89

18447

69084

Complications of surgical and medical care, not elsewhere classified

18078

97816

1.47

307.65

3.6

3.2

7.20

7.91

mmol/l

5.37

15337

82298

Neurological diseases

17819

62212

1.62

307.65

3.4

3.2

8.01

8.08

mmol/l

0.11

15151

53053

Gout, FINNGEN

5798

34802

2.22

307.65

4.5

3.1

7.11

7.81

mmol/l

35.28

4930

28588

Heart failure and antihypertensive medication

5385

9480

5.71

307.65

4.1

2.5

6.73

8.15

mmol/l

77.70

4567

7862

Obesity and other hyperalimentation

14855

72726

2.87

307.65

3.7

3.2

7.94

7.91

mmol/l

0.04

12544

61840

Glucagon-like peptide-1 (GLP-1) analogues

20965

38312

17.19

307.65

4.4

2.4

6.92

7.68

mmol/l

99.73

17294

32310

Disorders of choroid and retina

17216

79767

1.94

307.65

4.3

3.1

6.99

7.65

mmol/l

75.75

14331

66694

Disorders of lens

13708

58919

1.74

307.65

3.9

3.1

7.00

7.75

mmol/l

75.08

11421

49517

Implicit Sepsis

13907

77711

1.60

307.65

4.1

3.1

6.91

7.73

mmol/l

88.17

11772

64901

Opioids

20422

74755

1.62

307.65

3.6

3.1

7.69

8.13

mmol/l

1.53

17304

63452

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

7487

28271

1.93

307.65

3.6

2.7

7.42

8.35

mmol/l

52.34

6413

24006

Schizophrenia, schizotypal and delusional disorders

6097

36340

2.08

307.65

4.1

3.2

7.21

8.14

mmol/l

27.24

5194

31087

Suicide or other Intentional self-harm

4567

26233

2.20

307.65

4.5

3.2

7.19

8.14

mmol/l

26.82

3870

22554

Parodontitis and operation codes

16288

92125

1.57

307.65

3.7

3.2

7.48

7.71

mmol/l

8.07

13553

77779

Sleep apnoea, including avohilmo

22202

85013

2.15

307.65

3.4

3.2

8.23

7.59

mmol/l

68.09

18277

72224

Type 1 diabetes, wide definition

9119

15077

26.73

307.65

5.9

2.5

9.19

8.48

mmol/l

0.20

8244

13015

Neurotic, stress-related and somatoform disorders

16492

85614

1.53

307.65

3.5

3.2

7.86

8.00

mmol/l

0.37

14008

72979

Type 2 diabetes, wide definition

30601

43739

12.30

307.65

4.3

2.3

7.08

7.90

mmol/l

133.50

25662

37151

Sulfonylureas

9364

23443

5.68

307.65

4.7

2.3

6.39

7.51

mmol/l

128.96

7564

19565

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

7527

41174

1.88

307.65

3.6

3.0

9.05

6.97

mmol/l

0.57

6668

34868

Mood [affective] disorders

21204

94284

1.72

307.65

3.5

3.2

7.75

7.98

mmol/l

0.78

17914

79944

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

5243

30340

2.12

307.65

4.3

3.1

7.27

8.13

mmol/l

25.71

4477

26175

Pure hypercholesterolaemia

17614

64888

2.47

307.65

3.8

3.0

8.14

7.71

mmol/l

0.22

15093

53956

Antihypertensive medication - note that there are other indications

14273

26894

3.85

307.65

4.1

2.6

8.14

9.16

mmol/l

1.23

12518

23160

Type 1 diabetes, wide definition, subgroup 1

8912

14047

35.59

307.65

5.9

2.5

9.23

8.54

mmol/l

0.19

8053

12140

Poisoning by drugs, medicaments and biological substances

4660

24668

2.47

307.65

4.8

3.1

7.22

8.18

mmol/l

26.83

3982

21246

Other (not insulin) diabetes medications

40563

50524

13.62

307.65

3.8

2.2

7.44

7.95

mmol/l

58.42

33811

42968

Poisoning by medicine

4195

22004

2.51

307.65

4.8

3.2

7.21

8.19

mmol/l

25.17

3587

18982

Type 2 diabetes, definitions combined, including avohilmo

38324

46220

12.52

307.65

3.6

2.2

7.54

7.97

mmol/l

37.39

31903

39463

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

1617

5913

4.70

307.65

10.1

3.1

7.11

8.98

mmol/l

32.79

1408

5159

Depression

19473

90240

1.73

307.65

3.6

3.2

7.82

8.01

mmol/l

0.57

16491

76667

Type1 diabetes, definitions combined, early onset

2751

5150

37.27

307.65

5.6

3.7

13.87

8.98

mmol/l

0.49

2535

4570

Hypertension

21258

48001

3.64

307.65

3.9

2.8

7.65

8.16

mmol/l

38.86

18546

40446

Diabetes mellitus

44665

52396

14.25

307.65

4.1

2.3

7.89

8.06

mmol/l

0.21

37872

44768

Sub-endpoint used in defining T1D endpoints

10500

31399

7.91

307.65

5.8

3.1

8.85

8.05

mmol/l

0.26

9423

26385

Gout, strict definition

3614

19954

2.70

307.65

4.7

3.2

7.04

7.85

mmol/l

31.31

3087

16432

Disorders of thyroid, IBD co-morbidities

3040

7740

3.57

307.65

3.5

1.8

7.38

8.16

mmol/l

12.01

2557

6691

Endocrine, nutritional and metabolic diseases

23348

34773

4.99

307.65

3.8

2.3

8.12

8.46

mmol/l

13.09

20165

29912

Substance abuse

11114

72865

1.70

307.65

4.5

3.2

8.76

8.31

mmol/l

0.13

9387

61837

Kidney transplant status

1647

4752

17.87

307.65

13.3

3.2

5.32

8.28

mmol/l

198.12

1634

4043

Transplanted organ and tissue status

2480

9663

5.38

307.65

10.1

3.1

5.75

8.19

mmol/l

189.40

2410

8237

Diabetes medication

45685

55108

14.97

307.65

4.1

2.3

7.84

8.03

mmol/l

0.26

38616

47043

Condition for Implicit Sepsis (Organ dysfunction codes)

16421

85613

1.59

307.65

4.0

3.1

7.11

7.82

mmol/l

73.53

13918

71920

Dipeptidyl peptidase 4 (DPP-4) inhibitors

3497

8279

14.60

307.65

4.6

2.3

6.87

7.78

mmol/l

29.66

2936

6973

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

44211

49607

18.79

307.65

4.2

2.3

7.81

8.04

mmol/l

0.31

37437

42323

Mood disorders, excluding more controls

19966

80820

1.75

307.65

3.5

3.1

7.73

7.82

mmol/l

1.50

16822

68586

Diabetes, varying definitions

44336

52537

14.04

307.65

4.0

2.3

7.89

8.06

mmol/l

0.21

37569

44899

Type 1 diabetes, definitions combined

4106

6103

37.68

307.65

5.5

3.0

12.03

8.92

mmol/l

0.46

3765

5362

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3192

16073

2.67

307.65

4.9

3.2

7.19

8.26

mmol/l

21.91

2724

13962

Combinations of oral blood glucose lowering drugs

9964

22251

19.04

307.65

4.3

2.4

7.18

8.05

mmol/l

67.30

8442

18841

General symptoms and signs

21690

83159

1.43

307.65

3.6

3.1

7.61

8.15

mmol/l

2.48

18549

70355

Dialysis, with operation codes

3255

13261

4.99

307.65

9.6

3.0

5.57

8.13

mmol/l

297.30

3103

11073

Vocal cord dysfunction

1958

6989

3.21

307.65

3.2

2.0

7.47

8.23

mmol/l

9.23

1626

5952

Soft tissue disorders

20014

79182

1.43

307.65

3.5

3.2

7.83

8.09

mmol/l

0.78

16995

67011

Depression medications

6481

8451

4.97

307.65

3.5

1.8

8.41

9.11

mmol/l

11.10

5594

7437

Other and unspecified nonorganic psychotic disorders

3764

19467

2.55

307.65

4.5

3.2

7.45

8.45

mmol/l

16.65

3257

16846

Type 1 diabetes

10155

17519

21.94

307.65

5.8

2.5

8.97

8.49

mmol/l

0.14

9144

15096

Depression or dysthymia

14156

56607

1.57

307.65

3.3

3.2

7.92

7.87

mmol/l

0.51

11804

48150

Diseases of oesophagus, stomach and duodenum

20167

92769

1.46

307.65

3.5

3.2

7.41

7.98

mmol/l

3.40

16844

78547

Hypothyroidism and >3 levothyroxin purchases

5398

7746

5.25

307.65

3.7

1.9

8.12

8.91

mmol/l

16.39

4699

6796

Disorders of gallbladder, biliary tract and pancreas

18995

88942

1.56

307.65

3.5

3.1

7.35

7.68

mmol/l

18.74

15881

74891

Metabolic disorders

22908

77762

2.39

307.65

3.9

3.0

7.91

7.88

mmol/l

0.02

19681

65302

Other retinal disorders

14013

66272

2.23

307.65

4.5

3.1

6.87

7.53

mmol/l

66.11

11637

55103

Episodal and paroxysmal disorders

22922

81505

1.63

307.65

3.3

3.2

7.99

7.88

mmol/l

0.24

19286

69318

Type 2 diabetes

41481

49237

13.70

307.65

3.9

2.2

7.43

8.01

mmol/l

71.64

34867

41947

Mental and behavioural disorders due to opioids

932

2870

6.70

307.58

15.7

3.0

7.06

8.97

mmol/l

19.64

808

2487

Cholelithiasis

15262

80375

1.48

306.65

3.3

3.1

7.35

7.49

mmol/l

3.52

12637

67349

Alcohol use disorder, Swedish definition

10278

67878

1.62

306.23

4.1

3.2

7.35

8.33

mmol/l

75.51

8736

57446

Dental caries, including avohilmo

15118

57308

1.49

305.16

3.4

3.1

7.56

7.67

mmol/l

2.23

12762

47956

Dental caries 1

15129

57366

1.49

304.50

3.4

3.1

7.55

7.67

mmol/l

2.26

12772

48006

Infections of the skin and subcutaneous tissue

10218

72367

1.61

302.50

4.3

3.2

7.60

8.10

mmol/l

21.00

8737

61559

Unspecified kidney failure

2000

9275

3.38

302.04

6.0

2.9

6.00

7.54

mmol/l

68.07

1801

7552

Symptoms and signs involving cognition, perception, emotional state and behaviour

17725

95488

1.43

300.43

3.4

3.2

7.42

7.91

mmol/l

2.67

14907

80547

Other dorsopathies, not elsewhere classified

19367

78846

1.41

296.46

3.3

3.2

7.84

8.07

mmol/l

0.64

16471

66764

Lower back pain or/and sciatica

18868

101576

1.41

295.92

3.3

3.2

7.65

7.90

mmol/l

1.05

15973

85758

Dental caries 3, only avohilmo

16166

62266

1.46

294.85

3.3

3.1

7.65

7.67

mmol/l

0.24

13612

52350

10719

70953

1.59

293.91

4.1

3.2

8.77

8.31

mmol/l

0.13

9082

60092

Dental pulpitis 2, only avohilmo

13865

52203

1.51

293.07

3.3

3.1

7.52

7.66

mmol/l

2.62

11652

43656

Hypothyroidism, other/unspecified

16262

81642

1.45

292.93

3.5

3.2

7.31

7.80

mmol/l

2.08

13663

68741

Oral corticosteroids

19863

93755

1.40

291.21

3.6

3.2

7.39

8.01

mmol/l

3.87

16904

78940

Diseases of the skin and subcutaneous tissue

20008

77834

1.40

291.03

3.6

3.1

7.60

8.17

mmol/l

2.53

17026

65723

Hypothyreosis and Thyroxine purchase for inclusion criteria

16715

84328

1.44

290.50

3.5

3.2

7.29

7.77

mmol/l

2.10

14031

71000

Dental caries

4734

28607

2.01

289.90

5.5

3.1

7.13

8.16

mmol/l

41.55

4157

24370

Dental pulpitis 2

13595

51138

1.51

289.48

3.3

3.1

7.51

7.66

mmol/l

3.13

11427

42776

Dental operations

12743

47620

1.53

287.73

3.3

3.1

7.50

7.79

mmol/l

9.46

10741

39569

Spinal stenosis

9633

53683

1.64

287.73

3.3

3.2

7.13

7.41

mmol/l

8.43

8021

44390

Dental caries 1, only avohilmo

15346

58876

1.47

287.63

3.3

3.1

7.59

7.65

mmol/l

0.77

12939

49360

Asthma

15443

62299

1.47

287.38

3.3

3.1

7.51

8.16

mmol/l

2.22

13320

52895

Other reaction to severe stress, and adjustment disorders

6052

38894

1.80

286.68

3.7

3.2

7.79

8.30

mmol/l

0.74

5180

33548

Genitourinary diseases

12222

44197

1.53

286.02

4.1

2.9

8.20

8.98

mmol/l

1.69

10587

37745

Diseases of oral cavity, salivary glands and jaws

17626

69210

1.43

285.90

3.5

3.1

7.61

8.04

mmol/l

1.33

14796

58455

Low back pain

13275

75987

1.49

284.49

3.4

3.2

7.66

8.01

mmol/l

1.09

11157

64272

Other cataract

7991

42555

1.71

282.54

4.0

3.1

6.73

7.53

mmol/l

58.48

6673

35499

Gonarthrosis

12508

52631

1.53

282.08

3.1

7.64

7.75

mmol/l

1.78

10471

44173

Acute tubulo-interstitial nephritis

10706

68660

1.56

281.75

4.1

2.9

6.68

7.57

mmol/l

84.80

9016

56964

Presence of cardiac and vascular implants and grafts

8458

44668

1.70

281.58

3.5

3.1

7.03

7.74

mmol/l

47.80

7107

37015

Gonarthrosis,primary

16541

80065

1.45

281.53

3.1

3.2

7.43

7.53

mmol/l

2.29

13788

66954

Asthma, unspecified (mode)

10015

56627

1.59

280.70

3.3

3.1

7.20

8.02

mmol/l

2.71

8484

47823

Symptoms and signs involving the urinary system

13981

81551

1.49

280.49

3.7

3.2

7.32

7.66

mmol/l

14.90

11450

68503

Other diseases of intestines

19725

89595

1.39

280.47

3.4

3.2

7.67

8.08

mmol/l

1.83

16655

76191

Dental operations, only avohilmo

13440

50876

1.50

278.11

3.3

3.1

7.53

7.75

mmol/l

6.09

11326

42367

Emergency coronary revascularization (for ACS)

10134

52589

1.62

277.80

3.5

3.2

7.25

7.64

mmol/l

17.79

8498

43276

Asthma (mode)

15133

62788

1.46

274.46

3.3

3.1

7.51

8.16

mmol/l

2.21

13072

53307

Any gastric operation

15876

60225

1.44

272.76

3.6

3.0

7.79

8.27

mmol/l

1.31

13500

51705

GASTRO-related operations

15876

60225

1.44

272.76

3.6

3.0

7.79

8.27

mmol/l

1.31

13500

51705

Certain infectious and parasitic diseases

19441

75922

1.39

271.57

3.8

2.9

7.50

8.13

mmol/l

2.86

16548

64201

Mental and behavioural disorders due to use of other stimulants, including caffeine

715

2025

7.66

266.59

14.2

3.1

7.23

9.49

mmol/l

19.53

627

1777

Intracranial trauma

10066

53722

1.55

265.93

3.5

3.1

7.66

8.15

mmol/l

1.13

8509

45893

Inflammatory bowel disease treatment related agents

21376

96500

1.36

265.07

3.7

3.2

7.47

8.05

mmol/l

3.62

18323

81413

Dentinal caries

4177

25164

2.05

265.03

5.4

3.1

7.15

8.15

mmol/l

34.45

3651

21435

Disorders of the thyroid gland

17259

87686

1.41

263.85

3.5

3.2

7.38

7.88

mmol/l

2.42

14559

73844

Elevated blood glucose level

1741

8118

3.44

263.18

4.4

3.3

7.38

7.71

mmol/l

2.19

1492

6837

IgA nephropathy (IgA glomerulonephritis)

708

2176

13.55

261.15

10.2

3.3

6.99

8.42

mmol/l

15.92

686

1824

Presence of other functional implants

10394

53864

1.57

255.83

3.8

3.0

6.74

7.38

mmol/l

44.79

8106

44597

Influenza and pneumonia

19159

99606

1.37

255.67

3.8

3.2

7.39

8.04

mmol/l

4.63

16333

84337

Disorders resulting from impaired renal tubular function

920

3350

7.69

254.04

10.3

3.2

5.32

7.79

mmol/l

91.06

890

2812

Care involving use of rehabilitation procedures

11491

81430

1.50

252.30

3.7

3.1

7.34

7.74

mmol/l

17.56

10074

68293

Nonalcoholic fatty liver disease

1869

9101

3.16

251.80

3.7

3.2

7.80

7.82

mmol/l

0.05

1607

7749

Phobic anxiety disorders

2234

11166

2.53

250.32

3.9

3.2

8.31

8.49

mmol/l

0.64

1925

9804

L04AA Selective immunosuppressants

3896

23746

2.08

247.87

7.7

3.1

6.41

7.74

mmol/l

75.93

3617

20088

Asthma, including avohilmo

21601

100776

1.34

246.00

3.2

3.3

7.53

8.00

mmol/l

2.80

18447

85084

Mental and behavioural disorders due to alcohol

9242

65300

1.57

244.45

4.2

3.2

9.01

8.37

mmol/l

0.16

7819

55378

Complications of procedures, not elsewhere classified

14184

94448

1.43

244.39

3.5

3.2

7.26

7.86

mmol/l

3.62

12080

79301

Other disorders of skin and subcutaneous tissue

11956

82791

1.48

242.99

4.0

3.1

6.76

7.50

mmol/l

68.60

10200

68977

Artrosis, including avohilmo

15572

65941

1.42

241.84

3.2

7.87

7.86

mmol/l

0.07

13129

55721

Other disorders involving the immune mechanism, not elsewhere classified

813

2802

7.67

240.97

9.5

3.4

6.98

8.27

mmol/l

15.17

784

2366

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

774

2600

8.44

240.93

9.7

3.4

6.99

8.37

mmol/l

16.35

748

2198

Other dialysis

808

2838

8.89

239.74

13.0

3.3

5.21

8.09

mmol/l

113.07

800

2393

Diverticular disease of intestine

13201

66969

1.46

238.68

3.3

3.1

7.34

7.56

mmol/l

6.96

11045

56010

Pre-eclampsia or poor fetal growth

4469

27803

1.86

238.07

4.1

3.0

10.34

7.26

mmol/l

0.47

3901

23867

Mental and behavioural disorders due to cannabinoids

725

2222

6.32

237.58

9.7

3.0

7.54

9.62

mmol/l

14.64

634

1941

Factors influencing health status and contact with health services

6552

21698

1.70

237.01

3.4

2.7

8.05

8.52

mmol/l

10.38

5566

18460

Hypertensive Renal Disease

767

2437

5.70

234.91

6.6

2.6

5.92

7.75

mmol/l

34.81

708

1983

Other disorders of fluid, electrolyte and acid-base balance

5097

32178

1.83

233.96

4.1

3.0

5.96

7.35

mmol/l

109.39

4253

26449

16490

81054

1.39

232.82

3.8

3.1

7.30

7.96

mmol/l

3.36

14026

68553

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

16490

81054

1.39

232.82

3.8

3.1

7.30

7.96

mmol/l

3.36

14026

68553

Diarrhoea and gastroenteritis of presumed infectious origin

12146

83660

1.45

232.11

4.1

3.1

7.60

8.05

mmol/l

1.83

10512

70801

Other and unspecified mood [affective] disorders

1317

5529

3.34

230.79

4.1

3.2

7.51

8.27

mmol/l

4.54

1147

4850

Rotator cuff syndrome

11294

63092

1.49

230.50

3.3

3.1

7.71

7.65

mmol/l

0.86

9737

52824

Coronary angioplasty

6982

37641

1.70

228.37

3.4

3.2

7.32

7.71

mmol/l

12.49

5920

30956

Disorder of lipoprotein metabolism, unspecified

2610

14684

2.45

228.21

4.1

3.0

7.17

7.59

mmol/l

5.90

2181

12041

Concussion

8460

52342

1.55

227.63

3.5

3.1

7.70

7.88

mmol/l

2.54

7155

44685

First line medication for Crohn's disease

20734

91015

1.34

227.57

4.0

3.1

7.47

8.12

mmol/l

4.01

17791

76834

Asthma (only as main-diagnosis), excluding more controls

12996

58850

1.44

227.45

3.3

3.1

7.49

8.24

mmol/l

2.53

11155

50080

Heart failure, strict

10409

56132

1.53

226.91

3.8

3.2

6.62

7.50

mmol/l

94.36

8643

46257

Other disorders of urethra and urinary system

12025

68218

1.46

226.78

3.7

3.1

6.79

7.70

mmol/l

4.39

10082

57298

Paroxysmal tachycardia

3469

17163

2.00

226.64

3.2

2.8

7.56

8.22

mmol/l

12.66

2913

14404

Generalized anxiety disorder

2466

13207

2.30

226.31

3.4

3.2

7.99

8.13

mmol/l

0.40

2139

11493

Behavioural syndromes associated with physiological disturbances and physical factors

5132

33599

1.77

226.04

3.6

3.2

7.71

8.02

mmol/l

3.06

4404

28930

Other specific joint derangements/joint disorders

12877

65774

1.44

225.77

3.4

3.2

7.79

8.26

mmol/l

1.39

10923

56041

Hypoglycaemia, other or unspecified

1382

6180

3.50

225.09

5.1

3.3

7.13

7.85

mmol/l

6.57

1211

5215

Myocardial infarction

9156

48298

1.57

224.34

3.5

3.2

7.17

7.72

mmol/l

29.49

7588

39898

Major coronary heart disease event excluding revascularizations

11832

62325

1.49

223.96

3.4

3.2

7.22

7.61

mmol/l

18.52

9840

51675

Gestational [pregnancy-induced] hypertension

3672

22093

1.94

222.12

3.2

3.0

11.20

7.24

mmol/l

0.53

3293

18859

All pneumoniae

18047

99554

1.36

222.02

3.8

3.2

7.33

8.02

mmol/l

5.18

15357

84238

Bleeding

14807

84451

1.41

221.71

3.8

3.2

7.02

7.72

mmol/l

67.78

12372

70750

Cholecystectomy

12076

81697

1.45

221.23

3.3

3.1

7.47

7.31

mmol/l

3.50

10058

68288

Mental and behavioural disorders due to alcohol, excluding acute intoxication

8029

58000

1.59

220.82

4.2

3.3

7.33

8.40

mmol/l

68.43

6798

49116

All-cause Heart Failure

10227

55295

1.53

220.74

3.8

3.2

6.62

7.50

mmol/l

91.89

8480

45542

Arthrosis

13385

56361

1.43

220.64

3.2

3.1

7.73

7.84

mmol/l

1.94

11288

47505

Asthma (diagnoses ohter than nonallergic)

15151

101828

1.39

220.63

3.3

3.2

7.34

7.88

mmol/l

3.45

12993

85749

Oedema, not elsewhere classified

5547

37331

1.75

220.12

4.0

3.1

6.96

7.44

mmol/l

13.32

4597

30998

Cutaneous abscess, furuncle and carbuncle

4395

28227

1.88

219.78

4.6

3.2

7.42

8.10

mmol/l

17.81

3812

24037

Panic disorder

2417

12990

2.29

219.75

4.0

3.2

7.92

8.17

mmol/l

1.25

2089

11292

Chronic nephritic syndrome

956

3749

5.31

219.61

10.3

3.0

6.38

8.02

mmol/l

32.71

915

3138

Ulcer of lower limb, not elsewhere classified

2593

14788

2.43

219.04

4.9

3.1

5.88

7.54

mmol/l

102.46

2199

12196

Diseases of liver

5913

40688

1.73

218.83

3.9

3.2

7.26

7.72

mmol/l

12.38

4993

34173

Nephrotic syndrome

789

2818

6.65

217.18

14.1

3.1

6.61

8.02

mmol/l

19.36

766

2381

Persons encountering health services in other circumstances

6449

44695

1.65

217.00

3.9

3.1

7.47

7.84

mmol/l

6.95

5348

37608

Alcohol use disorder, ICD-based

7421

53142

1.61

216.58

4.2

3.3

7.31

8.39

mmol/l

63.75

6274

45004

Chronic viral hepatitis

1094

4451

3.93

215.84

11.6

3.2

7.01

8.77

mmol/l

23.70

966

3877

Mixed and other personality disorders

1527

7151

3.04

215.15

4.3

3.2

7.55

8.31

mmol/l

6.18

1293

6187

Pneumonias (Asthma/COPD co-morbidities)

17889

99340

1.35

214.80

3.8

3.2

7.32

8.02

mmol/l

5.27

15233

84022

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

7535

26155

1.59

214.70

3.4

2.9

8.06

8.92

mmol/l

0.90

6456

22422

Chronic lower respiratory diseases

22134

97715

1.31

213.81

3.3

7.55

8.03

mmol/l

2.77

18895

82568

Complications of medical and surgical care

12542

92167

1.43

213.38

3.5

3.2

7.19

7.57

mmol/l

17.52

10585

77238

Fall on same level

21247

96583

1.32

212.28

3.4

3.2

8.29

7.92

mmol/l

0.22

17653

82407

Disorders of other endocrine glands

7198

50396

1.60

211.47

4.1

3.2

7.26

7.48

mmol/l

3.53

6206

42432

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

1256

5350

3.20

211.04

3.8

3.0

7.74

7.51

mmol/l

0.94

1134

4652

Non-selective monoamine reuptake inhibitors

6843

46949

1.63

210.84

3.4

3.1

7.00

7.26

mmol/l

4.80

5647

39409

Other diseases of liver

3160

19088

2.13

210.26

3.8

3.2

7.48

7.63

mmol/l

1.04

2697

16101

Other CVD (FINNGEN)

1860

7235

2.62

209.79

3.8

2.7

6.71

7.95

mmol/l

27.84

1510

5879

KRA_PSY_EATING, excluding more controls

1225

5035

3.03

209.50

3.7

3.0

7.45

8.25

mmol/l

4.60

1031

4494

Pain in joint

10799

53725

1.47

209.19

3.4

3.2

7.72

8.22

mmol/l

1.15

9187

45584

Schizophrenia

2929

17235

2.15

208.51

4.5

3.2

7.01

8.38

mmol/l

23.96

2509

14829

Dorsopathies

19299

79237

1.33

207.94

3.3

3.2

7.82

8.07

mmol/l

0.73

16382

67133

Sciatica+with lumbago

8791

61553

1.52

207.69

3.3

3.2

7.60

7.63

mmol/l

0.24

7591

51833

Problems related to lifestyle

1921

9923

2.59

206.60

6.3

3.1

7.39

8.45

mmol/l

14.21

1645

8489

Abdominal and pelvic pain

19535

79226

1.33

206.39

3.4

3.2

7.89

8.11

mmol/l

0.60

16538

67081

Lumbar disc prolapse

11335

68868

1.45

204.61

3.3

3.2

7.84

7.98

mmol/l

0.29

9757

58072

Diseases of arteries, arterioles and capillaries

11742

67709

1.45

201.79

3.9

3.2

6.74

7.62

mmol/l

101.06

9863

56172

Pain (limb, back, neck, head abdominally)

14498

56621

1.39

201.27

3.4

3.2

7.92

8.21

mmol/l

0.57

12307

47951

ILD medications: immunosuppressive drugs

10796

79043

1.45

201.18

5.2

3.0

7.16

8.09

mmol/l

5.90

9577

66716

Cystic kidney disease

794

2980

6.03

200.24

8.3

3.3

5.84

7.88

mmol/l

42.86

761

2516

Vitreous haemorrhage

1925

10337

2.69

197.80

5.9

3.2

6.36

7.61

mmol/l

39.63

1699

8631

Mental and behavioural disorders due to sedatives or hypnotics

1330

6146

3.22

197.69

9.8

3.1

6.91

8.27

mmol/l

17.53

1127

5261

Other viral hepatitis

1222

5432

3.36

197.19

11.1

3.2

7.13

8.61

mmol/l

19.74

1079

4710

Diseases of pulp and periapical tissues

6033

42198

1.65

197.03

4.5

3.1

7.45

7.98

mmol/l

15.12

5107

35758

Isolated proteinuria

725

2619

6.66

196.82

8.5

3.2

7.21

8.12

mmol/l

6.87

682

2214

Bacterial Sepsis

7769

50671

1.56

195.29

4.4

3.1

6.58

7.64

mmol/l

93.62

6623

41871

Peripheral artery disease

7771

45922

1.58

195.13

4.2

3.1

6.40

7.53

mmol/l

129.09

6491

37663

Asthma (only as main-diagnosis)

13259

62299

1.40

194.86

3.2

3.1

7.46

8.16

mmol/l

2.47

11374

52895

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

17408

98901

1.34

194.17

3.8

3.2

7.30

8.01

mmol/l

5.33

14812

83619

Explicit Sepsis

7276

50627

1.57

193.88

4.6

3.1

6.53

7.64

mmol/l

92.88

6192

41980

Septicaemia

6997

48585

1.59

193.56

4.7

3.1

6.46

7.62

mmol/l

100.55

5949

40208

Gastro-oesophageal reflux disease

11901

82004

1.42

193.25

3.4

3.2

7.39

7.69

mmol/l

9.81

9699

69100

Charcot foot

469

1298

12.12

192.55

7.1

2.8

6.04

8.51

mmol/l

32.25

415

1074

Gonarthrosis, primary, with knee surgery

9835

61292

1.49

191.77

3.2

7.05

7.22

mmol/l

3.92

8065

50568

Other and unspecified iron deficiency

5271

36231

1.70

190.25

4.0

3.1

6.80

7.29

mmol/l

9.30

4393

30105

Iron deficiency anaemia

6733

47901

1.59

189.94

3.9

3.1

6.77

7.27

mmol/l

13.23

5593

39811

Other specified and unspecified personality disorders

1661

8414

2.67

189.43

4.4

3.2

7.30

8.20

mmol/l

9.34

1427

7240

Nonorganic sleeping disorders, excluding more controls

2841

16815

2.02

188.23

3.3

3.1

7.78

8.02

mmol/l

1.18

2445

14458

Diseases of the musculoskeletal system and connective tissue

10345

38812

1.45

188.21

3.5

3.1

8.05

8.58

mmol/l

0.79

8876

33172

Symptoms and signs involving the digestive system and abdomen

19404

79237

1.31

186.34

3.4

3.2

7.83

8.11

mmol/l

0.84

16452

67092

Myocardial infarction, strict

8383

45670

1.53

185.68

3.4

3.2

7.19

7.75

mmol/l

27.88

6942

37711

Aplastic and other anaemias

7461

51970

1.55

185.63

4.4

3.1

6.36

7.39

mmol/l

94.76

6312

42857

Fever of other and unknown origin

9450

66343

1.46

184.18

4.0

3.1

7.30

7.84

mmol/l

24.64

8138

55755

Other diseases of urinary system

18394

84250

1.32

183.86

3.7

3.1

7.17

7.98

mmol/l

5.21

15392

71146

Implicit bacterial Sepsis

6768

45023

1.59

183.19

4.5

3.1

6.52

7.60

mmol/l

87.82

5789

37099

Other septicaemia

6223

43725

1.61

181.55

4.8

3.1

6.40

7.57

mmol/l

95.50

5305

36142

Benign neoplasm of colon, rectum, anus and anal canal

10600

74375

1.44

180.11

3.5

3.2

7.27

7.39

mmol/l

2.10

8905

61555

Nutritional anaemias

7905

57153

1.51

179.85

3.8

3.1

6.79

7.28

mmol/l

15.53

6565

47458

Congenital malformations of the urinary system

1160

5322

3.41

179.41

7.3

3.4

6.29

7.92

mmol/l

35.61

1089

4545

Arthropathies

16633

68031

1.33

178.71

3.4

3.2

7.95

8.27

mmol/l

0.86

14127

57938

Other disorders of kidney and ureter

2328

13671

2.31

177.82

6.6

3.2

6.32

7.57

mmol/l

46.29

2103

11417

Dizziness and giddiness

12875

82755

1.38

177.76

3.3

3.2

7.31

7.55

mmol/l

7.69

10776

69313

Primary gonarthrosis, bilateral

8753

58159

1.50

176.96

3.2

7.07

7.21

mmol/l

2.59

7240

48078

Familial hypercholesterolemia

2837

17473

2.08

176.43

3.9

3.0

7.15

7.52

mmol/l

5.21

2349

14299

Benign neoplasm of colon, rectum, anus and anal canal

9896

54365

1.46

176.20

3.5

3.2

7.27

7.57

mmol/l

9.55

8324

45681

Chronic pancreatitis

2277

13307

2.32

176.20

4.1

3.2

6.72

8.01

mmol/l

38.92

1953

11219

Other and unspecified anaemias

6815

48195

1.56

175.27

4.2

3.1

6.38

7.36

mmol/l

77.82

5737

39675

Headache

11145

72405

1.40

173.83

3.4

3.1

7.68

8.03

mmol/l

1.02

9572

61261

Gastrointestinal diseases

11375

43754

1.40

173.68

3.5

3.0

7.87

8.46

mmol/l

1.09

9773

37358

Social phobias

1372

6561

2.69

173.57

3.8

3.3

8.45

8.66

mmol/l

0.62

1171

5779

Implicit viral Sepsis

3262

20733

1.93

173.50

4.8

3.1

6.72

7.61

mmol/l

25.76

2828

17222

Viral Sepsis

3267

20781

1.93

173.19

4.8

3.1

6.72

7.61

mmol/l

26.14

2833

17263

Pneumonia, organism unspecified

15864

93091

1.33

172.66

3.9

3.2

7.27

8.01

mmol/l

5.19

13430

78590

Viral hepatitis

1355

6635

2.88

171.98

10.3

3.2

7.19

8.46

mmol/l

16.83

1193

5736

Other anaemias

6863

48617

1.55

171.65

4.2

3.1

6.39

7.36

mmol/l

76.82

5775

40021

Post-traumatic stress disorder

1266

5887

2.74

169.86

3.5

3.2

8.20

8.16

mmol/l

0.10

1113

5190

Emotional disorders starting during childhood or adolecense, excluding more controls

725

2504

3.75

169.12

4.2

3.4

8.56

9.04

mmol/l

1.18

638

2286

Persistent mood disorders

3237

20504

1.89

169.11

3.5

3.1

7.37

7.58

mmol/l

1.54

2695

17333

Spondylosis

9265

60939

1.45

168.45

3.1

3.2

7.44

7.55

mmol/l

1.67

7718

50875

Exposure to unspecified factor

16734

106257

1.31

168.02

3.5

3.2

7.68

7.94

mmol/l

1.18

13919

90152

Other joint disorders

15816

67878

1.32

167.56

3.3

3.2

8.03

8.27

mmol/l

0.56

13328

57793

Maternal care for other conditions predominantly related to pregnancy

2679

15715

1.93

166.46

3.6

2.9

7.27

7.47

mmol/l

1.50

2358

13608

Hernia of abdominal wall, postoperative

3258

20941

1.91

166.07

3.8

3.0

7.55

7.82

mmol/l

2.60

2741

17724

Parodontitis or/and operation codes

11302

52714

1.41

165.14

3.7

3.3

7.48

7.72

mmol/l

6.05

9467

45168

Schizoaffective disorder

1395

7002

2.75

164.86

3.9

3.2

7.02

8.08

mmol/l

5.25

1204

6001

Intestinal infectious diseases

16109

102325

1.31

164.85

4.0

3.1

7.63

7.94

mmol/l

1.39

13817

86381

Other maternal disorders predominantly related to pregnancy

8337

39099

1.47

164.59

3.4

3.0

7.29

6.99

mmol/l

6.96

7301

33169

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

4059

26702

1.70

162.07

4.1

3.2

7.81

8.03

mmol/l

1.68

3507

23184

Other diseases of hard tissues of teeth

11047

64559

1.39

161.41

3.7

3.1

7.47

8.14

mmol/l

2.37

9350

54838

Disorders of eyelid, lacrimal system and orbit

14343

91333

1.33

157.90

3.3

3.2

7.12

7.59

mmol/l

31.67

12035

76599

Artificial joint operation, meniscal resection

16066

87794

1.32

157.09

3.1

3.2

7.58

7.64

mmol/l

0.87

13374

73711

Myocardial infarction, without ST-elevation

6697

45995

1.54

155.87

3.5

3.2

7.00

7.51

mmol/l

21.14

5490

37768

Haemorrhage from respiratory passages

5871

39503

1.57

155.73

3.5

3.2

7.02

7.62

mmol/l

21.46

4847

32858

Asthma-related infections

9460

72164

1.41

155.55

3.5

3.2

7.34

7.66

mmol/l

8.59

8091

60653

Asthma, hospital admission 2, infections

9460

72164

1.41

155.55

3.5

3.2

7.34

7.66

mmol/l

8.59

8091

60653

Other headache syndromes

6596

48516

1.51

155.16

3.1

7.59

7.65

mmol/l

0.08

5593

41228

Other disorders of ear

16036

87688

1.31

155.08

3.3

3.2

7.45

7.66

mmol/l

7.09

13151

74071

Hernia of abdominal wall

7598

57642

1.49

155.06

3.6

3.2

7.67

7.80

mmol/l

1.65

6404

48283

Other arthrosis

9159

50512

1.43

154.52

3.2

3.1

7.44

7.74

mmol/l

8.33

7783

42361

Polycystic ovarian syndrome, consortium definition

10842

51051

1.38

154.27

3.3

3.0

6.89

7.13

mmol/l

0.38

8992

43337

Falls/tendency to fall

20451

85479

1.27

153.84

3.5

3.2

8.42

7.92

mmol/l

0.31

17117

73055

Acute and transient psychotic disorders

2030

11732

2.19

153.63

4.2

3.2

7.21

8.06

mmol/l

6.20

1714

10056

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

10125

79342

1.40

153.58

3.5

3.2

7.17

7.51

mmol/l

12.54

8549

66400

Certain disorders involving the immune mechanism

3230

21111

1.87

153.58

5.2

3.2

7.29

7.73

mmol/l

7.12

2863

17876

Trigger finger

2475

15157

2.04

153.28

4.3

3.1

7.23

7.43

mmol/l

1.51

2145

12769

Other arrhythmias

10817

65239

1.38

152.82

3.1

7.26

7.82

mmol/l

32.50

9033

55044

Benign neoplasms

17663

81383

1.29

152.05

3.4

3.2

7.81

8.23

mmol/l

1.64

15059

69108

Abnormal findings on examination of blood, without diagnosis

7915

56721

1.48

151.52

3.6

3.3

7.64

7.91

mmol/l

6.70

6904

47080

Alcohol abuse, main dg, excluding more controls

2478

15130

2.00

150.88

4.2

3.2

13.09

8.60

mmol/l

0.36

2138

12990

Benign neoplasm: Colon

8590

50854

1.46

150.86

3.5

3.2

7.25

7.50

mmol/l

5.83

7224

42634

Nausea and vomiting

4344

29477

1.66

150.38

4.3

3.1

6.90

7.31

mmol/l

7.03

3705

24689

Exclusions for E4_PCOS_CONSORTIUM

11418

56515

1.37

149.67

4.1

3.1

7.01

7.55

mmol/l

1.40

9505

48259

Acute pancreatitis

3316

21950

1.83

148.14

3.7

3.2

7.17

7.86

mmol/l

15.43

2756

18381

Constipation

14953

87846

1.31

147.51

3.4

3.2

6.79

7.64

mmol/l

100.51

12257

73954

Coxarthrosis

8808

46060

1.43

147.37

3.1

7.27

7.60

mmol/l

10.15

7305

38332

Arthropathies in other diseases classified elsewhere

777

3295

4.12

147.25

6.3

3.1

6.31

7.69

mmol/l

18.21

671

2781

Follow-up examination after treatment for conditions other than malignant neoplasms

7412

36214

1.46

146.49

3.4

2.8

7.21

7.76

mmol/l

20.53

6294

30410

Unspecified haematuria

7131

46206

1.49

146.05

3.7

3.2

7.51

7.83

mmol/l

8.00

5866

38468

Abnormal findings on examination of urine, without diagnosis

898

4081

3.63

145.39

7.5

3.2

7.23

7.89

mmol/l

4.81

836

3428

Injuries to the head

19006

103809

1.27

143.24

3.6

3.2

7.57

7.96

mmol/l

2.10

15860

88040

Dermatitis

10020

79382

1.38

142.06

3.7

3.2

7.26

7.58

mmol/l

10.46

8562

66664

Cystitis

14424

71967

1.31

141.73

3.5

3.1

6.94

7.75

mmol/l

3.86

12166

60517

Disorders of synovium and tendon

8818

61761

1.41

140.83

3.7

3.1

7.49

7.94

mmol/l

1.16

7593

52071

Benign neoplasm: Colon

8762

67370

1.43

140.68

3.5

3.2

7.25

7.34

mmol/l

1.18

7365

55683

6908

51593

1.46

140.26

3.5

3.2

7.50

7.80

mmol/l

5.64

5908

43681

Mouth breathing

6817

51646

1.49

139.99

3.4

3.3

8.21

8.06

mmol/l

1.77

5733

43865

Injuries to the knee and lower leg

20862

101015

1.25

139.98

3.4

3.2

7.69

7.94

mmol/l

1.02

17593

85486

Other and unspecified polyneuropathies, also in other diseases

3205

21560

1.83

137.32

4.5

3.2

6.73

7.64

mmol/l

30.33

2765

17905

Other pulmonary diagnosis

15313

62946

1.30

137.30

3.4

3.1

7.67

8.16

mmol/l

1.41

12992

53450

Idiopathic gout

1641

9474

2.44

136.07

4.4

3.2

7.19

7.91

mmol/l

11.57

1433

7840

Asthma/COPD (KELA code 203)

16588

97380

1.28

135.94

3.2

3.3

7.35

8.03

mmol/l

4.92

14249

82269

Diseases of the ear and mastoid process

21059

90241

1.25

134.93

3.4

3.2

7.81

8.02

mmol/l

0.70

17573

76964

Conductive and sensorineural hearing loss

13718

78019

1.32

134.86

3.3

3.2

7.37

7.54

mmol/l

4.98

11224

65444

Coxibs

5139

19355

1.56

134.86

3.2

3.5

8.04

7.68

mmol/l

5.29

4264

16462

Coronary artery bypass grafting

4831

26568

1.62

134.07

3.6

3.2

7.10

7.84

mmol/l

31.43

3977

21683

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

1875

25861

0.53

133.49

3.0

3.2

7.20

7.46

mmol/l

1.81

1484

21465

Coxarthrosis [arthrosis of hip](FG)

9377

53579

1.39

131.66

3.1

7.19

7.54

mmol/l

12.95

7777

44406

Excluding asthma or asthma-COPD overlap

15251

62946

1.29

131.30

3.4

3.1

7.67

8.16

mmol/l

1.39

12946

53450

Chronic periapical parodontitis

3427

23350

1.73

131.21

4.8

3.1

7.13

7.93

mmol/l

20.33

2919

19738

Other problems related to primary support group, including family circumstances

1733

9621

2.13

131.05

5.0

3.4

7.72

8.03

mmol/l

1.48

1541

8443

Mixed hyperlipidaemia

827

3802

3.53

129.87

4.6

3.0

7.29

7.98

mmol/l

4.62

712

3165

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

9292

73795

1.38

129.87

3.5

3.2

7.16

7.49

mmol/l

10.12

7855

61711

Cellulitis

3507

24076

1.71

129.30

4.5

3.2

7.42

7.99

mmol/l

10.09

2978

20378

Malignant neoplasm of respiratory system and intrathoracic organs

1382

22579

0.49

128.14

2.8

3.2

7.27

7.40

mmol/l

0.47

1071

18419

Deposits [accretions] on teeth

1244

6326

2.57

128.12

6.3

3.2

6.70

8.14

mmol/l

22.27

1123

5445

Acute pancreatitis (for exclusion)

3316

22655

1.75

127.99

3.7

3.2

7.17

7.85

mmol/l

14.95

2756

18986

Sleep disorders

3289

22220

1.72

127.50

3.4

3.2

7.85

7.95

mmol/l

0.42

2823

19020

Pacemaker

5268

37966

1.55

127.11

3.3

3.2

6.76

7.25

mmol/l

16.83

4358

30966

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

1570

22177

0.51

125.06

2.9

3.2

7.13

7.39

mmol/l

1.49

1237

18354

COPD differential diagnosis

15143

62803

1.28

124.04

3.4

3.1

7.67

8.16

mmol/l

1.43

12855

53320

Polyneuropathies and other disorders of the peripheral nervous system

3559

24888

1.71

123.77

4.4

3.2

6.76

7.68

mmol/l

34.16

3058

20670

ILD differential diagnosis

15137

62788

1.28

123.76

3.4

3.1

7.67

8.16

mmol/l

1.43

12851

53307

Sensorineural hearing loss

12953

74728

1.31

123.64

3.3

3.2

7.35

7.50

mmol/l

3.59

10548

62523

COPD/asthma/ILD related infections

19132

81137

1.25

123.15

3.6

3.1

7.51

7.96

mmol/l

1.80

16143

68626

COPD/asthma related infections

19132

81137

1.25

123.15

3.6

3.1

7.51

7.96

mmol/l

1.80

16143

68626

Asthma, hospital admissions , main diagnosis only

13665

101397

1.29

122.54

3.2

7.45

7.88

mmol/l

2.31

11718

85555

Covid-19 confirmed case

4436

32019

1.58

122.51

3.9

3.2

7.13

7.74

mmol/l

15.59

3764

26889

Oter anti-inflammatory and antirheumatic agents, non-steroids

4056

15617

1.63

122.12

3.1

3.4

7.57

7.29

mmol/l

3.45

3353

13108

Conduction disorders

4860

29547

1.56

121.74

3.5

3.2

7.02

7.63

mmol/l

19.86

3922

24451

Meniscus derangement

9773

53439

1.36

121.72

3.2

3.1

7.88

7.82

mmol/l

0.51

8149

44979

Valvular heart disease excluding rheumatic fever

7961

45640

1.41

119.51

3.4

3.2

6.86

7.75

mmol/l

66.03

6560

38021

Autoimmune diseases related-to ILD

14211

104232

1.28

119.49

3.8

3.2

7.54

7.94

mmol/l

2.23

12146

87986

Other/unspecified dorsalgia

5974

44895

1.46

119.43

3.5

3.2

7.48

7.53

mmol/l

0.31

4940

37717

Other and unspecified dermatitis

8104

63906

1.39

119.33

3.7

3.2

7.25

7.54

mmol/l

7.15

6957

53720

Non-rheumatic valve diseases

7928

45397

1.41

119.24

3.4

3.2

6.86

7.75

mmol/l

66.42

6530

37806

Agoraphobia

562

2171

3.75

117.24

4.6

3.2

7.99

8.52

mmol/l

1.21

483

1903

Any operation in hilmo

852

1797

2.76

117.07

3.4

2.1

8.82

9.58

mmol/l

2.89

752

1612

Assault

2056

12743

1.93

116.49

5.0

3.3

7.94

8.85

mmol/l

10.47

1781

11119

Drug-induced hypoglycaemia without coma

398

1365

6.83

116.40

5.3

3.1

6.72

7.84

mmol/l

5.39

341

1145

Nonorganic sleeping disorders

2841

19005

1.73

115.21

3.3

7.78

7.95

mmol/l

0.69

2445

16312

Abnormalities of heart beat

5512

40993

1.47

115.00

3.4

3.1

7.29

7.50

mmol/l

2.67

4565

34403

Mixed disorders of conduct and emotions, excluding more controls

388

1202

4.57

114.85

7.3

3.4

8.75

9.34

mmol/l

0.87

340

1100

Speech and linguistic disorders, excluding more controls

1125

5406

2.35

114.64

4.2

3.3

8.57

8.64

mmol/l

0.15

1003

4775

Malaise and fatigue

8084

53160

1.38

114.59

3.5

3.1

6.99

7.57

mmol/l

23.92

6664

44280

Hyperkalaemia

932

4650

2.83

113.62

5.3

3.0

6.03

7.49

mmol/l

27.77

815

3813

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

1123

5934

2.49

113.26

5.4

3.3

6.98

8.03

mmol/l

8.00

972

5102

Bacterial infection, other or unspecified

8503

61234

1.37

113.23

4.3

3.1

6.70

7.63

mmol/l

80.30

7132

50791

Cough

6591

48836

1.42

112.53

3.3

3.2

7.38

7.54

mmol/l

2.09

5535

41153

Extreme obesity with alveolar hypoventilation

779

3717

3.35

112.52

3.5

3.1

7.30

7.53

mmol/l

0.68

607

3142

Alcohol dependence

4497

33117

1.55

111.57

4.5

3.2

7.06

8.38

mmol/l

61.77

3807

28011

Non-ischemic cardiomyopathy

4734

28764

1.54

111.48

3.8

3.1

6.66

7.42

mmol/l

30.72

3925

23522

Oxicams

4214

17018

1.57

111.34

3.2

3.5

7.85

7.44

mmol/l

6.40

3533

14377

20178

91478

1.23

110.90

3.5

3.1

7.55

7.89

mmol/l

1.38

16876

77232

Acetic acid derivatives and related substances

5043

19140

1.50

110.79

3.2

3.5

7.94

7.65

mmol/l

3.64

4159

16263

Malignant neoplasm of bronchus and lung

1151

19297

0.49

109.60

2.7

3.2

7.19

7.33

mmol/l

0.48

887

15713

Emotional disorders and disorders of social functioning with onset specific to childhood

790

3588

2.76

108.32

4.2

3.6

8.45

8.86

mmol/l

1.00

692

3245

Adhesive capsulitis of shoulder

2803

19122

1.74

107.81

4.0

3.1

7.34

7.42

mmol/l

0.49

2439

15986

Other external causes of accidental injury

15523

65345

1.26

107.64

3.4

3.2

7.67

7.86

mmol/l

4.53

12967

55990

Dermatitis and eczema

18554

104357

1.23

107.06

3.5

3.2

7.52

7.97

mmol/l

2.69

15785

88176

Alcohol-induced chronic pancreatitis

1201

6784

2.51

106.61

4.2

3.3

6.73

8.51

mmol/l

36.03

1037

5759

Other disorders starting during childhood or adolecense, excluding more controls

653

2655

2.94

105.96

4.3

3.6

8.37

8.93

mmol/l

1.45

590

2412

AV-block

2853

17703

1.72

105.93

3.5

3.1

6.88

7.62

mmol/l

19.26

2313

14502

Atherosclerosis, excluding cerebral and coronary sclerosis

6804

42685

1.42

105.74

4.0

3.1

6.39

7.47

mmol/l

108.32

5645

34897

Disorders of parathyroid gland

3187

22060

1.66

105.45

4.6

3.1

6.33

6.72

mmol/l

6.67

2779

18144

Heart failure and bmi 25plus

6377

34443

1.46

105.26

3.9

3.3

6.85

7.67

mmol/l

47.36

5170

27913

Any dementia

3304

32691

0.64

104.66

2.7

3.1

6.95

6.83

mmol/l

0.86

2538

26575

Chronic periodontitis

2440

16340

1.80

104.14

5.4

3.1

6.72

7.91

mmol/l

38.53

2106

13722

Obsessive-compulsive disorder

951

4795

2.45

103.35

3.5

3.3

8.35

8.55

mmol/l

0.47

820

4218

Eating disorder

1225

6701

2.18

103.23

3.7

3.3

7.45

8.24

mmol/l

4.46

1031

5918

Pain, not elsewhere classified

4228

31025

1.52

103.20

3.4

3.1

7.42

7.73

mmol/l

3.63

3646

26127

Unstable angina pectoris

6334

41049

1.43

102.65

3.3

3.2

7.20

7.51

mmol/l

7.61

5274

33673

Umbilical hernia

4428

33041

1.53

102.55

3.6

3.3

7.96

8.12

mmol/l

1.54

3728

27878

Acute sinusitis

8107

60438

1.35

101.71

3.7

3.2

7.79

8.14

mmol/l

0.78

6919

51696

Peripheral arterial reconstruction

2695

18561

1.74

101.22

4.1

3.2

6.16

7.44

mmol/l

65.19

2235

15134

Viral and other specified intestinal infections

3042

20487

1.61

100.59

4.8

3.2

8.02

8.46

mmol/l

4.84

2729

17737

Fibromyalgia

1305

7438

2.16

100.42

3.0

7.38

7.17

mmol/l

0.87

1134

6314

Degeneration of macula and posterior pole

7356

48359

1.39

100.32

3.4

3.1

6.68

7.11

mmol/l

16.84

5841

39592

External causes of morbidity and mortality

12536

52072

1.28

99.91

3.4

3.1

7.68

7.88

mmol/l

4.01

10599

44549

Degenerative diseases of the nervous system

2716

29486

0.63

99.39

2.6

3.1

6.97

6.85

mmol/l

0.84

2073

23921

Excessive, frequent and irregular menstruation

5955

25256

1.42

98.42

3.3

3.0

6.98

7.51

mmol/l

0.44

5006

21552

Use of disulfiram, acamprosate or naltrexone

1478

8934

2.11

97.99

4.4

3.3

7.11

8.67

mmol/l

28.32

1263

7706

Alcohol abuse, main dg

2478

16801

1.74

97.41

4.2

3.3

13.09

8.45

mmol/l

0.37

2138

14415

Benign neoplasms

13419

63682

1.26

97.11

3.5

3.3

7.95

8.45

mmol/l

1.52

11545

54799

Insomnia

2348

15677

1.74

96.68

3.4

3.2

7.79

7.88

mmol/l

0.26

2020

13427

Accidents

15382

65345

1.24

95.98

3.4

3.2

7.66

7.86

mmol/l

4.81

12879

55990

Menorrhagia

5331

22247

1.44

95.95

3.1

3.0

6.81

7.37

mmol/l

0.40

4429

18856

Disorders of skin appendages

7201

57394

1.36

94.83

3.7

3.2

7.58

7.86

mmol/l

5.52

6224

48852

Other disorders of teeth and supporting structures

3316

23849

1.59

93.68

4.2

3.1

7.12

7.76

mmol/l

12.68

2828

20071

Fracture of lower leg, including ankle

8818

71877

1.32

93.21

3.6

3.2

7.37

7.62

mmol/l

5.62

7449

60625

Other functional intestinal disorders

7005

53153

1.36

92.86

3.6

3.2

6.83

7.40

mmol/l

21.85

5828

44490

Syncope and collapse

7347

52181

1.35

92.57

3.3

3.1

7.25

7.65

mmol/l

11.49

6106

43417

Diseases of the digestive system

7107

56775

1.36

92.47

3.8

3.2

7.16

7.59

mmol/l

12.47

6011

47249

Disorders of psychological development

1659

9475

1.88

91.81

4.0

3.6

8.54

8.80

mmol/l

0.95

1464

8360

Eating disorders

1469

8800

1.95

91.19

3.7

3.3

7.48

8.09

mmol/l

3.63

1256

7685

Amputation of toe

1186

6951

2.30

91.07

5.3

3.2

5.83

7.69

mmol/l

62.79

1023

5760

Any dementia, excluding more controls

3175

30409

0.65

90.96

2.7

3.1

6.98

6.90

mmol/l

0.47

2452

24797

Alzheimer disease

2265

25075

0.61

90.50

2.5

3.1

6.96

6.65

mmol/l

2.83

1705

20245

Convulsions, not elsewhere classified

3695

26722

1.52

90.26

4.6

3.2

7.47

8.28

mmol/l

18.14

3169

22671

All influenza

3916

29097

1.51

89.95

3.8

3.2

7.33

7.93

mmol/l

13.25

3317

24467

Hernia

15765

91971

1.23

89.28

3.3

3.2

7.72

mmol/l

0.00

13296

77515

Redundant prepuce, phimosis and paraphimosis

3291

23711

1.57

89.16

3.8

3.4

8.75

9.20

mmol/l

5.91

2785

20441

Thyroiditis, ILD-related definition

1754

11228

1.87

88.52

4.4

3.1

7.21

7.28

mmol/l

0.23

1541

9514

Other neurological diseases

11654

79004

1.27

88.43

3.3

3.2

7.16

7.50

mmol/l

13.75

9828

65689

Lung cancer and mesothelioma

1604

21271

0.57

88.14

2.9

3.1

7.19

7.51

mmol/l

2.11

1264

17541

Hyperparathyroidism

2763

19279

1.64

87.85

4.7

3.0

6.34

6.72

mmol/l

5.99

2413

15825

Poisoning by narcotics and psychodysleptics [hallucinogens]

333

1171

4.94

87.07

9.9

3.3

7.47

8.90

mmol/l

4.02

286

1018

295

7840

0.31

86.14

2.5

3.2

7.49

8.09

mmol/l

1.31

236

6511

Mental disorders, not otherwise specified

1227

7186

2.07

85.94

3.5

3.2

7.62

7.98

mmol/l

1.55

1077

6220

Acute alcohol intoxication, ICD10

3072

22177

1.58

85.43

4.1

3.3

12.18

8.46

mmol/l

0.36

2592

18972

Cervical disc disorders

5915

46876

1.38

84.99

3.1

3.2

7.78

7.60

mmol/l

2.38

5016

39241

Chronic gastritis

4410

33747

1.47

84.62

3.6

3.1

6.94

7.14

mmol/l

2.50

3612

27833

Injuries to the ankle and foot

10612

80968

1.27

84.50

3.6

3.2

7.92

8.19

mmol/l

0.82

9011

69332

Hypokalaemia

1730

11206

1.85

83.92

3.6

3.0

6.64

7.32

mmol/l

8.08

1441

9278

ILD medications: azathioprine

2296

15730

1.68

83.48

5.9

3.1

7.15

8.08

mmol/l

17.78

2070

13404

Direct fill therapy

2059

13884

1.76

83.30

5.5

3.3

6.93

8.00

mmol/l

22.00

1851

11880

Peripheral artery operations in Hilmo

1994

13354

1.77

83.28

4.8

3.1

6.01

7.65

mmol/l

75.53

1676

10948

Alzheimer’s disease, wide definition

1634

21068

0.58

82.87

2.4

3.1

7.08

6.59

mmol/l

4.52

1229

16952

Other diseases of pancreas

1246

7586

2.15

82.85

3.9

3.1

6.79

7.60

mmol/l

8.61

1056

6364

Behavioural disorders, excluding more controls

335

1168

3.98

81.93

6.1

3.1

8.88

9.19

mmol/l

0.35

302

1043

Operations 2 for CAVS

4479

33811

1.46

81.79

3.6

3.1

6.61

7.25

mmol/l

24.45

3710

27437

Calcific aortic valvular stenosis, diagnosis (helper)

4479

33811

1.46

81.79

3.6

3.1

6.61

7.25

mmol/l

24.45

3710

27437

Calcific aortic valvular stenosis, operated

4484

33865

1.45

81.60

3.6

3.1

6.61

7.25

mmol/l

24.04

3715

27488

Calcific aortic valvular stenosis

4484

33865

1.45

81.60

3.6

3.1

6.61

7.25

mmol/l

24.04

3715

27488

Other eating disorders

735

3683

2.48

81.57

3.6

3.3

7.68

8.26

mmol/l

1.66

609

3276

Other specified/unspecified arthritis

4088

30975

1.46

81.20

3.6

3.1

7.29

7.63

mmol/l

5.18

3500

26034

Emotional disorders starting during childhood or adolescence

728

3616

2.49

81.15

4.2

3.7

8.56

8.96

mmol/l

0.89

640

3254

Calcific aortic valvular stenosis, including rheumatic fever

4491

33929

1.45

80.94

3.6

3.1

6.61

7.25

mmol/l

24.78

3718

27539

Amputation

1558

9992

1.92

80.94

5.1

3.1

5.79

7.63

mmol/l

79.62

1336

8226

Codes for special purposes

6569

52778

1.34

80.90

3.6

3.2

9.70

7.86

mmol/l

0.40

5696

44732

Myalgia

3308

24237

1.52

80.89

3.4

3.1

7.50

7.52

mmol/l

0.10

2710

20491

Provisional assignment of new diseases of uncertain etiology

6560

52701

1.34

80.85

3.6

3.2

9.70

7.86

mmol/l

0.40

5690

44675

Symptoms and signs involving the nervous and musculoskeletal systems

8917

74075

1.29

80.83

3.4

3.2

7.49

7.53

mmol/l

0.35

7672

62071

Visual disturbances and blindness

7701

63111

1.32

80.77

3.5

3.2

7.29

7.49

mmol/l

3.43

6428

52980

Familial hypercholesterolemia, with ischemic heart disease

1555

10053

1.94

80.38

3.9

3.1

7.13

7.58

mmol/l

4.32

1261

8199

Asthma-related pneumonia or sepsis

5310

41715

1.39

79.44

3.5

3.2

6.93

7.43

mmol/l

13.09

4575

34577

Asthma, hospital admissions 3, pneumonia

5310

41715

1.39

79.44

3.5

3.2

6.93

7.43

mmol/l

13.09

4575

34577

Asthma-related pneumonia

5298

41625

1.39

79.23

3.5

3.2

6.93

7.43

mmol/l

12.85

4563

34496

Osteopathies and chondropathies

8489

66731

1.30

78.89

3.7

3.2

6.83

7.45

mmol/l

32.71

7221

55838

Diseases of the respiratory system

12132

51419

1.25

78.67

3.4

3.1

7.56

8.09

mmol/l

1.15

10239

43400

Injury, poisoning and certain other consequences of external causes

10102

42050

1.27

78.66

3.4

3.1

7.62

7.88

mmol/l

5.05

8541

35762

Injuries to the shoulder and upper arm

13663

98723

1.23

78.36

3.3

3.2

7.64

7.78

mmol/l

2.60

11521

83193

Azathioprine

2296

15965

1.65

77.52

5.9

3.2

7.15

8.05

mmol/l

16.84

2070

13616

Other arthritis (FG)

4672

36276

1.41

77.51

3.6

3.1

7.29

7.69

mmol/l

7.72

3988

30487

Symptoms and signs involving the skin and subcutaneous tissue

10707

90355

1.25

76.77

3.6

3.2

7.43

7.74

mmol/l

1.12

9156

75930

Gingival hyperplasia

585

2865

3.00

76.49

7.3

3.1

6.62

7.92

mmol/l

12.07

522

2430

Other gastritis (incl. Duodenitis)

3570

26909

1.50

76.21

3.7

3.1

7.03

7.48

mmol/l

8.05

3054

22397

Rheumatism, unspecified

2135

14737

1.68

76.01

3.2

3.0

6.78

6.72

mmol/l

0.29

1802

12310

4266

29161

1.44

75.62

3.2

3.0

6.39

6.85

mmol/l

12.16

3322

23668

Cerebrovascular diseases

12124

74520

1.24

74.83

3.4

3.2

7.12

7.52

mmol/l

20.10

10017

62006

Acute upper respiratory infections of multiple and unspecified sites

11777

75185

1.23

74.40

3.8

3.2

7.94

8.07

mmol/l

0.28

9974

64003

Glaucoma

8787

64610

1.29

73.98

3.5

3.2

6.88

7.20

mmol/l

11.11

7261

53325

Pure hyperglyceridaemia

438

1953

3.67

73.82

4.5

3.1

7.57

8.00

mmol/l

1.15

386

1621

Psychotic depression

952

5420

2.16

73.73

3.4

3.1

7.89

7.76

mmol/l

0.32

812

4635

Other diseases of upper respiratory tract

19586

90075

1.18

73.72

3.3

3.2

7.76

7.89

mmol/l

0.36

16483

76076

Paracetamol of NSAID medication

3200

11584

1.50

72.85

3.4

3.3

8.25

8.28

mmol/l

0.09

2700

9940

Papulosquamous disorders

6033

48824

1.35

72.58

3.3

3.2

7.44

7.62

mmol/l

2.38

5064

41058

Disorders of mineral metabolism

1239

7709

1.99

72.47

4.3

3.0

6.84

7.62

mmol/l

8.21

1071

6460

Ventral hernia

3680

28091

1.47

72.24

3.6

3.2

7.30

7.43

mmol/l

1.01

3079

23354

Volume depletion

1314

8228

1.91

72.11

4.2

3.0

6.84

7.49

mmol/l

6.05

1096

6807

Alzheimer’s disease (Late onset)

1459

19148

0.59

71.60

2.4

3.1

7.05

6.51

mmol/l

4.74

1097

15356

Viral infections characterized by skin and mucous membrane lesions

6160

49927

1.33

70.73

4.2

3.2

7.65

7.82

mmol/l

1.89

5308

42240

Other sleep disorders

1656

11016

1.77

70.55

3.6

3.2

7.93

7.78

mmol/l

0.64

1425

9362

Persons encountering health services for specific procedures, not carried out

1176

7242

1.99

70.52

4.2

3.2

7.50

7.99

mmol/l

2.61

999

6150

Inflammatory diseases of female pelvic organs

8506

53341

1.27

70.43

3.4

3.0

6.88

7.11

mmol/l

0.38

7101

45167

Anaemia in chronic diseases classified elsewhere

465

2192

3.52

70.41

9.2

3.0

5.26

7.66

mmol/l

52.08

436

1798

Acute alcohol intoxication

3923

30207

1.44

70.39

4.0

3.2

11.12

8.36

mmol/l

0.33

3304

25557

Hypo-osmolality and hyponatraemia

2453

17558

1.59

70.30

3.8

3.0

5.29

7.21

mmol/l

114.11

2022

14373

Disorders of vitreous body and globe

7792

63484

1.30

69.94

3.8

3.2

6.90

7.19

mmol/l

7.80

6552

52638

1879

12807

1.68

69.30

3.9

3.0

7.23

7.75

mmol/l

4.34

1599

10859

Systemic connective tissue disorders

5174

41326

1.37

69.25

4.1

3.1

6.89

7.09

mmol/l

2.72

4422

34356

Alzheimer disease, including avohilmo

3006

29041

0.69

69.25

2.6

3.1

6.92

6.68

mmol/l

2.41

2345

23467

Diseases of male genital organs

9207

39015

1.27

68.96

3.6

3.4

8.77

9.03

mmol/l

5.06

7799

33417

Visual disturbances

7050

58224

1.30

68.66

3.4

3.2

7.36

7.52

mmol/l

2.09

5930

48940

Disorders of vitreous body

7581

61965

1.30

68.60

3.8

3.2

6.91

7.18

mmol/l

7.03

6379

51368

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

2363

16347

1.59

68.42

5.3

3.4

6.91

8.09

mmol/l

31.13

2144

14075

Dissociative [conversion] disorders

585

2910

2.59

68.03

3.9

3.1

7.88

7.74

mmol/l

0.21

496

2519

Assault by bodily force

1114

6792

1.97

67.56

4.9

3.4

7.75

8.78

mmol/l

7.90

941

5917

Irregular menses

6209

40772

1.31

67.03

3.5

3.0

7.33

7.46

mmol/l

0.13

5326

34969

Polyuria

3415

26131

1.47

66.60

3.4

3.2

7.31

7.71

mmol/l

5.82

2815

21734

Special screening examination for infectious and parasitic diseases

3350

18612

1.44

66.48

3.4

2.8

8.56

8.80

mmol/l

1.52

2743

16146

Dementia

4215

36941

0.73

66.32

2.8

3.2

7.02

6.89

mmol/l

1.18

3299

30050

Disorders of calcium metabolism

951

5668

2.13

66.11

4.4

3.0

6.54

7.46

mmol/l

10.29

839

4738

Isolated proteinuria with specified morphological lesion

260

973

5.89

65.99

10.0

2.9

6.51

7.76

mmol/l

5.43

248

809

Glaucoma suspect

5394

43696

1.35

65.78

3.5

3.1

6.96

7.10

mmol/l

1.71

4526

36139

Acidosis

387

1742

3.79

65.27

5.2

3.0

6.46

7.96

mmol/l

10.83

332

1458

Other disorders of skin and subcutaneous tissue, not elsewhere classified

2146

15304

1.62

65.19

4.4

3.1

6.78

7.47

mmol/l

10.87

1802

12758

Bronchitis

17670

102605

1.18

64.63

3.7

3.2

7.72

7.89

mmol/l

0.58

14813

86764

Allergic asthma (mode), excluding more controls

3510

26190

1.42

64.57

3.2

3.0

7.88

8.63

mmol/l

0.73

3094

22517

Mycoses

3844

29917

1.42

64.39

3.9

3.2

7.22

7.67

mmol/l

7.43

3245

25100

Osteomyelitis

1019

6276

2.08

63.93

5.2

3.2

6.29

7.93

mmol/l

30.94

877

5294

Bulimia nervosa (incl. atypical)

491

2320

2.68

63.90

4.0

3.3

7.52

8.04

mmol/l

1.21

418

2041

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

1154

16901

0.57

63.79

2.9

3.2

7.20

7.39

mmol/l

0.73

904

13957

Unspecific neurodegenerative disorder

3897

34299

0.72

63.61

2.7

3.2

7.03

6.78

mmol/l

3.23

3044

27810

Intracranial injury

8855

72459

1.25

63.57

3.5

3.2

7.54

7.79

mmol/l

5.19

7403

61105

Otitis externa

3173

24080

1.47

63.43

3.8

3.2

7.77

7.79

mmol/l

0.10

2558

20444

Migraine

6612

46100

1.29

63.28

3.1

3.2

7.79

7.85

mmol/l

0.07

5755

39732

6112

47372

1.32

63.27

3.4

3.1

6.67

7.01

mmol/l

9.48

5110

38602

Cervicobrachial syndrome

3253

24732

1.45

63.09

3.1

7.70

7.50

mmol/l

1.63

2866

20838

Presence of other devices

3331

25449

1.45

63.05

3.5

3.0

6.97

7.28

mmol/l

4.62

2894

20930

Other necrotizing vasculopathies (FG)

950

5762

2.10

62.58

6.8

3.0

6.77

7.21

mmol/l

2.59

842

4783

Other disorders of lacrimal gland

4898

39357

1.36

62.41

3.4

3.1

6.99

7.21

mmol/l

2.99

4120

32906

Lesion of ulnar nerve

2068

14740

1.61

62.36

3.3

3.1

7.79

7.97

mmol/l

1.05

1769

12477

Other disorders of gingiva or/and edentulous alveolar ridge

796

4586

2.24

62.33

6.4

3.1

6.61

7.73

mmol/l

12.13

709

3898

Soft tissue disorders related to use, overuse and pressure

3992

31314

1.40

62.28

3.3

3.1

7.38

7.52

mmol/l

1.20

3385

26234

Urolithiasis

4975

40178

1.36

62.01

3.6

3.3

8.50

7.87

mmol/l

18.22

4144

33488

Diseases of external ear

4941

39789

1.35

61.92

3.6

3.2

7.69

7.68

mmol/l

0.04

3909

33518

Psoriasis

4273

33868

1.39

61.85

3.4

3.2

7.66

7.79

mmol/l

1.07

3567

28610

Impingement syndrome of shoulder

3880

30434

1.41

61.82

3.4

3.1

7.84

7.71

mmol/l

1.05

3274

25565

Calculus of kidney and ureter

4606

36903

1.37

61.76

3.6

3.3

8.56

7.88

mmol/l

19.12

3845

30818

Dental pulpitis 3

1660

7946

1.66

61.71

4.2

3.3

9.14

mmol/l

0.01

1460

7134

Other acute lower respiratory infections

7967

63948

1.26

61.36

3.7

3.2

7.46

7.81

mmol/l

8.41

6639

53942

Disorders of sclera, cornea, iris and ciliary body

8191

69233

1.26

61.28

3.6

3.2

7.54

7.72

mmol/l

3.05

6998

58396

Specific development disorders of scholastic skills

612

3166

2.36

60.63

4.4

3.9

9.08

9.11

mmol/l

0.04

552

2839

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

743

4055

2.14

60.58

4.2

3.7

8.30

8.70

mmol/l

0.95

671

3664

Dissocial personality disorder

316

1318

3.88

60.44

9.2

3.5

7.65

9.29

mmol/l

6.62

266

1141

Superficial injury of lower leg

3470

26765

1.42

60.17

3.4

3.2

7.60

7.72

mmol/l

0.73

2894

22707

Acute upper respiratory infections

17408

96874

1.17

60.09

3.6

3.2

7.73

7.83

mmol/l

0.26

14696

81709

Other and unspecified effects of external causes

3773

29395

1.40

60.02

3.8

3.2

7.70

7.91

mmol/l

1.63

3178

25165

Allergic asthma (mode)

3510

26475

1.40

59.90

3.2

3.0

7.88

8.60

mmol/l

0.70

3094

22742

Other and unspecified nerve root and plexus disorders, also in other diseases

2691

20113

1.50

59.81

3.2

3.1

8.00

7.86

mmol/l

0.87

2324

17007

Monoamine oxidase A inhibitors

1811

12693

1.65

59.75

3.4

3.2

7.45

7.51

mmol/l

0.20

1501

10705

Skin changes due to chronic exposure to nonionizing radiation

5728

44670

1.33

59.35

3.4

3.1

6.61

6.96

mmol/l

9.93

4786

36306

Mixed disorders of conduct and emotions

388

1729

2.99

59.33

7.3

3.8

8.75

9.10

mmol/l

0.45

340

1554

Diabetic retinopathy, excluding more controls

8059

40572

1.47

58.85

5.3

3.6

6.64

8.23

mmol/l

4.67

6748

33633

Other abnormal uterine and vaginal bleeding

3303

17979

1.44

58.83

3.2

3.0

6.40

6.45

mmol/l

0.25

2599

15102

Late syphilis

286

1191

4.69

58.71

6.4

3.1

6.17

8.08

mmol/l

14.58

259

1004

Actinic keratosis

5565

43485

1.33

58.68

3.4

3.1

6.60

6.95

mmol/l

9.58

4646

35319

Exclusions for E4_PCOS_BROAD

2376

17436

1.53

58.67

4.0

3.3

7.63

7.83

mmol/l

1.10

2051

14907

Excessive attrition of teeth

6198

27592

1.31

58.60

3.6

3.1

7.71

8.39

mmol/l

0.71

5187

23923

Irritable bowel syndrome

3953

31100

1.38

58.57

3.2

3.1

7.43

mmol/l

0.01

3322

26288

Sequelae of external causes of morbidity and mortality

3668

28761

1.41

58.57

3.6

3.2

7.05

7.47

mmol/l

7.34

3150

23983

Acute bronchitis

5960

48057

1.30

58.39

3.7

3.2

7.25

7.59

mmol/l

6.42

4868

40313

Other and unspecified local infections of skin and subcutaneous tissue

1390

9319

1.77

58.24

4.7

3.2

7.21

7.81

mmol/l

5.49

1187

7888

Intentional self-harm by sharp object

412

1920

2.93

58.03

4.8

3.3

7.97

8.82

mmol/l

1.94

365

1669

Polyarthrosis

2936

21417

1.47

57.88

3.1

3.0

6.63

6.75

mmol/l

0.93

2442

17643

Adjustment and management of implanted device

2775

21041

1.49

57.73

3.5

3.1

6.73

7.41

mmol/l

16.43

2235

17222

Anosmia

264

945

3.40

57.54

3.3

1.6

7.30

8.21

mmol/l

2.38

213

795

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

1236

8062

1.81

57.50

4.3

3.1

6.78

6.75

mmol/l

0.09

1105

6753

Postmenopausal bleeding

4025

17327

1.39

57.43

3.1

2.9

6.42

6.26

mmol/l

1.60

3290

14512

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

4724

38139

1.34

57.19

3.5

3.2

7.31

7.34

mmol/l

0.16

3987

32180

Wide developmental disorders, excluding more controls

371

1597

2.83

56.92

3.3

3.6

8.55

9.27

mmol/l

1.29

312

1449

Psoriasis vulgaris

2776

21054

1.48

56.86

3.4

3.3

7.69

7.89

mmol/l

1.54

2337

17824

Unspecified nephritic syndrome

417

2038

3.13

56.28

8.3

3.0

6.36

7.94

mmol/l

15.17

399

1699

Viral warts

1426

9653

1.72

55.95

5.0

3.3

7.32

7.84

mmol/l

3.85

1275

8230

Other local infections of skin and subcutaneous tissue

1470

10053

1.72

55.78

4.6

3.2

7.29

7.84

mmol/l

4.75

1246

8491

Other metabolic disorders

1733

12125

1.62

55.66

3.4

3.0

6.85

7.34

mmol/l

5.17

1514

10192

Internal derangement of knee

5781

47574

1.29

55.47

3.4

3.1

8.07

7.94

mmol/l

1.28

4726

40249

Cirrhosis of liver, NAS

810

4930

2.20

55.28

4.1

3.2

7.04

7.68

mmol/l

3.99

678

4113

Disorders of lacrimal system

6043

50251

1.29

54.98

3.3

3.1

6.94

7.18

mmol/l

4.14

5096

41987

Other follicular disorders

1021

6446

1.90

54.90

4.2

3.2

7.88

8.13

mmol/l

0.85

888

5517

Gout due to impairment of renal function

231

907

5.83

54.86

8.2

3.1

6.07

7.80

mmol/l

11.28

221

741

Other disorders of eyelid

6695

54408

1.28

54.75

3.2

3.1

7.01

7.07

mmol/l

0.55

5562

44846

Other diseases of the digestive system

4678

38011

1.34

54.02

3.7

3.2

7.06

7.60

mmol/l

13.54

3893

31364

Fibrosis and cirrhosis of liver

1137

7498

1.88

54.01

4.1

3.1

6.84

7.48

mmol/l

5.47

961

6266

GI-bleeding

4689

38100

1.33

53.98

3.7

3.2

7.06

7.60

mmol/l

13.90

3935

31439

Intentional self-harm by unspecified means

235

892

4.35

53.62

4.7

3.1

7.36

8.81

mmol/l

2.68

208

785

Non-small cell lung cancer

1154

17308

0.60

53.45

2.9

3.2

7.20

7.34

mmol/l

0.48

904

14161

Transient ischemic attack

8142

57742

1.25

53.38

3.2

7.06

7.32

mmol/l

6.52

6856

47616

SLE (Finngen)

531

2811

2.46

53.36

6.1

2.8

6.86

7.24

mmol/l

1.10

470

2380

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

5045

41062

1.30

53.13

3.3

3.2

8.30

8.17

mmol/l

0.78

4280

35519

Hyperplasia of prostate

6178

29326

1.30

53.12

3.4

3.3

8.34

8.71

mmol/l

8.56

5111

24705

Other enthesopathies

4390

35411

1.34

52.89

3.2

3.1

7.70

7.54

mmol/l

1.47

3744

29883

Ovarian cyst

5170

24231

1.31

52.80

3.2

3.0

6.93

7.46

mmol/l

0.41

4343

20630

Personal history of certain other diseases

300

1266

3.31

52.63

7.1

3.0

7.31

8.31

mmol/l

2.40

261

1098

Other systemic involvement of connective tissue (FG)

3633

28508

1.38

52.40

3.2

3.0

6.90

7.08

mmol/l

1.74

3058

23686

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

2144

15942

1.55

52.22

3.9

3.2

6.95

7.93

mmol/l

22.41

1793

13373

Other obstetric conditions, not elsewhere classified

3428

17134

1.37

52.15

3.7

3.0

12.13

8.01

mmol/l

0.50

3021

15074

Somatoform disorder

2229

16480

1.50

52.02

3.3

3.1

7.56

7.53

mmol/l

0.10

1877

14021

Propionic acid derivatives

5020

20339

1.31

51.81

3.3

3.6

8.08

7.79

mmol/l

3.48

4218

17390

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

2138

28462

0.68

51.71

2.9

3.2

7.29

7.47

mmol/l

1.14

1690

23779

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

3331

16596

1.38

51.55

3.6

3.0

12.27

8.04

mmol/l

0.50

2937

14605

Deforming dorsopathies

4087

32839

1.35

51.20

3.0

3.2

7.16

7.48

mmol/l

4.38

3439

27641

Alcohol-induced acute pancreatitis

616

3550

2.39

50.99

4.2

3.3

7.10

8.63

mmol/l

12.06

513

2999

Chronic ulcer of skin, not elsewhere classified

1024

6654

1.89

50.98

4.7

3.1

6.50

7.43

mmol/l

10.65

893

5508

Early onset COPD, excluding more controls

3283

25836

1.41

50.94

3.5

3.1

7.16

7.98

mmol/l

20.82

2671

21645

Coxarthrosis, primary

9238

69591

1.22

50.93

3.1

3.2

7.10

7.26

mmol/l

3.51

7638

57472

Other necrotizing vasculopathies

1085

7166

1.87

50.83

6.8

3.1

6.74

7.13

mmol/l

2.44

962

5950

Dementia in Alzheimer disease

1189

15147

0.61

50.81

2.5

3.1

7.03

6.55

mmol/l

3.28

844

12168

Conduct disorder

342

1548

2.94

50.63

5.8

3.6

8.91

8.94

mmol/l

0.03

309

1375

Manic episode

481

2516

2.51

50.16

3.9

3.2

6.71

8.18

mmol/l

8.06

423

2155

Other symptoms and signs involving the nervous and musculoskeletal systems

6041

50607

1.27

50.04

3.4

3.2

7.59

7.57

mmol/l

0.07

5252

42593

Mental and behavioural disorders due to tobacco

1248

8477

1.76

49.99

4.5

3.1

7.40

7.97

mmol/l

3.86

1008

7212

Dementia, including avohilmo

4685

39314

0.77

49.95

2.8

3.2

7.01

6.92

mmol/l

0.84

3673

32063

Exposure to other specified factors

11319

93218

1.19

49.89

3.5

3.2

7.94

8.10

mmol/l

0.44

9562

79332

Speech and linguistic disorders

1142

7169

1.74

49.82

4.2

3.7

8.54

8.73

mmol/l

0.48

1020

6308

Fibroblastic disorders

3539

28134

1.38

49.76

3.5

3.1

7.47

7.60

mmol/l

1.02

2977

23366

Renal tubulo-interstitial disorders in diseases classified elsewhere

214

837

5.18

49.60

8.6

2.9

6.30

7.94

mmol/l

7.86

207

664

Diabetic retinopathy, strict definition

4900

37732

1.55

49.56

6.2

3.8

6.47

8.25

mmol/l

5.08

4173

31690

Benign neoplasm: Colon, unspecified

3633

29146

1.38

49.52

3.6

3.2

7.08

7.36

mmol/l

3.57

2967

24009

Injuries to the thorax

6647

56272

1.26

49.47

3.7

3.2

7.50

7.84

mmol/l

7.65

5545

47151

Other symptoms and signs involving cognitive functions and awareness

6628

52626

1.26

49.31

3.4

3.2

7.27

7.39

mmol/l

1.25

5581

43601

Maltreatment syndromes

719

4238

2.04

49.12

5.2

3.4

7.75

8.62

mmol/l

3.43

617

3688

Cervicalgia

2954

22964

1.41

48.98

3.3

3.1

7.41

7.39

mmol/l

0.10

2456

19227

Dental pulpitis 3, only avohilmo

1498

7476

1.60

48.88

3.9

3.3

9.19

9.18

mmol/l

0.01

1312

6725

2884

21209

1.43

48.84

3.2

3.0

6.32

6.70

mmol/l

6.09

2218

17184

Viral pneumonia

1814

13197

1.56

48.33

4.2

3.2

7.15

7.85

mmol/l

8.79

1515

11141

Infections with a predominantly sexual mode of transmission

3901

31198

1.33

48.28

4.0

3.2

7.76

8.49

mmol/l

0.90

3323

26965

Smoking dependency

1248

8549

1.74

48.03

4.5

3.2

7.40

7.94

mmol/l

3.52

1008

7276

N06DA Anticholinesterases

2897

29944

0.73

47.74

2.7

3.1

7.07

6.70

mmol/l

4.66

2235

24203

Use of anticholinesterases

2897

29944

0.73

47.74

2.7

3.1

7.07

6.70

mmol/l

4.66

2235

24203

Supplementary factors related to causes of morbidity and mortality classified elsewhere

4325

35257

1.32

47.68

3.6

3.2

7.40

7.89

mmol/l

9.53

3740

29856

Polyp of the female genital tract

4414

20738

1.32

47.63

3.0

6.58

7.31

mmol/l

0.52

3609

17525

Superficial injury of head

3148

24733

1.39

47.60

3.7

3.2

7.14

7.68

mmol/l

7.92

2666

20899

Retinal vascular occlusion

1700

12328

1.59

47.51

3.7

3.0

6.64

7.23

mmol/l

7.80

1399

10143

Chronic tubulo-interstitial nephritis

608

3507

2.21

47.20

6.0

2.8

5.98

7.13

mmol/l

11.89

540

2899

Bell's palsy

1664

11983

1.58

47.04

3.4

3.1

7.66

7.64

mmol/l

0.06

1393

10093

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

4580

48626

0.77

46.70

2.9

3.2

7.32

7.45

mmol/l

1.25

3664

40729

Disturbances of skin sensation

3704

29722

1.34

46.61

3.3

3.2

7.82

7.75

mmol/l

0.39

3158

25278

Hyperaldosteronism

475

2609

2.61

46.40

3.8

3.1

7.22

7.68

mmol/l

1.54

408

2183

Sequelae with surgical and medical care as external cause

2843

22282

1.42

46.29

3.6

3.2

6.99

7.36

mmol/l

4.57

2433

18537

Other disorders starting during childhood or adolescence

657

3780

2.02

46.17

4.3

3.8

8.34

8.77

mmol/l

0.96

594

3414

Retinal vascular disorders

1718

12531

1.57

46.10

3.7

3.0

6.62

7.23

mmol/l

8.25

1415

10299

Dentofacial anomalies [including malocclusion]

3658

28934

1.34

45.87

3.5

3.0

7.59

7.79

mmol/l

1.67

3152

24882

Other viral diseases

3921

31563

1.33

45.84

4.2

3.2

7.94

8.22

mmol/l

2.67

3423

27234

Chronic periodontitis, complicated

1418

10086

1.67

45.80

5.3

3.2

6.71

7.86

mmol/l

21.82

1220

8499

Wet age-related macular degeneration

2301

17208

1.47

45.60

3.1

3.0

6.39

6.68

mmol/l

3.18

1800

13905

Fracture of foot, except ankle

3282

26046

1.37

45.55

4.1

3.2

7.48

7.98

mmol/l

7.47

2810

22262

Benign neoplasm of other and ill-defined parts of digestive system

2530

19602

1.45

45.37

3.4

3.1

6.97

7.19

mmol/l

1.68

2144

16308

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

9782

79549

1.20

45.26

3.4

3.2

7.23

7.46

mmol/l

5.92

8208

66187

Necrobiosis lipoidica, not elsewhere classified

139

444

7.13

45.11

6.4

2.8

6.88

7.58

mmol/l

1.17

130

373

Heart failure and coronary heart disease

4790

29592

1.31

45.02

3.7

3.2

6.49

7.38

mmol/l

50.85

3961

24091

Pain and other conditions associated with female genital organs and menstrual cycle

2479

18092

1.41

44.83

3.0

7.44

8.05

mmol/l

0.35

2072

15638

Amenorrhoea

845

5258

1.82

44.81

4.3

3.1

7.29

7.58

mmol/l

0.89

749

4581

Functional dyspepsia

3769

30492

1.34

44.76

3.2

3.1

7.16

7.38

mmol/l

2.29

3139

25667

Hidradenitis suppurativa

524

2918

2.26

44.67

4.0

3.2

7.77

8.21

mmol/l

1.20

454

2529

Diaphragmatic hernia

5355

45008

1.28

44.63

3.2

7.17

7.21

mmol/l

0.27

4484

37267

Postprocedural endocrine and metabolic disorders, not elsewhere classified

1547

11038

1.57

44.53

3.3

3.0

6.81

7.30

mmol/l

4.72

1347

9287

Urticaria and erythema

4970

41303

1.28

44.22

3.6

3.2

7.60

7.59

mmol/l

0.07

4190

35162

Migraine without aura

2317

17497

1.42

44.07

3.3

3.2

8.02

7.72

mmol/l

1.88

2034

15226

Other noninflammatory disorders of uterus, except cervix

3134

16875

1.38

43.94

3.1

3.0

6.24

6.28

mmol/l

0.24

2599

14110

Flat foot [pes planus] (acquired)

1343

9433

1.64

43.85

3.1

6.82

7.13

mmol/l

1.76

1118

7937

Congenital malformations, deformations and chromosomal abnormalities

8467

70377

1.20

43.75

3.9

3.2

7.72

8.22

mmol/l

1.69

7420

60217

Undetermined asthma, excluding more controls

1827

13468

1.51

43.66

3.4

3.0

7.33

7.57

mmol/l

1.30

1531

11374

Autism spe, excluding more controls

277

1195

2.87

43.62

2.9

3.2

8.45

9.51

mmol/l

1.86

229

1073

Benign neoplasm: Sigmoid colon

2664

20947

1.43

43.44

3.5

3.2

7.47

7.38

mmol/l

0.47

2247

17324

Retention of urine

5053

35713

1.28

43.25

3.6

3.2

6.90

7.84

mmol/l

47.36

4139

29569

Erosion of teeth, including avohilmo

2788

21096

1.39

42.97

4.1

3.1

7.60

8.70

mmol/l

0.96

2349

18399

Benign neoplasm: Colon, unspecified

3633

29477

1.35

42.88

3.6

3.2

7.08

7.40

mmol/l

4.46

2967

24507

Cholecystitis

1941

14527

1.49

42.88

3.6

3.1

7.39

7.38

mmol/l

0.04

1604

12029

Use of pramipexole

3100

24782

1.38

42.83

3.6

3.2

7.04

7.16

mmol/l

0.85

2567

20539

Diseases of salivary glands

2674

20868

1.40

42.80

3.5

3.0

7.25

7.54

mmol/l

2.76

2255

17571

Open wound of ankle and foot

1428

10194

1.60

42.61

4.4

3.3

7.42

8.14

mmol/l

6.53

1200

8709

Parodontitis, under 40 years, or operation codes

1092

7273

1.66

42.55

5.4

3.6

8.59

8.99

mmol/l

1.42

970

6444

Chronic sinusitis

6335

53980

1.24

42.55

3.3

3.2

7.56

7.91

mmol/l

0.68

5314

45720

Anankastic personality disorder

546

3124

2.17

42.53

3.2

8.32

8.01

mmol/l

0.65

477

2690

Benign paroxysmal vertigo

4034

33158

1.32

42.53

3.1

7.24

7.04

mmol/l

2.01

3300

27625

Other and unspecified tonsillitis

4658

32587

1.28

42.52

3.6

3.2

8.87

8.76

mmol/l

0.67

4048

28559

Behavioural disorders

335

1621

2.70

42.39

6.1

3.6

8.88

9.09

mmol/l

0.21

302

1437

Background retinopathy and retinal vascular changes

353

1791

2.84

42.38

6.0

3.0

6.40

7.66

mmol/l

8.16

305

1503

Other disorders of penis

1445

10412

1.61

42.18

3.8

3.4

8.64

8.86

mmol/l

0.93

1189

8868

Parodontitis, under 40 years

1088

7254

1.66

42.18

5.4

3.6

8.60

8.99

mmol/l

1.37

967

6426

Syphilis

437

2394

2.53

42.14

5.2

3.3

6.84

8.22

mmol/l

9.52

385

2018

Cardiomyopathy

2576

20148

1.41

41.96

3.4

3.2

7.18

8.04

mmol/l

21.21

2178

16763

Trochanteric bursitis

1878

14043

1.50

41.87

3.0

6.97

6.78

mmol/l

1.15

1585

11693

Wegener granulomatosis

298

1446

3.27

41.84

10.0

3.0

6.95

7.71

mmol/l

2.55

285

1211

Injuries to the abdomen, lower back, lumbar spine and pelvis

5507

46184

1.26

41.66

3.6

3.2

7.28

7.62

mmol/l

5.82

4605

38675

Toxic effects of substances chiefly nonmedicinal as to source

1559

11317

1.56

41.65

4.7

3.3

7.66

8.13

mmol/l

3.14

1352

9699

Migraine with aura

2903

22807

1.36

41.60

3.0

3.1

7.71

7.54

mmol/l

0.96

2538

19666

Impotence

854

5623

1.91

41.57

4.2

3.3

8.33

8.70

mmol/l

1.52

727

4766

Schizotypal disorder

375

1926

2.58

41.39

4.1

3.2

7.47

8.49

mmol/l

2.79

313

1643

Ovarian dysfunction

851

5414

1.77

41.33

3.2

8.18

7.72

mmol/l

1.56

721

4724

Blepharochalasis

4248

35277

1.31

41.22

3.1

6.89

6.91

mmol/l

0.10

3485

29114

Disorders of vestibular function (Vertigo)

6767

57908

1.23

41.22

3.1

3.2

7.32

7.15

mmol/l

2.36

5533

48245

Spondylolisthesis/Spondylolysis

2624

20599

1.40

41.21

3.0

3.1

7.19

7.36

mmol/l

1.15

2204

17268

Other CVD

2592

20359

1.40

40.74

3.6

3.1

6.66

7.23

mmol/l

10.36

2085

16683

Maternal care for other known or suspected fetal problems

2610

12863

1.38

40.65

3.9

3.1

8.04

7.93

mmol/l

0.50

2333

11314

Explicit bacterial Sepsis

1451

10478

1.58

40.55

4.3

3.1

6.79

7.85

mmol/l

16.03

1230

8741

Diabetic retinopathy

9533

55196

1.32

40.44

5.2

3.8

6.64

7.88

mmol/l

5.19

7932

46096

Otitis externa, unspecified

1471

10637

1.57

40.41

3.9

3.3

7.97

7.86

mmol/l

0.37

1212

9105

Candidiasis

1796

13412

1.50

40.39

4.0

3.2

7.01

7.39

mmol/l

2.57

1481

11321

Sarcoidosis

1901

14379

1.49

40.13

3.8

3.1

7.47

7.65

mmol/l

1.08

1628

12170

Benign neoplasm: Sigmoid colon

2664

21162

1.41

40.10

3.5

3.2

7.47

7.40

mmol/l

0.36

2247

17595

Keratitis

4985

41911

1.27

39.97

3.7

3.2

7.62

7.78

mmol/l

1.59

4217

35375

Transport accidents

6998

53420

1.22

39.90

3.7

3.2

7.92

8.04

mmol/l

1.12

5971

46024

Injuries to the wrist and hand

15749

103326

1.14

39.84

3.5

3.2

8.09

7.94

mmol/l

0.50

13323

87563

Undetermined asthma

1827

13675

1.48

39.68

3.4

3.0

7.33

7.54

mmol/l

1.08

1531

11524

Any prescribed medicine buy

7.65

39.56

2.8

3.3

8.41

8.53

mmol/l

0.04

Other diseases of anus and rectum

4300

35692

1.29

39.53

3.3

3.1

7.26

7.39

mmol/l

1.04

3473

29681

Benign neoplasm: Adrenal gland

1090

7610

1.73

39.53

3.5

3.2

7.38

7.35

mmol/l

0.07

939

6361

Alzheimer’s disease (Late onset), excluding more controls

1231

11589

0.64

39.46

2.5

3.1

7.21

6.70

mmol/l

3.59

942

9371

Mental and behavioural disorders due to hallucinogens

118

364

6.63

39.34

10.9

3.1

6.65

9.37

mmol/l

5.07

317

Disorders of ocular muscles, binocular movement, accommodation and refraction

6525

55581

1.22

39.32

3.5

3.2

7.69

7.83

mmol/l

1.49

5568

47425

Plantar fascial fibromatosis

1349

9654

1.59

39.31

3.1

7.43

7.33

mmol/l

0.32

1153

8163

Cardiodefibrillation

5511

47026

1.26

39.23

3.1

3.2

7.33

7.59

mmol/l

4.50

4543

38746

Parodontitis, operation under 40 years and operation codes

1025

6856

1.65

39.18

5.4

3.6

8.62

8.97

mmol/l

1.08

912

6076

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

1219

8602

1.63

38.99

3.6

3.2

7.52

7.50

mmol/l

0.03

1036

7242

Other shoulder lesions

1261

8915

1.60

38.91

3.8

3.1

7.86

7.73

mmol/l

0.41

1062

7569

Streptococcal septicaemia

1206

8527

1.65

38.89

4.4

3.1

6.62

7.83

mmol/l

18.34

1016

7131

Complications of internal orthopaedic prosthetic devices, implants and grafts

3225

26183

1.35

38.87

3.2

3.1

6.75

7.13

mmol/l

6.09

2687

21486

Other extrapyramidal and movement disorders in other diseases

3138

25397

1.35

38.67

3.3

3.2

7.32

7.28

mmol/l

0.16

2600

21129

Anti-inflammatory and antirheumatic products, non-steroids

4883

20342

1.27

38.59

3.2

3.6

8.03

7.79

mmol/l

2.54

4108

17393

272

1246

2.80

38.55

3.5

3.3

9.04

9.01

mmol/l

0.02

234

1126

Parodontitis, under 40 years and operation codes

1021

6848

1.64

38.52

5.4

3.6

8.63

8.97

mmol/l

1.06

909

6068

Intestinal malabsorption

671

4208

1.97

38.51

4.5

3.3

6.71

7.69

mmol/l

7.01

588

3541

Other/unspecified cytomegaloviral diseases

323

1657

2.89

38.51

9.1

3.1

5.98

8.04

mmol/l

18.28

310

1378

Amputation of foot

407

2268

2.53

37.95

5.4

3.2

5.49

7.91

mmol/l

40.53

354

1867

Acute suppurative otitis media

3316

24953

1.31

37.93

4.1

3.3

8.38

8.61

mmol/l

1.54

2826

21846

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1342

9717

1.59

37.90

3.7

3.2

7.05

7.56

mmol/l

4.29

1139

8157

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

7902

67676

1.20

37.86

3.3

8.04

7.90

mmol/l

1.80

6627

57393

Benign neoplasm: Transverse colon

1474

10931

1.58

37.74

3.8

3.2

7.32

7.40

mmol/l

0.29

1278

9081

Iron deficiency anaemia secondary to blood loss (chronic)

2177

16870

1.42

37.70

3.8

3.1

6.64

7.20

mmol/l

7.77

1790

14009

Polycystic ovarian syndrome

619

3720

1.90

37.69

3.1

3.2

8.58

7.90

mmol/l

2.12

525

3263

Chronic rhinitis, nasopharyngitis and pharyngitis

4466

37355

1.27

37.63

3.3

3.2

7.78

7.64

mmol/l

1.07

3753

31679

Conjunctivitis (acute, non atopic)

3765

30872

1.30

37.60

3.6

3.3

7.55

7.78

mmol/l

2.27

3175

26386

Gastroduodenal ulcer

3773

31043

1.30

37.55

3.8

3.1

6.92

7.47

mmol/l

13.51

3148

25553

Benign neoplasm of other and ill-defined parts of digestive system

2530

20096

1.40

37.51

3.4

3.1

6.97

7.21

mmol/l

1.96

2144

16814

Noninflammatory disorders of female genital tract

6044

25783

1.23

37.28

3.2

3.0

7.10

7.55

mmol/l

0.36

5135

22022

Other and unspecified drugs and medicaments

1143

8055

1.65

37.27

3.7

3.2

7.47

7.46

mmol/l

0.04

974

6776

Mental retardation, excluding more controls

500

2826

2.09

37.17

4.0

3.5

6.87

8.21

mmol/l

7.78

453

2473

Asthma and allergy, excluding more controls

1694

12390

1.46

37.09

3.2

3.0

8.09

8.19

mmol/l

0.34

1497

10788

Symptoms and signs concerning food and fluid intake

1455

10659

1.54

37.01

3.7

3.2

6.76

7.61

mmol/l

9.94

1223

8901

Use of biperiden

785

5157

1.84

37.00

4.1

3.2

6.07

7.89

mmol/l

22.01

659

4371

Alzheimer’s disease, wide definition, excluding more controls

1364

12729

0.67

36.89

2.5

3.0

7.24

6.78

mmol/l

3.22

1043

10340

Cardiomyopathies, Primary/intrinsic

1807

13738

1.48

36.83

3.4

3.2

7.24

8.16

mmol/l

18.25

1527

11431

Failure and rejection of transplanted organs and tissues

246

1168

3.36

36.39

8.9

3.1

5.99

8.35

mmol/l

14.95

232

990

Tubulo-interstitial nephritis, not specified as acute or chronic

939

6359

1.70

36.32

4.4

2.9

6.46

7.34

mmol/l

8.87

801

5264

Subjective visual disturbances

3326

27200

1.32

36.25

3.4

3.2

7.37

7.42

mmol/l

0.28

2788

22838

Non-allergic asthma (mode), excluding more controls

2861

22736

1.34

36.24

3.2

3.0

7.26

7.58

mmol/l

3.46

2505

19174

Unspecified fall

7014

60563

1.21

36.11

3.4

3.2

7.43

7.66

mmol/l

3.65

5792

50928

Cytomegalovirus infection, IBD co-morbidity

364

1981

2.58

36.11

8.6

3.1

5.96

8.01

mmol/l

20.51

344

1652

Benign neoplasm: Adrenal gland

1090

7750

1.69

36.00

3.5

3.2

7.38

7.42

mmol/l

0.11

939

6510

Fitting and adjustment of other devices

5160

40902

1.25

35.94

3.3

3.1

7.10

7.29

mmol/l

2.72

4175

33573

Hypotension

2178

17015

1.42

35.85

3.6

3.1

6.63

7.17

mmol/l

8.14

1748

13899

Stroke, including SAH

9829

64754

1.18

35.81

3.3

3.2

7.10

7.48

mmol/l

14.90

8071

53650

Persistent delusional disorders

1053

7352

1.66

35.80

3.9

3.2

7.17

7.58

mmol/l

1.68

908

6188

Benign neoplasm of other and unspecified endocrine glands

1781

13590

1.48

35.76

3.5

3.2

7.42

7.47

mmol/l

0.15

1540

11437

Asthma and allergy

1693

12454

1.45

35.75

3.2

3.1

8.09

8.17

mmol/l

0.22

1496

10832

Neoplasms

12809

61587

1.15

35.73

3.4

3.3

8.02

8.53

mmol/l

1.50

11044

53065

Habit and impulse disorders

267

1280

2.87

35.73

4.2

3.3

8.74

8.98

mmol/l

0.26

231

1120

Other viral diseases, not elsewhere classified

2407

18894

1.38

35.57

4.1

3.3

7.78

8.10

mmol/l

2.44

2112

16277

Diseases of inner ear

7971

68707

1.19

35.54

3.1

3.2

7.42

7.28

mmol/l

2.03

6523

57302

Nail disorders

1133

8035

1.62

35.29

4.0

3.2

7.33

7.81

mmol/l

2.76

963

6811

Cytomegaloviral disease

372

2052

2.50

35.13

8.5

3.1

6.08

8.01

mmol/l

17.78

352

1713

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

280

1388

2.82

35.01

6.1

3.3

7.07

8.09

mmol/l

3.61

248

1198

Endometriosis

4717

23509

1.25

34.86

3.1

3.0

6.86

7.42

mmol/l

0.43

3955

19974

Primary coxarthrosis, bilateral

4108

34560

1.28

34.72

3.1

7.08

7.07

mmol/l

0.05

3407

28360

SLE, strict definition

512

3088

2.09

34.44

6.2

3.0

6.94

7.14

mmol/l

0.46

455

2623

SLE, ICD10

512

3088

2.09

34.44

6.2

3.0

6.94

7.14

mmol/l

0.46

455

2623

Retinal detachments and breaks

5040

43084

1.25

34.41

3.7

3.1

7.10

7.49

mmol/l

9.18

4212

35773

Systemic lupus erythematosus

531

3237

2.05

34.16

6.1

3.0

6.86

7.15

mmol/l

0.79

470

2749

Fall on same level involving ice and snow

8328

73651

1.18

34.03

3.4

3.2

7.50

7.57

mmol/l

0.70

6998

61994

Nonalcoholic steatohepatitis

161

660

4.63

33.94

4.4

3.0

7.47

7.87

mmol/l

0.58

143

557

Myocarditis

577

3509

1.88

33.90

3.4

2.8

8.07

8.74

mmol/l

2.41

493

2945

Lichen simplex chronicus and prurigo

907

6255

1.71

33.74

3.7

3.1

7.10

7.47

mmol/l

1.85

777

5242

Squamous cell neoplasms and carcinomas of the skin

1642

12474

1.48

33.74

3.8

3.1

6.74

7.04

mmol/l

2.61

1375

10127

Need for other prophylactic measures

793

5331

1.79

33.69

4.0

3.3

7.25

7.70

mmol/l

1.97

710

4512

Granulomatous disorders of skin and subcutaneous tissue

400

2263

2.30

33.68

4.8

3.1

6.83

7.43

mmol/l

1.93

350

1904

Unspecified dementia

648

9113

0.59

33.66

2.7

3.1

6.75

6.64

mmol/l

0.28

486

7297

Other skin changes

2327

18506

1.39

33.66

4.1

3.2

6.94

7.35

mmol/l

5.12

1994

15389

Pilonidal cyst

1143

8129

1.57

33.57

3.8

3.2

8.59

8.98

mmol/l

1.80

979

7068

Any event in hilmo or specialist outpatient

144

243

3.79

33.46

2.8

2.0

8.99

9.95

mmol/l

0.99

126

211

Other diseases of lip and oral mucosa

2188

17231

1.39

33.31

3.7

3.0

7.00

7.45

mmol/l

5.33

1840

14462

Glucosamine medication

7579

53348

1.20

33.09

3.1

6.65

6.92

mmol/l

7.34

6160

43777

Type of accident

3874

32402

1.28

33.02

3.4

3.2

7.44

7.85

mmol/l

6.30

3352

27409

Pruritus

1417

10512

1.50

33.01

4.1

3.1

6.81

7.21

mmol/l

2.62

1184

8817

Corns and callosities

976

6856

1.67

32.96

4.7

3.1

6.69

7.50

mmol/l

7.21

880

5737

Ingrowing nail

751

4986

1.78

32.84

4.2

3.3

7.48

7.98

mmol/l

1.99

632

4257

Benign neoplasm: Transverse colon

1474

11175

1.53

32.83

3.8

3.2

7.32

7.47

mmol/l

0.63

1278

9318

Cardiomyopathy (excluding other)

1840

14252

1.44

32.75

3.4

3.2

7.26

8.12

mmol/l

16.65

1555

11869

Missing teeth due to accident, extraction or parodontitis

1594

12103

1.48

32.66

4.2

3.1

6.89

7.54

mmol/l

8.07

1394

10126

Other/unspecified synovitis and tenosynovitis

1581

11947

1.46

32.46

3.9

3.1

7.41

7.58

mmol/l

0.79

1353

10063

958

6561

1.59

32.31

3.5

3.1

7.89

8.01

mmol/l

0.26

825

5815

Suppurative and unspecified otitis media

4733

35571

1.23

32.19

3.8

3.3

8.15

8.74

mmol/l

0.81

4024

30812

Non-allergic asthma (mode)

2861

23053

1.32

32.12

3.2

3.1

7.26

7.55

mmol/l

2.86

2505

19411

Other symptoms and signs involving the circulatory and respiratory systems

898

6199

1.67

32.03

3.3

3.1

7.38

7.75

mmol/l

1.47

744

5275

Enthesopathies of lower limb, excluding foot

3044

24936

1.31

32.03

3.2

7.77

7.66

mmol/l

0.62

2540

21040

Adverse effects, not elsewhere classified

2506

20089

1.34

31.95

3.5

3.2

7.65

mmol/l

0.00

2082

17127

Pain associated with micturition

1558

11812

1.47

31.87

3.6

3.1

7.24

7.32

mmol/l

0.28

1280

9944

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

15374

91493

1.13

31.78

3.4

3.2

7.20

7.78

mmol/l

50.21

12856

77083

Other enthesopathy of foot (+metatarsalgia)

1347

9976

1.51

31.70

3.2

3.1

7.27

7.28

mmol/l

0.02

1138

8424

Acute nephritic syndrome

352

1968

2.42

31.64

9.8

3.0

6.97

8.11

mmol/l

5.65

330

1652

Unspecified urinary incontinence

1202

8798

1.56

31.59

3.4

3.0

6.75

6.70

mmol/l

0.13

866

7313

Pain in thoracic spine

2000

15635

1.39

31.55

3.0

3.2

7.50

7.56

mmol/l

0.22

1742

13213

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

1094

7898

1.59

31.40

4.0

3.1

6.52

7.04

mmol/l

3.98

942

6527

Previous suicide attempt

170

715

3.58

31.39

3.7

3.0

6.46

8.51

mmol/l

4.61

144

630

Anxious personality disorder

287

1476

2.53

31.34

3.2

7.23

8.58

mmol/l

4.31

249

1284

Pre-eclampsia superimposed on chronic hypertension

102

322

5.23

31.29

5.3

2.5

7.63

7.95

mmol/l

0.31

281

Hyperkinetic disorders (excl. ADHD)

256

1240

2.62

31.28

5.7

4.3

8.20

9.05

mmol/l

1.27

227

1133

Gastric ulcer

2505

20211

1.35

31.19

3.8

3.1

6.76

7.39

mmol/l

11.95

2082

16618

Misadventures to patients during surgical and medical care

1887

14738

1.41

31.15

3.7

3.1

7.17

7.49

mmol/l

2.50

1609

12366

All influenza (not pneumonia)

2082

16407

1.38

31.07

3.9

3.2

7.71

8.19

mmol/l

4.58

1774

13961

Other benign neoplasms of skin

5255

45382

1.23

30.96

3.5

3.2

7.21

7.30

mmol/l

0.76

4331

37737

Fracture of rib(s), sternum and thoracic spine

4150

35209

1.26

30.90

3.6

3.2

7.37

7.79

mmol/l

7.63

3450

29365

Diseases of peritoneum

1371

10263

1.50

30.85

6.0

3.2

6.69

7.43

mmol/l

9.08

1196

8601

Stroke, excluding SAH

9201

61172

1.17

30.84

3.3

3.2

7.08

7.46

mmol/l

13.41

7516

50612

Radial styloid tenosynovitis [de Quervain]

730

4852

1.73

30.83

4.2

3.1

7.53

7.37

mmol/l

0.41

632

4139

Secondary polycythaemia

370

2121

2.34

30.82

3.7

3.2

8.29

8.04

mmol/l

0.43

295

1775

Event of undetermined intent

828

5674

1.69

30.71

4.6

3.4

7.95

8.36

mmol/l

1.30

700

4881

Open wound of wrist and hand

6304

54550

1.20

30.61

3.8

3.3

8.33

8.36

mmol/l

0.22

5253

46591

Use of donepezil

1522

19150

0.71

30.59

2.6

3.1

7.26

6.60

mmol/l

7.03

1138

15422

Brachial plexus disorders

1144

8272

1.54

30.47

2.9

3.0

8.05

7.84

mmol/l

0.76

1031

7105

Dermatophytosis

1790

13968

1.43

30.45

3.8

3.2

7.34

7.79

mmol/l

4.27

1547

11737

Acute peritonitis

867

6035

1.67

30.37

7.7

3.2

6.49

7.69

mmol/l

15.47

777

5047

Tobacco use

716

4804

1.77

30.32

5.5

3.2

7.70

8.08

mmol/l

1.19

617

4084

Personal history of other diseases and conditions

1288

9423

1.48

30.24

4.1

3.1

7.52

7.93

mmol/l

1.88

1109

8187

Early onset COPD

3283

27411

1.30

30.17

3.5

3.2

7.16

7.89

mmol/l

16.93

2671

22958

Metatarsalgia

1253

9254

1.51

30.15

3.2

3.1

7.20

7.26

mmol/l

0.17

1055

7796

Urticaria

3866

32527

1.26

30.14

3.6

3.2

7.70

7.64

mmol/l

0.32

3263

27748

Nondiabetic hypoglycaemic coma

298

6.99

30.11

6.4

3.1

7.02

8.04

mmol/l

1.28

258

Benign neoplasm of other and unspecified endocrine glands

1781

13923

1.43

30.09

3.5

3.2

7.42

7.52

mmol/l

0.37

1540

11718

Preterm labour and delivery

3101

25545

1.29

30.09

3.6

3.1

7.08

6.93

mmol/l

1.14

2686

21748

Unknown and unspecified causes of morbidity

1028

7348

1.58

30.01

4.2

3.1

7.26

7.70

mmol/l

2.65

962

6167

Coagulation defects, purpura and other haemorrhagic conditions

2506

20282

1.34

30.00

4.2

3.2

7.18

7.63

mmol/l

5.55

2165

17109

Other systemic involvement of connective tissue

3705

31158

1.27

29.98

3.2

3.1

6.92

7.04

mmol/l

0.93

3124

25906

Other diseases of arteries and capillaries

1229

9093

1.53

29.97

4.5

3.1

6.51

7.50

mmol/l

15.98

1051

7565

Medical abortion

8790

42417

1.17

29.93

3.2

3.0

6.73

7.13

mmol/l

0.58

7345

35815

Paranoid personality disorder

295

1573

2.49

29.88

4.7

3.0

7.39

8.20

mmol/l

1.77

249

1337

Systemic lupus erythematosus, unspecified

439

2641

2.10

29.86

5.7

3.0

6.79

7.08

mmol/l

0.67

388

2249

Hydronephrosis

1498

11402

1.46

29.83

4.3

2.9

6.75

7.69

mmol/l

15.88

1276

9446

Hypopituitarism

912

6407

1.63

29.74

4.5

3.5

8.50

mmol/l

0.00

792

5517

Osteoporosis with pathological fracture (FG)

890

6262

1.66

29.62

3.4

2.9

5.46

6.04

mmol/l

5.13

753

5104

Other hearing loss

3764

31196

1.26

29.47

3.3

3.1

7.03

7.13

mmol/l

0.73

2920

25694

Undefined dementia

652

9095

0.61

29.46

2.7

3.0

6.74

6.67

mmol/l

0.17

488

7247

Benign neoplasm: Ascending colon

1824

14400

1.43

29.35

3.7

3.2

7.28

mmol/l

0.00

1542

11910

Benign neoplasm: Rectum, anus and anal canal

2813

23232

1.32

29.30

3.3

3.2

7.49

7.37

mmol/l

0.78

2375

19215

Restless leg syndrome

1601

12363

1.44

29.27

3.3

3.2

7.38

7.28

mmol/l

0.41

1322

10396

Open wound of head

7704

67397

1.17

29.19

3.6

3.2

7.46

7.97

mmol/l

16.60

6315

56855

Single delivery by forceps and vacuum extractor

986

8474

0.66

29.19

3.1

3.4

7.97

7.82

mmol/l

0.40

867

7471

Other complications of surgical and medical care, not elsewhere classified

1278

9532

1.50

29.11

3.6

3.2

7.31

7.49

mmol/l

0.63

1088

8042

Other general symptoms and signs

669

4376

1.75

28.97

3.2

7.46

7.78

mmol/l

0.85

543

3735

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

1911

14954

1.37

28.93

3.6

3.1

7.12

7.11

mmol/l

0.02

1653

12772

Other symptoms and signs involving the digestive system and abdomen

2227

17846

1.35

28.89

3.3

3.1

6.80

6.93

mmol/l

0.74

1787

14996

Thyrotoxicosis

3273

27297

1.28

28.84

3.4

3.1

6.99

7.08

mmol/l

0.53

2703

22946

Other female pelvic inflammatory diseases

2074

16491

1.36

28.81

3.5

3.0

6.74

6.58

mmol/l

0.85

1678

13844

Leiomyoma of uterus

8394

42420

1.17

28.75

3.0

6.64

6.61

mmol/l

0.25

6878

35834

Unspecified privation

1431

10890

1.46

28.61

4.0

3.3

7.32

7.73

mmol/l

2.57

1233

9197

Abnormal results of function studies

1157

8546

1.53

28.60

3.8

3.3

7.42

7.69

mmol/l

1.18

982

7254

Disorders of conjunctiva

12178

92742

1.13

28.51

3.4

3.2

7.43

7.85

mmol/l

1.91

10312

78646

L04AX Other immunosuppressants

7993

71274

1.17

28.45

3.8

3.2

7.42

7.65

mmol/l

4.52

6940

60211

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

1642

12778

1.43

28.42

3.8

3.1

6.74

7.08

mmol/l

3.22

1375

10458

Childhood asthma (age<16), excluding more controls

1563

9354

1.40

28.39

3.7

3.2

8.72

9.14

mmol/l

2.02

1398

8350

Fenamates

2229

11949

1.35

28.34

3.0

3.5

7.15

7.14

mmol/l

0.05

1857

10147

Benign neoplasm: Rectum

2501

20511

1.34

28.30

3.3

3.2

7.52

7.39

mmol/l

0.78

2114

16961

Hypertrophy of breast in women and men

2428

19680

1.32

28.03

3.0

3.1

7.55

7.20

mmol/l

3.00

2023

16691

Later onset COPD

2908

27436

0.78

27.97

3.1

3.2

6.80

7.16

mmol/l

5.36

2315

22182

Heartburn

1404

10680

1.46

27.88

3.2

3.1

7.76

7.57

mmol/l

0.78

1161

9033

Thyrotoxicosis, other and/or unspecified

2493

20291

1.32

27.74

3.3

3.1

7.14

7.21

mmol/l

0.29

2062

17079

Oligomenorrhoea

457

2777

1.92

27.74

3.7

3.1

7.28

7.24

mmol/l

0.06

387

2388

Childhood asthma (age<16)

1563

9391

1.40

27.73

3.7

3.2

8.72

9.14

mmol/l

2.02

1398

8386

Other diseases of intestine

1705

13377

1.41

27.72

3.9

3.1

7.30

7.53

mmol/l

1.38

1460

11176

Second line medication for Crohn's disease

8184

73195

1.16

27.63

3.8

3.2

7.44

7.67

mmol/l

4.49

7112

61865

Other symptoms and signs involving general sensations and perceptions

537

3450

1.87

27.60

3.7

3.2

7.20

7.43

mmol/l

0.49

454

2892

Other and unspecified vascular occlusions

1251

9424

1.50

27.60

3.6

3.0

6.68

7.12

mmol/l

3.30

1021

7760

Stomatitis and related lesions

1068

7784

1.53

27.56

3.8

3.1

7.48

7.85

mmol/l

1.59

892

6653

Erosion of teeth

254

1326

2.58

27.46

6.7

3.2

6.63

8.40

mmol/l

8.68

229

1168

Dysphagia

3414

28766

1.27

27.41

3.3

3.1

7.19

7.36

mmol/l

1.42

2841

23894

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

409

6568

0.54

27.40

2.8

3.2

7.09

7.29

mmol/l

0.42

321

5439

Radiculopathy

2279

18447

1.34

27.39

3.2

3.1

7.37

7.32

mmol/l

0.17

1897

15256

Ischaemic Stroke, excluding all haemorrhages

8520

57782

1.17

27.38

3.3

3.2

7.09

7.42

mmol/l

10.34

6936

47689

Benign neoplasm: Stomach

1330

10141

1.49

27.36

3.4

3.1

6.76

7.04

mmol/l

1.67

1108

8407

Other diseases of stomach and duodenum

890

6359

1.62

27.33

4.0

3.1

6.89

7.35

mmol/l

2.57

763

5320

Abnormalities of gait and mobility

1612

12605

1.43

27.33

3.6

3.2

7.17

7.43

mmol/l

1.36

1348

10447

Cardiac murmurs and other cardiac sounds

1205

8836

1.48

27.25

4.1

3.3

7.45

7.74

mmol/l

1.17

1057

7614

Other disorders of nervous system

927

6695

1.61

27.21

3.9

3.2

7.29

7.62

mmol/l

1.50

760

5609

Oesophageal varices

605

4059

1.84

27.03

4.1

3.2

6.98

7.93

mmol/l

5.90

503

3390

Fungal Sepsis

538

3506

1.89

26.97

5.1

3.1

6.21

7.62

mmol/l

13.11

465

2918

Temporomandibular joint disorders

2053

16350

1.34

26.95

3.0

7.50

7.37

mmol/l

0.56

1741

13929

Other disorders of the musculoskeletal system and connective tissue

1958

15665

1.37

26.93

3.1

3.2

7.44

7.43

mmol/l

0.04

1675

13117

Infective dermatitis

1574

12253

1.42

26.80

3.6

3.2

7.53

7.75

mmol/l

1.07

1314

10310

Disorders of muscles

1324

10032

1.46

26.77

3.4

3.2

7.62

7.82

mmol/l

0.84

1110

8481

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

1692

13377

1.41

26.57

3.6

3.2

7.06

7.56

mmol/l

5.27

1397

11118

Use of memantine

2127

22898

0.76

26.57

2.5

3.1

7.00

6.59

mmol/l

4.68

1622

18414

Use of other anti-dementia drugs

2127

22898

0.76

26.57

2.5

3.1

7.00

6.59

mmol/l

4.68

1622

18414

Benign neoplasm: Rectum, anus and anal canal

2813

23464

1.30

26.54

3.3

3.2

7.49

7.39

mmol/l

0.66

2375

19553

Diplopia

1733

13682

1.40

26.49

3.6

3.2

7.43

7.58

mmol/l

0.62

1455

11489

Benign neoplasm: Rectum

2501

20657

1.33

26.46

3.3

3.2

7.52

7.42

mmol/l

0.60

2114

17214

Open wound of lower leg

1906

15180

1.37

26.43

4.1

3.2

7.04

7.77

mmol/l

10.03

1631

12802

Open wound of forearm

1207

9057

1.48

26.38

4.4

3.3

7.67

8.05

mmol/l

1.50

990

7684

Abnormal blood-pressure reading, without diagnosis

609

4049

1.76

26.35

3.0

3.2

7.75

7.41

mmol/l

1.02

522

3436

Traction detachment of retina

157

704

3.54

26.28

7.5

2.8

6.10

7.98

mmol/l

8.43

142

589

Iridocyclitis

3055

25566

1.28

26.27

3.6

3.2

7.42

7.69

mmol/l

2.76

2656

21535

Neovascular glaucoma

546

3555

1.83

26.27

4.8

3.0

6.50

7.61

mmol/l

9.12

468

2949

Pustular psoriasis

646

4386

1.75

26.16

3.5

3.1

7.16

7.32

mmol/l

0.40

522

3720

Donors of organs and tissues

219

1111

2.72

25.90

2.7

3.0

7.64

8.32

mmol/l

1.48

211

951

In situ neoplasms

4834

42058

1.21

25.69

3.5

3.1

6.77

7.03

mmol/l

4.28

3959

34795

Assault by unspecified means

296

1650

2.27

25.59

5.7

3.4

7.51

8.83

mmol/l

3.36

251

1429

Examination and encounter for administrative purposes

601

4026

1.76

25.53

3.9

3.0

8.04

8.03

mmol/l

0.01

525

3337

Zoster [herpes zoster]

2329

19077

1.32

25.48

4.0

3.1

7.09

7.19

mmol/l

0.51

1947

15837

Other maltreatment syndromes

431

2664

1.94

25.41

4.8

3.4

8.49

8.78

mmol/l

0.49

385

2296

Other noninfective gastroenteritis and colitis

3205

26957

1.26

25.30

3.7

3.2

7.34

7.56

mmol/l

1.85

2731

22727

Superficial injury of wrist and hand

2482

20368

1.30

25.29

3.7

3.2

8.11

8.06

mmol/l

0.14

2114

17549

Toxic effect of other and unspecified substances

203

1003

2.74

25.29

6.1

3.3

6.68

8.68

mmol/l

7.04

179

858

Benign neoplasm: Descending colon

936

6887

1.59

25.28

3.7

3.2

7.44

7.39

mmol/l

0.12

823

5706

Chronic hepatitis, not elsewhere classified

483

3111

1.90

25.10

3.9

3.1

7.04

7.49

mmol/l

1.55

417

2635

Pustulosis palmaris et plantaris

585

3925

1.78

25.08

3.5

3.1

7.09

7.30

mmol/l

0.57

473

3338

Cyst of kidney

946

6971

1.58

25.02

3.8

3.2

7.04

7.43

mmol/l

2.18

808

5797

Personal history of risk-factors, not elsewhere classified

200

985

2.73

25.02

3.8

3.3

6.42

8.30

mmol/l

5.00

169

850

Drug-induced cataract

361

2184

2.16

25.02

6.7

3.1

6.28

7.61

mmol/l

8.41

327

1835

Fall on and from stairs and steps

3372

28595

1.25

24.98

3.3

3.2

7.46

7.54

mmol/l

0.41

2748

24046

Car occupant injured in other and unspecified transport accidents

2390

19578

1.30

24.88

3.9

3.2

7.84

8.03

mmol/l

1.07

2028

16788

Type 1 diabetes, wide definition, subgroup 2

172

766

2.63

24.73

4.9

2.4

7.19

7.51

mmol/l

0.43

158

645

Disorders of tooth development and eruption

608

3934

1.69

24.71

6.2

3.3

7.31

8.63

mmol/l

8.59

551

3475

L02BA Anti-estrogens

1308

16956

0.72

24.66

2.6

3.0

6.50

6.49

mmol/l

0.03

1064

14175

Other symptoms and signs involving the urinary system

1407

10935

1.43

24.66

3.8

3.2

7.37

7.93

mmol/l

4.84

1228

9171

Renal agenesis and other reduction defects of kidney

101

380

4.95

24.64

7.9

3.4

6.57

7.87

mmol/l

2.49

327

Social disorders starting during childhood or adolecense, excluding more controls

108

394

3.68

24.62

3.4

3.6

8.27

9.18

mmol/l

0.78

357

Benign neoplasm: Ascending colon

1824

14716

1.38

24.60

3.7

3.2

7.28

7.31

mmol/l

0.08

1542

12227

Fissure and fistula of anal and rectal regions

3455

29397

1.25

24.51

3.3

3.2

7.88

7.78

mmol/l

0.69

2840

24769

Basal cell carcinoma, including avohilmo

8436

59942

1.16

24.51

3.3

3.2

6.89

7.17

mmol/l

8.55

6835

49267

Follicular cysts of skin and subcutaneous tissue

2439

20140

1.30

24.43

3.5

3.2

7.39

7.84

mmol/l

5.31

2120

17009

Short Achilles tendon (acquired)

388

2371

2.00

24.42

2.8

3.1

6.80

7.37

mmol/l

2.32

371

2014

Leisure time condition

2301

18872

1.31

24.37

3.5

3.2

7.38

7.76

mmol/l

3.34

1941

15998

Non-small cell lung cancer, adenocarcinoma

409

6401

0.56

24.30

2.8

3.2

7.09

7.23

mmol/l

0.27

321

5268

Non-small cell lung cancer, adenocarcinoma, helper endpoint

409

6401

0.56

24.30

2.8

3.2

7.09

7.23

mmol/l

0.27

321

5268

Polycystic ovarian syndrome, broad definition

1095

8083

1.45

24.28

3.3

3.2

8.20

7.87

mmol/l

1.25

957

7091

Calcific tendinitis of shoulder

773

5472

1.61

24.27

3.2

3.1

7.40

7.47

mmol/l

0.19

662

4638

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

1482

11669

1.42

24.24

3.7

3.2

7.10

7.55

mmol/l

3.87

1227

9727

Lateral epicondylitis

1753

13948

1.36

24.20

3.2

3.1

8.11

7.81

mmol/l

1.89

1528

11901

Basal cell carcinoma

8215

59029

1.16

24.16

3.3

3.2

6.89

7.15

mmol/l

7.61

6653

48498

Other benign neoplasms of skin

5255

45325

1.20

24.14

3.5

3.2

7.21

7.34

mmol/l

1.35

4331

38025

Neuromuscular dysfunction of bladder

1228

9397

1.46

24.07

3.5

3.1

6.84

7.70

mmol/l

9.23

997

7903

Vascular disorders of the intestines

894

6521

1.56

24.05

3.7

3.1

6.54

7.21

mmol/l

6.34

759

5378

Malignant neoplasm of urinary organs

1338

10395

1.45

24.05

3.6

3.2

7.05

7.52

mmol/l

3.85

1099

8611

Toxic effect of ethanol

549

3639

1.76

23.99

5.8

3.3

7.60

8.46

mmol/l

3.78

485

3110

Conjunctivitis

10768

85573

1.13

23.97

3.4

3.2

7.48

7.83

mmol/l

1.30

9139

72767

Vitamin deficiency

609

4127

1.71

23.93

3.9

3.1

7.33

7.43

mmol/l

0.20

516

3467

Vitamin deficiency, wide

609

4127

1.71

23.93

3.9

3.1

7.33

7.43

mmol/l

0.20

516

3467

Striking against or struck by other objects

4376

37912

1.21

23.92

3.6

3.4

8.26

8.39

mmol/l

0.90

3644

32592

Prolonged pregnancy

853

10861

0.68

23.91

2.1

3.2

7.64

7.81

mmol/l

0.44

768

9498

Strabismus

3440

29224

1.24

23.83

3.5

3.3

7.62

7.78

mmol/l

1.12

2925

24917

Atrophic disorders of skin

1824

14645

1.35

23.79

3.4

3.0

6.86

6.93

mmol/l

0.30

1523

12224

Other problems related to upbringing

286

2.59

7.66

6.0

3.0

8.02

9.40

mmol/l

0.89

255

Diabetic nephropathy

3877

36145

1.18

7.65

7.4

3.8

5.98

7.80

mmol/l

223.55

3557

29914

L04AC Interleukin inhibitors

542

4334

1.35

7.63

3.3

8.14

8.15

mmol/l

0.03

471

3748

Malignant neoplasm of oesophagus

156

2318

0.60

7.62

2.5

3.2

7.54

7.83

mmol/l

0.32

125

1913

Ankylosing hyperostosis [Forestier]

186

1282

1.74

7.61

3.4

3.2

8.03

7.87

mmol/l

0.21

162

1060

Hallux rigidus

1788

15865

1.18

7.61

3.0

3.1

7.38

7.13

mmol/l

1.52

1456

13165

153

1002

1.80

7.58

4.5

3.1

7.30

8.21

mmol/l

1.06

122

850

Other degenerative diseases of the nervous system

2899

24206

0.88

7.58

2.9

3.1

7.26

7.22

mmol/l

0.18

2293

20073

Bicipital tendinitis

581

4702

1.34

7.57

3.1

3.2

8.20

7.96

mmol/l

0.62

512

3991

Malignant neoplasm of pancreas

473

5956

0.74

7.57

2.6

3.1

6.79

7.21

mmol/l

1.61

371

4898

Other spirochaetal diseases

2726

29981

0.88

7.56

3.0

3.2

7.54

7.40

mmol/l

0.88

2121

25167

Traumatic subdural haemorrhage

1529

13184

1.19

7.55

3.2

3.1

6.95

7.45

mmol/l

4.49

1259

10845

Psoriatic arthropathies, ICD10

1256

10890

1.22

7.53

3.0

3.2

7.87

7.81

mmol/l

0.17

1047

9269

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

326

2.70

7.51

4.5

2.8

7.99

7.72

mmol/l

0.15

274

Motor disorders

170

1124

1.70

7.51

4.2

4.7

7.93

8.87

mmol/l

1.14

150

1046

Erythema nodosum

353

2686

1.46

7.50

3.5

3.1

7.27

mmol/l

0.00

298

2255

Disorders of optic nerve and visual pathways

1050

8962

1.24

7.50

4.0

3.3

7.31

7.62

mmol/l

1.44

906

7620

Other disorders of pigmentation

517

4139

1.37

7.50

3.3

3.1

6.83

7.23

mmol/l

1.48

436

3463

Neuroendocrine tumor and carcinoma of pancreas

502

2.30

7.48

3.0

3.2

6.71

7.89

mmol/l

1.95

417

Malignant neoplasm of heart, mediastinum and pleura

1077

0.45

7.46

2.1

3.2

9.03

7.39

mmol/l

1.67

867

TMD related operations

1904

16939

1.17

7.46

3.0

3.2

7.79

mmol/l

0.00

1645

14483

Other localized connective tissue disorders

247

1790

1.59

7.44

4.1

3.0

6.79

7.03

mmol/l

0.36

202

1501

Deficiency of other B group vitamins

242

1735

1.57

7.43

3.3

3.0

7.06

mmol/l

0.00

196

1427

Adenocarcinoma and ductal carcinoma of pancreas

229

3164

0.66

7.43

2.5

3.2

6.98

7.25

mmol/l

0.49

184

2593

Other specified and unspecified disorders of lens

117

727

1.98

7.40

3.4

3.0

5.96

6.35

mmol/l

0.55

603

Sulfasalazine

3826

35265

1.11

7.40

3.1

7.58

7.71

mmol/l

0.97

3286

29642

Pulmonary embolism

3696

34046

1.12

7.39

3.4

3.1

7.39

7.32

mmol/l

0.40

3037

28140

Benign neoplasm: Rectosigmoid junction

502

4032

1.38

7.39

3.5

3.2

7.40

7.30

mmol/l

0.20

416

3347

Temporomandibular joint disorders, including avohilmo

4979

46239

1.10

7.37

3.0

3.2

7.73

7.94

mmol/l

0.28

4221

39654

Algoneurodystrophy

372

2853

1.43

7.36

3.7

3.0

8.15

7.71

mmol/l

0.85

323

2429

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

7140

46432

1.09

7.35

3.3

3.2

6.94

7.27

mmol/l

9.54

5784

38682

COPD, hospital admissions 3, with asthma pneumonia sepsis

2972

27670

0.89

7.35

3.3

3.2

6.62

7.46

mmol/l

25.25

2427

22647

Hypertension, Pulmonary Arterial

541

2.05

7.34

3.5

2.6

6.23

7.14

mmol/l

1.55

442

Brain glioblastoma

1180

0.47

7.33

2.5

3.0

9.35

7.76

mmol/l

1.04

962

Muscle strain

359

2737

1.44

7.33

3.2

3.1

7.96

8.06

mmol/l

0.13

299

2335

Endocrine disorders, other/unspecified

247

1789

1.57

7.32

3.5

3.1

7.30

7.64

mmol/l

0.50

185

1499

Pneumococcal septicemia

387

2997

1.43

7.31

4.2

3.3

6.50

7.92

mmol/l

8.06

322

2516

Malignant neoplasm, without specification of site

175

2556

0.63

7.30

2.8

3.1

7.30

7.12

mmol/l

0.19

131

2059

Eosinophilia

206

1453

1.65

7.29

3.4

3.3

7.15

7.67

mmol/l

1.00

167

1212

Pulmonary heart disease

3696

34067

1.12

7.29

3.4

3.1

7.39

7.32

mmol/l

0.41

3037

28160

Polyarteritis nodosa

544

2.13

7.28

6.3

3.1

6.75

7.55

mmol/l

0.88

448

Additional codes for the location of defect, injury or illness

653

5373

1.31

7.28

3.4

3.2

7.47

7.62

mmol/l

0.37

586

4553

Complications of genitourinary prosthetic devices, implants and grafts

291

2163

1.51

7.27

3.8

3.1

6.64

7.22

mmol/l

1.73

249

1806

Other orthopaedic follow-up care

671

5532

1.30

7.26

3.5

3.1

7.35

7.58

mmol/l

0.66

563

4634

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

280

3728

0.68

7.23

2.8

3.2

7.36

8.00

mmol/l

1.63

231

3103

Carrier of infectious disease

271

1992

1.52

7.20

8.9

3.2

7.22

7.76

mmol/l

1.08

223

1683

Reactive arthropathies, FINNGEN

811

6795

1.26

7.20

3.2

7.52

7.89

mmol/l

1.40

691

5781

Findings of drugs and other substances, not normally found in blood

351

2.53

7.19

3.6

3.1

6.44

8.19

mmol/l

3.05

286

Rosacea

1291

11243

1.21

7.19

3.5

3.1

7.24

7.39

mmol/l

0.56

1110

9501

Other and unspecified diseases of blood and blood-forming organs

310

2343

1.50

7.19

4.4

3.1

7.47

7.58

mmol/l

0.14

247

1962

Pervasive developmental disorders excl. Autism + Asperger

132

833

1.81

7.17

3.9

4.5

8.66

8.75

mmol/l

0.05

110

770

Other psoriatic arthropathies

1220

10599

1.21

7.15

3.0

3.2

7.86

7.83

mmol/l

0.08

1014

9017

Bursitis of shoulder

300

2247

1.49

7.14

3.3

3.1

7.50

7.59

mmol/l

0.13

261

1910

117

725

1.90

7.13

4.0

3.1

7.13

8.34

mmol/l

1.68

631

Other and unspecified disorders of white blood cells

482

3856

1.37

7.10

3.7

3.3

7.23

7.54

mmol/l

0.73

401

3241

Open wound of thorax

192

1336

1.65

7.10

4.9

3.2

7.39

8.56

mmol/l

2.54

171

1130

Separation of retinal layers (serosa)

486

3889

1.37

7.09

3.8

3.1

8.08

8.26

mmol/l

0.36

427

3291

Carcinoma in situ of other and unspecified sites

447

3573

1.40

7.07

3.3

3.2

7.45

7.89

mmol/l

1.63

351

2956

Impacted cerumen

1156

10027

1.22

7.06

3.4

3.2

7.25

7.36

mmol/l

0.35

808

8376

Open wound of hip and thigh

372

2871

1.42

7.05

4.6

3.4

7.71

8.51

mmol/l

2.19

316

2443

Other abnormal immunological findings in serum

223

1593

1.58

7.04

3.6

3.2

7.56

7.74

mmol/l

0.23

198

1359

Carcinoma in situ of skin of lower limb, including hip

254

1885

1.58

7.03

4.2

3.1

6.13

6.67

mmol/l

1.38

208

1559

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

184

1276

1.68

7.03

3.3

3.1

7.69

7.58

mmol/l

0.10

165

1076

Other and unspecified injuries of ankle and foot

449

3541

1.37

7.01

3.8

3.3

7.68

8.03

mmol/l

0.83

364

3050

Other congenital malformations

910

7702

1.24

7.00

3.4

3.5

8.15

7.85

mmol/l

0.92

826

6685

Other other unspecified disorders of the circulatory system

435

3445

1.39

6.99

3.7

3.1

6.86

7.33

mmol/l

1.59

354

2879

Melanocytic naevi of trunk

1356

11875

1.20

6.98

4.1

3.2

7.43

7.75

mmol/l

1.95

1199

10096

Paget disease

465

2.37

6.96

4.3

3.2

6.65

7.56

mmol/l

1.48

379

Other and unspecified iridocyclitis

488

3909

1.36

6.95

3.2

7.75

7.66

mmol/l

0.15

426

3306

Impetigo

456

3604

1.36

6.92

4.4

3.3

7.88

8.37

mmol/l

1.27

408

3109

LSIL lesion of the vulva

316

2389

1.46

6.92

4.4

2.9

6.45

6.87

mmol/l

1.17

258

2034

L01XE Protein kinase inhibitors

476

5891

0.75

6.91

3.1

3.2

7.01

7.36

mmol/l

1.08

381

4933

Other erythematous conditions

408

3208

1.40

6.91

3.6

3.2

6.99

7.34

mmol/l

0.75

345

2696

Other misadventures during surgical and medical care

251

1845

1.55

6.91

4.3

3.1

7.11

7.68

mmol/l

1.10

204

1535

Somnolence, stupor and coma

493

3948

1.35

6.89

4.3

3.2

6.90

7.68

mmol/l

3.46

423

3328

Other drug-induced secondary parkinsonism

128

836

1.91

6.88

3.5

3.2

5.94

7.42

mmol/l

3.35

105

692

Traumatic ischaemia of muscle

167

1141

1.71

6.88

4.3

3.2

7.61

8.35

mmol/l

1.37

147

970

Benign intracranial hypertension

105

636

1.92

6.86

3.1

3.2

7.22

8.41

mmol/l

1.61

552

Injury of nerves at forearm level

167

1143

1.71

6.85

3.2

3.3

8.53

mmol/l

0.00

148

968

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

1635

14536

1.18

6.84

3.3

3.2

7.76

7.60

mmol/l

0.74

1400

12291

Herpesviral keratitis and keratoconjunctivitis

510

4121

1.35

6.83

4.1

3.2

7.51

7.53

mmol/l

0.02

442

3457

Cystic fibrosis

179

3.29

6.80

4.3

3.0

7.13

7.98

mmol/l

0.46

149

Benign neoplasm: Rectosigmoid junction

502

4073

1.36

6.80

3.5

3.2

7.40

7.36

mmol/l

0.08

416

3417

Other and unspecified disorders of vitreous body

5527

51650

1.09

6.79

3.1

7.08

7.06

mmol/l

0.14

4587

42829

Atypical facial pain

570

4653

1.32

6.78

2.9

3.0

7.59

7.14

mmol/l

1.35

480

3917

Disorders of phosphorus metabolism and phosphatases

396

2.39

6.78

4.3

2.7

7.23

8.09

mmol/l

0.72

345

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

7244

47126

1.08

6.77

3.3

3.2

6.95

7.28

mmol/l

9.89

5870

39275

Other disorders of electrolyte and fluid balance, not elsewhere classified

109

677

1.93

6.76

3.5

2.8

5.82

7.19

mmol/l

2.51

554

Entropion and trichiasis of eyelid

989

8501

1.23

6.76

3.3

3.1

6.89

7.08

mmol/l

0.77

822

6981

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

483

5984

0.76

6.73

3.0

3.2

7.32

7.50

mmol/l

0.36

382

4964

Endometriosis of pelvic peritoneum

1698

14864

1.16

6.69

2.8

3.1

7.31

8.03

mmol/l

0.33

1435

12753

Pollen allergy

1972

17460

1.15

6.69

3.3

3.4

8.36

8.32

mmol/l

0.11

1675

15301

Other specified and unspecified retinal disorders

403

3183

1.39

6.64

4.0

3.1

6.86

7.45

mmol/l

2.12

347

2660

Hyperprolactinaemia

351

2698

1.40

6.62

3.5

3.2

8.22

7.86

mmol/l

0.53

300

2336

Acute generalized exanthematous pustulosis

505

4085

1.34

6.61

3.6

3.2

6.99

7.52

mmol/l

2.01

423

3438

Other chronic obstructive pulmonary disease

6127

47984

1.09

6.60

3.3

3.2

6.99

7.56

mmol/l

20.96

4936

39428

Myositis

307

2337

1.46

6.60

4.0

3.2

7.14

7.61

mmol/l

1.14

257

1980

Filling of root of tooth

358

2786

1.42

6.58

4.7

3.3

7.01

7.93

mmol/l

3.57

318

2360

Other disorders of veins

5122

47951

1.09

6.56

3.1

6.91

7.26

mmol/l

7.17

4147

40204

Mesothelioma, excluding all cancers (controls excluding all cancers)

1229

0.51

6.56

2.8

3.2

8.93

7.66

mmol/l

1.29

1017

Contusion of toe(s) without damage to nail

267

1983

1.48

6.55

3.2

7.38

8.19

mmol/l

2.06

238

1705

Other hyperalimentation

242

2.81

6.55

4.0

2.7

7.45

7.33

mmol/l

0.04

205

Heterophoria

871

7405

1.24

6.54

3.4

3.3

7.67

7.78

mmol/l

0.26

741

6371

Benign neoplasm of major salivary glands

1169

10206

1.21

6.53

3.3

3.2

7.39

7.48

mmol/l

0.29

972

8538

Injury of eye and orbit

1712

15269

1.16

6.52

3.7

3.3

8.22

8.45

mmol/l

1.06

1469

13124

Toxic encephalopathy

211

3.53

6.52

4.6

3.0

8.16

8.12

mmol/l

0.02

169

L02BX Other hormone antagonists and related agents

461

5661

0.75

6.52

3.2

3.3

7.36

8.08

mmol/l

4.21

358

4681

Other fall from one level to another

2720

24843

1.13

6.52

3.5

3.3

8.01

8.19

mmol/l

1.06

2330

21193

Sequelae of hyperalimentation

114

4.04

6.48

4.9

2.8

6.81

8.03

mmol/l

0.60

Neuroendocrine tumor and carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

526

2.16

6.46

3.0

3.2

6.71

7.79

mmol/l

1.72

447

Varicose veins

9193

66138

1.07

6.45

3.2

3.1

6.68

7.28

mmol/l

40.23

7686

55047

Other pulmonary heart/vessel disease

520

4237

1.33

6.44

3.5

3.1

6.55

7.13

mmol/l

2.69

435

3458

Decubitus ulcer and pressure area

633

5253

1.29

6.44

4.5

3.1

6.00

7.45

mmol/l

18.30

526

4314

Alzheimer’s disease (Atypical or mixed)

634

7618

0.79

6.42

2.4

3.0

6.71

6.51

mmol/l

0.64

483

6033

Calculus of lower urinary tract

633

5273

1.30

6.41

3.5

3.3

8.24

7.87

mmol/l

1.32

514

4362

Spondyloarthritis

2161

19520

1.14

6.40

3.4

3.2

7.57

7.87

mmol/l

2.18

1840

16506

Other and unspecified abdominal hernia

484

3924

1.35

6.40

3.6

3.2

7.26

7.23

mmol/l

0.05

402

3281

Vascular syndromes of brain in cerebrovascular disorders

540

4432

1.32

6.37

3.3

3.2

7.15

7.21

mmol/l

0.13

481

3662

Other and unspecified bullous disorders

128

845

1.82

6.37

4.0

3.0

6.70

7.51

mmol/l

1.29

115

708

Cluster headache, strict, including avohilmo

522

4244

1.32

6.36

2.9

3.3

8.17

8.16

mmol/l

0.01

450

3640

Lipomatosis, not elsewhere classified

219

2.95

6.36

3.9

2.8

7.71

7.72

mmol/l

0.00

185

Infective bursitis

346

2699

1.42

6.31

3.8

3.2

7.58

8.21

mmol/l

1.95

303

2295

Other corneal oedema

102

643

1.98

6.29

3.3

3.1

6.31

7.09

mmol/l

1.23

528

Viral haemorrhagic fevers, not elsewhere classified/unspecified

948

8176

1.23

6.28

3.2

8.22

7.96

mmol/l

0.95

853

6959

Personal history of medical treatment

115

740

1.86

6.28

3.7

3.0

7.69

7.70

mmol/l

0.01

625

Inflammatory disorders of breast

628

5197

1.28

6.26

3.6

3.2

6.79

7.09

mmol/l

0.95

533

4469

Cerebral aneurysm, nonruptured

1027

8912

1.22

6.26

3.2

3.1

7.24

7.38

mmol/l

0.44

899

7502

Histrionic personality disorder

428

2.24

6.26

3.5

3.0

6.36

7.64

mmol/l

1.73

355

Drug-induced osteoporosis

150

1029

1.73

6.26

4.4

3.1

6.14

7.18

mmol/l

2.30

129

841

Magnesium deficiency

236

2.91

6.25

3.5

3.1

6.16

7.73

mmol/l

1.96

192

Other and unspecified mental retardation

174

1212

1.62

6.24

4.5

4.1

6.42

8.17

mmol/l

5.54

160

1081

Non-Hodgkin lymphoma, all

276

3620

0.71

6.21

2.5

3.1

6.87

7.38

mmol/l

1.51

216

2975

Kyphosis

168

1177

1.67

6.21

3.4

3.2

6.59

7.42

mmol/l

1.87

146

987

Ulcerative enterocolitis

365

2862

1.39

6.20

3.5

3.2

8.48

8.11

mmol/l

0.74

323

2429

Benign neoplasm of mouth and pharynx

1314

11601

1.19

6.19

3.6

3.2

7.53

7.48

mmol/l

0.16

1098

9757

Postinfectious hypothyroidism

441

2.15

6.17

5.8

2.9

6.33

6.82

mmol/l

0.52

365

Narcolepsy and cataplexy

528

1.99

6.17

3.4

3.0

7.52

8.09

mmol/l

0.48

447

Severe visual impairment, binocular

375

2.28

6.16

5.4

3.0

6.33

7.32

mmol/l

1.02

311

Normotensive glaucoma

1005

8741

1.22

6.16

3.3

3.1

6.52

6.68

mmol/l

0.59

798

7166

Combined immunodeficiencies

138

929

1.74

6.15

3.5

3.0

7.04

7.51

mmol/l

0.57

112

785

Trigeminal neuralgia

643

5362

1.28

6.15

3.0

7.28

7.19

mmol/l

0.17

528

4489

Disorders of parathyroid gland, other and/or unspecified

600

2.00

6.14

3.4

3.0

6.18

6.76

mmol/l

0.71

488

Benign neoplasm: Duodenum

324

2536

1.45

6.14

3.1

3.2

7.32

7.38

mmol/l

0.07

264

2122

Benign neoplasm: Endocrine pancreas

559

2.10

6.14

3.2

6.96

7.69

mmol/l

0.96

455

Monoplegia

184

1311

1.61

6.14

3.9

3.1

8.16

7.58

mmol/l

0.75

160

1099

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

210

3.01

6.11

6.9

3.2

7.35

8.76

mmol/l

1.21

189

Dislocation of lens

163

1127

1.63

6.10

3.5

3.0

6.46

7.08

mmol/l

1.58

132

926

Speech disturbances, not elsewhere classified

993

8608

1.22

6.09

3.3

3.1

7.25

7.35

mmol/l

0.27

802

7145

Other and unspecified disorders of psychological development

118

745

1.77

6.08

3.8

4.8

7.89

8.70

mmol/l

0.81

110

692

Malignant neoplasm of ovary

344

4363

0.73

6.08

2.9

3.0

6.13

6.24

mmol/l

0.16

290

3618

Seropositive rheumatoid arthritis

3214

29604

1.11

6.08

3.2

3.1

6.77

7.11

mmol/l

4.53

2759

24528

Malignant neoplasm of stomach

379

4770

0.75

6.07

2.9

3.2

7.41

7.43

mmol/l

0.04

294

3923

Vascular dementia

604

7041

0.80

6.06

2.8

3.1

6.74

6.59

mmol/l

0.43

471

5588

Disorders of aromatic amino-acid metabolism

227

2.71

6.06

4.2

3.1

6.70

8.35

mmol/l

1.51

188

Other specified/unspecified spondylopathies

306

2364

1.44

6.02

3.2

3.1

7.01

7.16

mmol/l

0.24

247

1947

Lactose intolerance, other/unspecified

289

2197

1.43

6.02

3.7

3.0

7.60

7.75

mmol/l

0.21

255

1881

Disorders of orbit

502

4103

1.32

6.01

3.2

7.42

7.37

mmol/l

0.10

423

3460

Prolapse and hernia of ovary and fallopian tube

430

3413

1.34

6.01

3.1

2.9

5.42

5.67

mmol/l

0.87

342

2760

Cardiomyopathy in other diseases

411

2.23

5.99

3.5

3.2

6.02

7.19

mmol/l

1.45

327

Dystonia

624

5214

1.28

5.98

3.3

3.1

7.29

7.36

mmol/l

0.14

527

4412

Hypothyroidism due to medicaments and other exogenous substances

134

905

1.75

5.95

5.0

3.0

7.09

7.26

mmol/l

0.15

117

750

Other peripheral vertigo

1072

9369

1.21

5.95

3.1

3.2

7.32

7.17

mmol/l

0.50

855

7848

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

1517

13518

1.17

5.95

3.2

7.21

7.69

mmol/l

5.14

1203

11157

Cluster headache, wide,, including avohilmo

556

4586

1.29

5.94

2.9

3.3

8.14

8.07

mmol/l

0.12

477

3939

Fracture of femur

2709

26941

0.89

5.92

3.4

3.1

6.41

7.04

mmol/l

13.03

2205

21994

Bacterial pneumoniae

5682

47415

1.08

5.91

3.8

3.2

7.10

7.71

mmol/l

15.28

4990

39528

Abnormal findings in nipple discharge synovial fluid wound secretions

184

1319

1.59

5.91

3.6

3.1

7.23

7.77

mmol/l

0.88

154

1118

Thyrotoxicosis with toxic multinodular goitre

692

5855

1.27

5.91

3.2

3.0

6.49

6.62

mmol/l

0.35

553

4829

Juvenile Open Angle Glaucoma

470

2.08

5.90

5.6

3.2

6.95

8.41

mmol/l

2.36

408

Disorders of breast

5910

51653

1.08

5.90

3.0

3.1

6.78

7.00

mmol/l

0.35

4982

43481

Generalized skin eruption due to drugs and medicaments

442

3573

1.34

5.89

3.6

3.2

7.03

7.50

mmol/l

1.48

367

3013

Complications predominantly related to the puerperium

2723

24954

1.12

5.89

3.0

3.1

7.10

7.12

mmol/l

0.07

2319

21384

Postpartum care and examination

1408

7903

1.17

5.88

3.8

3.0

7.70

8.06

mmol/l

1.87

1247

6880

Universal erythroderma, KELA reimbursement

184

1324

1.60

5.88

3.4

3.1

7.56

8.19

mmol/l

1.15

145

1103

Secondary malignant neoplasm of respiratory and digestive organs

1120

0.52

5.82

2.5

3.1

7.10

7.23

mmol/l

0.09

910

Other and unspecified nail disorders

239

1792

1.49

5.81

3.7

3.1

7.17

7.60

mmol/l

0.74

216

1513

Motor neuron disease

100

1549

0.58

5.80

2.4

3.0

7.67

7.46

mmol/l

0.17

1279

Acute epiglottitis

182

1303

1.58

5.79

3.5

3.1

8.17

mmol/l

0.00

153

1112

Sequelae of injuries of head

598

4991

1.28

5.79

3.5

3.3

8.00

8.29

mmol/l

0.64

475

4259

Other disorders of conjunctiva

1719

15492

1.16

5.78

3.6

3.2

6.99

7.35

mmol/l

3.17

1424

12940

Malignant neoplasm of head and neck

723

8477

0.81

5.78

3.1

3.2

7.19

7.70

mmol/l

2.33

581

7070

Other specified disorders of muscle

328

2562

1.40

5.77

3.3

3.2

7.47

7.80

mmol/l

0.60

279

2191

Tracheo-bronchomalasia

176

2.57

5.75

2.7

1.9

8.59

7.92

mmol/l

0.31

153

Other disorders of carbohydrate metabolism

337

2.26

5.74

4.2

2.9

7.50

8.48

mmol/l

0.82

287

Juvenile rheumatoid arthirtis

230

1698

1.47

5.74

4.5

3.2

6.91

8.10

mmol/l

3.47

205

1480

Vascular diseases of the intestine

420

3386

1.34

5.73

3.6

3.1

6.36

7.23

mmol/l

5.24

358

2765

Other infectious diseases

891

7695

1.22

5.72

4.4

3.2

7.01

7.50

mmol/l

2.73

757

6443

Peritonsillar abscess

2507

22938

1.12

5.71

3.2

3.3

8.36

8.25

mmol/l

0.47

2158

19725

Systemic atrophies primarily affecting the central nervous system

308

3929

0.73

5.71

4.3

3.2

7.26

7.54

mmol/l

0.56

252

3271

Acute posthaemorrhagic anaemia

378

3007

1.36

5.70

4.1

3.0

6.31

7.37

mmol/l

6.20

305

2474

Contact with heat and hot substances

589

4911

1.28

5.69

4.0

3.4

7.80

8.18

mmol/l

1.02

501

4218

Chondropathies

1811

16340

1.15

5.69

3.4

3.2

7.75

7.95

mmol/l

1.08

1500

14005

Other vitreous opacities

455

3717

1.33

5.68

3.2

3.1

6.95

7.36

mmol/l

1.25

376

3098

Other noninflammatory disorders of vagina

831

7119

1.22

5.68

3.2

3.0

6.56

6.67

mmol/l

0.36

680

6027

Embolic stroke with flimmer

273

2079

1.43

5.68

3.1

6.68

7.28

mmol/l

1.61

233

1674

Mesothelioma

1185

0.53

5.68

2.8

3.2

8.93

7.45

mmol/l

1.62

949

Ulcerative colitis

3056

28238

1.11

5.67

3.4

3.3

7.99

8.03

mmol/l

0.19

2635

24045

Benign neoplasm: Parathyroid gland

150

1059

1.71

5.67

5.1

3.2

7.27

7.09

mmol/l

0.18

135

880

Other endocrine disorders

558

4445

1.28

5.65

3.9

3.7

6.92

7.90

mmol/l

5.11

464

3861

Secondary right heart disease

462

3775

1.32

5.64

3.6

3.1

6.43

7.10

mmol/l

3.21

392

3079

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

101

633

1.78

5.63

3.8

3.1

6.35

7.66

mmol/l

2.36

544

Somnolence

148

1024

1.65

5.63

3.9

3.3

7.48

7.83

mmol/l

0.38

131

871

Disorders of oesophagus in diseases classified elsewhere

246

1869

1.48

5.61

3.9

3.0

6.25

7.47

mmol/l

5.20

212

1544

Atopic conjunctivitis

481

3933

1.30

5.60

3.5

3.3

8.00

7.71

mmol/l

0.58

421

3400

Disorders of male genital organs in diseases classified elsewhere

534

1.99

5.59

5.0

3.3

9.03

8.92

mmol/l

0.07

454

Alcoholic gastritis

198

1459

1.56

5.57

3.5

3.2

6.80

8.49

mmol/l

5.53

164

1223

Infection of intervertebral disc (pyogenic)

164

1174

1.64

5.57

5.0

3.4

6.30

8.00

mmol/l

5.79

139

961

Inflammatory disorders of male genital organs, not elsewhere classified

164

1164

1.61

5.57

4.6

3.4

7.83

8.78

mmol/l

1.94

136

991

ILD, hospital admissions 3, with pneumonia sepsis

973

8495

1.21

5.57

3.6

3.1

6.90

7.31

mmol/l

2.51

797

7003

Other disorders of male genital organs

433

3513

1.33

5.56

3.5

9.53

9.06

mmol/l

1.05

368

3011

Aphakia

163

1141

1.58

5.55

4.4

3.0

6.41

7.69

mmol/l

4.28

143

952

Arterial embolism and thrombosis

642

5404

1.26

5.55

3.9

3.1

6.61

7.46

mmol/l

6.51

542

4433

Other and unspecified erythematous conditions

358

2852

1.37

5.54

3.6

3.2

7.04

7.30

mmol/l

0.45

308

2403

Scoliosis

934

8090

1.21

5.54

3.1

3.3

6.85

7.49

mmol/l

3.62

777

6879

Carcinoma in situ of skin

945

8255

1.22

5.53

3.8

3.1

6.48

6.98

mmol/l

3.91

798

6812

Guttate psoriasis

166

1181

1.60

5.52

4.0

3.1

7.44

7.95

mmol/l

0.71

142

999

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

765

6533

1.23

5.51

3.2

7.03

7.21

mmol/l

0.55

649

5379

Acute bronchiolitis

603

4513

1.26

5.50

4.1

3.5

8.20

8.74

mmol/l

1.33

535

4038

Melanocytic naevi, other sites/unspecified

864

7466

1.22

5.49

4.1

3.2

7.19

7.76

mmol/l

3.61

770

6349

Factitial dermatitis

445

2.10

5.48

4.6

2.8

6.39

7.48

mmol/l

1.32

370

Delivery

4849

27313

0.92

5.47

3.0

3.2

6.73

6.63

mmol/l

0.76

4149

22858

Puerperal sepsis

1451

12972

1.16

5.46

3.0

3.1

6.78

6.68

mmol/l

0.45

1226

10942

Hypertrophic disorders of skin

602

5040

1.26

5.45

4.0

3.2

7.56

7.68

mmol/l

0.23

524

4306

Other acute skin changes due to ultraviolet radiation

398

3211

1.34

5.44

3.2

3.0

7.61

7.50

mmol/l

0.19

349

2690

Early lumbar disc prolapse operation

1071

9365

1.18

5.43

3.1

3.3

9.31

8.77

mmol/l

2.60

943

8301

Postprocedural disorders of digestive system, not elsewhere classified

367

2939

1.36

5.43

3.6

3.2

7.15

7.43

mmol/l

0.55

319

2459

Postprocedural disorders of nervous system

724

6152

1.23

5.42

3.3

7.72

7.91

mmol/l

0.47

624

5333

Crushed, pushed or stepped on by crowd or human stampede

750

6396

1.23

5.41

3.6

3.5

8.25

8.60

mmol/l

0.98

661

5580

Arthropod-borne viral fevers and viral haemorrhagic fevers

1151

10174

1.19

5.41

3.2

8.25

7.94

mmol/l

1.42

1029

8654

Other articular cartilage disorders

291

2265

1.41

5.40

3.5

3.0

7.70

7.77

mmol/l

0.09

258

1918

195

1413

1.49

5.40

3.5

2.8

7.60

7.91

mmol/l

0.34

173

1226

Renal cell carcinoma of kidney

393

3173

1.35

5.39

3.8

3.1

6.94

7.29

mmol/l

0.84

327

2595

Triptan medication for migraine, min. 3 purchases

6135

51165

0.93

5.39

2.9

3.2

8.02

7.92

mmol/l

0.13

5315

44087

Other abnormal findings of blood chemistry

488

4031

1.30

5.38

3.3

3.2

7.34

7.70

mmol/l

1.10

429

3403

Injury of nerves at wrist and hand level

429

3493

1.32

5.37

3.5

3.3

8.23

8.31

mmol/l

0.12

359

2989

Congenital malformations of trachea and bronchus

114

762

1.77

5.36

3.7

3.3

6.57

7.32

mmol/l

1.06

101

638

Injury of muscle and tendon at lower leg level

1853

16822

1.14

5.36

3.4

3.3

8.23

8.24

mmol/l

0.02

1578

14305

Abscess of tendon sheath

484

2.00

5.35

4.1

3.0

6.97

7.92

mmol/l

1.12

397

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

999

8777

1.21

5.35

3.7

3.2

6.66

7.28

mmol/l

5.38

851

7295

Acromegaly and pituitary gigantism

579

1.91

5.35

2.8

3.0

9.13

7.70

mmol/l

1.48

484

Carcinoma in situ of other and unspecified genital organs

206

1535

1.52

5.34

4.2

3.0

6.41

6.46

mmol/l

0.07

168

1273

therapeutic use

358

2877

1.37

5.34

3.8

3.1

6.77

7.24

mmol/l

1.20

276

2382

Nasal polyp

2498

22991

1.12

5.34

3.1

3.3

8.02

7.96

mmol/l

0.28

2121

19343

Effects of foreign body entering through natural orifice

3058

28353

1.11

5.34

3.5

3.3

8.39

8.36

mmol/l

0.16

2585

24273

Exclusion endpoint for clefts

211

1562

1.48

5.33

5.0

3.7

7.32

8.54

mmol/l

3.24

196

1382

Encephalopathy

124

847

1.73

5.32

4.0

3.1

6.94

7.89

mmol/l

1.74

112

699

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

4174

26680

0.91

5.32

3.1

3.4

8.31

8.55

mmol/l

2.91

3333

22453

Benign neoplasm: Other and unspecified parts of mouth

403

3276

1.34

5.30

3.7

3.2

7.64

7.48

mmol/l

0.27

341

2750

Other specified/unspecified inflammatory spondylopathies

502

4140

1.28

5.28

2.6

3.3

7.40

7.87

mmol/l

1.33

429

3578

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

932

8143

1.21

5.26

3.0

3.2

7.49

7.36

mmol/l

0.36

785

6857

Physiological and behavioural disorders associated with sexual development and orientation

113

3.46

5.25

3.2

3.0

7.06

8.68

mmol/l

0.77

Pyoderma

224

1688

1.47

5.24

3.9

3.1

7.91

7.81

mmol/l

0.10

181

1417

Melanocytic naevi of trunk

1356

12115

1.17

5.23

4.1

3.2

7.43

7.80

mmol/l

2.44

1199

10315

Lipoprotein deficiency

146

3.12

5.22

5.1

2.6

7.45

8.16

mmol/l

0.47

120

Alkalosis

166

2.95

5.22

4.8

2.9

6.95

8.17

mmol/l

0.98

129

Other facial nerve disorders

320

2530

1.38

5.21

3.1

3.0

7.70

7.47

mmol/l

0.38

270

2138

Other diseases of pleura

6124

51497

1.08

5.20

3.6

3.2

7.09

7.57

mmol/l

15.27

5011

42528

Other sexually transmitted chlamydial diseases

599

5010

1.24

5.20

3.1

3.5

8.90

8.85

mmol/l

0.05

511

4410

Bacterial pneumonia, not elsewhere classified

5338

44633

1.08

5.20

3.8

3.1

7.07

7.67

mmol/l

14.03

4700

37182

Non-allergic asthma

1046

9201

1.19

5.19

3.2

3.3

7.43

7.49

mmol/l

0.16

928

7798

Use of entacapone

659

0.43

5.17

2.2

3.1

6.67

6.97

mmol/l

0.16

519

Chronic iridocyclitis

558

4680

1.27

5.17

3.8

3.2

7.10

7.63

mmol/l

1.97

482

3950

Macular cyst

306

2430

1.41

5.16

3.8

3.1

6.93

7.17

mmol/l

0.51

252

2008

Monoarthritis, not elsewhere classified

475

3918

1.29

5.14

3.5

3.1

7.59

7.75

mmol/l

0.30

389

3308

Benign neoplasm: Endocrine pancreas

587

1.97

5.14

3.2

6.96

7.75

mmol/l

1.06

487

Injury of nerves at lower leg level

125

859

1.70

5.13

3.2

3.1

7.16

7.98

mmol/l

1.22

111

736

Visual field defects

975

8555

1.20

5.13

3.4

3.2

7.04

7.47

mmol/l

2.32

824

7173

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

985

11184

0.84

5.12

3.2

7.19

7.71

mmol/l

3.19

803

9371

Nontoxic single thyroid nodule

806

6973

1.22

5.10

3.2

3.1

6.98

mmol/l

0.01

678

5825

Glaucoma, exfoliation

1258

11212

1.17

5.10

3.3

3.0

6.58

6.61

mmol/l

0.10

1048

9081

Open wound of shoulder and upper arm

220

1658

1.47

5.10

3.8

3.4

8.17

8.33

mmol/l

0.14

187

1398

Whooping cough

447

1.96

5.09

3.5

3.1

7.19

8.44

mmol/l

1.69

400

Preparation and fitting of bite rail to mouth

1515

13627

1.15

5.08

3.0

3.2

7.91

7.86

mmol/l

0.16

1319

11672

Inflammatory diseases of the central nervous system

931

8138

1.20

5.07

4.0

3.3

7.61

7.78

mmol/l

0.47

789

6930

Benign neoplasm: Parotid gland

924

8094

1.20

5.07

3.3

3.2

7.49

7.51

mmol/l

0.05

774

6781

Exposure to unspecified smoke, fire and flames

118

803

1.71

5.07

4.4

3.2

7.06

8.22

mmol/l

2.14

107

682

Secondary parkinsonism, excluding more controls

276

2146

1.40

5.06

3.3

3.0

6.56

7.40

mmol/l

2.05

223

1775

Disorders of optic nerve, not elsewhere classified

248

1918

1.45

5.05

3.9

3.1

6.92

7.39

mmol/l

0.89

221

1576

Diffuse brain injury

388

3129

1.32

5.05

3.8

3.0

7.86

8.09

mmol/l

0.36

329

2651

Multiple delivery

676

7904

0.82

5.03

3.1

3.4

7.12

6.90

mmol/l

0.64

589

6769

Conductive hearing loss, unspecified

961

8428

1.19

5.03

3.2

7.33

7.61

mmol/l

1.14

797

7152

Cerebral cysts

585

4928

1.25

5.03

3.4

3.3

7.39

7.96

mmol/l

2.03

506

4172

COPD, hospital admissions 1, only main diagnosis

4155

37635

0.92

5.01

3.2

6.95

7.48

mmol/l

13.27

3353

30904

Dental caries 2, only avohilmo

10543

79859

1.05

5.00

3.4

3.3

7.89

8.07

mmol/l

0.47

8808

68452

Thrombocytopenia, unspecified

793

6874

1.22

5.00

4.0

3.2

7.19

7.64

mmol/l

1.99

669

5795

Complications of the puerperium, not elsewhere classified

357

2848

1.32

4.99

3.0

3.2

7.17

7.57

mmol/l

0.85

313

2512

Other inflammation of vagina/vulva

339

2695

1.34

4.96

3.0

3.2

7.06

7.29

mmol/l

0.32

292

2343

Viral infections of the central nervous system

789

6822

1.21

4.96

3.9

3.3

7.52

7.72

mmol/l

0.52

684

5801

Benign neoplasm: Skin of trunk

474

3938

1.29

4.95

3.9

3.2

7.03

7.52

mmol/l

1.71

392

3333

Other noninfective disorders of lymphatic vessels and lymph nodes

399

3258

1.32

4.95

3.3

3.1

7.15

7.38

mmol/l

0.51

337

2738

Campylobacter enteritis

302

2389

1.38

4.94

4.0

3.2

8.06

7.98

mmol/l

0.09

265

2007

HSIL lesion of the vagina

155

1114

1.58

4.93

3.5

2.9

6.60

6.87

mmol/l

0.37

125

923

Vascular dementia (undefined)

202

2686

0.71

4.92

2.5

3.0

6.62

6.45

mmol/l

0.26

145

2105

Primary biliary cholangitis (PBC)

239

1835

1.43

4.91

3.6

2.8

6.18

6.90

mmol/l

1.95

202

1535

Overexertion and strenuous or repetitive movements

1138

10103

1.17

4.90

3.1

3.3

7.82

8.06

mmol/l

0.95

993

8615

Benign neoplasm: Skin of other and unspecified parts of face

1257

11238

1.17

4.87

3.5

3.1

7.07

7.21

mmol/l

0.50

1014

9361

Other arterial embolism and thrombosis

306

2424

1.37

4.87

4.1

3.1

6.53

7.53

mmol/l

4.52

254

1981

Injury of muscle and tendon at wrist and hand level

1658

15047

1.14

4.85

3.9

3.3

8.13

8.23

mmol/l

0.35

1442

12858

Other specified/unspecified bacterial intestinal infections

741

6407

1.22

4.84

3.5

3.1

7.29

7.45

mmol/l

0.40

609

5374

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

1296

14413

0.86

4.83

3.3

3.2

7.52

mmol/l

0.00

1044

11989

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

507

4232

1.27

4.83

3.0

3.2

8.20

7.91

mmol/l

0.65

452

3637

Fracture of neck

653

5596

1.24

4.82

3.7

3.3

7.37

7.79

mmol/l

1.40

539

4668

Sequelae of injuries of neck and trunk

335

2692

1.35

4.81

3.0

3.2

7.30

8.15

mmol/l

2.26

287

2274

Hepatocellular carcinoma

231

1779

1.45

4.80

3.6

3.2

7.41

7.79

mmol/l

0.72

183

1450

Burns and corrosions of multiple and unspecified body regions

252

1955

1.41

4.80

4.4

3.4

7.39

8.43

mmol/l

2.73

217

1674

Traumatic amputation of ankle and foot

209

2.68

4.79

3.0

7.13

8.33

mmol/l

1.03

178

Medial epicondylitis

421

3460

1.30

4.79

3.1

3.0

7.96

7.74

mmol/l

0.44

364

2952

Oral leukoplakia and related diseases

658

5657

1.24

4.78

3.4

3.2

6.81

7.23

mmol/l

2.01

549

4726

Postprocedural disorders of ear and mastoid process, not elsewhere classified

104

701

1.76

4.78

4.0

3.2

7.20

7.28

mmol/l

0.06

586

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

311

2474

1.36

4.77

3.2

8.03

7.94

mmol/l

0.11

255

2111

Inflammatory bowel disease

3992

37496

1.09

4.77

3.4

3.3

7.97

8.04

mmol/l

0.38

3430

31941

L01XX Other antineoplastic agents

473

5637

0.79

4.76

3.0

3.2

6.89

7.13

mmol/l

0.47

390

4652

TMD related pain

352

2837

1.33

4.75

2.9

3.1

7.56

7.33

mmol/l

0.36

297

2424

Circumscribed brain atrophy

130

1823

0.65

4.75

2.5

3.2

7.45

7.17

mmol/l

0.35

116

1487

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

387

3156

1.31

4.75

4.3

3.3

7.82

7.99

mmol/l

0.31

337

2698

Abnormality of red blood cells

432

2.02

4.74

3.2

3.0

6.95

7.61

mmol/l

0.60

363

Hypermetropia

757

6548

1.21

4.74

4.0

3.3

7.28

7.79

mmol/l

2.31

651

5604

Carcinoma in situ of vulva

637

1.79

4.74

5.6

2.9

5.80

6.77

mmol/l

1.52

523

Traumatic subarachnoid haemorrhage

378

3076

1.32

4.73

3.2

3.0

7.19

7.54

mmol/l

0.75

303

2544

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

4288

27770

0.92

4.73

3.1

3.4

8.35

8.60

mmol/l

2.94

3432

23419

Cauda equina syndrome

154

1118

1.57

4.72

3.3

3.1

6.67

7.62

mmol/l

1.88

132

935

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

269

3390

0.73

4.72

3.2

3.0

6.09

6.19

mmol/l

0.12

228

2812

Enterocolitis due to Clostridium difficile

1178

10501

1.17

4.72

4.2

3.1

6.35

7.21

mmol/l

10.43

1009

8697

Other, unspecified and serous retinal detachments

342

2768

1.34

4.70

3.5

3.0

7.21

7.65

mmol/l

1.18

296

2312

Crohn disease

1483

13384

1.14

4.70

3.4

3.3

7.98

8.09

mmol/l

0.38

1271

11470

Benign neoplasm: Skin of ear and external auricular canal

440

3650

1.29

4.69

3.4

3.1

7.55

7.39

mmol/l

0.34

358

3035

Superficial injury of hip and thigh

1649

14960

1.14

4.69

3.5

3.2

6.99

7.38

mmol/l

2.91

1368

12449

Benign neoplasm of ovary

2010

18435

1.12

4.68

3.1

3.0

6.34

6.35

mmol/l

0.02

1687

15339

Ménière disease

1120

9981

1.17

4.68

3.2

3.1

7.11

7.07

mmol/l

0.12

931

8346

Melanocytic naevi, other sites/unspecified

864

7562

1.20

4.68

4.1

3.2

7.19

7.81

mmol/l

4.13

770

6476

340

2.13

4.66

3.7

2.9

7.01

8.45

mmol/l

2.04

298

Other specified congenital malformation syndromes affecting multiple systems

175

1289

1.50

4.65

5.4

3.8

7.38

8.47

mmol/l

2.41

162

1153

Certain conditions originating in the perinatal period

825

6339

1.19

4.64

4.3

3.4

8.65

8.67

mmol/l

0.04

758

5663

Carcinoma in situ of skin, other sites/unspecified

144

1042

1.60

4.63

3.9

3.1

6.17

6.96

mmol/l

1.95

113

844

Other benign neoplasms of connective and other soft tissue

1139

10157

1.17

4.62

3.3

3.2

7.51

7.53

mmol/l

0.05

961

8564

Congenital malformations of the respiratory system

189

1418

1.48

4.62

3.9

3.6

6.82

7.52

mmol/l

1.33

164

1213

Macular hole

650

5612

1.24

4.61

3.3

3.1

7.09

6.90

mmol/l

0.49

526

4645

Foreign body in alimentary tract

609

5205

1.24

4.61

3.7

3.3

7.63

7.86

mmol/l

0.59

522

4399

Contact with hot air and gases

527

1.85

4.60

3.3

3.0

6.70

8.52

mmol/l

3.57

442

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

560

6569

0.81

4.60

3.0

6.19

6.24

mmol/l

0.09

470

5454

Benign neoplasm of mouth and pharynx

1314

11830

1.16

4.60

3.6

3.2

7.53

mmol/l

0.01

1098

9986

Correction of physiology of bite - demanding therapy visit

712

6146

1.21

4.55

3.1

3.2

7.50

7.62

mmol/l

0.25

595

5268

Torticollis

185

1380

1.47

4.55

2.8

3.4

7.92

8.30

mmol/l

0.48

159

1201

Other nonthrombocytopenic purpura

105

715

1.71

4.55

5.0

2.9

6.49

7.61

mmol/l

1.86

587

Hypertrophic cardiomyopathy

471

3958

1.28

4.54

3.5

3.3

7.03

7.74

mmol/l

3.54

389

3312

Other and unspecified acute skin changes due to ultraviolet radiation

299

2393

1.36

4.54

3.3

3.1

7.59

7.43

mmol/l

0.24

265

1969

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

409

3383

1.30

4.53

3.7

3.1

6.77

7.18

mmol/l

1.10

341

2821

Benign neoplasm of major salivary glands

1169

10471

1.17

4.53

3.3

3.2

7.39

7.50

mmol/l

0.38

972

8799

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

186

2437

0.70

4.53

2.9

3.2

8.24

8.19

mmol/l

0.05

149

2054

Other diseases of peritoneum

506

4267

1.26

4.53

3.2

3.1

7.05

7.06

mmol/l

0.00

421

3574

Sexual dysfunction

175

1303

1.50

4.52

3.6

3.2

8.45

8.74

mmol/l

0.30

154

1124

Other bursitis of hip

227

1755

1.43

4.51

2.8

3.0

7.53

6.94

mmol/l

1.18

194

1478

Hypertrophic scar

548

4635

1.24

4.51

3.6

3.2

7.60

7.70

mmol/l

0.17

478

3957

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

932

8237

1.19

4.51

3.0

3.2

7.49

7.40

mmol/l

0.23

785

6980

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

774

6762

1.21

4.51

3.5

3.2

7.72

mmol/l

0.01

670

5678

Other and unspecified acne

142

1014

1.55

4.51

4.7

3.3

8.12

8.83

mmol/l

0.67

118

882

Urethritis and urethral syndrome

249

1944

1.39

4.50

3.3

3.0

7.58

7.74

mmol/l

0.20

202

1638

Ehlers-Danlos syndrome

642

1.70

4.50

1.9

3.0

8.02

8.17

mmol/l

0.08

566

Severe visual impairment, monocular

108

743

1.70

4.49

3.8

3.1

7.05

7.26

mmol/l

0.15

625

Primary ovarian failure

182

1352

1.46

4.49

3.7

3.0

7.21

7.52

mmol/l

0.40

157

1174

Contracture of joint

145

1046

1.56

4.49

3.4

3.1

7.13

7.51

mmol/l

0.56

127

892

Familial erythrocytosis

414

1.98

4.48

2.8

3.0

8.61

7.94

mmol/l

0.55

350

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

393

3246

1.31

4.46

3.8

3.1

6.94

7.38

mmol/l

1.18

327

2716

Other specified/unspecified systemic involvement of connective tissue

639

5494

1.23

4.46

3.4

3.1

6.72

7.11

mmol/l

1.56

553

4646

Intracranial and intraspinal abscess and granuloma

140

1015

1.59

4.45

5.7

3.1

6.68

7.98

mmol/l

2.12

113

843

Other congenital malformations of kidney

315

2.15

4.44

6.0

3.5

5.77

7.58

mmol/l

3.00

265

Alzheimer’s disease (Atypical or mixed), excluding more controls

625

6302

0.82

4.44

2.5

3.0

6.73

6.65

mmol/l

0.20

476

5048

Carcinoma in situ of colon

169

1270

1.54

4.43

3.2

7.65

7.68

mmol/l

0.03

146

1039

Other and unspecified mononeuropathies of upper limb

336

2726

1.33

4.43

3.5

3.1

7.42

7.86

mmol/l

0.99

293

2308

Burn and corrosion of ankle and foot

163

1207

1.52

4.42

4.4

3.1

7.71

8.38

mmol/l

0.92

145

1014

Convergent concomitant strabismus

601

5129

1.23

4.41

3.5

8.06

8.09

mmol/l

0.04

524

4450

Recurring oral aphthae

512

4332

1.26

4.41

3.7

3.2

6.89

7.42

mmol/l

2.00

432

3664

Serous carcinoma of ovary

269

3362

0.74

4.41

3.2

3.0

6.09

6.16

mmol/l

0.08

228

2781

Total colectomy

452

3779

1.27

4.41

3.7

3.3

8.68

7.98

mmol/l

2.05

392

3192

Total colectomy operation

452

3779

1.27

4.41

3.7

3.3

8.68

7.98

mmol/l

2.05

392

3192

Artificial opening status

594

5096

1.24

4.39

3.6

3.1

7.58

7.65

mmol/l

0.12

499

4281

Localized scleroderma [morphea]

175

1314

1.50

4.39

3.4

2.9

7.05

7.03

mmol/l

0.01

143

1097

Postpartum haemorrhage

2010

19088

0.90

4.37

3.0

3.1

7.45

7.53

mmol/l

0.30

1775

16588

Focal brain injury

721

6247

1.20

4.37

3.5

3.1

7.65

7.92

mmol/l

0.77

580

5264

Chondrocostal junction syndrome [Tietze]

400

3310

1.29

4.37

3.1

6.95

7.26

mmol/l

0.75

318

2793

MS-disease / Multiple Sclerosis

545

6417

0.82

4.37

3.7

3.2

7.95

7.80

mmol/l

0.32

468

5519

Other specified/unspecified hearing loss

915

8085

1.18

4.35

3.4

3.2

7.23

7.31

mmol/l

0.21

799

6732

Benign neoplasm: Small intestine

465

3926

1.28

4.32

3.2

7.09

7.23

mmol/l

0.28

389

3251

Biomechanical lesions, not elsewhere classified

536

4566

1.25

4.32

2.9

3.2

7.42

mmol/l

0.01

440

3832

Budesonide

1538

13974

1.13

4.30

3.4

3.1

7.71

7.82

mmol/l

0.39

1298

11821

Other or unspecified ileus, impaction or obstruction

2238

20684

1.11

4.30

3.3

3.1

7.30

7.45

mmol/l

0.86

1863

17101

Cholangitis (primary sclerosing, PSC), with reimbursement 202

202

1548

1.44

4.28

3.7

3.3

7.16

8.09

mmol/l

1.89

189

1314

Premenstrual syndrome

106

720

1.62

4.27

2.9

3.2

7.06

7.58

mmol/l

0.52

630

Obstructed labour due to malposition and malpresentation of fetus

1760

18172

0.90

4.27

3.0

3.1

15.90

7.52

mmol/l

0.53

1551

15853

Generalized pustular psoriasis

314

2.17

4.26

3.1

7.58

7.62

mmol/l

0.02

263

Spinal osteochondrosis

132

947

1.57

4.25

3.3

7.51

8.47

mmol/l

1.35

118

809

Cardiomyopathy, Hypertrophic obstructive

219

1703

1.42

4.24

3.2

7.18

7.92

mmol/l

1.93

176

1413

Exposure to smoke, fire and flames

274

2186

1.36

4.24

3.9

3.3

7.25

8.45

mmol/l

4.27

240

1856

Colectomy operation

2039

18822

1.12

4.24

3.4

3.2

7.63

7.35

mmol/l

2.06

1723

15661

Bacterial pneumonia (organism specified)

5955

51693

1.07

4.23

3.8

3.2

7.10

7.65

mmol/l

13.30

5232

42924

Other and unspecified immunodeficiencies with predominantly antibody defects

145

1062

1.54

4.23

4.3

3.3

6.47

7.72

mmol/l

3.05

134

899

Generalized epilepsy, strict definition

239

1866

1.38

4.23

3.3

3.4

7.35

8.12

mmol/l

1.49

198

1624

Purulent endophthalmitis

477

1.88

4.22

3.4

3.1

7.11

7.14

mmol/l

0.02

389

Blindness, monocular

105

726

1.67

4.22

4.4

3.0

6.94

7.37

mmol/l

0.44

601

Oral lichen ruber planus, including avohilmo

669

5816

1.22

4.21

3.0

3.1

7.09

7.01

mmol/l

0.18

558

4879

Toxic effect of alcohol

249

1967

1.38

4.21

4.8

3.2

7.73

8.31

mmol/l

0.98

216

1671

Acute otitis externa, noninfective

194

1487

1.45

4.19

3.6

3.1

7.28

7.58

mmol/l

0.39

163

1247

Other/unspecified crystal arthropathies

503

1.86

4.18

3.5

3.1

7.22

7.34

mmol/l

0.07

407

Motor neuron disease (with DMD)

113

1596

0.65

4.18

2.9

3.0

7.16

7.45

mmol/l

0.28

1324

Benign neoplasm: Skin of lower limb, including hip

313

2545

1.33

4.16

4.2

3.1

6.92

7.42

mmol/l

1.36

257

2134

Anomalies of dental arch relationship, including avohilmo

2120

17552

1.11

4.15

3.5

3.2

8.04

8.14

mmol/l

0.34

1805

15221

Sequelae of other and unspecified infectious and parasitic diseases

590

5066

1.22

4.14

4.0

3.3

7.90

8.23

mmol/l

0.95

512

4350

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

217

0.23

4.13

2.2

3.1

6.23

7.35

mmol/l

—

183

Fentanyl

888

10034

0.86

4.12

3.3

3.0

7.05

7.28

mmol/l

0.76

705

8228

Benign neoplasm: salivary glands, exclude unknown (D119)

1013

9053

1.17

4.12

3.3

3.2

7.44

7.50

mmol/l

0.14

843

7587

Other acquired deformities of musculoskeletal system and connective tissue

525

4481

1.24

4.11

3.1

3.2

8.04

7.78

mmol/l

0.59

457

3810

Diabetic nephropathy, excluding more controls

3844

30816

1.13

4.10

7.4

3.6

5.97

8.56

mmol/l

6.85

3529

25508

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

317

2562

1.31

4.10

4.2

3.8

7.53

8.38

mmol/l

2.08

288

2263

Pedestrian injured in transport accident

764

6698

1.19

4.09

3.5

3.2

7.58

7.65

mmol/l

0.13

653

5658

Ankle and foot

103

715

1.67

4.08

3.8

3.0

6.80

7.64

mmol/l

1.66

607

Acne varioliformis

206

2.47

4.08

5.9

2.8

6.80

8.03

mmol/l

1.16

173

Other immunodeficiencies

122

870

1.58

4.08

4.7

3.2

7.36

7.73

mmol/l

0.42

111

750

Third [oculomotor] nerve palsy

209

1629

1.43

4.06

4.0

3.1

6.86

7.53

mmol/l

1.57

169

1350

Other surgical follow-up care

353

2903

1.30

4.06

3.8

3.2

7.71

7.90

mmol/l

0.30

310

2454

Acute nasopharyngitis (common cold)

1427

12883

1.14

4.06

3.4

3.3

8.44

8.81

mmol/l

2.08

1270

11224

Disorders of plasma-protein metabolism, not elsewhere classified

517

1.78

4.06

3.1

2.8

7.41

8.21

mmol/l

0.89

435

Chronic hepatitis NAS

157

1174

1.50

4.06

4.2

3.0

6.41

7.66

mmol/l

3.56

135

971

Benign neoplasm: Parotid gland

924

8227

1.18

4.04

3.3

3.2

7.49

7.55

mmol/l

0.16

774

6916

Delayed milestone in childhood

169

1142

1.45

4.03

4.9

5.2

7.24

8.46

mmol/l

1.97

162

1077

Chronic myringitis

421

1.94

4.02

2.9

3.1

7.48

7.52

mmol/l

0.03

353

Divergent concomitant strabismus

834

7355

1.18

4.02

3.4

3.3

7.44

7.77

mmol/l

1.32

716

6303

Intermittent heterotropia

580

4975

1.22

4.01

3.6

3.5

7.42

8.12

mmol/l

2.65

498

4351

Benign mammary dysplasia

1365

15017

0.88

4.01

3.2

3.0

6.20

6.30

mmol/l

0.42

1165

12443

Other specified and unspecified disorders of eyelid

165

1249

1.49

4.01

3.0

3.2

7.00

7.41

mmol/l

0.63

143

1041

Antenatal screening

2058

12608

0.90

4.01

2.8

3.0

7.95

7.74

mmol/l

1.01

1862

11025

Other/unspecified disorders of vestibular function

425

3576

1.27

3.99

3.0

3.1

7.23

7.16

mmol/l

0.12

342

2982

Status post-ami

606

5776

0.83

3.99

3.2

3.1

6.76

7.42

mmol/l

4.87

491

4555

Parapsoriasis

214

1671

1.40

3.99

3.7

3.1

7.02

7.96

mmol/l

2.59

184

1408

Embedded teeth, including avohilmo

872

7691

1.17

3.97

4.0

3.4

8.00

8.44

mmol/l

1.58

769

6721

Other specified/unspecified disorders of tympanic membrane

298

2.15

3.96

4.0

3.1

7.83

8.03

mmol/l

0.10

253

Lupus erythematosus

271

2181

1.35

3.96

4.4

3.0

6.94

7.04

mmol/l

0.14

234

1830

Sacroiliitis, not elsewhere classified

462

3889

1.24

3.96

3.1

3.5

8.07

8.01

mmol/l

0.09

391

3384

Melanocytic naevi of lip

675

1.66

3.96

3.1

2.9

6.73

7.43

mmol/l

0.70

570

Carcinoma in situ of other and unspecified digestive organs

293

2393

1.35

3.94

3.3

3.2

7.58

7.54

mmol/l

0.04

248

1970

Vertical strabismus

368

3056

1.29

3.93

3.4

3.2

7.46

7.62

mmol/l

0.31

323

2581

Other injuries of upper limb, level unspecified

123

887

1.57

3.93

4.7

3.2

7.60

8.21

mmol/l

0.54

106

756

All dysplastic lesions of the cervix uteri, vagina or vulva

2795

25913

1.09

3.93

3.4

3.1

7.22

7.86

mmol/l

0.59

2398

22313

Valgus deformity, not elsewhere classified

602

1.70

3.93

3.2

3.0

8.07

7.45

mmol/l

0.50

514

Xanthelasma of eyelid

112

799

1.62

3.93

2.9

3.0

8.03

7.23

mmol/l

0.96

673

Childhood allergy (age < 16)

1444

10771

1.13

3.92

4.0

3.6

8.85

9.00

mmol/l

0.39

1294

9635

Malignant neoplasm of nasal cavity and sinuses, excluding all cancers (controls excluding all cancers)

926

0.57

3.92

3.7

3.1

8.07

7.74

mmol/l

0.18

767

Carcinoma in situ of other and unspecified genital organs

206

1613

1.42

3.91

4.2

3.0

6.41

6.53

mmol/l

0.17

168

1353

Superficial injury of neck

203

1570

1.40

3.91

4.4

3.5

8.88

8.48

mmol/l

0.42

186

1358

Pyoderma gangrenosum

573

1.73

3.91

4.3

3.1

6.73

7.44

mmol/l

0.75

486

Pneumonia due to Streptococcus pneumoniae

472

4007

1.25

3.90

4.0

3.2

7.54

7.94

mmol/l

0.97

403

3368

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

154

1149

1.48

3.89

3.7

3.2

9.11

8.61

mmol/l

0.49

129

995

Gangrene, not elsewhere classified

606

1.71

3.89

4.5

3.1

5.55

7.64

mmol/l

6.55

483

Postzoster neuralgia

165

1251

1.47

3.89

3.9

2.9

6.73

6.98

mmol/l

0.32

140

1036

Vestibular neuronitis

1029

9238

1.16

3.88

3.2

7.87

7.49

mmol/l

1.81

843

7782

Female infertility, tubal origin

467

3940

1.24

3.88

3.1

3.0

7.60

7.16

mmol/l

1.19

397

3434

Other benign neoplasms of connective and other soft tissue

1139

10271

1.15

3.87

3.3

3.2

7.51

7.53

mmol/l

0.06

961

8711

Unspecified visual impairment (binocular)

166

1259

1.46

3.86

4.7

3.2

6.79

7.46

mmol/l

0.99

149

1062

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

400

4735

0.80

3.84

3.2

3.1

7.01

7.67

mmol/l

2.16

333

3973

Complications peculiar to reattachment and amputation

534

1.75

3.84

5.2

3.1

6.73

7.92

mmol/l

1.70

436

Malignant neoplasm of oral cavity

267

3286

0.76

3.84

3.0

3.2

6.81

7.67

mmol/l

2.29

218

2736

Chronic myeloproliferative disease

1228

0.62

3.84

2.8

3.1

6.11

7.31

mmol/l

2.75

1004

Shoulder region

157

1186

1.49

3.83

3.2

7.53

7.83

mmol/l

0.37

141

996

Encephalitis

306

2500

1.31

3.82

4.3

3.2

7.59

7.87

mmol/l

0.45

260

2117

Benign neoplasm: Skin of trunk

474

4043

1.25

3.81

3.9

3.1

7.03

7.65

mmol/l

2.44

392

3448

Carcinoma in situ of skin, other sites/unspecified

144

1080

1.53

3.81

3.9

3.0

6.17

7.14

mmol/l

2.70

113

890

Benign neoplasm: Other and unspecified parts of mouth

403

3398

1.28

3.81

3.7

3.1

7.64

7.54

mmol/l

0.16

341

2888

5-aminosalicylic acid

2578

24061

1.09

3.79

3.2

8.08

8.18

mmol/l

0.42

2205

20521

Melanocytic naevi of other and unspecified parts of face

629

5471

1.21

3.79

3.2

7.73

7.47

mmol/l

0.63

550

4641

Hordeolum and other deep inflammation of eyelid

597

5175

1.21

3.79

3.7

3.3

7.46

7.80

mmol/l

0.90

504

4403

Other chondrocalcinosis

141

1054

1.53

3.79

3.2

6.78

7.06

mmol/l

0.35

115

865

Acquired clawhand, clubhand, clawfoot and clubfoot

416

1.86

3.78

4.1

3.0

8.38

7.95

mmol/l

0.27

367

Pityriasis lichenoides chronica

324

2.03

3.78

4.2

2.9

7.16

7.90

mmol/l

0.70

270

Nezelof syndrome

339

1.98

3.75

3.3

2.7

7.32

7.83

mmol/l

0.32

280

Primary angle-closure glaucoma

494

4237

1.24

3.73

3.4

3.1

6.89

6.80

mmol/l

0.18

411

3461

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

132

972

1.52

3.72

3.6

2.9

8.07

7.77

mmol/l

0.20

114

815

Benign neoplasm: Liver/bile ducts

251

2014

1.34

3.70

3.7

3.1

7.94

7.59

mmol/l

0.53

223

1699

Congenital deformities of feet

259

2081

1.33

3.70

4.4

3.2

8.32

8.30

mmol/l

0.02

237

1795

Early syphilis

138

1026

1.51

3.70

2.9

3.4

8.46

8.66

mmol/l

0.18

115

877

Other specified/unspecified disorders of bone/cartilage

323

2671

1.30

3.69

3.4

3.0

8.04

8.08

mmol/l

0.04

262

2258

Localized adiposity

394

1.87

3.69

3.2

2.8

8.18

7.45

mmol/l

0.53

333

Benign neoplasm: Liver

225

1785

1.36

3.67

3.6

3.1

7.67

7.57

mmol/l

0.11

199

1510

Onychogryphosis

222

2.31

3.65

4.5

2.8

6.13

7.42

mmol/l

1.18

181

Iridocyclitis in diseases classified elsewhere

205

1614

1.39

3.65

3.0

3.2

7.46

7.74

mmol/l

0.34

172

1364

Suppurative otitis media, unspecified

275

2229

1.32

3.64

3.4

3.2

7.47

8.03

mmol/l

1.09

235

1872

Lesion of sciatic nerve

502

4313

1.23

3.64

3.1

3.0

7.09

6.97

mmol/l

0.30

423

3543

Acute hepatitis B

366

1.92

3.63

7.1

3.0

7.52

8.28

mmol/l

0.59

319

Other rupture of muscle

500

1.75

3.63

2.6

2.9

7.64

7.94

mmol/l

0.22

427

Other papulosquamous disorders

127

935

1.53

3.62

3.8

3.1

6.61

7.55

mmol/l

2.12

110

778

Peptic ulcer

118

859

1.55

3.61

4.1

3.0

7.49

7.50

mmol/l

0.01

101

709

Disorders of puberty

143

1060

1.45

3.60

3.8

3.9

9.48

9.13

mmol/l

0.26

132

950

Dermatitis herpetiformis

214

1700

1.38

3.60

3.0

3.1

7.65

7.54

mmol/l

0.13

182

1432

Contact with nonpowered hand tool

495

4258

1.23

3.60

3.8

3.4

8.15

8.57

mmol/l

1.19

410

3619

Benign neoplasm: Skin of other and unspecified parts of face

1257

11444

1.14

3.59

3.5

3.1

7.07

7.26

mmol/l

0.77

1014

9574

Otorrhagia

519

1.74

3.59

4.5

3.3

7.27

7.72

mmol/l

0.38

434

Ankylosing spondylitis

1013

9107

1.15

3.58

3.3

8.06

8.10

mmol/l

0.09

871

7793

TMD muscular pain linked with fibromyalgia

101

715

1.60

3.57

3.1

2.8

7.09

7.26

mmol/l

0.11

607

Polyarthritis, unspecified

400

3377

1.26

3.57

3.6

3.1

6.98

7.50

mmol/l

1.61

348

2857

Burn and corrosion, body region unspecified

454

1.79

3.57

7.5

3.4

7.60

8.18

mmol/l

0.41

388

Tooth eruption problems

1351

12164

1.12

3.56

4.0

3.4

8.22

8.57

mmol/l

1.41

1186

10759

Chronic Coagulation defects

247

1987

1.33

3.54

3.4

3.2

7.59

7.78

mmol/l

0.26

210

1714

Other specified disorders of external ear

435

3722

1.25

3.54

3.5

3.2

8.15

8.11

mmol/l

0.07

348

3113

Nontoxic diffuse goitre

345

2880

1.28

3.53

3.0

6.92

6.71

mmol/l

0.41

288

2412

Fall involving bed

310

2563

1.30

3.53

3.4

3.2

6.19

6.95

mmol/l

2.70

267

2089

Chronic suppurative otitis media, including avohilmo

878

7843

1.16

3.53

3.5

3.4

7.61

7.69

mmol/l

0.21

723

6654

Tinnitus

2921

27497

1.09

3.53

3.2

7.59

7.52

mmol/l

0.34

2429

23123

Crohn's disease of large intestine

557

4829

1.21

3.52

3.5

3.3

7.99

8.04

mmol/l

0.10

479

4151

Malignant otitis externa

145

2.72

3.52

3.2

2.8

6.63

8.25

mmol/l

1.33

126

Benign neoplasm: Skin of ear and external auricular canal

440

3759

1.24

3.51

3.4

3.2

7.55

7.44

mmol/l

0.20

358

3167

Ethmoidectomy

1496

13741

1.12

3.49

3.3

3.2

7.74

7.88

mmol/l

0.55

1213

11685

Other congenital malformations of upper alimentary tract

624

1.67

3.48

4.5

3.1

6.92

7.59

mmol/l

0.83

529

Uterine polyps

1026

9245

1.15

3.47

2.9

3.0

6.48

6.53

mmol/l

0.13

824

7804

Drug-induced tremor

534

1.73

3.47

3.8

3.2

6.37

7.36

mmol/l

1.12

441

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

774

6893

1.18

3.47

3.5

3.2

7.72

7.78

mmol/l

0.13

670

5834

Disorders of puberty, all

161

1223

1.41

3.47

4.1

3.8

9.53

8.98

mmol/l

0.49

148

1104

Intestinal adhesions without obstruction

955

8593

1.16

3.47

3.5

3.1

6.94

7.34

mmol/l

1.98

780

7175

Disorders of adrenal gland, other and/or unspecified

360

1.87

3.47

3.1

2.8

8.20

7.79

mmol/l

0.20

301

Other and unspecified disorders of pigmentation

536

1.68

3.46

3.8

2.9

6.45

7.68

mmol/l

2.15

458

Hemiplegia

535

4629

1.21

3.45

3.7

3.1

7.57

7.53

mmol/l

0.06

438

3897

Anorexia

152

1152

1.44

3.45

4.2

2.9

6.89

7.51

mmol/l

0.91

137

979

Embolic stroke

508

4381

1.22

3.45

3.1

7.04

7.36

mmol/l

0.95

428

3585

Other encephalitis

284

2331

1.30

3.44

4.3

3.2

7.68

7.90

mmol/l

0.30

239

1977

Aneurysms, operations, SAH

1971

18326

1.10

3.44

3.2

3.1

7.15

7.35

mmol/l

1.26

1708

15248

Nonhereditary hypogammaglobulinemia

123

911

1.52

3.43

4.2

3.1

6.97

7.76

mmol/l

1.18

115

777

Acquired pure red cell aplasia [erythroblastopenia]

355

1.89

3.43

4.1

3.2

6.82

7.64

mmol/l

0.74

291

Ectopic pregnancy

1824

16871

1.11

3.43

3.2

3.0

7.06

6.90

mmol/l

0.82

1534

14451

Gender identity disorders

119

863

1.49

3.43

2.5

3.0

9.09

9.12

mmol/l

0.01

772

Striae atrophicae

117

855

1.52

3.43

4.5

2.9

7.51

7.63

mmol/l

0.09

730

Hyperosmolality and hypernatraemia

139

1045

1.47

3.42

3.5

2.9

5.74

7.31

mmol/l

5.70

118

858

Contusion of ankle

398

3366

1.25

3.42

3.7

3.5

8.19

8.18

mmol/l

0.02

342

2896

Erythema multiforme

250

2029

1.33

3.40

3.8

3.2

7.10

7.60

mmol/l

1.06

217

1708

Pneumothorax

625

7107

0.84

3.39

3.1

3.3

7.66

7.91

mmol/l

0.63

531

5964

Glaucoma secondary to drugs

273

2.09

3.39

4.7

3.0

7.96

7.79

mmol/l

0.09

231

Diabetes insipidus

106

768

1.57

3.38

3.3

2.9

6.85

7.92

mmol/l

1.42

655

Melanoma in situ

451

3890

1.24

3.34

3.6

3.2

7.13

7.23

mmol/l

0.21

348

3209

Dislocation, sprain and strain of joint and ligaments of hip

395

3361

1.25

3.33

3.2

3.1

7.36

7.38

mmol/l

0.03

342

2784

Endometriosis of rectovaginal septum and vagina

816

7276

1.16

3.33

2.8

3.1

6.64

6.54

mmol/l

0.27

683

6130

Other congenital malformations of limb(s)

520

1.65

3.33

3.1

3.2

8.45

8.63

mmol/l

0.10

460

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

150

1151

1.45

3.33

3.9

3.0

6.90

6.88

mmol/l

0.02

129

938

Ulcer of vagina/vulva

247

2003

1.32

3.32

3.0

3.1

6.55

6.80

mmol/l

0.39

212

1695

Congenital malformations of the musculoskeletal system, not elsewhere classified

139

1045

1.44

3.31

2.9

7.74

8.11

mmol/l

0.31

124

915

FESS (DNB20)

1431

13154

1.12

3.31

3.3

3.2

7.72

7.88

mmol/l

0.70

1155

11196

Rhinophyma

569

1.71

3.29

3.7

3.2

7.64

8.19

mmol/l

0.60

457

Oral leukoplakia, including avohilmo

312

2611

1.29

3.28

3.7

3.2

7.04

7.54

mmol/l

1.27

253

2193

Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)

132

1724

0.70

3.28

2.8

3.2

8.04

8.19

mmol/l

0.13

106

1453

Mixed connective tissue disease

687

6082

1.18

3.28

3.5

3.1

6.77

7.10

mmol/l

1.27

585

5143

Congenital malformations of eye, ear, face and neck

654

5756

1.18

3.27

3.5

7.95

8.15

mmol/l

0.46

556

5007

Malignant neoplasm of rectum

910

10079

0.87

3.27

3.3

3.2

7.59

7.47

mmol/l

0.35

728

8362

HSIL lesion of the cervix uteri, vagina or vulva

1805

16707

1.10

3.25

3.5

3.1

7.24

7.40

mmol/l

0.70

1544

14414

Contact with other hot fluids

314

2617

1.27

3.24

4.5

3.4

8.26

8.27

mmol/l

0.01

256

2253

Sicca syndrome [Sjögren]

954

8616

1.15

3.24

3.2

3.0

6.55

6.75

mmol/l

0.86

795

7194

Carcinoma in situ of breast, intraductal

761

8511

0.86

3.24

2.8

3.0

6.39

6.37

mmol/l

0.05

626

7100

Nail dystrophy

584

1.66

3.24

3.3

3.0

7.21

7.46

mmol/l

0.15

493

Liver disorders in diseases classified elsewhere

229

2.13

3.23

4.2

2.8

5.45

7.85

mmol/l

4.31

197

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

1416

15358

0.89

3.23

3.1

3.2

7.19

7.48

mmol/l

1.88

1153

12801

Malignant neoplasm of nasal cavity and middle ear, excluding all cancers (controls excluding all cancers)

675

0.54

3.23

3.5

3.1

7.16

7.83

mmol/l

0.70

556

Pregnancy examination and test

1553

8891

1.11

3.23

3.5

3.0

8.37

7.98

mmol/l

1.91

1360

7768

Burn and corrosion of shoulder and upper limb, except wrist and hand

227

1835

1.33

3.22

3.1

3.3

7.46

8.34

mmol/l

1.91

199

1550

Primary_lymphoid and hematopoietic malignant neoplasms

2697

28592

0.92

3.21

3.2

3.3

7.22

7.51

mmol/l

3.02

2258

23902

Postpartum hemorraghe, all women as controls

2010

21521

0.92

3.21

3.0

3.2

7.45

8.25

mmol/l

0.63

1775

18759

Orthopaedic devices associated with adverse incidents

207

1673

1.38

3.21

4.1

3.2

6.95

7.03

mmol/l

0.08

149

1368

Foreign body or object entering through skin

678

6005

1.18

3.20

3.7

3.3

8.15

8.38

mmol/l

0.54

560

5140

Disorders of myoneural junction and muscle in diseases classified elsewhere

677

1.60

3.18

5.1

3.0

6.77

7.13

mmol/l

0.33

562

Other osteochondropathies

782

6988

1.16

3.17

3.3

8.03

8.17

mmol/l

0.36

676

5991

Subacute thyroiditis

372

3157

1.24

3.15

3.0

7.02

7.19

mmol/l

0.28

315

2662

LSIL lesion of the cervix uteri, vagina or vulva

1293

11824

1.12

3.15

3.4

3.1

7.23

7.24

mmol/l

0.05

1101

10166

Disorders of synovium and tendon in diseases classified elsewhere

235

1915

1.33

3.15

4.5

3.2

7.31

8.01

mmol/l

1.48

199

1626

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

343

4043

0.80

3.15

3.0

3.2

6.91

7.44

mmol/l

1.69

291

3383

Carcinoma in situ of vulva

697

1.59

3.15

5.6

2.9

5.80

6.67

mmol/l

1.30

579

Viral encephalitis, not elsewhere classified/unspecified

218

1761

1.34

3.15

4.1

3.2

7.18

7.80

mmol/l

1.17

196

1483

Disease of hard tissues of teeth, NOS

118

878

1.49

3.14

3.9

3.0

7.31

7.69

mmol/l

0.32

103

740

Nystagmus and other irregular eye movements

145

1111

1.43

3.14

3.7

3.4

7.72

7.92

mmol/l

0.19

132

947

Single delivery by caesarean section

1964

10542

1.10

3.13

3.6

3.3

7.66

7.64

mmol/l

0.07

1782

9238

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

168

2115

0.73

3.13

2.7

3.2

8.08

8.17

mmol/l

0.08

136

1778

Other and unspecified trigeminal disorders

172

1352

1.39

3.12

3.3

3.0

8.18

7.23

mmol/l

1.54

136

1139

Other disorders of choroid

154

1194

1.42

3.12

4.0

2.9

6.95

7.55

mmol/l

1.18

133

991

Drug-induced thyroiditis

204

2.27

3.12

4.6

3.0

7.88

8.23

mmol/l

0.22

177

Overjet

222

1777

1.32

3.12

4.8

3.7

8.40

8.76

mmol/l

0.43

203

1601

Other disorders following mastoidectomy

343

1.89

3.11

3.2

3.1

7.22

7.41

mmol/l

0.11

288

Benign neoplasm of bone and articular cartilage

896

8076

1.15

3.11

3.4

3.3

7.98

7.85

mmol/l

0.33

760

6885

Other injuries of lower limb, level unspecified

652

1.58

3.10

3.7

3.2

7.54

7.93

mmol/l

0.28

550

Chromophobe cell carcinoma of kidney

478

1.77

3.10

4.0

3.2

7.15

7.77

mmol/l

0.40

395

Melanocytic naevi of scalp and neck

253

2077

1.30

3.09

3.4

3.2

7.60

7.91

mmol/l

0.45

221

1754

Infectious mononucleosis

801

7151

1.15

3.09

3.4

3.3

9.10

8.76

mmol/l

0.80

690

6299

Giant cell arteritis

460

3997

1.22

3.09

3.1

6.96

6.81

mmol/l

0.31

372

3281

Dacryoadenitis

636

1.59

3.09

3.4

2.9

7.61

7.40

mmol/l

0.13

546

Problems related to social environment

272

2240

1.28

3.09

3.5

3.0

6.98

7.59

mmol/l

1.28

224

1883

Methotrexate

1744

16202

1.10

3.08

3.1

6.99

7.34

mmol/l

2.58

1506

13572

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

103

756

1.54

3.08

2.8

3.0

6.95

7.22

mmol/l

0.25

623

Hereditary hypogammaglobulinemia

303

1.93

3.08

5.1

3.2

6.42

7.94

mmol/l

2.23

261

All dysplastic lesions of the vagina

262

2160

1.30

3.07

3.4

3.0

6.52

6.84

mmol/l

0.71

217

1840

Vascular dementia (multiple infarctions)

932

0.63

3.07

2.8

3.1

6.98

6.58

mmol/l

0.32

760

Dislocation, sprain and strain of joints and ligaments of elbow

647

5723

1.17

3.06

4.0

3.3

7.90

7.92

mmol/l

0.03

559

4937

Congenital absence, atresia and stenosis of large intestine

2.81

3.04

8.4

5.1

5.51

8.09

mmol/l

1.51

Generalized epilepsy

429

3689

1.22

3.03

3.5

7.73

8.08

mmol/l

0.67

360

3197

Aortic aneurysm

2896

26919

1.08

3.02

3.1

3.2

7.52

7.95

mmol/l

6.48

2370

22143

Viral meningitis

366

3111

1.24

3.01

4.0

3.3

7.81

8.04

mmol/l

0.37

313

2684

Melanocytic naevi of other and unspecified parts of face

629

5570

1.18

3.01

3.2

3.1

7.73

7.51

mmol/l

0.49

550

4744

Injury of muscle and tendon at hip and thigh level

1076

9818

1.13

3.01

3.2

7.93

7.98

mmol/l

0.11

920

8356

Disorders of iron metabolism

153

1192

1.41

3.01

3.6

2.9

8.58

8.24

mmol/l

0.31

121

1006

Impaction of intestines

555

1.62

3.00

3.7

3.0

7.63

7.30

mmol/l

0.25

453

Dyshidrosis [pompholyx]

168

1322

1.38

3.00

3.6

3.0

7.18

8.05

mmol/l

1.65

128

1127

Giant cell arteritis with polymyalgia rheumatica

412

3562

1.23

2.99

3.1

6.84

6.78

mmol/l

0.09

335

2912

Temporal arteritis

412

3562

1.23

2.99

3.1

6.84

6.79

mmol/l

0.09

335

2910

Personal history of malignant neoplasm

391

3353

1.23

2.99

3.1

3.0

6.59

7.00

mmol/l

1.13

323

2828

Exophthalmic conditions

122

923

1.47

2.99

3.6

3.0

7.11

7.46

mmol/l

0.36

101

776

Chronic mastoiditis

300

2522

1.27

2.98

3.8

3.2

7.05

7.49

mmol/l

0.95

228

2087

Inguinal hernia, bilateral

1131

12328

0.89

2.98

3.2

3.4

8.19

8.25

mmol/l

0.16

966

10268

Other and unspecified injuries of abdomen, lower back and pelvis

154

1199

1.40

2.98

3.9

3.1

7.66

8.16

mmol/l

0.63

131

1017

Burn and corrosion of wrist and hand

387

3312

1.23

2.97

3.8

3.4

8.03

8.46

mmol/l

0.96

329

2831

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

568

4974

1.18

2.96

3.6

3.1

7.59

7.68

mmol/l

0.17

499

4374

Neuroendocrine tumor and carcinoma of stomach

395

1.78

2.96

4.0

2.9

6.34

7.60

mmol/l

1.08

322

Diseases of spleen

193

1554

1.36

2.96

3.5

3.1

6.60

7.72

mmol/l

3.73

164

1303

Idiopathic urticaria

199

1596

1.33

2.96

3.2

3.1

7.67

7.90

mmol/l

0.27

172

1361

Sequelae of infectious and parasitic diseases

811

7288

1.15

2.95

3.9

3.2

7.47

7.82

mmol/l

1.41

696

6137

Other disorders of skin and subcutaneous tissue related to radiation

140

2.53

2.95

3.5

2.6

7.05

7.75

mmol/l

0.35

107

Female infertility

3400

19880

1.07

2.95

3.2

3.1

7.40

7.82

mmol/l

0.24

2964

17080

Asthma mixed form (mode), excluding more controls

587

5169

1.18

2.95

2.9

3.0

7.76

7.53

mmol/l

0.55

522

4370

Postpartum hemorraghe, parous women as controls

2010

18865

0.92

2.95

3.0

3.1

7.45

8.34

mmol/l

0.61

1775

16456

Carcinoma in situ of other and unspecified digestive organs

293

2474

1.28

2.93

3.3

3.1

7.58

7.64

mmol/l

0.08

248

2069

Pulmonary oedema

174

1376

1.36

2.93

5.1

3.1

6.40

7.07

mmol/l

1.63

156

1115

Tongue abnormality

675

6029

1.17

2.93

3.4

3.1

7.01

7.10

mmol/l

0.22

578

5022

Portal vein thrombosis

174

1388

1.38

2.92

3.1

3.2

7.73

7.91

mmol/l

0.15

143

1156

Burns and corrosions of multiple body regions

103

762

1.51

2.92

3.3

3.4

7.82

8.36

mmol/l

0.55

648

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

1023

11187

0.88

2.91

3.3

3.2

7.43

7.53

mmol/l

0.33

824

9308

Postpartum haemorrhage due to anatomy

641

7248

0.87

2.90

3.0

3.2

7.69

7.86

mmol/l

0.37

572

6392

Other secondary coxarthrosis

375

3220

1.24

2.90

3.2

3.1

6.86

7.51

mmol/l

2.26

315

2693

Testicular dysfunction, other/unspecified

364

1.80

2.90

5.4

3.4

9.20

8.94

mmol/l

0.14

324

Other (seronegative) rheumatoid arthritis, wide

2277

21416

1.09

2.90

3.1

3.2

6.82

7.10

mmol/l

2.41

1942

17823

Deaf mutism, not elsewhere classified

410

1.72

2.90

3.8

2.9

6.71

7.60

mmol/l

1.02

352

Other disorders of peripheral nervous system

529

1.64

2.89

3.5

3.1

7.86

7.70

mmol/l

0.10

432

Inguinal or femoral hernia, bilateral

1155

12559

0.89

2.89

3.2

3.4

8.16

8.23

mmol/l

0.20

985

10457

Other and unspecified papulosquamous disorders

503

1.65

2.88

4.0

3.2

6.49

7.48

mmol/l

1.65

426

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

781

8661

0.87

2.88

2.7

3.2

6.80

7.31

mmol/l

3.22

629

7175

Erythema ab igne [dermatitis ab igne]

4.03

2.87

3.9

1.9

7.57

8.31

mmol/l

—

Achalasia of cardia

196

1583

1.34

2.87

3.4

3.0

7.32

7.65

mmol/l

0.46

163

1321

Benign neoplasm: Liver

225

1843

1.31

2.86

3.6

3.0

7.67

7.64

mmol/l

0.02

199

1571

Abnormality of white blood cells, not elsewhere classified

690

1.54

2.85

3.7

2.9

7.77

8.28

mmol/l

0.49

587

Benign neoplasm: Skin of lower limb, including hip

313

2655

1.26

2.84

4.2

3.0

6.92

7.52

mmol/l

1.79

257

2258

Chalazion

1282

11812

1.12

2.84

3.2

3.3

7.77

7.74

mmol/l

0.07

1098

10027

Livedoid vasculitis

294

1.90

2.83

4.4

3.1

7.07

7.45

mmol/l

0.24

236

Benign neoplasm: Small intestine

465

4079

1.21

2.81

3.2

3.1

7.09

7.26

mmol/l

0.33

389

3420

Sequelae of cerebrovascular disease

4521

38011

1.06

2.81

3.4

3.2

7.14

7.36

mmol/l

2.69

3679

31247

Severe combined immunodeficiency [SCID] with reticular dysgenesis

255

1.97

2.81

4.2

2.8

6.15

7.86

mmol/l

1.88

218

Carcinoma in situ of colon

169

1361

1.39

2.81

3.2

7.65

7.80

mmol/l

0.15

146

1125

Other disorders of the genitourinary system

1438

13335

1.11

2.81

3.3

3.1

6.36

6.55

mmol/l

1.03

1188

11023

Other and unspecified mononeuropathies of lower limb

306

2590

1.26

2.81

3.3

3.0

7.32

7.22

mmol/l

0.13

234

2175

Autoimmune hepatitis

604

1.56

2.80

2.7

6.87

7.32

mmol/l

0.41

505

Injury of urinary and pelvic organs

219

1794

1.31

2.80

4.1

3.3

7.49

8.25

mmol/l

1.66

190

1497

Adrenogenital disorders

348

1.77

2.80

5.1

3.0

6.86

7.50

mmol/l

0.40

291

Demyelinating diseases of the central nervous system

692

7739

0.87

2.79

3.7

3.2

7.75

7.79

mmol/l

0.08

587

6662

Chromosomal abnormalities, not elsewhere classified

189

1512

1.32

2.78

3.7

3.9

8.10

8.30

mmol/l

0.18

174

1358

Disorders of globe

264

2205

1.28

2.78

4.0

3.1

6.70

7.33

mmol/l

1.55

223

1827

Other and unspecified glaucoma

739

6648

1.16

2.78

3.6

3.1

6.41

6.94

mmol/l

3.34

584

5474

Malignant neoplasm of oropharynx

118

1526

0.71

2.77

2.4

3.1

8.37

8.13

mmol/l

0.20

1270

Maternal care for known or suspected fetal abnormality and damage

1317

10771

1.11

2.75

3.8

3.2

7.82

7.76

mmol/l

0.15

1163

9439

Thyroiditis, unspecified

157

1239

1.37

2.74

2.9

3.0

6.90

7.19

mmol/l

0.28

132

1060

Paraplegia, diplegia of upper limbs

237

1964

1.29

2.74

4.4

3.1

6.21

7.79

mmol/l

7.19

191

1621

Idiopathic thrombocytopenic purpura

322

2743

1.25

2.74

4.1

3.2

7.62

7.74

mmol/l

0.18

280

2301

ILD medications: pirfenidone

129

1012

1.47

2.74

3.2

3.1

7.61

7.98

mmol/l

0.44

112

818

Failed attempted abortion

105

778

1.45

2.73

3.8

3.2

7.83

8.07

mmol/l

0.18

696

Exposure to controlled fire, not in building or structure

249

1.96

2.72

3.1

3.0

6.81

8.32

mmol/l

1.24

217

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

263

2205

1.28

2.72

3.5

3.1

7.06

7.47

mmol/l

0.79

201

1837

Amoebiasis

449

1.65

2.71

3.6

3.0

5.94

7.92

mmol/l

4.06

375

Chronic suppurative otitis media

740

6657

1.15

2.71

3.6

3.3

7.53

7.77

mmol/l

0.72

606

5643

Selective deficiency of immunoglobulin G [IgG] subclasses

585

1.57

2.70

3.9

3.2

6.84

7.56

mmol/l

0.78

498

Peroneal tendinitis

164

1305

1.35

2.69

3.0

3.2

8.24

7.67

mmol/l

0.85

134

1116

Malignant neoplasm of nasal cavity and sinuses

563

0.55

2.69

3.4

3.1

8.01

7.86

mmol/l

0.05

462

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

993

10828

0.89

2.69

3.3

3.2

7.43

7.53

mmol/l

0.32

795

9009

Corneal degeneration

165

1323

1.37

2.68

3.7

3.1

7.07

7.08

mmol/l

0.01

141

1091

Foreign body entering into or through eye or natural orifice

896

8152

1.14

2.68

3.4

3.3

8.13

8.39

mmol/l

0.88

762

6958

Status epilepticus

359

3081

1.22

2.68

3.4

3.2

7.05

7.59

mmol/l

1.20

293

2580

Pedestrian injured in other and unspecified transport accidents

128

990

1.42

2.67

3.0

3.1

8.07

7.72

mmol/l

0.34

115

823

Sacrococcygeal disorders, not elsewhere classified

313

2657

1.24

2.67

3.0

3.1

7.53

7.38

mmol/l

0.22

253

2275

Cysts of oral region, not elsewhere classified

477

4187

1.19

2.67

4.0

3.1

8.20

8.05

mmol/l

0.30

395

3577

Other and unspecified types of non-Hodgkin lymphoma, hilmo

343

3983

0.82

2.66

3.0

3.2

6.91

7.39

mmol/l

1.45

291

3275

Other specified/unspecified deforming dorsopathies

187

1511

1.32

2.65

3.0

3.3

7.19

7.55

mmol/l

0.51

157

1285

Other conjunctival vascular disorders and cysts

260

2186

1.28

2.64

3.3

3.1

6.89

7.19

mmol/l

0.59

212

1828

Other and unspecified spinal muscular atrophies

730

0.61

2.64

3.3

3.2

6.81

7.62

mmol/l

0.77

610

Lichenoid drug reaction

272

1.98

2.64

3.0

2.9

6.83

7.05

mmol/l

0.11

216

Benign neoplasm: Liver/bile ducts

251

2098

1.27

2.64

3.7

3.0

7.94

7.65

mmol/l

0.42

223

1788

Drug-induced neutropenia

641

7141

0.86

2.63

3.4

3.2

6.74

7.34

mmol/l

3.23

531

6008

Crohn's disease NAS

680

6099

1.15

2.63

3.7

3.3

7.79

8.05

mmol/l

0.75

587

5223

Other specified and unspecified strabismus

122

939

1.42

2.63

4.2

3.4

8.41

7.89

mmol/l

0.45

104

803

Pleural plaque

1188

10986

1.12

2.62

3.3

7.60

7.73

mmol/l

0.51

932

8932

Carcinoma in situ of vagina

331

1.77

2.61

4.0

2.7

6.90

6.97

mmol/l

0.04

275

Glaucoma-related operations

616

5519

1.17

2.61

3.5

3.1

6.71

6.88

mmol/l

0.46

500

4532

Melanoma in situ of other and unspecified parts of face

130

1021

1.43

2.61

3.6

3.1

6.63

6.82

mmol/l

0.22

101

828

Melanocytic naevi of lip

734

1.49

2.61

3.1

2.9

6.73

7.40

mmol/l

0.66

623

Contusion of toe(s) with damage to nail

116

888

1.43

2.60

3.5

3.2

7.73

8.35

mmol/l

0.57

770

Acute myeloid leukaemia and myelodysplastic syndromes

112

1459

0.72

2.59

2.6

3.1

6.71

7.16

mmol/l

0.51

1189

Foreign body in genitourinary tract

101

759

1.47

2.58

3.2

2.9

7.07

7.70

mmol/l

0.71

648

Autonomic disorders

237

1978

1.28

2.57

3.1

3.2

7.78

7.73

mmol/l

0.06

193

1647

Other/unspecified reactive arthropathies

701

6314

1.15

2.56

3.3

7.33

7.78

mmol/l

1.80

598

5365

Exposure to other and unspecified animate mechanical forces

280

2364

1.25

2.56

3.9

3.3

8.22

8.24

mmol/l

0.02

231

2044

Spermatocele

927

8483

1.13

2.56

3.2

3.3

8.35

8.58

mmol/l

0.82

788

7098

Disorders of lacrimal system and orbit in diseases classified elsewhere

261

2197

1.26

2.56

2.8

3.0

7.04

7.19

mmol/l

0.20

222

1849

Non-follicular lymphoma, hilmo, excluding all cancers

954

10396

0.89

2.55

3.2

7.13

7.50

mmol/l

1.93

786

8670

Multiple myeloma

183

2236

0.77

2.55

2.8

3.1

6.68

7.10

mmol/l

0.69

162

1817

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

183

2236

0.77

2.55

2.8

3.1

6.68

7.10

mmol/l

0.69

162

1817

Eustachian salpingitis and obstruction

751

6771

1.14

2.55

4.1

3.4

8.05

8.60

mmol/l

2.28

630

5933

Exfoliative dermatitis

120

929

1.42

2.55

3.1

3.2

7.51

8.12

mmol/l

0.69

101

773

Unequal limb length (acquired)

636

1.49

2.53

3.3

3.0

7.88

8.75

mmol/l

0.84

558

Pulmonary eosinophilia, not elsewhere classified

135

1064

1.39

2.53

4.0

3.0

6.78

7.19

mmol/l

0.63

116

861

Malignant neoplasm of tongue

146

1821

0.75

2.52

3.1

6.82

7.90

mmol/l

1.75

116

1515

Malignant neoplasm of tonsil

106

1371

0.71

2.52

2.5

3.1

8.26

8.14

mmol/l

0.09

1143

Other and unspecified disorders of orbit

444

1.66

2.52

2.7

3.0

8.33

7.81

mmol/l

0.29

373

Acute lymphadenitis

599

5345

1.16

2.51

4.0

3.2

7.72

8.04

mmol/l

0.94

517

4584

Other and specified injuries of hip and thigh

226

1880

1.28

2.51

3.5

3.1

7.13

7.45

mmol/l

0.44

186

1571

Hereditary corneal dystrophies

353

3061

1.23

2.51

3.6

3.2

6.77

6.98

mmol/l

0.45

288

2524

Carcinoma in situ of breast, other/unspecified

107

1380

0.71

2.51

3.0

2.9

5.53

6.27

mmol/l

1.72

1160

Selective deficiency of immunoglobulin A [IgA]y

342

1.73

2.50

4.3

3.1

8.16

8.52

mmol/l

0.16

296

Ulcerative ileocolitis

425

3717

1.19

2.50

3.5

3.3

8.45

8.22

mmol/l

0.40

354

3189

Adhesive middle ear disease

177

1437

1.32

2.49

3.1

3.2

8.12

7.94

mmol/l

0.18

147

1216

ILD medications: nintedanib

613

1.58

2.49

3.2

7.22

7.80

mmol/l

0.61

500

Injury of blood vessels at abdomen, lower back and pelvis level

319

1.77

2.48

3.3

2.9

6.93

7.81

mmol/l

0.74

261

Occupational exposure to risk-factors

364

3163

1.22

2.48

3.1

3.3

8.17

mmol/l

0.01

311

2668

Other noninflammatory disorders of cervix uteri

526

4673

1.17

2.48

3.5

3.0

6.29

6.28

mmol/l

0.03

440

3903

Ulcerative proctitis

628

5631

1.15

2.47

3.2

3.3

7.75

8.02

mmol/l

0.73

548

4822

Common variable immunodeficiency

510

1.58

2.46

4.0

3.2

6.43

7.68

mmol/l

2.24

431

Benign neoplasm of bone and articular cartilage

896

8187

1.13

2.46

3.4

3.3

7.98

7.86

mmol/l

0.29

760

7023

Symptoms and signs involving appearance and behaviour

687

1.48

2.46

3.4

3.1

7.65

8.05

mmol/l

0.26

589

Melanoma in situ

451

3989

1.20

2.46

3.6

3.2

7.13

7.26

mmol/l

0.28

348

3337

Other disorders of binocular movement

223

1853

1.27

2.44

2.8

3.2

7.41

8.00

mmol/l

1.01

193

1589

Congenital malformations of anterior segment of eye

681

1.48

2.44

3.3

2.8

6.91

7.76

mmol/l

1.09

575

Acute thyroiditis

319

1.74

2.44

5.0

2.7

7.96

7.34

mmol/l

0.35

260

Use of ropinirole

317

3661

0.82

2.44

3.0

3.2

7.72

7.46

mmol/l

0.51

260

3027

Cellulitis of external ear

129

1014

1.39

2.44

3.0

3.3

7.51

7.78

mmol/l

0.27

111

869

Other superficial injuries of ankle and foot

484

1.58

2.44

4.5

3.3

7.83

8.09

mmol/l

0.14

421

Other congenital malformations of skin

409

3576

1.19

2.43

3.1

3.4

8.42

7.70

mmol/l

1.83

365

3067

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

113

1449

0.72

2.43

3.2

3.1

7.53

7.27

mmol/l

0.19

1189

Follow-up care involving plastic surgery

414

3629

1.20

2.42

3.6

3.0

7.11

7.14

mmol/l

0.04

288

3032

Other and unspecified paralytic syndromes

146

1166

1.35

2.40

6.0

3.4

7.89

7.70

mmol/l

0.18

134

979

Cerebral palsy

159

1276

1.32

2.39

3.9

3.7

7.49

8.65

mmol/l

2.02

138

1125

Patellar tendinitis

172

1394

1.31

2.39

3.9

3.5

9.08

8.83

mmol/l

0.24

147

1213

Obstructed labour due to maternal pelvic abnormality

1638

15342

1.09

2.39

3.0

6.80

6.67

mmol/l

0.62

1399

12985

Folate deficiency anaemia

703

1.47

2.38

3.4

3.2

6.37

7.45

mmol/l

1.65

587

Idiopathic pulmonary fibrosis

829

7579

1.13

2.37

3.4

3.2

7.27

mmol/l

0.01

679

6200

Malignant neoplasm of base of tongue, excluding all cancers (controls excluding all cancers)

845

0.65

2.36

2.9

3.1

9.05

8.42

mmol/l

0.36

708

Other or unspecified immunodeficiency

282

1.79

2.35

4.1

3.6

7.25

8.19

mmol/l

0.51

243

Benign neoplasm of thyroid gland

357

3109

1.21

2.35

3.2

3.1

6.98

7.01

mmol/l

0.05

291

2603

Laparoscopic right hemicolectomy

623

5631

1.16

2.35

3.2

7.36

7.09

mmol/l

0.88

517

4653

Papillary adenocarcinoma of thyroid gland

546

4883

1.16

2.35

3.1

7.14

mmol/l

0.00

458

4128

Colitis, primary sclerosing

143

1142

1.35

2.35

3.1

3.2

8.54

8.65

mmol/l

0.09

131

989

Glaucoma secondary to eye trauma

568

1.54

2.34

4.4

3.0

7.07

7.77

mmol/l

0.72

477

Crossbite

651

5427

1.14

2.34

4.4

3.5

8.24

8.53

mmol/l

0.72

556

4817

Foreign body in ear

194

1603

1.29

2.33

3.6

3.3

7.82

8.11

mmol/l

0.38

173

1352

Carcinoma in situ of breast, intraductal

761

8346

0.88

2.32

2.8

3.0

6.39

6.36

mmol/l

0.07

626

6938

Paralytic ileus

402

3529

1.19

2.32

3.7

3.1

7.21

7.65

mmol/l

1.25

350

2958

Other nutritional anaemias

102

779

1.42

2.32

3.6

3.0

6.74

7.25

mmol/l

0.63

650

Lethal midline granuloma

4.27

2.31

13.9

2.5

5.45

8.00

mmol/l

2.29

Mental and behavioural disorders associated with the puerperium

101

768

1.41

2.31

3.8

2.9

6.35

7.58

mmol/l

2.17

660

Malignant neoplasm of corpus uteri

892

8195

1.13

2.31

3.1

2.9

6.21

5.95

mmol/l

1.26

728

6690

Bruxism

177

1446

1.30

2.31

3.2

3.0

7.36

7.77

mmol/l

0.53

145

1244

Viral conjunctivitis

211

1758

1.27

2.30

3.3

3.1

8.08

8.01

mmol/l

0.07

171

1500

Benign neoplasm of ovary

2010

18992

1.08

2.29

3.1

3.0

6.34

mmol/l

0.00

1687

15869

Motorcycle rider injured in noncollision transport accidents

313

2697

1.22

2.29

4.3

3.5

9.06

9.11

mmol/l

0.06

276

2329

Scleritis

135

1077

1.36

2.28

4.1

3.1

7.46

7.49

mmol/l

0.02

121

916

Malignant neoplasm of base of tongue

501

0.56

2.28

2.8

3.0

9.10

8.26

mmol/l

0.32

418

Other aneurysm

577

5186

1.16

2.28

3.6

3.2

6.94

7.64

mmol/l

3.71

507

4296

Mucosal proctocolitis

1404

13104

1.09

2.27

3.4

3.3

8.38

8.25

mmol/l

0.44

1215

11238

Struck by thrown, projected or falling objec

502

4473

1.17

2.27

3.2

3.4

8.61

8.50

mmol/l

0.17

445

3815

Melanocytic naevi of scalp and neck

253

2149

1.25

2.27

3.4

3.1

7.60

7.96

mmol/l

0.54

221

1826

Endometriosis ASRM stages 3,4

2476

23506

1.07

2.27

3.0

3.1

6.88

6.73

mmol/l

0.82

2092

19809

Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere

4.70

2.27

4.2

2.8

6.36

6.58

mmol/l

—

Stenosis and insufficiency of lacrimal passages

1031

9525

1.11

2.26

3.2

3.1

6.59

7.07

mmol/l

3.57

882

7950

Other puerperal infections

614

5507

1.14

2.26

3.0

3.2

7.89

7.76

mmol/l

0.24

523

4823

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

638

7042

0.87

2.26

3.0

3.2

7.29

7.37

mmol/l

0.18

521

5883

Malignant neoplasm of adrenal gland, excluding all cancers (controls excluding all cancers)

641

1.49

2.26

3.8

3.6

6.03

7.54

mmol/l

3.10

537

Exposure to other and unspecified man-made environmental factors

165

1346

1.31

2.25

3.6

3.0

7.98

8.24

mmol/l

0.28

149

1139

Drug-induced myopathy

238

1.87

2.25

4.7

3.2

7.40

7.96

mmol/l

0.29

205

Burns classified according to extent of body surface involved

104

804

1.42

2.25

3.7

3.2

6.93

8.41

mmol/l

2.67

684

Androgenic alopecia

682

1.46

2.25

3.2

2.8

7.06

7.00

mmol/l

0.04

560

Pathological resorption of teeth

303

2609

1.22

2.25

3.3

3.0

7.51

7.98

mmol/l

0.96

253

2224

Covid-19 suspected case

2257

21373

1.07

2.24

3.0

3.2

14.24

7.99

mmol/l

0.51

2044

18353

Asthma mixed form (mode)

587

5271

1.15

2.24

2.9

3.1

7.76

7.49

mmol/l

0.67

522

4455

Chromophobe cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

512

1.61

2.23

4.0

3.1

7.15

7.93

mmol/l

0.54

432

Malignant neoplasm of adrenal gland

311

1.73

2.23

4.4

3.9

6.13

7.86

mmol/l

1.95

277

Erosion and ectropion of cervix uteri

309

2672

1.22

2.22

2.9

3.0

6.38

6.33

mmol/l

0.08

249

2236

Drug-induced polyneuropathy

767

1.44

2.22

3.5

3.6

6.06

7.40

mmol/l

3.08

640

Torsion of ovary, ovarian pedicle and fallopian tube

204

1694

1.26

2.21

2.6

3.1

7.03

7.23

mmol/l

0.27

178

1453

Other and unspecified hypertrophic disorders of skin

520

1.53

2.21

6.8

2.8

7.83

7.58

mmol/l

0.15

438

Benign neoplasm: Ill-defined sites within the digestive system

514

1.55

2.21

2.9

3.0

7.17

7.11

mmol/l

0.04

434

Other acquired deformities of ankle and foot

675

1.45

2.20

3.1

3.0

6.80

7.34

mmol/l

0.46

573

Induced delusional disorder

3.04

2.20

2.6

2.7

8.80

8.63

mmol/l

0.04

Otorrhoea

232

1.87

2.19

4.6

3.5

6.30

7.80

mmol/l

2.00

200

Melanoma in situ, other sites/unspecified

266

1.83

2.19

3.4

3.0

7.33

7.39

mmol/l

0.04

215

Pedestrian injured in collision with pedal cycle

338

2946

1.20

2.19

3.3

3.2

7.02

7.87

mmol/l

3.00

298

2488

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

331

2867

1.20

2.19

4.9

3.7

8.18

8.29

mmol/l

0.14

293

2492

Arterial embolism and thrombosis of lower extremity artery

354

3091

1.20

2.19

3.7

3.1

6.65

7.51

mmol/l

3.84

299

2528

Colitis, primary sclerosing, strict definition

109

850

1.39

2.18

3.3

3.0

8.56

8.65

mmol/l

0.06

101

739

Malignant neoplasm of prostate

5366

35032

0.95

2.18

3.1

3.4

8.08

8.31

mmol/l

3.52

4228

29118

Generalized epilepsy, mode (most common among epilepsy diagnosis)

312

2697

1.21

2.18

3.5

3.4

7.57

8.09

mmol/l

0.97

263

2333

Malignant neoplasm of gum, excluding all cancers (controls excluding all cancers)

915

0.68

2.18

2.8

3.1

6.91

7.32

mmol/l

0.35

767

Degenerative conditions of globe

393

1.60

2.17

4.9

3.0

5.99

7.59

mmol/l

2.64

311

Corneal scars and opacities

282

2431

1.23

2.17

4.7

3.1

7.11

7.67

mmol/l

1.18

246

2026

Parkinson's disease, strict definition, excluding more controls

1299

13637

0.91

2.16

2.8

3.1

7.46

7.24

mmol/l

1.12

1045

11142

Malignant neoplasm

13123

79566

0.97

2.16

3.2

7.44

7.76

mmol/l

12.46

10891

67730

Crushing injury of wrist and hand

174

1441

1.31

2.16

3.6

3.3

8.63

8.50

mmol/l

0.13

148

1218

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

974

10521

0.90

2.16

3.3

3.2

7.46

7.47

mmol/l

0.04

785

8718

Sequelae of transport accidents

344

1.64

2.16

3.9

2.8

7.25

8.35

mmol/l

0.78

298

Other congenital malformations, not elsewhere classified

623

1.46

2.16

3.4

3.5

8.32

8.18

mmol/l

0.09

548

Biological medication for rheuma

1663

15637

1.08

2.16

3.0

3.3

8.08

8.13

mmol/l

0.14

1444

13497

Myositis ossificans

215

1.85

2.16

3.5

2.9

7.73

7.99

mmol/l

0.13

174

Ovarian dysfunction: estrogen excess

2.43

2.15

2.4

2.5

7.89

6.89

mmol/l

0.31

Malignant neoplasm of endocrine gland

765

6997

1.13

2.15

3.3

3.2

7.10

7.22

mmol/l

0.32

644

5898

Primary_lymphoid and hematopoietic malignant neoplasms

2697

28251

0.94

2.15

3.2

7.22

7.51

mmol/l

2.90

2258

23385

Intestinal stricture

3758

36114

1.06

2.15

3.4

3.2

7.19

7.39

mmol/l

2.06

3154

29882

Tuberculosis

547

6086

0.87

2.14

3.3

3.1

6.85

7.18

mmol/l

1.03

449

4980

Dysplasia of cervi uteri

2490

18282

1.07

2.14

3.4

3.1

7.28

7.85

mmol/l

0.32

2134

15700

Other and unspecified nonscarring hair loss

522

1.51

2.13

4.0

2.8

7.58

7.44

mmol/l

0.08

439

Pyothorax

447

3981

1.17

2.13

3.7

3.2

7.12

8.04

mmol/l

4.30

380

3315

Other and unspecified parapsoriasis

417

1.62

2.13

3.1

2.9

6.73

7.82

mmol/l

1.05

331

Anuria and oliguria

532

1.51

2.13

5.6

3.1

6.28

7.79

mmol/l

2.45

434

Rheumatoid arthritis, including avohilmo

4900

47338

1.05

2.11

3.3

3.1

6.95

7.16

mmol/l

2.79

4192

39432

Hereditary deficiency of other clotting factors

696

1.43

2.11

3.7

2.9

7.70

7.92

mmol/l

0.17

590

Other autoimmune haemolytic anaemias

130

1047

1.36

2.11

3.5

3.1

6.62

7.34

mmol/l

1.18

111

858

Neuroendocrine tumor and carcinoma of rectum

326

1.71

2.11

3.1

2.9

7.96

7.54

mmol/l

0.26

269

Suppurative and necrotic conditions of lower respiratory tract

576

5205

1.15

2.10

3.7

3.3

7.03

7.97

mmol/l

5.67

490

4349

Scissor bite

237

1999

1.23

2.10

3.9

3.8

8.87

9.22

mmol/l

0.42

216

1815

Defects in the complement system

559

1.49

2.10

5.0

3.1

7.70

7.77

mmol/l

0.05

487

Morphin

120

1501

0.75

2.10

4.6

3.0

7.19

7.39

mmol/l

0.16

1235

Hypertrophy of tongue papillae

133

1073

1.35

2.09

3.7

3.1

6.93

7.60

mmol/l

1.21

110

895

Supervision of high-risk pregnancy

2073

11835

1.07

2.09

3.4

3.0

7.81

7.71

mmol/l

0.36

1830

10318

Thoracic aortic aneurysm

1675

15822

1.09

2.08

3.1

3.2

7.69

8.06

mmol/l

2.96

1339

13138

Other salmonella infections

395

3492

1.18

2.08

3.6

3.1

7.73

7.61

mmol/l

0.17

313

2947

Adenocarcinoma and papilloma adenocarcinoma of rectum

935

10096

0.90

2.07

3.3

3.2

7.46

7.47

mmol/l

0.02

750

8375

Correction of physiology of bite - very demanding therapy visit

271

2330

1.22

2.07

3.1

7.66

7.61

mmol/l

0.05

229

2005

Deep bite

1134

9214

1.10

2.07

3.7

3.4

8.03

8.21

mmol/l

0.55

981

8067

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

924

8538

1.11

2.07

3.3

3.2

7.10

7.26

mmol/l

0.56

781

7198

Injury of muscle and tendon at ankle and foot level

254

2177

1.23

2.07

3.4

3.2

7.89

8.13

mmol/l

0.33

215

1854

Respiratory insufficiency

917

8452

1.11

2.06

3.5

3.1

6.81

7.36

mmol/l

3.49

741

7017

Vertigo of central origin

163

1346

1.30

2.06

3.7

3.1

6.43

7.11

mmol/l

1.23

125

1116

Inguinal hernia

8448

58481

0.97

2.06

3.1

3.4

8.32

8.26

mmol/l

0.44

7110

49330

Disorders of sexual preference

205

1.92

2.06

3.8

3.1

10.16

8.70

mmol/l

0.48

175

Osteosarcoma

164

2.00

2.05

3.7

3.0

6.85

8.51

mmol/l

0.83

148

Immunodeficiency with short-limbed stature

4.05

2.05

6.8

3.4

5.58

7.57

mmol/l

—

Complications of other internal prosthetic devices, implants and grafts

397

3517

1.18

2.04

3.7

3.1

6.87

7.16

mmol/l

0.68

344

2919

Lower leg

477

1.53

2.04

2.8

7.77

7.75

mmol/l

0.01

408

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

228

2660

0.81

2.03

3.4

3.2

7.03

7.93

mmol/l

1.97

187

2226

Choroidal haemorrhage and rupture

252

1.76

2.02

3.8

2.9

6.47

7.73

mmol/l

1.25

215

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

263

2271

1.23

2.02

3.5

3.1

7.06

7.52

mmol/l

0.96

201

1915

Acute appendicitis, with complications

2393

22797

1.07

2.02

3.4

3.2

7.78

7.83

mmol/l

0.24

2070

19209

Respiratory and cardiovascular disorders specific to the perinatal period

193

1434

1.25

2.02

5.6

4.7

8.01

8.82

mmol/l

1.04

183

1365

Other and unspecified disorders of autonomic nervous system

310

1.67

2.01

4.0

3.0

8.17

8.03

mmol/l

0.06

265

Osteomalacia

748

1.41

2.01

3.2

3.0

8.09

8.05

mmol/l

0.03

625

Other nonscarring hair loss

719

1.41

2.01

3.7

2.9

7.27

7.44

mmol/l

0.13

598

Intercostal neuropathy

670

1.44

2.01

3.6

3.0

7.17

7.78

mmol/l

0.83

538

Malignant neoplasm of renal pelvis, excluding all cancers (controls excluding all cancers)

130

1054

1.34

2.00

3.0

3.1

6.73

7.60

mmol/l

1.82

104

857

Intrahepatic Cholestasis of Pregnancy (ICP)

568

5116

1.14

2.00

3.6

3.1

7.59

7.63

mmol/l

0.07

499

4490

Graves ophthalmopathy

255

2195

1.23

2.00

2.8

3.0

7.08

7.13

mmol/l

0.06

216

1851

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

231

2686

0.81

2.00

3.2

3.0

5.90

6.07

mmol/l

0.36

200

2223

Caught, crushed, jammed or pinched in or between objects

498

4473

1.15

2.00

3.5

3.4

8.39

8.50

mmol/l

0.20

430

3834

Benign neoplasm: Oesophagus

132

1072

1.34

2.00

3.1

7.38

7.44

mmol/l

0.06

115

884

Spinal instabilities

302

2631

1.20

1.99

3.3

3.2

7.55

7.59

mmol/l

0.06

260

2235

Other assisted single delivery

100

1276

0.74

1.99

3.1

3.5

8.55

7.53

mmol/l

1.26

1124

Family history of certain disabilities and chronic diseases leading to disablement

411

3641

1.16

1.99

3.3

3.1

7.95

8.17

mmol/l

0.38

346

3140

Other/unspecified soft tissue disorders related to use, overuse and pressure

297

2583

1.20

1.98

3.0

3.1

7.60

7.64

mmol/l

0.05

249

2211

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

1083

10099

1.10

1.98

3.1

3.0

6.30

6.04

mmol/l

1.36

893

8338

Pyogenic granuloma

176

1468

1.28

1.98

3.7

3.0

7.01

7.94

mmol/l

2.16

157

1233

Guillain-Barre syndrome

172

1435

1.28

1.97

4.5

3.2

7.30

7.93

mmol/l

1.24

139

1195

Disorders of brain, other and unspecified

101

793

1.38

1.97

3.8

3.1

6.56

7.70

mmol/l

1.80

664

Injury of muscle and tendon at forearm level

199

1680

1.26

1.97

4.4

3.3

8.74

8.36

mmol/l

0.47

168

1430

Injury of cranial nerves

550

1.48

1.96

3.2

3.0

8.40

8.06

mmol/l

0.21

465

Benign neoplasm: Pituitary gland, craniopharyngeal duct

531

4795

1.15

1.96

2.9

3.2

7.76

7.78

mmol/l

0.03

456

4058

Pneumonia due to other infectious organisms, not elsewhere classified

338

2975

1.19

1.96

5.0

3.1

7.35

7.80

mmol/l

1.03

294

2477

Scar conditions and fibrosis of skin

406

3610

1.17

1.95

3.4

3.0

7.56

7.53

mmol/l

0.03

340

3058

Other bursitis of elbow

737

1.41

1.95

4.2

3.2

7.69

8.32

mmol/l

0.64

612

Acrodermatitis continua

143

2.03

1.94

2.2

2.9

7.29

7.87

mmol/l

0.28

116

Apocrine sweat disorders, other sweat gland disorders

364

1.61

1.94

3.1

2.8

7.07

7.64

mmol/l

0.39

291

Other disorders of binocular vision

125

1004

1.32

1.94

2.6

3.0

6.99

7.94

mmol/l

1.29

117

860

Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers)

434

1.57

1.94

4.0

3.0

6.34

7.59

mmol/l

1.06

362

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

475

4269

1.16

1.94

3.2

7.75

7.51

mmol/l

0.52

405

3618

Thyrotoxicosis with toxic single thyroid nodule

726

1.40

1.93

3.0

2.9

7.25

7.14

mmol/l

0.09

605

Pleural effusion

1798

17043

1.08

1.92

3.5

3.2

6.96

7.48

mmol/l

5.85

1464

14028

Mental and behavioural disorders of puerperium, not classified elsewhere

101

791

1.36

1.92

3.8

3.0

6.35

7.63

mmol/l

2.32

684

Toxic effect of other gases, fumes and vapours

438

1.52

1.92

2.9

3.3

8.48

8.47

mmol/l

0.01

370

Respiratory tuberculosis, confirmed and not-confirmed

470

5234

0.87

1.92

3.3

3.1

6.99

7.27

mmol/l

0.70

388

4292

Melanoma in situ, other sites/unspecified

275

1.75

1.92

3.4

2.9

7.33

7.49

mmol/l

0.09

232

Malignant neoplasm of mesothelium and soft tissue

373

4195

0.85

1.92

2.9

3.2

7.18

7.40

mmol/l

0.48

304

3483

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

252

2165

1.21

1.92

3.7

3.0

6.96

7.02

mmol/l

0.07

209

1863

Keratoconus

247

2126

1.22

1.91

3.3

8.04

8.28

mmol/l

0.31

214

1817

Respiratory tuberculosis

470

5233

0.87

1.91

3.3

3.1

6.99

7.27

mmol/l

0.71

388

4292

Female infertility, uterine origin

267

0.48

1.91

1.9

2.9

5.79

7.42

mmol/l

1.93

232

Unspecified jaundice

535

4840

1.14

1.90

3.3

3.2

6.90

7.61

mmol/l

3.32

437

4046

Pedal cyclist injured in other and unspecified transport accidents

1207

11296

1.09

1.90

3.6

3.3

7.42

7.93

mmol/l

2.98

1025

9643

Endovascular or surgical operations to intracerebral aneurysms

705

6472

1.13

1.90

3.1

7.45

7.41

mmol/l

0.07

629

5417

Outcome of delivery

1418

9373

0.92

1.90

2.8

3.0

8.09

7.85

mmol/l

0.79

1223

8178

malignant neoplasm of male genital organs

5496

35975

0.96

1.89

3.1

3.4

8.11

8.35

mmol/l

3.65

4337

29945

Malignant neoplasm of other and unspecified female genital organs

102

1272

0.74

1.89

3.1

3.0

5.82

6.12

mmol/l

0.49

1042

Benign leiomyoma with endometriosis

1779

16861

1.08

1.89

3.0

6.46

6.29

mmol/l

0.95

1437

13999

Other abnormal findings in urine

161

1341

1.29

1.89

3.4

3.1

7.34

7.53

mmol/l

0.20

142

1101

Other appendicitis

919

8520

1.11

1.88

3.6

3.2

7.77

7.73

mmol/l

0.10

762

7249

Benign neoplasm: Vulva

225

1931

1.24

1.88

3.3

2.9

6.13

6.39

mmol/l

0.44

182

1617

Bullous keratopathy

694

1.41

1.88

3.3

3.1

5.94

6.87

mmol/l

1.73

565

Disorders of other and unspecified cranial nerves

441

1.52

1.88

4.2

2.8

7.09

7.63

mmol/l

0.43

365

Alopecia areata

255

2203

1.21

1.87

3.3

3.2

7.85

7.67

mmol/l

0.21

218

1878

Pemphigus

599

1.45

1.87

3.9

2.9

5.98

7.54

mmol/l

3.48

496

Benign neoplasm: Pharynx, unspecified

660

1.42

1.87

3.8

3.1

7.76

7.56

mmol/l

0.15

545

Use of interferon beta-1a

144

1750

0.79

1.86

4.6

3.1

8.14

8.08

mmol/l

0.04

132

1538

Loose body in joint

256

2217

1.21

1.86

3.1

8.33

8.11

mmol/l

0.30

221

1868

Other injuries of spine and trunk, level unspecified

695

1.40

1.86

5.6

3.0

6.52

8.08

mmol/l

2.54

574

Other ulcerative colitis

595

5417

1.13

1.85

3.4

3.3

8.43

8.08

mmol/l

0.90

510

4639

Blindness or visual impairment, binocular

383

1.57

1.85

5.4

2.9

5.60

7.64

mmol/l

3.43

320

Abnormal findings on diagnostic imaging of central nervous system

454

4079

1.15

1.85

3.4

3.3

7.79

7.76

mmol/l

0.05

379

3480

Burn and corrosion of head and neck

223

1912

1.23

1.85

3.2

3.4

8.42

8.73

mmol/l

0.41

197

1633

Other benign neoplasm of uterus: Corpus uteri

708

1.41

1.85

3.1

3.0

6.82

6.36

mmol/l

0.37

574

Use of pergolide

173

0.41

1.84

1.6

2.9

8.01

7.10

mmol/l

—

141

Listeriosis

376

1.58

1.84

3.7

2.8

6.95

7.20

mmol/l

0.17

301

Contact with other specified venomous animals

538

1.46

1.83

2.9

3.0

7.82

7.83

mmol/l

0.01

449

Postviral fatigue syndrome

507

1.44

1.83

2.3

2.9

9.05

8.58

mmol/l

0.27

454

Other specified and unspecified disorders of iris and ciliary body

325

1.61

1.83

2.8

2.9

8.81

8.24

mmol/l

0.32

272

IBD (strict) with PSC

774

1.37

1.82

2.9

3.0

8.46

8.64

mmol/l

0.12

666

Chronic thyroiditis

325

1.61

1.82

3.4

2.8

6.54

6.65

mmol/l

0.07

261

Rheumatic fever without mention of heart involvement

284

1.67

1.82

4.2

3.1

7.05

7.82

mmol/l

0.53

233

Other and unspecified haemorrhagic conditions

160

1335

1.27

1.82

3.7

3.1

7.20

7.40

mmol/l

0.22

136

1110

Infarction of spleen

517

1.49

1.81

3.0

6.92

7.43

mmol/l

0.47

417

Fall on and from ladder

890

8276

1.11

1.81

3.3

8.12

8.18

mmol/l

0.14

750

6954

Accidental poisoning by and exposure to alcohol

179

1506

1.25

1.81

4.8

3.1

7.69

8.64

mmol/l

1.47

159

1281

Bacterial sepsis of newborn

398

1.51

1.80

3.3

5.3

8.09

8.42

mmol/l

0.14

375

Other disorders of bone density and structure

266

2316

1.20

1.80

4.0

3.1

7.55

7.93

mmol/l

0.67

239

1958

Benign lipomatous neoplasm of other sites/unspecified

985

9184

1.10

1.80

3.4

3.1

7.33

7.21

mmol/l

0.34

811

7644

Other and unspecified primary disorders of muscles

628

1.42

1.80

3.3

7.00

7.92

mmol/l

1.00

536

Other trisomies and partial trisomies of the autosomes, not elsewhere classified

2.32

1.80

4.2

4.8

7.23

8.35

mmol/l

0.56

Respiratory tuberculosis, not confirmed

345

3891

0.86

1.79

3.2

3.1

7.06

7.17

mmol/l

0.17

282

3189

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

154

1836

0.79

1.79

2.9

3.1

7.47

7.41

mmol/l

0.05

113

1525

Congenital malformations of the nervous system

203

1727

1.23

1.78

3.9

3.4

7.35

8.33

mmol/l

1.90

184

1507

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

695

6396

1.12

1.78

3.1

7.21

7.23

mmol/l

0.04

588

5411

Malignant neoplasm of gallbladder, excluding all cancers (controls excluding all cancers)

579

0.64

1.78

3.7

3.0

6.35

7.02

mmol/l

0.61

479

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

751

6910

1.11

1.77

3.7

3.0

7.28

mmol/l

0.01

652

5980

Motorcycle rider injured in other and unspecified transport accidents

595

5427

1.13

1.77

4.0

3.4

9.25

9.09

mmol/l

0.27

525

4730

Other conditions related to polyarteritis nodosa

204

1.81

1.77

6.4

3.0

6.51

7.84

mmol/l

1.07

168

Contraceptive management

4924

35739

0.96

1.76

3.2

8.07

8.13

mmol/l

0.43

4328

30906

Malignant neoplasm of other and ill-defined digestive organs

558

0.64

1.76

3.2

2.9

8.67

7.43

mmol/l

0.50

458

Benign neoplasm of middle ear and respiratory system

880

8179

1.11

1.76

3.5

3.2

7.36

7.68

mmol/l

1.43

743

6868

Defect, injury or illness of neck

420

1.51

1.76

3.8

3.0

8.09

7.83

mmol/l

0.12

360

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

330

2922

1.18

1.76

3.6

3.4

7.70

7.83

mmol/l

0.18

272

2494

Thyrotoxicosis factitia

245

1.70

1.74

3.2

2.7

6.20

7.21

mmol/l

0.71

200

Hypersplenism

346

1.58

1.73

3.8

3.2

6.51

8.27

mmol/l

3.02

296

Contact with lifting and transmission devices, not elsewhere classified

201

1724

1.24

1.73

3.2

3.3

8.57

8.59

mmol/l

0.01

176

1457

Vitreous prolapse

240

1.76

1.73

5.5

3.1

6.83

7.14

mmol/l

0.20

200

Other and unspecified intracranial injuries

302

2661

1.18

1.72

3.3

7.92

8.03

mmol/l

0.15

260

2220

Congenital malformations of posterior segment of eye

423

1.51

1.72

4.5

3.6

6.77

8.16

mmol/l

1.88

364

Medical treatment for female infertility

1558

16454

0.93

1.72

2.9

3.2

7.97

8.61

mmol/l

0.33

1405

14375

Von Willebrand disease

129

1059

1.30

1.72

2.9

3.0

7.28

7.60

mmol/l

0.36

109

922

Frostbite

112

908

1.33

1.71

3.3

3.2

7.55

8.44

mmol/l

0.97

100

770

Toxic effect of corrosive substances

405

1.50

1.70

5.1

3.1

8.96

8.58

mmol/l

0.18

350

Injury of blood vessels at lower leg level

390

1.53

1.70

3.0

7.37

8.14

mmol/l

0.58

327

Acute myeloid leukaemia, excluding all cancers (controls excluding all cancers)

839

0.71

1.70

2.4

3.2

6.98

7.47

mmol/l

0.37

700

Acute myeloid leukaemia, helper endpoint

839

0.71

1.70

2.4

3.2

6.98

7.47

mmol/l

0.37

700

Benign neoplasm: Hypopharynx

409

1.53

1.69

5.0

3.1

7.17

7.87

mmol/l

0.52

328

Tuberculosis, IBD comorbidity

659

7165

0.90

1.69

3.3

3.1

6.83

7.20

mmol/l

1.46

542

5878

Lesion of medial popliteal nerve

331

1.58

1.69

3.3

3.0

7.68

7.57

mmol/l

0.06

274

Benign neoplasm: Skin of lip

146

1221

1.28

1.69

3.9

3.0

7.08

7.31

mmol/l

0.28

133

1012

Communicating hydrocephalus

163

1926

0.80

1.69

3.3

3.2

7.34

7.41

mmol/l

0.06

144

1599

Viral infections of central nervous system, not elsewhere classified/unspecified

119

973

1.31

1.69

3.7

3.0

7.86

8.01

mmol/l

0.13

101

828

Helminthiases

179

1521

1.24

1.68

3.6

3.4

7.84

7.71

mmol/l

0.12

155

1278

Juvenile osteochondrosis

319

2821

1.17

1.68

3.7

3.4

8.00

8.48

mmol/l

1.07

285

2422

Internuclear ophthalmoplegia

306

1.61

1.68

3.5

2.9

8.41

8.04

mmol/l

0.13

245

Twin gestation

739

6808

1.11

1.68

3.1

3.0

7.66

7.57

mmol/l

0.20

660

5940

Other and unspecified injuries of thorax

181

1540

1.24

1.67

3.5

3.1

8.16

8.03

mmol/l

0.12

150

1299

Melanocytic naevi of lower limb, including hip

433

3907

1.15

1.67

4.3

3.3

7.14

7.56

mmol/l

1.17

381

3318

Osteitis due to dental implant

587

1.44

1.67

4.3

3.0

7.03

7.32

mmol/l

0.20

487

Use of amantadine

112

1371

0.77

1.67

3.2

3.0

8.16

7.16

mmol/l

1.18

1126

Pneumoconiosis due to asbestos and other mineral fibres

209

1797

1.22

1.67

3.6

3.2

7.33

7.53

mmol/l

0.35

170

1460

Other diseases of spinal cord

310

2746

1.18

1.67

3.0

3.2

6.90

7.79

mmol/l

3.23

252

2311

Myocardial infarction, unclassifiable

2456

22857

0.95

1.66

3.4

3.1

7.09

7.36

mmol/l

2.63

1986

18578

Pregnancy, childbirth and the puerperium

3734

18840

1.05

1.66

3.0

6.63

6.66

mmol/l

0.17

3145

15682

Other congenital malformations of nervous system

683

1.36

1.66

3.7

3.5

7.20

8.30

mmol/l

1.24

592

Crohn's disease of small intestine

696

6417

1.11

1.66

3.3

8.03

8.07

mmol/l

0.08

594

5497

Birth trauma

431

1.47

1.66

6.9

3.5

9.22

8.89

mmol/l

0.12

395

Carcinoma in situ of vagina

367

1.55

1.66

4.0

2.8

6.90

6.89

mmol/l

0.01

302

Certolizumab pegol

158

1327

1.25

1.66

2.7

3.1

7.82

7.84

mmol/l

0.02

138

1145

Malignant neoplasm of meninges, excluding all cancers (controls excluding all cancers)

345

0.56

1.65

2.2

2.8

8.04

7.19

mmol/l

0.36

285

Endometriosis ASRM stages 1,2

1745

16573

1.07

1.65

2.8

3.1

7.28

7.10

mmol/l

0.81

1475

14159

Rheumatic fever incl heart disease

314

2780

1.17

1.65

3.6

3.1

7.03

7.37

mmol/l

0.78

258

2275

Graves ophthalmopathy, strict

224

1944

1.21

1.64

2.8

3.0

7.14

mmol/l

0.00

189

1627

Other abortion

642

1.37

1.64

2.9

6.84

7.40

mmol/l

0.46

562

Tularaemia

136

1133

1.28

1.64

3.3

3.1

8.06

7.91

mmol/l

0.15

122

943

Abdominal aortic aneurysm (AAA)

1080

10039

1.09

1.64

3.2

3.1

7.13

7.75

mmol/l

6.00

908

8119

Acute inflammation of orbit

539

1.42

1.63

5.7

3.2

8.15

8.07

mmol/l

0.06

473

Unspecified transport accident

357

1.53

1.63

3.3

3.2

7.94

8.59

mmol/l

0.31

307

Benign neoplasm: Skin, unspecified

413

3726

1.15

1.63

3.5

3.2

7.28

7.45

mmol/l

0.36

345

3125

Pneumocystosis

176

1507

1.25

1.63

5.6

3.1

6.66

7.64

mmol/l

2.33

160

1254

Cicatricial alopecia [scarring hair loss]

647

1.39

1.63

3.0

7.23

7.32

mmol/l

0.07

538

Vasomotor rhinitis (mode)

781

7251

1.11

1.63

3.2

7.51

7.45

mmol/l

0.12

663

6121

Myasthenia gravis

181

1550

1.24

1.63

2.9

3.1

7.97

7.56

mmol/l

0.61

157

1282

Benign neoplasm of other and unspecified female genital organs

452

4099

1.14

1.62

3.3

3.0

6.57

6.43

mmol/l

0.29

374

3435

Other retinal disorders in diseases classified elsewhere

151

1.88

1.62

4.6

3.2

6.54

8.07

mmol/l

1.29

125

Unspecified parasitic disease

737

1.36

1.62

3.8

3.1

7.20

7.87

mmol/l

0.65

617

Other and unspecified disease of Bartholin gland

303

2689

1.18

1.62

3.8

3.0

6.88

6.43

mmol/l

0.92

261

2257

Anoxic brain damage

1198

0.76

1.61

3.3

7.40

8.04

mmol/l

0.64

990

Cholesteatoma of middle ear

578

5307

1.13

1.61

3.4

3.2

7.60

7.47

mmol/l

0.27

474

4432

Injury of nerves and spinal cord at neck level

238

2081

1.21

1.61

4.2

3.3

7.55

8.09

mmol/l

1.05

203

1744

Asthma and opportunity respiratory infection

495

4516

1.14

1.61

3.2

3.1

6.48

6.98

mmol/l

2.10

418

3724

Other and unspecified acquired haemolytic anaemias

782

1.35

1.61

4.5

3.0

6.47

7.47

mmol/l

1.67

649

Other menopausal disorders

2977

17845

0.95

1.61

2.7

3.0

6.90

6.56

mmol/l

4.42

2497

15078

Benign neoplasm: Nasopharynx

100

811

1.34

1.60

3.9

3.2

7.39

7.48

mmol/l

0.07

672

Benign neoplasm: Rectum/anal canal icd-9

724

1.34

1.60

3.8

3.0

6.83

6.67

mmol/l

0.14

576

Other congenital malformations of face and neck

277

2438

1.18

1.60

3.3

8.26

8.25

mmol/l

0.01

234

2091

Graves disease, strict definition

971

9078

1.09

1.60

3.2

7.39

7.27

mmol/l

0.33

822

7750

Benign neoplasm: Bladder

800

1.34

1.60

3.4

3.1

7.27

7.58

mmol/l

0.31

651

Other and unspecified pemphigoid

740

1.36

1.60

4.2

2.9

6.55

6.90

mmol/l

0.42

606

Other lack of coordination

173

1476

1.24

1.60

4.3

3.1

6.78

7.64

mmol/l

2.11

146

1229

Other bursal cyst

166

1412

1.25

1.60

2.8

3.0

7.34

7.64

mmol/l

0.37

142

1192

Follicular lymphoma

395

4366

0.87

1.59

3.1

3.2

7.00

7.32

mmol/l

0.90

310

3658

Contact with blunt object, undetermined intent

498

1.44

1.59

4.2

3.0

8.48

8.59

mmol/l

0.05

427

Foreign body in respiratory tract

529

4835

1.13

1.59

3.4

3.2

7.80

7.72

mmol/l

0.14

438

4134

Tuberculosis, wide

681

7370

0.90

1.58

3.3

3.1

6.82

7.16

mmol/l

1.34

563

6046

Contact with and exposure to communicable diseases

3334

32014

1.05

1.58

3.3

8.34

8.29

mmol/l

0.21

2766

27978

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1803

17175

1.07

1.58

3.3

8.49

8.21

mmol/l

1.47

1559

14741

Open bite

438

3955

1.14

1.58

3.4

3.5

7.89

8.32

mmol/l

1.02

391

3505

Congenital malformations of the circulatory system

1527

14031

1.07

1.58

3.5

3.4

7.69

8.07

mmol/l

2.21

1332

12101

Abnormal findings in peritoneal fluid saliva

292

1.58

4.1

3.0

6.59

7.47

mmol/l

0.74

250

Caries in Clefts patients

707

1.34

1.57

3.1

3.0

8.90

8.75

mmol/l

0.07

625

Ulcer of oesophagus, drug-induced

413

1.49

1.57

3.0

3.2

5.72

7.60

mmol/l

3.58

336

Other meningitis

157

1327

1.25

1.57

3.4

3.0

7.54

7.82

mmol/l

0.31

139

1117

Protozoal diseases

288

2557

1.18

1.56

4.9

3.2

6.91

7.66

mmol/l

2.16

254

2142

Multiple gestation

760

7035

1.10

1.56

3.1

3.0

7.62

7.56

mmol/l

0.12

680

6132

Later onset COPD, excluding more controls

2663

21562

0.95

1.56

3.2

6.77

7.23

mmol/l

7.70

2133

17585

Distal bite

321

2832

1.16

1.56

4.2

3.5

8.21

8.86

mmol/l

1.22

285

2566

Multifocal fibrosclerosis

545

1.41

1.56

4.0

3.0

6.70

6.97

mmol/l

0.28

455

Benign neoplasm: Skin of upper limb, including shoulder

208

1806

1.21

1.55

3.9

3.2

7.26

7.47

mmol/l

0.33

173

1512

Pneumonia due to Haemophilus influenzae

277

1.61

1.55

3.4

2.7

6.89

7.89

mmol/l

0.73

232

Congenital malformations of spine and bony thorax

446

1.44

1.55

4.5

3.5

7.43

8.50

mmol/l

0.96

398

Granulosa cell carcinoma of ovary, excluding all cancers (controls excluding all cancers)

266

0.53

1.55

2.3

3.0

6.90

7.06

mmol/l

0.05

212

Kela reimbursement Agammaglobulinemia (D80-84)

705

1.35

1.54

3.3

3.1

7.43

8.10

mmol/l

0.60

601

Disorders of pituitary gland, other and/or unspecified

520

1.42

1.54

3.0

2.9

7.44

7.68

mmol/l

0.15

436

Acute alcohol intoxication ICD-9

372

3350

1.15

1.53

3.6

3.2

6.76

8.16

mmol/l

7.27

317

2782

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

2048

19588

1.06

1.53

3.3

8.40

8.19

mmol/l

1.08

1767

16823

Malignant neoplasm of lip, excluding all cancers (controls excluding all cancers)

107

875

1.31

1.53

3.3

3.1

7.01

7.44

mmol/l

0.54

714

Other bursitis of knee

146

1233

1.26

1.53

3.2

3.1

7.30

8.31

mmol/l

2.00

120

1049

Non-follicular lymphoma

954

10159

0.92

1.52

3.2

7.13

7.46

mmol/l

1.59

786

8435

Benign neoplasm: Trachea

2.24

1.52

2.2

2.7

7.59

7.50

mmol/l

0.03

Other pleural conditions

1130

10656

1.08

1.52

3.7

3.2

6.74

7.41

mmol/l

6.05

914

8779

Inflammation of lacrimal passages (acute and unspecified)

172

1472

1.23

1.51

3.1

3.0

7.08

7.22

mmol/l

0.14

147

1237

Explosion of other materials

261

1.61

1.51

3.2

3.3

10.43

8.94

mmol/l

0.55

225

Malignant neoplasm of accessory sinuses, excluding all cancers (controls excluding all cancers)

410

0.62

1.51

4.8

3.1

9.38

7.89

mmol/l

0.50

342

Neuroendocrine tumor and carcinoma of rectum, excluding all cancers (controls excluding all cancers)

350

1.55

1.51

3.1

7.96

7.53

mmol/l

0.27

291

Benign neoplasm: Mesothelial tissue of pleura

0.00

1.51

0.0

2.5

—

9.43

—

Malignant neoplasm of renal pelvis

442

1.45

1.51

2.8

3.2

6.47

7.44

mmol/l

1.08

359

Other diseases caused by chlamydiae

108

883

1.30

1.51

4.7

2.8

7.82

7.71

mmol/l

0.09

758

Malignant neoplasm of liver and intrahepatic bile ducts

319

2852

1.16

1.50

3.5

3.2

7.19

7.64

mmol/l

1.20

251

2344

Malignant neoplasm of other and unspecified parts of biliary tract

1121

0.76

1.50

2.9

3.1

8.31

7.42

mmol/l

1.00

919

Congenital malformations of genital organs

850

7874

1.09

1.50

3.2

3.4

7.67

7.76

mmol/l

0.18

738

6879

Gonococcal infection

341

3061

1.16

1.50

3.4

3.2

7.10

7.45

mmol/l

0.71

283

2623

Bacterial, viral and other infectious agents

899

8410

1.09

1.50

3.7

3.4

8.10

8.31

mmol/l

0.62

774

7281

IBD patients in KELA-register

2694

25928

1.05

1.49

3.3

8.31

8.20

mmol/l

0.58

2330

22266

Ulcerative colitis (strict definition, require KELA)

1876

17920

1.06

1.49

3.3

8.44

8.20

mmol/l

1.22

1619

15382

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

772

1.33

1.49

3.2

3.0

7.81

8.10

mmol/l

0.21

641

Burn and corrosion of hip and lower limb, except ankle and foot

230

2014

1.19

1.49

4.0

3.1

7.69

8.38

mmol/l

1.23

199

1699

Dermatopolymyositis (FG)

143

1208

1.25

1.48

3.2

3.0

6.67

7.36

mmol/l

1.13

124

1009

Other melanin hyperpigmentation

235

2069

1.20

1.48

3.5

3.0

6.74

6.92

mmol/l

0.31

195

1709

Secondary parkinsonism

276

2451

1.18

1.48

3.3

3.1

6.56

7.45

mmol/l

2.27

223

2021

Colorectal cancer, excluding all cancers (controls excluding all cancers)

3332

33298

0.96

1.48

3.2

7.49

7.37

mmol/l

0.92

2741

27702

Left hemicolectomy

251

2219

1.19

1.48

3.2

7.05

7.31

mmol/l

0.39

198

1819

Other obstetric trauma

332

3716

0.87

1.48

2.9

3.2

7.47

7.77

mmol/l

0.63

289

3269

Benign neoplasm: other/unspecified salivary gland

288

2566

1.17

1.47

3.1

6.98

7.17

mmol/l

0.33

235

2132

Melanoma in situ of other and unspecified parts of face

130

1099

1.29

1.47

3.6

3.2

6.63

6.89

mmol/l

0.32

101

909

ILD medications: acetylcysteine

613

0.70

1.47

2.6

2.9

5.95

6.84

mmol/l

0.93

491

Other specific arthropathies, wide

218

1904

1.20

1.47

3.2

3.0

7.34

7.58

mmol/l

0.31

199

1610

Thiamine deficiency

480

1.43

1.47

3.4

3.1

6.73

8.08

mmol/l

1.39

397

Secondary and unspecified malignant neoplasm of lymph nodes

806

8622

0.91

1.47

3.1

3.2

7.31

7.55

mmol/l

0.86

653

7213

Carcinoma in situ of oral cavity, oesophagus and stomach

435

1.45

1.46

3.4

3.2

7.09

7.46

mmol/l

0.25

354

Shock, not elsewhere classified

800

1.31

1.46

3.9

3.2

6.66

7.74

mmol/l

2.26

664

Calcific tendinitis

103

847

1.31

1.45

3.3

2.9

7.78

7.73

mmol/l

0.04

716

Carcinoma in situ of endometrium

421

1.47

1.45

2.8

7.00

6.33

mmol/l

0.70

332

Haemorrhagic and haematological disorders of fetus and newborn

150

1210

1.23

1.45

3.4

5.2

7.82

8.66

mmol/l

0.96

145

1151

Toxoplasmosis

489

1.42

1.45

3.6

2.8

7.39

7.91

mmol/l

0.37

413

Heredofamilial amyloidosis, unspecified

3.56

1.45

2.5

2.4

4.67

6.24

mmol/l

—

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

161

1377

1.23

1.45

3.5

8.68

9.00

mmol/l

0.30

144

1175

Other and unspecified injuries of forearm

557

1.37

1.44

3.9

3.4

7.68

8.07

mmol/l

0.23

471

Etanercept

618

5714

1.11

1.43

3.0

3.4

7.82

7.80

mmol/l

0.02

540

4919

Multiple myeloma and malignant plasma cell neoplasms

429

4693

0.88

1.42

3.4

3.2

7.01

7.29

mmol/l

0.67

373

3901

Other disorders of optic disc

129

1086

1.26

1.42

3.8

3.2

7.78

7.74

mmol/l

0.03

112

923

Toxic effect of contact with venomous animals

393

3566

1.14

1.42

2.9

3.3

7.79

7.78

mmol/l

0.02

329

3027

Benign neoplasm: Conjunctiva

334

3009

1.15

1.41

3.5

3.1

7.14

7.56

mmol/l

0.96

278

2523

Precocious central puberty

434

1.41

4.7

3.7

8.92

8.41

mmol/l

0.22

381

Ovarian dysfunction, other/unspecified

400

1.43

1.41

2.4

2.7

7.63

7.66

mmol/l

0.02

333

Tarsal tunnel syndrome

107

886

1.29

1.41

2.7

2.9

7.07

7.00

mmol/l

0.05

753

Malignant neoplasm of other and ill-defined sites, excluding all cancers (controls excluding all cancers)

116

1386

0.80

1.41

3.1

7.39

7.16

mmol/l

0.22

1141

Toxic erythema

141

1.83

1.40

2.6

2.8

6.75

7.63

mmol/l

0.24

110

Other endophthalmitis

412

1.45

1.40

5.6

3.0

6.29

7.38

mmol/l

1.10

331

Unspecified organic or symptomatic mental disorder

290

1.53

1.40

7.0

3.1

5.76

7.49

mmol/l

1.31

243

Ankylosing spondylitis, ICD10

960

9032

1.08

1.39

3.3

8.07

8.14

mmol/l

0.19

833

7738

Cutis laxa senilis

681

1.34

1.39

2.8

2.9

6.41

6.59

mmol/l

0.22

557

Myeloid leukaemia

211

2400

0.84

1.39

3.1

3.2

7.66

7.67

mmol/l

0.01

186

2008

Benign neoplasm: Trachea

2.15

1.39

2.2

3.1

7.59

7.47

mmol/l

0.04

Benign neoplasm: Pharynx, unspecified

690

1.34

1.38

3.8

3.1

7.76

7.78

mmol/l

0.01

570

Fistulae involving female genital tract

159

1364

1.23

1.38

4.9

2.9

6.17

6.46

mmol/l

0.40

138

1143

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

475

4359

1.12

1.38

3.2

3.1

7.75

7.61

mmol/l

0.27

405

3712

Frontotemporal dementia, wide, incl. Pick's disease

584

0.69

1.38

2.6

3.2

7.91

7.17

mmol/l

0.55

473

Horner syndrome

130

1100

1.26

1.38

3.0

3.1

7.81

7.74

mmol/l

0.06

100

910

Iliotibial band syndrome

111

922

1.27

1.37

2.5

3.2

7.57

7.74

mmol/l

0.13

789

Carcinoma in situ of breast, other/unspecified

107

1280

0.79

1.37

3.0

5.53

6.20

mmol/l

1.49

1063

Benign neoplasm: Long bones of lower limb

320

2877

1.15

1.37

3.7

3.2

8.12

8.18

mmol/l

0.08

270

2460

Colour vision deficiencies

351

1.47

1.37

3.7

2.8

9.16

9.40

mmol/l

0.13

302

Secondary parkinsonism+Parkinsonism in other disease

284

2542

1.16

1.36

3.3

3.1

6.54

7.42

mmol/l

2.32

230

2099

Adalimumab

883

8286

1.09

1.36

3.0

3.3

8.24

8.16

mmol/l

0.18

760

7150

Benign neoplasm: Nasopharynx

100

829

1.30

1.35

3.9

3.1

7.39

7.68

mmol/l

0.27

702

Infection due to other mycobacteria

117

1390

0.80

1.35

4.2

3.0

5.80

7.33

mmol/l

5.26

108

1142

Mild or no visual impairment, binocular

370

1.46

1.35

3.9

3.4

7.53

7.72

mmol/l

0.09

321

Family history of other specific disorders

114

950

1.26

1.35

3.6

2.9

7.51

8.10

mmol/l

0.68

102

806

Benign neoplasm: Spinal meninges

111

930

1.28

1.34

3.0

2.9

6.36

7.04

mmol/l

1.30

761

Benign neoplasm of other and unspecified female genital organs

452

4146

1.13

1.34

3.3

3.0

6.57

6.42

mmol/l

0.31

374

3474

Myotonic disorders

654

1.33

1.34

3.1

3.0

7.03

7.89

mmol/l

0.91

544

Malignant neoplasm of thyroid gland

701

6541

1.10

1.34

3.2

7.14

7.18

mmol/l

0.08

592

5513

Complications following infusion, transfusion and therapeutic injection

155

1334

1.23

1.34

3.5

3.1

6.58

7.52

mmol/l

1.58

134

1106

Localized skin eruption due to drugs and medicaments

116

974

1.27

1.33

3.6

3.2

7.07

7.78

mmol/l

0.99

815

Ulcerative colitis (strict) with PSC

627

1.33

2.8

3.0

8.62

8.74

mmol/l

0.06

545

Other and unspecified injuries of neck

681

1.32

1.33

4.3

3.0

9.42

8.52

mmol/l

0.75

589

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

496

1.39

1.32

4.8

3.4

9.65

9.22

mmol/l

0.23

426

Biological medicines for asthma

130

1102

1.25

1.32

3.5

3.2

8.12

8.22

mmol/l

0.09

114

933

Convergence insufficiency and excess

123

1034

1.25

1.32

2.5

3.1

7.48

8.13

mmol/l

0.79

113

889

Enteropathic arthropathies

216

1900

1.18

1.32

3.3

3.1

7.88

7.95

mmol/l

0.09

194

1634

Other/unspecified mastoiditis and related conditions

390

1.44

1.31

3.8

2.7

7.08

7.49

mmol/l

0.20

312

Brain meningioma, excluding all cancers (controls excluding all cancers)

472

5124

0.89

1.31

2.9

3.1

6.73

6.88

mmol/l

0.33

400

4281

Multiple myeloma, excluding all cancers (controls excluding all cancers)

435

4735

0.89

1.31

3.4

3.2

6.94

7.28

mmol/l

0.92

379

3934

Retrobulbar neuritis in diseases classified elsewhere

259

1.53

1.31

7.2

2.8

7.48

7.97

mmol/l

0.25

221

Benign neoplasm: Pituitary gland, craniopharyngeal duct

531

4909

1.11

1.30

2.9

3.2

7.76

7.80

mmol/l

0.06

456

4213

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, excluding all cancers (controls excluding all cancers)

737

0.73

1.30

2.8

2.9

7.36

7.64

mmol/l

0.18

621

Myelodysplastic syndrome

640

0.72

1.30

2.8

3.1

6.31

7.13

mmol/l

0.74

521

Other and unspecified medical devices associated with adverse incidents

446

1.42

1.30

3.6

3.2

6.18

7.55

mmol/l

2.57

371

Benign neoplasm of thyroid gland

357

3247

1.14

1.30

3.2

3.0

6.98

7.00

mmol/l

0.03

291

2728

Benign neoplasm of breast

1180

12429

0.93

1.29

2.9

3.0

6.53

6.45

mmol/l

0.26

966

10423

Benign neoplasm: Skin of scalp and neck

256

2285

1.17

1.29

3.7

3.2

7.31

7.70

mmol/l

0.72

210

1920

Dermatopolymyositis, unspecified

445

1.41

1.29

3.4

2.9

7.52

7.73

mmol/l

0.12

372

Polymyositis

713

1.31

1.29

3.2

3.1

6.50

7.26

mmol/l

1.02

592

Traumatic amputation of wrist and hand

481

4438

1.12

1.29

3.3

3.4

8.34

8.43

mmol/l

0.17

418

3762

Maternal care related to the fetus and amniotic cavity and possible delivery problems

4651

28143

0.97

1.29

3.1

3.0

7.56

7.27

mmol/l

3.83

4064

24276

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

120

1409

0.80

1.29

3.1

3.2

6.57

8.03

mmol/l

4.37

1164

Motor- or nonmotor-vehicle accident in traffic area

513

1.36

1.29

5.0

2.9

8.55

8.37

mmol/l

0.10

447

Melanoma in situ of scalp and neck

232

1.66

1.28

4.5

3.3

7.98

7.57

mmol/l

0.16

178

Congenital malformation syndromes predominantly affecting facial appearance

184

1.63

1.28

3.0

3.8

8.59

8.39

mmol/l

0.06

162

Oesophagitis, drug-induced

213

1.64

1.28

3.1

7.10

7.64

mmol/l

0.24

179

Malignant neoplasm of palate, excluding all cancers (controls excluding all cancers)

608

0.71

1.27

3.3

3.2

7.81

7.35

mmol/l

0.31

501

Congenital absence, atresia and stenosis of small intestine

2.06

1.27

7.0

3.6

4.86

7.79

mmol/l

2.11

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

806

7574

1.09

1.27

3.2

7.18

7.23

mmol/l

0.11

681

6392

Pedestrian injured in collision with heavy transport vehicle or bus

262

1.53

1.26

3.1

2.8

9.51

8.00

mmol/l

0.53

217

Effects of heat and light

578

1.34

1.26

2.7

3.1

7.36

7.67

mmol/l

0.23

491

CR(E)ST syndrome

115

1357

0.81

1.26

3.3

3.0

6.36

6.77

mmol/l

0.45

1126

Frostbite involving multiple body regions and unspecified frostbite

153

1.72

1.26

2.5

3.1

8.71

7.78

mmol/l

0.36

134

Benign neoplasm: Lip

224

1989

1.18

1.26

3.0

3.1

7.35

7.56

mmol/l

0.30

171

1637

Other chronic figurate erythema

2.92

1.26

3.3

1.9

6.09

7.30

mmol/l

—

Injury of nerves at shoulder and upper arm level

110

925

1.26

3.3

3.1

7.10

8.10

mmol/l

1.63

786

LeFortI or BSSRO operation

302

3352

0.88

1.25

2.5

3.2

8.03

8.08

mmol/l

0.07

276

2897

Benign neoplasm of meninges

1081

10255

1.08

1.25

3.1

6.76

6.83

mmol/l

0.19

902

8508

Oher contracture of tendon (sheath)

307

1.50

1.25

4.2

3.1

7.46

8.14

mmol/l

0.54

266

Oral leukoplakia

191

1683

1.20

1.25

3.6

3.1

6.58

7.34

mmol/l

2.00

163

1395

Other Crohn's disease

695

6495

1.09

1.24

3.4

3.3

8.06

8.23

mmol/l

0.37

597

5579

Contact with other hot metals

156

1352

1.21

1.24

3.4

3.1

7.54

8.26

mmol/l

1.26

139

1127

Contact with machinery

1283

12234

1.07

1.24

3.4

3.3

8.73

8.56

mmol/l

0.63

1076

10376

Moderate visual impairment, monocular

333

1.46

1.24

2.7

3.2

7.33

7.67

mmol/l

0.16

287

Hypertrophy of (infrapatellar) fat pad

103

861

1.27

1.23

3.0

3.2

8.80

7.94

mmol/l

0.76

746

Migraine with aura, drug-induced

110

926

1.26

1.23

2.5

2.9

7.40

7.58

mmol/l

0.14

102

785

Polymorphous light eruption

589

1.33

1.22

2.8

8.00

7.47

mmol/l

0.44

504

Unattended death

665

0.73

1.22

3.2

8.02

7.59

mmol/l

0.19

541

Benign neoplasm: Hypopharynx

433

1.41

1.22

5.0

3.1

7.17

8.09

mmol/l

0.76

356

Secondary thrombocytopenia

126

1078

1.24

1.21

3.6

3.2

6.61

7.76

mmol/l

2.54

104

895

Follicular lymphoma, hilmo

395

4298

0.89

1.21

3.1

3.2

7.00

7.30

mmol/l

0.81

310

3555

Bronchiectasis

870

8214

1.08

1.21

3.1

6.73

7.06

mmol/l

1.50

710

6772

Other overlap syndromes

182

1598

1.19

1.21

3.7

3.1

6.72

7.18

mmol/l

0.73

149

1339

Acute myeloid leukaemia

798

0.76

1.21

2.4

3.0

6.98

7.36

mmol/l

0.27

650

Epiphora

230

2054

1.17

1.20

2.9

3.1

6.36

7.07

mmol/l

1.84

188

1710

Neonatal jaundice due to other excessive haemolysis

3.12

1.20

3.2

2.5

9.06

10.49

mmol/l

—

Benign neoplasm: Vulva

225

2007

1.17

1.20

3.3

3.0

6.13

6.40

mmol/l

0.46

182

1697

Other disorders of central nervous system

114

965

1.25

1.20

3.6

3.1

7.35

7.99

mmol/l

0.63

818

Cholera

453

4181

1.12

1.20

3.1

3.0

6.51

6.73

mmol/l

0.47

257

3483

Toxic colitis

266

1.52

1.20

2.5

2.9

7.06

8.05

mmol/l

0.59

229

Traumatic shock

3.49

1.20

4.0

3.1

8.39

7.19

mmol/l

—

Epidural haemorrhage

753

1.28

1.19

3.4

3.1

7.63

8.30

mmol/l

0.68

630

Other and unspecified vaccines and biological substances

474

1.36

1.19

2.3

3.1

9.10

8.08

mmol/l

0.51

412

Benign neoplasm: Eye, unspecified

389

1.42

1.19

3.0

2.9

6.31

7.56

mmol/l

1.40

322

Congenital malformations of heart and great arteries

1350

12472

1.06

1.19

3.5

7.49

8.14

mmol/l

5.27

1178

10781

Meningitis

499

4620

1.11

1.18

3.5

3.2

7.82

7.85

mmol/l

0.04

424

3929

Placenta praevia

285

3168

0.88

1.18

3.2

3.1

8.09

7.63

mmol/l

0.69

250

2772

Other complications of labour and delivery, not elsewhere classified

759

7803

0.93

1.18

3.2

3.3

7.70

8.06

mmol/l

1.14

668

6846

Pedestrian injured in collision with car, pick-up truck or van

250

2242

1.16

1.18

4.1

3.1

7.80

7.70

mmol/l

0.10

208

1881

Immunodeficiency associated with other specified major defects, or unspecified

2.38

1.18

3.6

3.3

5.83

8.15

mmol/l

1.61

Mantle cell lymphoma

801

0.76

1.18

2.8

3.2

6.70

7.76

mmol/l

2.30

663

Eccrine sweat disorders

207

1.59

1.17

3.5

2.9

6.20

8.10

mmol/l

1.07

176

Other specified transport accidents

387

1.40

1.17

2.7

3.1

9.33

8.68

mmol/l

0.39

340

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

422

3889

1.12

1.17

3.3

3.2

7.18

7.66

mmol/l

1.51

362

3260

Benign neoplasm: Appendix

112

953

1.25

1.17

3.1

3.2

7.65

7.26

mmol/l

0.38

784

Malnutrition

186

1639

1.18

1.17

3.9

3.4

6.73

7.37

mmol/l

0.89

152

1364

UC patients in KELA-register (code 208), prior to 1994

482

4469

1.11

1.16

3.4

3.2

8.32

7.76

mmol/l

1.83

410

3764

Spontaneous abortion

5251

34867

1.03

1.16

3.1

7.15

7.35

mmol/l

0.20

4498

29653

Injury of blood vessels at wrist and hand level

596

1.32

1.15

3.5

3.4

7.39

8.18

mmol/l

0.79

499

Pseudomembranous colitis

703

1.29

1.15

5.3

2.9

6.48

7.54

mmol/l

1.39

592

Melanoma in situ of trunk

141

1226

1.22

1.15

3.7

3.2

7.66

7.68

mmol/l

0.02

103

1005

Diseases caused by chlamydiae

783

1.26

1.15

5.0

2.7

7.72

7.73

mmol/l

0.01

674

Melanocytic naevi of ear and external auricular canal

452

1.37

1.15

2.9

7.68

7.74

mmol/l

0.03

379

Other benign neoplasm of uterus: Corpus uteri

755

1.29

1.15

3.1

3.0

6.82

6.53

mmol/l

0.22

620

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

751

7053

1.08

1.15

3.7

3.1

7.28

7.25

mmol/l

0.07

652

6083

Inflammatory bowel disease, strict (require KELA)

2694

26087

1.04

1.15

3.3

8.31

8.20

mmol/l

0.57

2330

22403

Nosocomial condition (hospital)

470

1.36

1.15

4.2

2.9

6.85

7.23

mmol/l

0.25

390

Benign neoplasm: Other parts of oropharynx

816

1.27

1.15

3.7

3.0

8.03

7.72

mmol/l

0.26

678

Maternal care for known or suspected disproportion

333

3024

1.12

1.14

3.1

8.43

7.63

mmol/l

2.16

299

2653

Gastrojejunal ulcer

123

1054

1.23

1.14

3.6

3.0

7.10

7.68

mmol/l

0.67

106

862

Benign neoplasm: Short bones of upper limb

155

1353

1.20

1.14

3.0

3.2

8.02

7.75

mmol/l

0.24

123

1132

Other deformity of hallux (acquired)

725

1.28

1.13

2.5

3.0

7.36

6.93

mmol/l

0.43

599

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

670

6290

1.09

1.13

3.4

3.1

7.22

7.51

mmol/l

1.00

539

5222

Anomalies of pupillary function

198

1755

1.17

1.13

3.8

3.1

7.47

7.64

mmol/l

0.19

170

1497

Benign neoplasm: Oesophagus

132

1143

1.23

1.13

3.1

3.0

7.38

7.59

mmol/l

0.23

115

943

Benign neoplasm: Retina

463

1.36

1.13

3.1

2.9

6.06

7.76

mmol/l

3.49

385

Hereditary retinal dystrophy

146

1270

1.21

1.12

3.2

2.9

8.02

8.00

mmol/l

0.01

124

1070

Mandibular prognathia

149

1296

1.20

1.12

4.2

3.6

7.74

8.36

mmol/l

0.80

131

1135

Use of tolcapone

0.00

1.12

0.0

3.0

—

8.11

—

Benign neoplasm: Skin, unspecified

413

3811

1.12

3.5

3.1

7.28

7.56

mmol/l

0.67

345

3246

COPD, hospital admissions

6142

50919

1.03

1.12

3.3

3.2

6.99

7.54

mmol/l

19.50

4951

41999

Contact with other and unspecified heat and hot substances

516

1.33

1.12

3.7

3.1

7.25

8.45

mmol/l

1.50

434

Degeneration of the brain due to alcohol

198

2218

0.86

1.11

3.1

3.2

6.76

8.30

mmol/l

4.63

155

1857

Lesion of femoral nerve

672

1.29

1.11

3.4

2.8

6.54

7.23

mmol/l

1.11

567

Benign neoplasm: Bladder

837

1.26

1.11

3.4

3.1

7.27

7.42

mmol/l

0.13

687

Malignant neoplasm of lip

578

1.30

1.10

3.5

3.1

6.80

7.23

mmol/l

0.42

453

Rheumatic fever with heart involvement

447

1.37

1.10

3.2

3.0

6.90

7.49

mmol/l

0.52

371

Lymphoid leukaemia

527

5646

0.91

1.10

3.2

3.3

7.35

7.56

mmol/l

0.51

453

4726

Maternal care for cervical incompetence

384

3532

1.12

1.10

3.5

3.2

6.99

6.75

mmol/l

0.49

324

2997

Injury of blood vessels at neck level

323

1.44

1.10

2.9

3.0

7.68

8.19

mmol/l

0.32

272

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

169

1914

0.85

1.09

3.4

3.3

6.89

8.13

mmol/l

4.00

132

1596

Contracture of muscle

322

1.43

1.09

3.3

2.8

8.95

7.73

mmol/l

0.77

273

COPD, hospital admission 2, with asthma infections

3856

33733

0.97

1.09

3.3

3.2

6.79

7.53

mmol/l

22.62

3142

27741

Melanoma in situ of scalp and neck

240

1.58

1.09

4.5

3.3

7.98

7.89

mmol/l

0.03

190

Dysplastic lesion of unknown severity of the cervix uteri

713

0.76

1.09

3.7

2.8

7.14

7.75

mmol/l

0.52

609

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

190

2130

0.86

1.09

3.6

3.2

6.54

7.90

mmol/l

4.08

155

1778

Bus occupant injured in other and unspecified transport accidents

518

1.33

1.09

3.9

2.9

7.41

7.46

mmol/l

0.03

429

Malignant neoplasm of bone and articular cartilage of limbs

350

1.42

1.08

3.8

3.2

7.77

7.82

mmol/l

0.03

307

Use of fingolimod

614

0.75

1.08

8.0

3.0

8.58

8.26

mmol/l

0.18

547

Calcium deposit in bursa

177

1.62

1.08

2.4

2.9

6.97

7.55

mmol/l

0.28

145

Mumps

272

2466

1.14

1.08

3.3

3.1

8.57

8.26

mmol/l

0.46

228

2082

Restrictive cardiomyopathy

298

1.46

1.07

2.9

3.2

6.24

7.77

mmol/l

1.51

240

Benign neoplasm: Scapula and long bones of upper limb

838

1.25

1.07

2.8

3.1

8.30

8.26

mmol/l

0.02

718

Tumor necrosis factor alpha inhibitors

1450

13899

1.06

1.07

3.0

3.3

8.07

8.14

mmol/l

0.20

1260

12001

Benign neoplasm: Ill-defined sites within the digestive system

577

1.32

1.07

2.9

3.1

7.17

7.23

mmol/l

0.04

482

Congenital dyserythropoietic anaemia

2.31

1.07

3.5

2.7

5.30

8.36

mmol/l

—

Malignant neoplasm of larynx

120

1389

0.83

1.06

3.6

3.2

6.76

7.95

mmol/l

2.68

1131

Galactorrhea

726

1.26

1.06

3.9

3.0

8.13

7.45

mmol/l

0.45

628

Other and unspecified degenerative diseases of nervous system

182

2047

0.86

1.06

3.2

3.1

6.77

7.17

mmol/l

0.64

143

1670

Disorders of peritoneum in infectious diseases classified elsewhere

2.97

1.06

3.0

2.9

6.35

6.49

mmol/l

—

Infections of breast associated with childbirth

239

2659

0.88

1.06

2.8

3.2

7.49

7.40

mmol/l

0.12

210

2315

Complications of labour and delivery

7394

42014

0.98

1.06

3.0

3.1

7.04

6.87

mmol/l

2.72

6344

35445

Increased muscle tone

575

1.30

1.05

3.5

3.3

8.56

7.61

mmol/l

0.85

482

Benign neoplasm: Anus and anal canal

294

2682

1.14

1.05

3.3

3.1

7.16

7.31

mmol/l

0.22

251

2215

Granulosa cell carcinoma of ovary

241

0.60

1.05

2.3

2.8

6.90

7.09

mmol/l

0.05

192

Other and unspecified aplastic anaemias

106

905

1.23

1.05

4.1

3.0

6.88

7.68

mmol/l

0.92

750

Pedestrian injured in collision with two- or three-wheeled motor vehicle

289

1.44

1.05

2.3

2.8

7.56

8.34

mmol/l

0.39

248

Postprocedural disorders of eye and adnexa, not elsewhere classified

239

1.52

1.05

3.8

2.9

6.70

7.14

mmol/l

0.25

186

Benign neoplasm of middle ear and respiratory system

880

8354

1.07

1.04

3.5

3.2

7.36

7.72

mmol/l

1.78

743

7050

Nonpyogenic thrombosis of intracranial venous system

758

1.26

1.04

4.3

3.1

8.04

7.63

mmol/l

0.39

642

Leptospirosis

2.83

1.04

2.7

3.1

11.18

9.03

mmol/l

—

Other specified air transport accidents

2.70

1.03

5.8

2.7

7.67

8.53

mmol/l

—

Myeloid leukaemia

211

2348

0.87

1.03

3.1

3.2

7.66

7.49

mmol/l

0.20

186

1933

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

252

2782

0.88

1.03

2.9

3.1

7.22

7.09

mmol/l

0.16

202

2267

Varus deformity, not elsewhere classified

108

925

1.23

1.02

3.1

7.23

7.05

mmol/l

0.17

777

Leiomyosarcoma, excluding all cancers (controls excluding all cancers)

846

1.25

1.02

2.6

2.9

7.21

7.15

mmol/l

0.05

699

Benign neoplasm: Connective and other soft tissue of head, face and neck

172

1525

1.18

1.02

3.4

3.2

7.96

7.86

mmol/l

0.10

146

1278

Certain zoonotic bacterial diseases

184

1639

1.17

1.02

3.4

3.1

7.74

7.82

mmol/l

0.08

164

1361

Melanocytic naevi of lower limb, including hip

433

4020

1.11

1.02

4.3

3.2

7.14

7.60

mmol/l

1.36

381

3440

Parkinson's disease, excluding more controls

1449

14695

0.95

1.02

2.9

3.1

7.27

7.26

mmol/l

0.04

1173

12065

Other specified and unspecified disorders of conjunctiva

808

1.25

1.01

4.2

2.9

6.85

7.66

mmol/l

1.57

680

Benign lipomatous neoplasm of other sites/unspecified

985

9387

1.07

1.01

3.4

3.1

7.33

7.24

mmol/l

0.23

811

7846

Other congenital malformations of intestine

724

1.26

1.01

3.8

3.6

7.91

7.95

mmol/l

0.03

610

Complications following abortion and ectopic and molar pregnancy

358

3302

1.12

1.01

3.0

6.38

6.52

mmol/l

0.26

270

2792

Mastocytosis

443

1.34

1.00

2.6

3.3

9.38

8.01

mmol/l

1.08

375

Postpartum haemorrhage due to retained placenta

890

9386

0.94

1.00

2.8

3.1

7.25

7.67

mmol/l

2.04

772

8226

Use of dimethyl fumarate

584

0.75

1.00

3.1

8.51

8.09

mmol/l

0.23

516

Oral lichen ruber planus

253

2302

1.14

1.00

3.0

3.1

6.40

6.98

mmol/l

1.64

211

1914

Multiple myeloma and malignant plasma cell neoplasms

429

4609

0.91

1.00

3.4

3.2

7.01

7.25

mmol/l

0.56

373

3781

Agranulocytosis

1095

11455

0.94

1.00

3.8

3.2

6.79

7.36

mmol/l

4.44

928

9629

Benign neoplasm: other/unspecified salivary gland

288

2634

1.13

1.00

3.1

6.98

7.26

mmol/l

0.53

235

2216

Other specified/unspecified nutritional deficiencies

578

1.29

0.99

5.4

3.0

6.49

7.42

mmol/l

1.07

484

Vitamin A deficiency

353

1.38

0.99

4.4

2.8

6.35

7.39

mmol/l

0.94

298

Enterohaemorrhagic Escherichia coli infection

129

1.69

0.99

3.8

2.6

7.44

8.14

mmol/l

0.26

114

Disturbances of smell and taste

436

4057

1.10

0.99

3.2

3.1

7.58

7.28

mmol/l

0.69

360

3424

Noise effects on inner ear

449

4185

1.10

0.99

3.1

3.4

9.01

8.67

mmol/l

0.78

377

3538

Other fibroblastic disorders

319

1.40

0.99

3.2

2.9

7.46

7.36

mmol/l

0.05

271

LSIL lesion of the cervix uteri

942

8953

1.06

0.98

3.3

3.1

7.46

7.37

mmol/l

0.22

816

7750

Degeneration of nervous system due to alcohol

198

2199

0.87

0.98

3.1

3.2

6.76

8.33

mmol/l

4.79

155

1839

Acquired keratosis [keratoderma] palmaris et plantaris

401

1.36

0.98

3.5

2.9

7.37

7.87

mmol/l

0.29

336

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

142

1605

0.84

0.98

3.3

3.1

7.25

7.54

mmol/l

0.37

119

1338

Benign neoplasm: Long bones of lower limb

320

2939

1.12

0.98

3.7

3.2

8.12

8.22

mmol/l

0.13

270

2536

Carcinoma in situ of oral cavity

172

1.59

0.98

3.5

3.0

5.09

7.53

mmol/l

4.72

143

Long labour

2069

18691

0.96

0.98

2.9

3.2

14.50

7.44

mmol/l

0.52

1824

16179

Benign neoplasm: Rectum/anal canal icd-9

771

1.24

0.97

3.8

2.9

6.83

6.77

mmol/l

0.05

629

Chronic diseases of tonsils and adenoids

11697

72983

1.02

0.97

3.3

8.05

8.08

mmol/l

0.05

10045

62310

Benign neoplasm: Skin of scalp and neck

256

2331

1.14

0.97

3.7

3.1

7.31

7.75

mmol/l

0.85

210

1978

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

2221

22891

0.96

0.97

3.3

3.2

7.40

7.35

mmol/l

0.25

1818

18998

Embedded and impacted teeth

2607

21496

1.04

0.97

3.5

3.4

8.65

8.64

mmol/l

0.04

2333

18874

Erectile dysfunction

948

9051

1.07

0.97

3.4

8.09

8.19

mmol/l

0.29

765

7477

Benign neoplasm: Skin of upper limb, including shoulder

208

1876

1.15

0.97

3.9

3.2

7.26

7.53

mmol/l

0.46

173

1580

Exposure to vibration

2.20

0.96

2.6

2.7

7.15

9.37

mmol/l

—

Vitiligo

106

912

1.22

0.96

5.6

3.1

7.93

8.08

mmol/l

0.13

773

Other infiltrative disorders of skin and subcutaneous tissue

410

1.35

0.96

3.8

2.9

8.46

7.45

mmol/l

0.67

339

Benign neoplasm: Larynx

328

3022

1.12

0.96

3.9

3.2

7.36

7.87

mmol/l

1.36

275

2492

Family history of other conditions

110

947

1.21

0.96

3.6

2.8

7.55

8.36

mmol/l

1.01

827

Osteosarcoma, excluding all cancers (controls excluding all cancers)

330

1.39

0.96

3.4

3.3

6.95

8.13

mmol/l

0.86

290

Cervical root disorders

610

1.28

0.96

2.5

3.0

7.90

7.77

mmol/l

0.10

502

Unspecified threat to breathing

736

1.24

0.95

3.8

3.3

7.60

7.99

mmol/l

0.30

625

Other porphyria

139

1.65

0.95

3.9

2.9

6.49

8.45

mmol/l

1.34

112

Fracture of lower limb, level unspecified

2.39

0.95

7.5

2.7

10.67

9.97

mmol/l

—

Amputation of thigh

250

2271

1.13

0.95

3.5

3.1

5.71

7.17

mmol/l

7.96

204

1833

Carcinoid syndrome

101

872

1.23

0.95

2.9

3.1

6.58

7.49

mmol/l

1.69

713

Congenital malformations of larynx

197

1.50

0.95

2.7

5.0

6.58

7.82

mmol/l

0.50

180

Essential (haemorrhagic) thrombocythaemia

353

3809

0.90

0.95

2.9

3.1

6.88

7.23

mmol/l

0.86

291

3194

Follicular adenocarcinoma of thyroid gland

541

0.75

0.95

4.0

3.0

7.37

7.22

mmol/l

0.08

456

Eosinophilic cellulitis [Wells]

2.13

0.94

3.4

2.8

6.06

8.27

mmol/l

—

Unspecified chronic bronchitis

354

3267

1.11

0.94

3.4

3.1

7.22

7.44

mmol/l

0.39

289

2671

Volvulus

216

2388

0.88

0.94

3.5

3.1

6.89

7.34

mmol/l

0.64

171

1984

Intussusception

217

1963

1.15

0.94

2.7

3.2

7.18

6.94

mmol/l

0.32

195

1661

Lagophthalmos

125

1096

1.20

0.93

3.9

3.2

6.84

7.19

mmol/l

0.47

102

894

Forearm

2.02

0.93

8.3

2.8

6.13

8.09

mmol/l

0.62

Fetal alcohol syndrome (dysmorphic)

2.07

0.93

5.3

2.5

7.24

8.41

mmol/l

—

Benign neoplasm: Other parts of oropharynx

835

1.23

0.93

3.7

3.1

8.03

7.75

mmol/l

0.23

697

Acquired stenosis of external ear canal

102

883

1.23

0.92

2.9

3.0

8.70

8.29

mmol/l

0.36

729

Haemoglobinuria due to haemolysis from other external causes

2.34

0.92

6.7

3.1

4.42

5.83

mmol/l

—

Fourth [trochlear] nerve palsy

233

2121

1.14

0.92

3.3

3.1

7.66

7.68

mmol/l

0.02

189

1771

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

935

0.81

0.92

4.0

2.9

6.82

7.47

mmol/l

0.78

790

Female infertility, cervigal, vaginal, other or unspecified origin

2950

19206

1.03

0.92

3.2

3.1

7.37

7.83

mmol/l

0.27

2579

16505

Allergic contact dermatitis due to drugs in contact with skin

217

1967

1.14

0.91

3.2

3.1

7.02

7.32

mmol/l

0.50

180

1643

Benign neoplasm: Other and unspecified parts of small intestine

142

1597

0.85

0.91

3.4

3.0

6.66

7.18

mmol/l

0.90

125

1317

Golimumab

256

2803

0.89

0.90

3.2

3.3

7.99

8.10

mmol/l

0.13

225

2429

Injury of other and unspecified intrathoracic organs

670

6346

1.08

0.90

4.0

3.3

7.70

8.12

mmol/l

1.47

547

5369

Acute poliomyelitis

141

1250

1.18

0.90

3.2

3.1

6.98

7.10

mmol/l

0.12

116

1039

Other disorders of breast

1257

12076

1.05

0.89

3.2

3.1

6.75

6.72

mmol/l

0.07

1080

10138

Degenerative macular diseases, drug-induced

252

1.42

0.89

4.3

3.0

6.74

7.59

mmol/l

0.54

208

Diphyllobothriasis and sparganosis

2.98

0.89

2.4

2.3

5.16

7.08

mmol/l

—

Benign neoplasm: Connective and other soft tissue, unspecified

119

1043

1.20

0.89

3.2

3.1

7.32

7.45

mmol/l

0.15

109

881

Perichondritis of external ear

177

1591

1.16

0.89

3.4

3.1

7.27

7.24

mmol/l

0.04

161

1329

Frostbite with tissue necrosis

263

1.42

0.88

3.7

3.2

6.96

8.73

mmol/l

1.57

223

Fetus and newborn affected by maternal complications of pregnancy

406

0.73

0.88

7.0

5.2

7.01

8.22

mmol/l

0.63

379

Benign neoplasm: Conjunctiva

334

3096

1.11

0.88

3.5

3.1

7.14

7.59

mmol/l

1.08

278

2618

Gastrointestinal stromal tumor and sarcoma, excluding all cancers (controls excluding all cancers)

1072

0.82

0.88

3.1

7.54

7.47

mmol/l

0.05

878

Disorders of branched-chain amino-acid metabolism, other/unspecified

2.88

0.88

2.0

3.4

7.56

8.39

mmol/l

—

Malignant neoplasm of vagina

151

1.60

0.87

2.6

3.1

5.69

6.41

mmol/l

0.56

119

Melanoma in situ of upper limb, including shoulder

562

1.27

0.87

4.0

2.9

7.19

7.26

mmol/l

0.05

457

Bilateral sagittal split ramus osteotomy operation

251

2747

0.89

0.87

2.3

3.1

8.11

8.10

mmol/l

0.01

231

2366

Kissing spine

177

1.55

0.87

3.3

3.4

8.50

7.62

mmol/l

0.40

151

Colitis due to radiation

103

896

1.21

0.87

3.5

3.2

7.11

7.85

mmol/l

1.20

727

Changes in corneal membranes

193

1.49

0.87

3.5

2.9

7.85

7.20

mmol/l

0.24

159

Trichomoniasis

786

1.23

0.87

3.4

3.0

6.29

6.52

mmol/l

0.21

647

Malignant neoplasm of peripheral nerves and autonomic nervous system, excluding all cancers (controls excluding all cancers)

318

1.38

0.86

3.9

3.2

6.45

7.72

mmol/l

1.71

261

Benign neoplasm: Larynx

328

3040

1.11

0.86

3.9

3.2

7.36

7.95

mmol/l

1.72

275

2547

Injury of blood vessels of thorax

272

1.39

0.86

3.4

2.8

7.17

7.89

mmol/l

0.37

229

Vascular dementia (subcortical)

215

2364

0.89

0.85

2.9

3.1

6.80

6.42

mmol/l

0.82

185

1879

Carcinoma in situ of cervix uteri, endocervix

842

0.81

0.85

3.4

3.1

8.06

7.58

mmol/l

0.44

716

Transitory endocrine and metabolic disorders specific to fetus and newborn

103

872

1.19

0.85

4.4

4.7

9.23

8.21

mmol/l

0.86

825

Abnormal reflex

389

1.32

0.84

3.3

3.0

8.77

7.66

mmol/l

0.77

332

Simple and mucopurulent chronic bronchitis

416

3886

1.09

0.84

3.2

7.37

7.34

mmol/l

0.05

331

3208

Other specified types of T/NK-cell lymphoma, hilmo, excluding all cancers

0.00

0.84

0.0

2.9

—

9.77

—

Other infective spondylopathies

214

1.49

0.84

2.9

3.2

5.97

7.67

mmol/l

2.16

181

Any event in cancer register

13668

82008

0.98

0.84

3.2

7.48

7.97

mmol/l

2.09

11377

69918

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

422

3955

1.09

0.83

3.3

3.2

7.18

7.72

mmol/l

1.83

362

3333

Follicular adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

942

0.82

0.83

3.2

2.9

7.09

7.51

mmol/l

0.40

786

Handgun discharge

2.16

0.83

2.0

3.6

8.43

8.81

mmol/l

—

Birth injury to scalp

2.16

0.83

20.1

3.2

9.27

8.83

mmol/l

—

Inflammatory disease of cervix uteri

649

6158

1.07

0.83

3.3

3.0

6.24

6.40

mmol/l

0.47

529

5132

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

658

1.24

0.83

2.9

3.0

7.87

7.67

mmol/l

0.11

551

Fibrosarcoma

621

1.25

0.82

3.0

3.1

8.01

7.45

mmol/l

0.45

517

Injury of nerves and spinal cord at thorax level

437

1.30

0.82

5.0

3.2

7.56

8.18

mmol/l

0.30

372

Carcinoma in situ of cervix uteri

741

7042

1.06

0.82

3.4

3.2

7.27

7.40

mmol/l

0.28

632

6098

Other demyelinating diseases of the central nervous system

283

3069

0.90

0.82

4.3

3.3

7.44

8.01

mmol/l

1.25

231

2653

Synovial hypertrophy, not elsewhere classified

776

1.21

0.82

3.4

3.0

8.32

8.25

mmol/l

0.04

670

Fracture of forearm

7196

66340

1.02

0.82

3.4

3.2

9.11

7.36

mmol/l

0.40

6101

55725

LSIL lesion of the vagina

131

1162

1.17

0.81

3.4

3.0

6.41

6.95

mmol/l

1.07

113

982

Other bursitis, not elsewhere classified

100

872

1.20

0.81

2.6

3.0

7.80

7.64

mmol/l

0.13

730

Traumatic arthropathy

1.82

0.81

3.1

3.0

7.46

7.25

mmol/l

—

Abnormal findings on diagnostic imaging of breast

138

1232

1.17

0.81

3.2

3.0

6.55

6.43

mmol/l

0.14

118

1029

Other bacterial agents as the cause of diseases classified to other chapters

816

1.21

0.81

4.7

3.2

6.32

7.54

mmol/l

1.49

689

Other congenital malformations of digestive system

196

1.47

0.80

3.6

3.0

8.10

7.72

mmol/l

0.13

173

Inflammatory myopathy

128

1.63

0.80

2.6

3.3

7.72

7.14

mmol/l

—

102

Sequelae of burns, corrosions and frostbite

411

1.31

0.80

2.9

3.0

7.44

8.38

mmol/l

0.66

351

Hypersensitivity pneumonitis due to organic dust

168

1517

1.15

0.80

3.7

3.1

7.75

7.58

mmol/l

0.17

151

1261

Benign neoplasm: Retina

485

1.28

0.80

3.1

2.9

6.06

7.93

mmol/l

4.06

415

Birth injury to peripheral nervous system

195

1.44

0.79

5.0

3.0

10.17

8.80

mmol/l

0.24

178

Undescended testicle

823

1.20

0.79

4.1

4.2

8.08

8.74

mmol/l

0.53

747

Other specified acquired deformities of limbs

365

1.31

0.79

2.9

3.2

8.45

7.51

mmol/l

0.54

311

Deep endometriosis

928

8891

1.06

0.79

2.8

3.1

6.86

6.72

mmol/l

0.40

778

7470

Torsion of testis

174

1570

1.14

0.78

3.6

9.49

9.65

mmol/l

0.12

151

1382

Mononeuritis multiplex

260

1.40

0.78

2.9

3.0

7.13

7.48

mmol/l

0.19

224

Carcinoma in situ of endometrium

461

1.30

0.78

2.8

2.9

7.00

6.54

mmol/l

0.43

375

Calcification and ossification of muscle

197

1.45

0.78

3.8

2.9

6.91

7.89

mmol/l

0.61

165

Periodontal disease, other/unspecified

341

1.34

0.78

4.8

3.1

6.86

7.77

mmol/l

0.85

284

Disorders of eyelid in diseases classified elsewhere

315

2927

1.10

0.78

3.8

3.1

7.60

7.41

mmol/l

0.30

274

2463

Dislocation, sprain and strain of joints and ligaments of head

378

3532

1.09

0.78

3.3

7.87

7.95

mmol/l

0.11

316

3032

Erythema elevatum diutinum

1.99

0.77

3.9

2.6

6.67

7.54

mmol/l

—

Carcinoma in situ of oral cavity, oesophagus and stomach

478

1.28

0.77

3.4

3.2

7.09

7.57

mmol/l

0.34

400

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

490

0.76

0.77

2.6

3.2

8.16

8.02

mmol/l

0.07

408

All dysplastic lesions of the cervix uteri

2281

22144

1.03

0.77

3.4

3.1

7.44

8.07

mmol/l

0.47

1980

19134

Anisometropia and aniseikonia

309

2872

1.10

0.77

3.4

3.2

7.14

7.59

mmol/l

0.89

235

2441

Abscess of Bartholin gland

224

2050

1.12

0.77

3.3

3.0

7.09

7.19

mmol/l

0.09

186

1758

Disorder of thyroid, unspecified

121

1074

1.17

0.76

3.5

2.9

7.74

6.85

mmol/l

1.19

108

901

Adult-onset Still disease

322

1.33

0.76

3.7

2.8

7.66

7.86

mmol/l

0.07

275

Exposure to other and unspecified forces of nature

450

1.28

0.76

4.6

2.9

6.33

7.98

mmol/l

2.68

383

Sequelae of other accidents

111

1256

0.86

0.76

3.0

3.1

6.65

7.86

mmol/l

2.36

1041

Acute myringitis

569

1.24

0.76

4.3

3.1

7.60

7.96

mmol/l

0.25

491

Congenital lens malformations

395

1.29

0.76

3.5

3.0

8.69

8.11

mmol/l

0.27

345

Benign neoplasm: Lip

224

2059

1.12

0.76

3.0

3.1

7.35

7.56

mmol/l

0.30

171

1712

Delayed puberty

548

1.23

0.76

4.3

3.6

8.94

9.61

mmol/l

0.42

494

Alcohol induced polyneuropathy

105

927

1.19

0.76

3.3

3.1

6.61

8.35

mmol/l

3.85

763

Benign neoplasm: Skin of lip

146

1315

1.16

0.76

3.9

3.0

7.08

7.48

mmol/l

0.57

133

1103

Congenital malformation syndromes due to known exogenous causes, not elsewhere classified

1.69

0.76

6.4

2.8

8.36

8.78

mmol/l

0.08

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

846

1.18

0.76

4.3

4.7

9.29

8.15

mmol/l

0.95

800

Benign neoplasm: Lower jaw bone

332

1.32

0.75

3.3

3.0

6.78

7.34

mmol/l

0.35

284

Benign neoplasm: Eye, unspecified

416

1.30

0.75

3.0

6.31

7.57

mmol/l

1.43

346

Palindromic rheumatism

102

897

1.19

0.75

3.2

3.0

6.88

7.43

mmol/l

0.70

755

Foreign body on external eye

1696

16462

1.04

0.74

3.5

3.4

8.97

8.74

mmol/l

1.14

1428

14180

Osteomyelitis of vertebra

298

1.36

0.74

5.1

3.1

6.85

8.09

mmol/l

1.52

247

Other or ill-defined heart diseases

519

4908

1.07

0.74

4.0

3.2

7.04

8.16

mmol/l

7.06

453

4141

Pedal cyclist injured in collision with train or tram

2.17

0.74

3.4

2.7

5.80

7.66

mmol/l

—

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

149

1646

0.87

0.73

2.6

3.1

6.31

6.82

mmol/l

0.78

117

1362

Lichen ruber moniliformis

1.96

0.73

3.9

2.8

4.08

7.15

mmol/l

—

Unspecified lump in breast

1559

16079

0.96

0.73

3.1

3.0

6.33

6.50

mmol/l

0.93

1336

13434

Echinococcosis

1.96

0.73

2.8

3.7

6.34

7.74

mmol/l

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

1977

20311

0.96

0.73

3.3

7.67

7.75

mmol/l

0.28

1679

17182

Sequelae of other and unspecified effects of external causes

425

1.28

0.73

3.5

3.1

7.54

8.05

mmol/l

0.28

364

Benign neoplasm: Connective and other soft tissue of head, face and neck

172

1564

1.14

0.73

3.4

3.2

7.96

7.83

mmol/l

0.13

146

1323

Transient global amnesia

981

10183

0.95

0.72

2.8

3.1

7.00

6.90

mmol/l

0.39

810

8414

Inhalation and ingestion of other objects causing obstruction of respiratory tract

498

1.25

0.72

3.4

3.3

7.44

8.06

mmol/l

0.46

416

COPD, early/later onset

6165

51250

1.02

0.72

3.3

3.2

6.99

7.54

mmol/l

19.58

4965

42270

Maternal care for known or suspected malpresentation of fetus

1396

10773

0.96

0.72

2.9

3.2

8.05

7.84

mmol/l

0.76

1235

9450

Exposure to excessive natural cold

843

1.19

0.72

5.3

3.1

6.79

8.23

mmol/l

2.15

701

Human immunodeficiency virus [HIV] disease resulting in other specified diseases

1.92

0.72

5.3

2.7

10.09

9.33

mmol/l

—

Adult respiratory distress syndrome

118

1051

1.17

0.72

3.6

3.1

6.77

7.75

mmol/l

1.66

100

855

Other and unspecified localized connective tissue disorders

281

1.35

0.72

6.1

2.9

6.15

7.39

mmol/l

0.95

239

Hereditary ataxia

126

1128

1.16

0.72

5.2

3.2

7.34

7.62

mmol/l

0.29

109

942

Personal history of allergy to drugs, medicaments and biological substances

871

1.18

0.72

3.3

3.0

6.93

8.01

mmol/l

1.54

736

Mucinous and mucinous cystic tumor, excluding all cancers (controls excluding all cancers)

617

0.80

0.71

3.0

6.76

6.55

mmol/l

0.15

513

Brain meningioma

462

4883

0.93

0.71

2.9

3.1

6.70

6.79

mmol/l

0.18

391

4065

Melanocytic naevi of ear and external auricular canal

482

1.26

0.71

2.9

7.68

7.63

mmol/l

0.02

401

Retinoschisis and retinal cysts

245

2270

1.11

0.71

3.5

3.1

7.40

7.50

mmol/l

0.12

201

1874

Intracerebral haemorrhage

1250

12926

0.96

0.71

3.2

6.99

7.26

mmol/l

1.37

1029

10557

Occupant of pick-up truck or van injured in other and unspecified transport accidents

454

1.26

0.71

4.0

3.2

7.74

8.80

mmol/l

0.82

382

Chondrosarcoma, excluding all cancers (controls excluding all cancers)

463

0.77

0.71

2.9

3.1

6.91

7.75

mmol/l

0.58

386

Malignant neoplasm of other and unspecified parts of tongue

115

1286

0.86

0.70

3.2

3.1

6.17

7.61

mmol/l

2.62

1056

Neuroendocrine tumor and carcinoma of lung

708

1.21

0.70

2.8

3.0

7.52

7.19

mmol/l

0.19

580

Carcinoma in situ of cervix uteri, exocervix

499

1.24

0.70

2.2

2.9

7.69

7.42

mmol/l

0.15

428

HSIL lesion of the cervix uteri

1531

14839

1.04

0.69

3.5

3.1

7.45

7.50

mmol/l

0.17

1323

12854

Other disorders of amniotic fluid and membranes

1089

10392

1.05

0.69

3.0

3.1

7.85

7.71

mmol/l

0.39

926

9053

Benign neoplasm: Bones of skull and face

809

1.19

0.69

2.7

3.0

7.96

7.51

mmol/l

0.33

679

Benign neoplasm: Cerebral meninges

961

9258

1.05

0.69

3.1

6.80

mmol/l

0.00

804

7685

Disorders of muscle in diseases classified elsewhere

115

1.60

0.69

3.4

2.7

6.82

7.63

mmol/l

0.30

Hydrocephalus

742

7743

0.94

0.69

3.1

3.2

7.30

7.17

mmol/l

0.34

636

6402

Abscess of lung

143

1293

1.14

0.69

4.7

3.4

6.47

8.05

mmol/l

4.69

125

1081

Benign neoplasm: Short bones of upper limb

155

1408

1.14

0.68

3.0

3.2

8.02

7.88

mmol/l

0.12

123

1186

Pityriasis rosea

565

1.22

0.68

4.0

2.8

7.43

7.93

mmol/l

0.40

481

Other and unspecified diseases of spleen

337

1.30

0.68

4.3

3.0

5.98

7.87

mmol/l

2.16

281

Reiter disease

521

1.24

0.68

2.6

3.5

8.83

8.31

mmol/l

0.28

445

Carcinoma in situ of middle ear and respiratory system

392

1.28

0.68

3.3

3.1

7.35

7.28

mmol/l

0.06

311

Exclusion endpoint for supernumerary teeth

107

949

1.16

0.68

3.3

3.6

8.27

8.51

mmol/l

0.13

847

Anencephaly and similar malformations

0.00

0.67

0.0

2.1

—

8.57

—

6-mercaptopurine

270

2509

1.10

0.67

3.1

3.4

8.15

8.43

mmol/l

0.41

241

2165

Benign neoplasm: Scapula and long bones of upper limb

877

1.18

0.67

2.8

3.0

8.30

8.28

mmol/l

0.01

758

Tibial collateral bursitis [Pellegrini-Stieda]

107

953

1.17

0.67

2.9

3.0

7.75

7.54

mmol/l

0.17

810

Colon adenocarcinoma

1303

12630

1.04

0.67

3.3

3.2

7.38

7.16

mmol/l

1.14

1083

10407

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

485

1.24

0.67

5.6

3.2

6.93

8.02

mmol/l

1.06

408

Other disorders of Eustachian tube

283

2642

1.10

0.66

3.5

3.1

7.01

7.58

mmol/l

1.53

238

2231

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx, excluding all cancers (controls excluding all cancers)

217

0.68

0.66

2.6

3.3

6.64

7.56

mmol/l

0.71

182

Accidental poisoning by and exposure to other gases and vapours

430

1.26

0.66

4.1

3.0

8.38

8.05

mmol/l

0.14

362

Procedures for purposes other than remedying health state

207

2244

0.90

0.66

3.2

3.0

6.61

7.03

mmol/l

0.90

177

1908

Atypical virus infections of central nervous system

880

1.18

0.66

3.2

3.1

8.00

7.60

mmol/l

0.29

743

Syndrome of inappropriate secretion of antidiuretic hormone

431

1.26

0.65

2.9

3.0

5.51

7.15

mmol/l

3.55

347

Benign leiomyoma with endometriosis

1779

17328

1.04

0.65

3.0

6.46

6.32

mmol/l

0.73

1437

14516

Benign neoplasm of meninges

1081

10452

1.05

0.65

3.1

6.76

6.84

mmol/l

0.23

902

8691

Benign neoplasm: Uterine tubes and ligaments

662

0.81

0.65

3.1

2.9

6.24

6.39

mmol/l

0.14

539

Carcinoma in situ of other/unspecified female genital organs

1.99

0.65

3.0

2.7

8.63

7.75

mmol/l

—

Other hereditary haemolytic anaemias

486

1.23

0.65

3.3

3.2

7.16

7.91

mmol/l

0.51

416

Infliximab

592

0.81

0.65

2.6

3.1

9.11

8.82

mmol/l

0.12

520

Unspecified renal colic

524

1.23

0.64

3.6

3.2

8.77

7.99

mmol/l

0.54

440

Nanophthalmos, microphthalmos and macrophthalmos

1.97

0.64

6.0

2.6

7.35

8.05

mmol/l

—

Juvenile dermatomyositis

0.51

0.64

5.4

4.0

4.34

8.41

mmol/l

—

Injury of muscle and tendon at neck level

142

1.48

0.64

2.9

10.58

8.31

mmol/l

0.70

127

Seminoma of testis, excluding all cancers (controls excluding all cancers)

878

0.84

0.64

3.1

3.8

8.81

9.29

mmol/l

0.41

760

Contact urticaria

251

0.71

0.64

3.2

2.8

7.16

7.74

mmol/l

0.17

207

Other diseases of appendix

1078

0.86

0.64

3.1

6.95

7.35

mmol/l

0.38

890

Abnormal spermatozoa

1359

13984

0.96

0.64

3.3

8.28

8.34

mmol/l

0.18

937

11667

Disorders of multiple cranial nerves

1.74

0.64

2.5

2.9

7.53

7.34

mmol/l

0.05

Bacterial meningitis

338

3179

1.09

0.64

3.6

3.2

7.80

7.87

mmol/l

0.08

279

2690

Other and unspecified myoneural disorders

322

1.30

0.64

2.8

2.9

8.28

7.79

mmol/l

0.26

274

Respiratory conditions due to other external agents

169

1841

0.89

0.63

3.3

3.1

6.19

6.98

mmol/l

1.97

126

1512

Hyperprolactinaemia, drug-induced

469

1.24

0.63

3.3

3.0

6.68

7.23

mmol/l

0.47

392

Mandibular retrognathia AND surgery (BSSRO)

189

2055

0.90

0.63

2.1

3.1

8.28

8.14

mmol/l

0.15

178

1773

Obstructive hydrocephalus

121

1341

0.88

0.63

3.3

3.2

7.21

7.58

mmol/l

0.35

102

1123

Other combined immunodeficiencies

126

1.53

0.63

4.3

2.7

6.74

8.06

mmol/l

0.62

110

Malignant neoplasm of other endocrine glands and related structures

135

1.52

0.63

2.7

3.1

7.92

8.18

mmol/l

0.06

107

Laparoscopic left hemicolectomy

176

1621

1.12

0.62

3.0

3.1

7.67

7.59

mmol/l

0.09

155

1341

Exposure to other specified electric current

109

975

1.15

0.62

3.1

3.5

10.14

9.05

mmol/l

1.10

852

Malignant neoplasm of other and unspecified major salivary glands

278

1.32

0.62

2.9

3.1

7.75

7.11

mmol/l

0.25

223

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

451

4748

0.93

0.62

2.7

3.1

6.81

6.69

mmol/l

0.27

408

4007

Carcinoma in situ of cervix uteri, endocervix

815

0.85

0.62

3.4

2.9

8.06

7.66

mmol/l

0.35

699

Carcinoma in situ of rectum

735

1.19

0.62

3.1

3.0

7.26

7.50

mmol/l

0.22

609

Benign neoplasm: Brain, infratentorial

532

0.80

0.61

2.6

3.3

7.86

7.74

mmol/l

0.05

455

Myasthenia gravis, drug-induced

126

1.50

0.61

4.2

2.9

6.19

7.63

mmol/l

0.94

102

Perioral dermatitis, drug-induced

1.64

0.61

3.6

2.3

7.03

8.14

mmol/l

0.44

Congenital malformations of eyelid, lacrimal apparatus and orbit

674

0.83

0.61

3.8

8.89

8.32

mmol/l

0.28

599

Respiratory tuberculosis, bacteriologically and histologically confirmed

148

1622

0.89

0.61

3.4

3.1

6.54

7.50

mmol/l

2.09

126

1335

Benign neoplasm: Lower jaw bone

342

1.28

0.61

3.3

3.2

6.78

7.35

mmol/l

0.36

292

Endometriosis diagnosis and infertility diagnosis occurring together

837

8695

0.95

0.60

3.1

7.50

7.31

mmol/l

0.51

735

7527

Carcinoma in situ of oral cavity

189

1.40

0.60

3.5

3.0

5.09

7.62

mmol/l

5.00

150

Respiratory tuberculosis, confirmed

143

1568

0.89

0.60

3.5

3.1

6.56

7.50

mmol/l

1.96

123

1294

Colorectal neuroendocrine tumor and carcinoma

136

1239

1.14

0.60

2.9

3.1

7.82

7.37

mmol/l

0.51

112

1029

Benign neoplasm: Orbit, unspecified

519

1.22

0.59

3.1

2.9

7.70

7.50

mmol/l

0.13

438

Other acantholytic disorders

235

1.36

0.59

3.6

3.2

5.97

7.51

mmol/l

1.27

193

Benign neoplasm: Bone and articular cartilage, unspecified

631

1.19

0.59

2.8

3.1

8.10

7.78

mmol/l

0.19

547

Systemic sclerosis,strict definition

787

0.84

0.59

3.5

2.9

7.32

7.06

mmol/l

0.20

649

Seminoma of testis

872

0.85

0.59

3.1

3.8

8.81

9.21

mmol/l

0.32

748

Glaucoma secondary to eye inflammation

735

1.18

0.59

2.8

2.9

6.80

7.56

mmol/l

0.75

616

False labour

2796

17194

1.03

0.59

2.8

3.1

8.04

7.71

mmol/l

2.61

2456

15035

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

165

1791

0.90

0.59

3.1

3.2

7.30

7.71

mmol/l

0.54

138

1502

Benign neoplasm: Spinal meninges

111

1004

1.15

0.59

3.0

6.36

7.08

mmol/l

1.43

840

Hydatidiform mole

1075

0.87

0.59

3.5

3.0

7.07

7.30

mmol/l

0.22

941

Crohn disease (strict definition, require KELA, min 2 HDR)

589

5636

1.06

0.59

3.2

3.4

8.14

8.19

mmol/l

0.08

513

4854

Retinal breaks without detachment

1797

17544

1.03

0.58

3.3

3.1

7.55

mmol/l

0.00

1507

14637

Allergic colitis

181

1664

1.11

0.58

3.6

3.8

8.23

8.77

mmol/l

0.66

165

1515

Flatulence and related conditions

887

1.16

0.58

3.1

3.3

7.77

7.42

mmol/l

0.22

735

161

1429

1.11

0.58

5.9

4.7

8.20

8.70

mmol/l

0.42

152

1352

Ependymoma

127

1.47

0.58

1.8

4.6

7.98

7.61

mmol/l

0.08

111

Seropositive rheumatoid arthritis, strict definition

1624

16654

0.97

0.58

3.1

3.2

7.04

7.20

mmol/l

0.80

1398

13941

Other congenital malformations of female genitalia

583

1.19

0.57

3.5

2.9

6.88

8.39

mmol/l

1.66

504

Leiomyosarcoma

606

1.20

0.57

2.6

3.0

7.07

7.18

mmol/l

0.08

505

186

1635

1.10

0.57

5.8

4.5

8.22

8.72

mmol/l

0.47

175

1542

Malignant neoplasm of ureter, excluding all cancers (controls excluding all cancers)

778

1.17

0.57

3.1

3.2

6.29

7.60

mmol/l

2.50

632

Benign neoplasm: Anus and anal canal

294

2770

1.09

0.57

3.3

3.1

7.16

7.41

mmol/l

0.42

251

2325

Syndactyly

156

0.66

0.57

2.5

2.6

7.40

8.60

mmol/l

0.43

137

Melanoma in situ of trunk

141

1294

1.13

0.57

3.7

3.1

7.66

7.69

mmol/l

0.02

103

1083

Burn and corrosion confined to eye and adnexa

219

2039

1.10

0.57

3.8

3.3

8.11

8.58

mmol/l

0.74

193

1750

Benign neoplasm: Vagina

124

1128

1.14

0.57

3.8

2.9

6.95

6.57

mmol/l

0.37

106

935

Organic amnesic syndrome, not induced by alcohol and other psychoactive substances

111

1.53

0.56

3.8

2.9

6.23

8.06

mmol/l

—

Abnormalities of forces of labour

873

8423

1.05

0.56

2.8

3.0

7.59

7.36

mmol/l

0.74

769

7328

Tonsillectomy and adenotomy

6906

47489

1.02

0.56

3.5

3.3

8.54

8.58

mmol/l

0.05

6032

41332

Biliary cirrhosis, NAS

245

1.33

0.56

3.7

3.1

6.68

7.22

mmol/l

0.28

196

Dermatopolymyositis

143

1310

1.12

0.56

3.2

6.67

7.40

mmol/l

1.24

124

1087

Optic atrophy

174

1608

1.11

0.56

3.2

3.4

7.33

7.76

mmol/l

0.68

149

1359

Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism

1.56

0.56

3.6

2.8

8.22

8.45

mmol/l

0.05

Postdysenteric arthropathy

843

1.16

0.56

2.4

3.2

8.08

8.09

mmol/l

0.01

710

Benign neoplasm of breast

1180

12151

0.96

0.56

2.9

3.0

6.53

6.50

mmol/l

0.09

966

10137

Endometroid carcinoma of ovary, excluding all cancers (controls excluding all cancers)

896

0.86

0.55

2.8

2.9

6.05

6.21

mmol/l

0.14

744

Respiratory tuberculosis, clinically confirmed

1038

0.87

0.55

3.9

3.1

6.66

7.51

mmol/l

1.12

849

Congenital malformations of ovaries, fallopian tubes and broad ligaments

469

4469

1.06

0.55

3.1

3.2

7.49

7.29

mmol/l

0.38

404

3883

Hereditary sideroblastic anaemia

290

1.28

0.55

4.7

3.0

6.33

7.46

mmol/l

1.31

234

Other medical care

5048

49969

0.98

0.55

3.0

3.1

7.07

7.49

mmol/l

9.17

4185

41361

Malignant neoplasm of bladder

713

6866

1.05

0.55

3.1

3.2

6.97

7.59

mmol/l

4.42

575

5585

Localized hypertrichosis

1.78

0.55

3.3

2.4

7.11

9.15

mmol/l

—

Chronic myeloid leukaemia [CML], BCR/ABL-positive

807

1.16

0.55

3.5

3.1

8.22

7.79

mmol/l

0.38

668

Fetus and newborn affected by other complications of labour and delivery

145

1.40

0.54

7.6

4.8

8.07

8.45

mmol/l

0.11

134

Malignant neoplasm of ureter

182

1.36

0.54

2.0

3.1

6.74

7.37

mmol/l

0.44

147

Vaginal lichen planus

357

1.26

0.54

3.0

2.9

5.75

6.43

mmol/l

0.65

286

Sequelae of poliomyelitis

713

1.17

0.54

4.0

3.1

6.45

7.12

mmol/l

0.85

578

Spirochaetal infections, other/unspecified

818

8460

0.96

0.53

3.1

3.2

7.66

7.40

mmol/l

0.89

624

7140

severe traumatic brain injury, does not include concussion

2535

24865

1.03

0.53

3.3

3.2

7.23

7.66

mmol/l

4.92

2096

20581

Pedal cyclist injured in collision with motor vehicle

265

2818

0.92

0.53

3.2

7.78

7.96

mmol/l

0.27

213

2389

Other effects of reduced temperature

183

1.37

0.53

5.7

3.3

8.32

8.02

mmol/l

0.12

149

Other and unspecified disorders of binocular movement

449

1.21

0.53

2.8

3.3

6.84

8.36

mmol/l

1.63

382

Other disorders of breast and lactation associated with childbirth

105

1163

0.89

0.53

2.7

3.3

7.51

7.67

mmol/l

0.12

1006

Perioral dermatitis

180

1668

1.10

0.53

3.7

3.1

7.09

7.41

mmol/l

0.36

156

1427

Complications following myocardial infarction

591

0.84

0.53

3.5

3.2

7.41

7.67

mmol/l

0.12

470

Benign neoplasm of other and unspecified intrathoracic organs

110

1000

1.14

0.53

3.3

3.1

8.06

7.52

mmol/l

0.57

102

829

Disorders of porphyrin and bilirubin metabolism

103

931

1.14

0.53

3.4

3.0

8.10

8.37

mmol/l

0.20

781

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

422

1.22

0.53

2.6

3.2

7.10

7.98

mmol/l

0.76

359

Male infertility

435

4146

1.06

0.53

4.2

3.5

9.39

9.72

mmol/l

0.70

397

3628

Acute disseminated encephalitis/encephalomyelitis

111

1.45

0.52

3.8

2.6

5.99

7.70

mmol/l

1.40

Haemangioma, any site

849

8214

1.05

0.52

3.3

3.2

7.52

7.47

mmol/l

0.13

735

6960

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

447

0.80

0.52

2.1

3.2

6.65

7.36

mmol/l

0.40

370

Varicose veins of other sites

713

6880

1.05

0.52

3.3

3.2

8.13

8.22

mmol/l

0.18

602

5845

Benign neoplasm: Connective and other soft tissue, unspecified

119

1087

1.13

0.52

3.2

3.0

7.32

7.54

mmol/l

0.27

109

917

Other fusion of spine

139

1.42

0.52

2.8

2.7

8.44

8.21

mmol/l

0.07

117

Subarachnoid haemorrhage

1123

10916

1.04

0.52

3.2

3.1

7.09

7.31

mmol/l

0.97

971

9073

Use of rotigotine

1018

0.87

0.52

3.2

3.1

7.59

7.44

mmol/l

0.12

842

Effects of other external causes

252

2367

1.08

0.51

3.1

3.4

9.11

8.63

mmol/l

0.68

225

2048

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

320

3375

0.93

0.51

3.4

3.2

6.88

7.29

mmol/l

0.93

271

2795

Gastrointestinal stromal tumor and sarcoma

1027

0.87

0.51

3.1

7.54

7.38

mmol/l

0.14

837

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

154

1666

0.90

0.51

3.1

3.8

9.34

9.15

mmol/l

0.15

123

1423

Impacted teeth

1725

15677

1.03

0.51

3.4

8.94

8.77

mmol/l

0.57

1555

13786

Cleft lip and palate

441

1.20

0.51

3.0

8.22

8.75

mmol/l

0.32

383

Carcinoma in situ of breast

396

1.22

0.51

2.7

2.8

6.17

6.97

mmol/l

0.69

325

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

666

1.16

0.50

3.6

3.5

7.86

8.56

mmol/l

0.61

598

Benign neoplasm: Male genital organ, other/unspecified

0.59

0.50

3.5

3.1

8.98

8.65

mmol/l

—

Benign neoplasm: Male genital organ, other/unspecified

0.59

0.50

3.5

3.0

8.98

8.92

mmol/l

—

Cholesteatoma of external ear

632

1.17

0.50

3.1

6.93

7.53

mmol/l

0.57

525

Atrial septal defect

351

3312

1.07

0.50

3.5

3.6

7.50

7.79

mmol/l

0.54

303

2872

Other benign neoplasms of uterus

559

5377

1.06

0.50

2.9

3.0

5.96

5.90

mmol/l

0.14

410

4392

Melanocytic naevi of upper limb, including shoulder

210

1966

1.09

0.50

3.7

3.1

6.88

7.59

mmol/l

1.61

175

1651

Migraine without aura, drug-induced

102

925

1.13

0.50

3.3

3.0

8.27

7.75

mmol/l

0.47

799

Burns and corrosions confined to eye and internal organs

255

2402

1.08

0.50

4.1

3.3

8.30

8.57

mmol/l

0.35

226

2054

Neuroendocrine tumor and carcinoma of small intestine

136

1255

1.12

0.50

2.8

3.0

6.76

7.53

mmol/l

1.41

113

1025

Melanoma of uvea

962

0.87

0.49

3.7

3.2

7.44

7.55

mmol/l

0.09

790

Ependymoma, excluding all cancers (controls excluding all cancers)

131

1.42

0.49

1.8

4.5

7.98

7.25

mmol/l

0.18

113

Colorectal cancer

2672

27184

0.98

0.49

3.3

3.2

7.45

7.31

mmol/l

0.94

2183

22310

Haemangioma and lymphangioma, any site

911

8837

1.04

0.49

3.3

7.54

7.47

mmol/l

0.18

788

7502

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

271

2865

0.93

0.49

3.2

3.3

7.01

7.89

mmol/l

2.61

228

2445

Carcinoma in situ of cervix uteri

741

7155

1.04

0.49

3.4

3.2

7.27

7.37

mmol/l

0.20

632

6195

Turner's syndrome

157

1.35

0.49

4.0

2.8

7.38

8.13

mmol/l

0.21

139

Nonadministration of surgical and medical care

140

1.40

0.49

2.3

2.7

8.00

8.35

mmol/l

0.12

126

Diffuse large B-cell lymphoma, helper endpoint

434

4529

0.94

0.49

3.2

7.07

7.47

mmol/l

1.21

360

3794

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

434

4529

0.94

0.49

3.2

7.07

7.47

mmol/l

1.21

360

3794

Dermatitis due to ingested food

283

2573

1.07

0.48

3.3

3.8

9.38

8.76

mmol/l

0.81

252

2360

Congenital malformations of cardiac septa

634

5910

1.05

0.48

3.6

7.42

7.89

mmol/l

1.66

553

5140

Tooth agenesis EXCLUDE clefts and syndromes

300

2838

1.07

0.48

3.6

3.5

8.24

8.75

mmol/l

0.82

267

2539

Use of glatiramer acetate

112

1226

0.90

0.48

4.7

3.0

8.14

7.91

mmol/l

0.22

1086

ICD 8 haemorrhage (epidural, subarachnoid, subduralis)

343

1.23

0.47

2.9

3.0

7.62

8.20

mmol/l

0.43

283

Migraine, unspecified, drug-induced

596

1.17

0.47

2.6

2.9

7.93

7.32

mmol/l

0.48

499

Right side

561

1.18

0.47

2.8

3.2

7.25

7.30

mmol/l

0.03

454

Malignant neoplasm of cervix uteri

131

1207

1.11

0.47

3.3

2.9

6.44

6.88

mmol/l

0.72

110

1014

Onycholysis

521

1.18

0.47

4.2

2.8

7.02

7.57

mmol/l

0.42

433

Chronic conjunctivitis

290

2751

1.07

0.46

3.7

3.1

6.64

7.38

mmol/l

2.27

256

2328

Malignant neoplasm of vagina, excluding all cancers (controls excluding all cancers)

308

1.26

0.46

2.6

2.9

6.24

6.34

mmol/l

0.06

254

Hereditary motor and sensory neuropathy

740

1.15

0.46

3.3

3.0

7.22

8.36

mmol/l

1.34

619

Asymmetry of jaw

105

1150

0.89

0.46

2.8

3.2

8.81

8.35

mmol/l

0.34

1003

Other and unspecified water transport accidents

288

1.25

0.46

2.5

2.9

7.06

8.73

mmol/l

1.22

248

Rheumatic valve diseases

202

1894

1.09

0.46

3.6

3.1

7.07

7.20

mmol/l

0.16

166

1540

Chloasma

353

1.22

0.45

3.7

2.7

6.28

7.04

mmol/l

0.60

289

Mixed disorder of acid-base balance

1.69

0.45

5.8

2.8

4.42

9.55

mmol/l

—

Toxic effect of noxious substances eaten as seafood

0.00

0.45

0.0

1.9

—

6.34

—

Other or unspecified paralytic strabismus

579

1.16

0.45

3.2

2.9

8.18

7.77

mmol/l

0.23

480

Placental disorders

615

1.15

0.45

2.8

3.4

7.54

7.53

mmol/l

0.01

543

Short stature, not elsewhere classified

166

1446

1.09

0.45

4.9

4.6

6.67

8.45

mmol/l

4.53

151

1341

Benign neoplasm: Appendix

112

1031

1.12

0.45

3.1

3.2

7.65

7.41

mmol/l

0.21

848

Malignant neoplasm of colon

1648

16142

1.03

0.45

3.3

3.1

7.45

7.18

mmol/l

1.72

1355

13261

Malignant neoplasm of vulva, excluding all cancers (controls excluding all cancers)

143

1330

1.11

0.45

3.4

3.0

5.67

6.16

mmol/l

0.78

120

1095

Malignant neoplasm of nasopharynx, excluding all cancers (controls excluding all cancers)

440

0.82

0.45

2.7

3.1

7.47

7.73

mmol/l

0.12

372

Hypospadias

307

1.23

0.44

3.6

3.3

9.27

9.02

mmol/l

0.11

287

Pterygium

272

2864

0.93

0.44

2.8

3.2

7.10

7.54

mmol/l

1.12

223

2374

Polycythaemia vera

333

3487

0.94

0.44

3.2

7.03

7.27

mmol/l

0.45

274

2915

Crohn disease (strict definition, require KELA)

596

5752

1.05

0.44

3.2

3.4

8.12

8.19

mmol/l

0.12

520

4953

Open wounds involving multiple body regions

308

1.23

0.44

3.4

3.1

5.79

7.98

mmol/l

2.52

261

Diabetic neuropathy

2549

25047

1.03

0.44

5.6

3.9

6.41

7.71

mmol/l

65.28

2251

20806

Lymphoid leukaemia

527

5465

0.95

0.44

3.2

3.3

7.35

7.52

mmol/l

0.40

453

4557

Colorectal adenocarcinoma

2221

22597

0.98

0.44

3.3

3.2

7.40

7.32

mmol/l

0.39

1818

18545

Memory loss

1004

9784

1.04

0.43

3.5

3.1

7.08

7.03

mmol/l

0.13

843

8059

Polydactyly

1.47

0.43

4.7

2.5

6.18

8.85

mmol/l

0.75

Benign neoplasm: Bone and articular cartilage, unspecified

648

1.15

0.43

2.8

3.1

8.10

8.01

mmol/l

0.05

551

Neuroendocrine tumor and carcinoma of lung, excluding all cancers (controls excluding all cancers)

736

1.15

0.43

2.8

3.1

7.52

7.24

mmol/l

0.17

616

Malignant neoplasm of rectosigmoid junction

153

1428

1.10

0.43

3.4

3.1

7.02

7.49

mmol/l

0.76

130

1173

Systemic sclerosis (FG)

220

2076

1.08

0.43

3.3

3.0

6.38

6.93

mmol/l

1.21

187

1762

Chondrosarcoma

267

0.78

0.43

2.6

3.1

6.74

7.71

mmol/l

0.78

224

170

0.73

0.43

2.2

4.9

7.53

8.24

mmol/l

0.18

163

Victim of lightning

1.49

0.43

4.0

3.0

10.00

8.73

mmol/l

0.35

Beningn neoplasm: Meninges, unspecified

138

1482

0.91

0.42

2.9

3.0

7.08

6.88

mmol/l

0.18

116

1239

Intentional self-harm by drowning and submersion

125

1.37

0.42

4.7

3.0

6.86

8.35

mmol/l

0.82

104

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

2255

22171

1.02

0.42

3.2

7.42

7.26

mmol/l

1.00

1878

18375

Carcinoma in situ of other/unspecified female genital organs

1.69

0.42

3.0

2.5

8.63

7.53

mmol/l

—

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx

0.61

0.42

2.8

3.1

5.76

7.44

mmol/l

—

Other intracranial haemorrhages

301

2871

1.07

0.41

3.4

3.2

7.24

7.41

mmol/l

0.29

250

2355

Surgical ablation of atrial fibrillation

519

1.17

0.41

2.7

3.4

7.92

8.40

mmol/l

0.29

426

Crushing injury of ankle and foot

310

1.22

0.41

3.2

7.16

7.99

mmol/l

0.47

261

Ototoxic hearing loss

144

1.34

0.41

4.6

3.0

5.61

7.57

mmol/l

1.07

116

Kela-code for behavioural disturbances in mental retardation

786

1.13

0.40

3.7

3.1

5.97

7.77

mmol/l

4.50

661

Congenital malformations of breast

126

1167

1.10

0.40

2.2

2.9

8.07

7.91

mmol/l

0.13

113

998

Benign neoplasm: Scrotum

358

1.20

0.40

3.1

3.3

7.91

8.80

mmol/l

0.64

307

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)

104

1126

0.90

0.40

2.8

3.2

7.25

7.70

mmol/l

0.40

941

Benign neoplasm: Brain, supratentorial

152

1422

1.09

0.40

4.4

3.2

8.10

7.81

mmol/l

0.30

132

1214

Other specified/unspecified disorders of middle ear and mastoid

200

1.28

0.39

1.6

2.9

8.12

7.41

mmol/l

0.23

161

Exposure to uncontrolled fire in building or structure

595

1.15

0.39

4.3

3.3

6.12

8.44

mmol/l

4.15

508

conjunctival scars

127

1.36

0.39

2.7

2.8

6.47

8.33

mmol/l

0.81

101

Carcinoma in situ of cervix uteri, exocervix

528

1.15

0.39

2.2

2.9

7.69

7.39

mmol/l

0.17

451

Ankylosis of joint

424

1.17

0.39

3.0

3.1

7.23

7.45

mmol/l

0.15

358

Malignant neoplasm of peripheral nerves and autonomic nervous system

1.44

0.39

4.6

3.5

6.31

7.53

mmol/l

0.64

Femoral hernia, bilateral

256

1.23

0.39

2.1

2.8

6.57

7.23

mmol/l

0.30

200

Benign neoplasm: Other/unspecified site

151

1416

1.09

0.38

3.3

3.2

6.64

7.43

mmol/l

1.59

130

1178

Sclerosis of liver

1.46

0.38

2.2

3.0

4.32

7.66

mmol/l

—

Labyrinthitis

247

1.23

0.38

2.0

2.8

8.35

7.72

mmol/l

0.25

207

Lymphocyte function antigen-1 [LFA-1] defect

1.50

0.37

3.4

3.0

7.33

7.25

mmol/l

—

Malignant neoplasm of other and unspecified parts of mouth, excluding all cancers (controls excluding all cancers)

820

0.89

0.37

2.6

3.2

6.91

7.23

mmol/l

0.29

665

Mandibular retrognathia

589

5688

1.04

0.37

3.1

3.4

8.30

8.24

mmol/l

0.11

520

4983

Felty syndrome

486

0.85

0.37

3.3

2.9

6.59

6.65

mmol/l

0.04

399

Chondromalacia

256

2684

0.94

0.37

3.8

3.1

7.53

7.75

mmol/l

0.38

191

2290

Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)

145

1544

0.92

0.37

3.6

3.2

7.33

7.46

mmol/l

0.15

119

1293

Operations for atrial fibrillation

155

1460

1.09

0.37

2.8

3.2

7.17

8.08

mmol/l

1.73

132

1207

437

4520

0.96

0.37

3.2

2.9

7.00

7.14

mmol/l

0.20

373

3655

Muscular dystrophy

714

1.13

0.37

3.9

3.3

6.19

7.68

mmol/l

2.54

609

Conotruncal defects

111

1030

1.10

0.36

3.9

4.1

6.30

8.37

mmol/l

5.45

103

934

Benign neoplasm: Connective and other soft tissue of thorax

400

0.84

0.36

3.4

2.9

7.09

7.68

mmol/l

0.45

336

Other and unspecified atrophic disorders of skin

390

1.18

0.36

3.8

2.9

5.64

6.78

mmol/l

2.04

324

Nontraumatic intracranial haemmorrhage

2215

22482

0.98

0.36

3.2

3.1

7.01

7.32

mmol/l

2.71

1867

18438

Vascular dementia (mixed)

123

1147

1.09

0.36

2.6

3.2

6.68

6.54

mmol/l

0.16

104

940

Disorders of glossopharyngeal nerve

147

1.31

0.36

2.5

3.0

6.88

6.79

mmol/l

0.02

123

Maze procedure for atrial fibrillation

420

1.17

0.35

2.5

3.3

6.85

7.79

mmol/l

0.88

345

Dissection of cerebral arteries, nonruptured

619

1.13

0.35

3.0

3.1

7.29

8.25

mmol/l

1.01

527

Supernumerary teeth EXCLUDE clefts and syndromes

295

1.19

0.35

4.2

3.7

7.55

8.74

mmol/l

0.76

266

Benign neoplasm: Other and unspecified parts of small intestine

142

1508

0.92

0.34

3.4

3.1

6.66

7.04

mmol/l

0.57

125

1239

Polypectomy (DHB20)

740

7214

1.04

0.34

3.2

3.3

7.91

8.13

mmol/l

0.76

646

6083

Other and unspecified cicatricial alopecia

213

1.25

0.34

3.1

2.7

6.58

6.98

mmol/l

0.19

174

Other protozoal intestinal diseases

109

1170

0.91

0.34

2.8

3.0

8.09

7.75

mmol/l

0.26

984

Tick-borne viral encephalitis

324

0.83

0.34

2.0

3.2

8.56

8.09

mmol/l

0.17

271

Malignant neoplasm of nasopharynx

249

0.80

0.34

3.0

7.38

7.95

mmol/l

0.23

214

Right hemicolectomy

596

5794

1.04

0.34

3.5

3.1

7.41

7.21

mmol/l

0.53

508

4783

Carcinoma in situ of middle ear and respiratory system

421

1.16

0.34

3.3

3.2

7.35

7.45

mmol/l

0.08

341

Benign neoplasm: Female genital organ, unspecified

291

0.82

0.34

3.0

2.8

5.59

6.79

mmol/l

1.44

238

Benign neoplasm: Brain, infratentorial

503

0.87

0.34

2.6

3.3

7.86

7.61

mmol/l

0.12

421

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

6879

56586

0.99

0.33

3.2

3.1

7.25

7.63

mmol/l

0.83

5745

47970

Venous complications and haemorrhoids in pregnancy

111

1033

1.09

0.33

3.0

7.25

7.65

mmol/l

0.43

915

Carcinoma in situ of breast, lobular

652

1.13

0.33

2.8

2.9

6.16

6.62

mmol/l

0.48

529

Fatigue fracture of vertebra

393

1.16

0.33

2.6

3.3

7.52

7.50

mmol/l

0.01

344

Dissection of aorta

306

2942

1.05

0.33

2.7

3.1

6.85

7.84

mmol/l

4.05

249

2418

Malignant neoplasm of other and unspecified major salivary glands, excluding all cancers (controls excluding all cancers)

730

0.89

0.32

3.1

7.69

7.53

mmol/l

0.08

603

Ankylosing spondylitis, strict definition

407

3933

1.05

0.32

3.1

3.4

8.39

8.48

mmol/l

0.13

363

3400

Protein-energy malnutrition of moderate and mild degree

661

1.12

0.32

2.9

3.5

8.02

7.14

mmol/l

0.53

551

Carcinoma in situ of uteri, other/unspecified

517

1.14

0.32

2.5

2.7

6.27

6.90

mmol/l

0.41

431

Tetraplegia

594

1.13

0.32

3.1

3.2

6.38

7.87

mmol/l

1.67

490

Actinomycosis

308

1.18

0.32

4.5

2.9

5.03

7.84

mmol/l

3.68

255

Fasciculation

103

961

1.10

0.32

3.2

3.1

7.22

8.10

mmol/l

1.59

819

Other specified diseases of spinal cord, drug-induced

0.62

0.31

2.0

3.0

6.94

8.33

mmol/l

—

Crohn's disease (strict) with PSC

131

1.30

0.31

3.6

3.1

8.25

8.85

mmol/l

0.17

121

Other congenital malformations of circulatory system

243

2329

1.06

0.31

3.2

8.25

7.79

mmol/l

0.73

206

1963

Meningococcal infection

614

1.12

0.31

3.3

2.9

7.26

8.30

mmol/l

1.34

528

Haemangioma and lymphangioma, any site

911

8917

1.03

0.31

3.3

3.2

7.54

7.55

mmol/l

0.01

788

7587

Tuberculosis of other organs, strict

222

2122

1.06

0.31

3.4

3.1

6.53

6.88

mmol/l

0.69

185

1734

Haemangioma, any site

849

8305

1.03

0.31

3.3

3.2

7.52

7.54

mmol/l

0.05

735

7061

Procreative management

3615

30815

0.99

0.30

3.4

8.11

8.18

mmol/l

0.29

3200

26653

Viral agents as the cause of diseases classified to other chapters

198

1889

1.06

0.30

3.6

3.2

6.78

7.79

mmol/l

2.61

176

1603

Exposure to ignition of highly flammable material

386

1.16

0.30

3.4

3.1

8.18

8.73

mmol/l

0.36

331

Wilms' tumor

510

1.13

0.30

4.1

3.4

5.92

7.32

mmol/l

2.25

418

Malignant neoplasm of other and unspecified urinary organs, excluding all cancers (controls excluding all cancers)

655

1.12

0.30

3.2

6.93

7.65

mmol/l

0.83

533

Melanoma in situ of upper limb, including shoulder

617

1.12

0.30

4.0

3.0

7.19

7.46

mmol/l

0.20

510

Benign neoplasm: Orbit, unspecified

549

1.13

0.30

3.1

2.8

7.70

7.75

mmol/l

0.03

460

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

424

1.15

0.30

3.3

2.9

6.62

7.12

mmol/l

0.43

346

Habitual aborter

131

1232

1.07

0.30

2.8

3.3

8.03

8.00

mmol/l

0.02

116

1090

Inguinal hernia, unilateral

246

2562

0.95

0.30

3.0

3.1

6.62

7.30

mmol/l

2.21

209

2129

Femoral hernia, unilateral

246

2562

0.95

0.30

3.0

3.1

6.62

7.30

mmol/l

2.21

209

2129

Inguinal of femoral hernia, unilateral

246

2562

0.95

0.30

3.0

3.1

6.62

7.30

mmol/l

2.21

209

2129

Use of galantamine

594

6097

0.97

0.30

2.8

3.0

7.22

6.52

mmol/l

3.68

457

4889

Liposarcoma, excluding all cancers (controls excluding all cancers)

103

966

1.09

0.30

2.6

3.1

7.28

7.83

mmol/l

0.53

807

Focal epilepsy, strict definition

2123

21510

0.98

0.30

3.4

3.3

7.60

7.74

mmol/l

0.65

1804

18178

Diving or jumping into water causing injury other than drowning or submersion

394

0.86

0.29

2.0

3.2

7.38

8.99

mmol/l

1.35

352

Other congenital malformations of peripheral vascular system

115

1081

1.08

0.29

3.8

3.2

8.26

8.13

mmol/l

0.09

100

930

Benign neoplasm of other and unspecified sites

312

3011

1.05

0.29

3.2

3.1

7.13

7.43

mmol/l

0.63

266

2519

Endometriosis of fallopian tube

568

1.12

0.29

4.0

3.1

6.70

6.96

mmol/l

0.21

485

Abnormal findings in secretions and smears from cervix uteri vagina vulva

5258

40952

1.01

0.29

3.2

3.1

7.04

7.40

mmol/l

0.50

4584

34936

Benign neoplasm: Scrotum

369

1.15

0.28

3.1

3.2

7.91

9.07

mmol/l

0.93

317

Benign neoplasm: Cerebral meninges

961

9428

1.03

0.28

3.1

6.80

6.81

mmol/l

0.03

804

7859

Other and unspecified hydrocephalus

169

1610

1.07

0.28

3.4

3.2

7.35

7.38

mmol/l

0.03

145

1335

Malignant neoplasm of floor of mouth, excluding all cancers (controls excluding all cancers)

858

0.91

0.28

2.6

3.1

6.76

7.88

mmol/l

1.30

713

Hydrocephalus in other diseases

496

0.88

0.28

4.0

3.1

6.16

7.38

mmol/l

1.10

410

Other acute disseminated demyelination

762

1.10

0.28

5.4

2.9

7.54

7.98

mmol/l

0.45

658

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

3133

31004

1.01

0.28

3.2

3.1

6.77

7.06

mmol/l

3.38

2689

25776

Atypical mycobacterium lung infection

1034

0.92

0.28

4.3

3.1

5.91

7.06

mmol/l

2.46

842

Benign neoplasm: Spinal cord

137

1299

1.08

0.28

3.3

3.0

7.72

7.75

mmol/l

0.02

119

1081

686

1.10

0.28

2.5

2.9

8.08

7.48

mmol/l

0.43

577

Deformity of finger(s)

532

1.12

0.28

4.4

3.1

6.60

7.53

mmol/l

1.40

450

Carcinoma in situ of prostate

592

1.12

0.28

2.9

3.4

9.75

8.42

mmol/l

1.47

486

Benign neoplasm: Short bones of lower limb

900

0.91

0.28

4.6

3.1

7.79

7.97

mmol/l

0.12

758

Wilms' tumor, excluding all cancers (controls excluding all cancers)

513

1.12

0.28

4.1

3.6

5.92

7.47

mmol/l

2.66

424

Epileptic seizures related to alcohol

562

1.12

0.28

3.6

3.0

7.57

8.77

mmol/l

1.00

477

Rare circulating lymphoid malignancy

271

2810

0.95

0.28

3.2

3.4

7.01

7.82

mmol/l

2.25

228

2360

Congenital musculoskeletal deformities of head, face, spine and chest

922

0.92

0.28

3.5

3.4

8.74

8.59

mmol/l

0.08

823

Other deformities of toe(s)

339

3281

1.04

0.27

3.0

6.66

6.94

mmol/l

0.69

285

2741

Oesophageal obstruction

357

3460

1.04

0.27

3.3

3.2

7.00

7.56

mmol/l

1.77

293

2869

Benign neoplasm of brain and other parts of central nervous system

658

6432

1.03

0.27

3.3

3.2

7.72

7.53

mmol/l

0.48

562

5432

Burn and corrosion of respiratory tract

1.38

0.27

3.8

3.1

6.34

8.96

mmol/l

—

Pedal cyclist injured in collision with pedestrian or animal

630

0.90

0.27

5.7

3.0

7.21

8.16

mmol/l

1.11

536

Tuberculosis of other organs

195

1867

1.06

0.27

3.3

3.0

6.52

6.90

mmol/l

0.67

161

1522

Benign neoplasm: Central nervous system, other parts/unspecified

317

0.85

0.27

2.7

3.0

7.21

7.96

mmol/l

0.44

265

Malignant melanoma

1640

16174

1.02

0.27

3.5

3.2

7.24

7.36

mmol/l

0.56

1342

13428

Glaucoma in diseases classified elsewhere

1.47

0.27

5.0

2.7

5.20

9.74

mmol/l

—

Other/unspecified rheumatoid arthritis

1351

13303

1.02

0.27

3.1

6.45

6.92

mmol/l

4.35

1160

11008

Intentional self-harm by hanging, strangulation and suffocation

495

0.89

0.26

3.3

3.1

7.88

8.52

mmol/l

0.22

427

Delivery, wide proxy

4139

22216

0.99

0.26

3.1

6.71

6.65

mmol/l

0.34

3543

18509

Malignant neoplasm of other and ill-defined sites

169

0.80

0.26

2.8

8.66

7.20

mmol/l

0.65

144

Neurological devices associated with adverse incidents

1.40

0.26

2.2

2.5

7.50

8.56

mmol/l

—

Familial dysautonomia

1.44

0.26

3.4

3.1

8.52

8.92

mmol/l

—

Atlantoaxial subluxation

612

1.11

0.26

3.0

3.1

6.80

7.57

mmol/l

0.68

510

Traumatic amputation of lower leg

210

1.21

0.26

4.2

3.2

7.34

8.57

mmol/l

0.62

171

Other disorders of thyroid

124

1176

1.07

0.26

3.6

2.9

7.67

6.88

mmol/l

1.01

111

977

Malignant neoplasm of parotid gland, excluding all cancers (controls excluding all cancers)

916

0.92

0.26

3.3

3.1

7.33

7.49

mmol/l

0.12

760

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

122

1285

0.93

0.26

3.0

3.1

7.47

7.81

mmol/l

0.44

1050

Hyperimmunoglobulin E [IgE] syndrome

1.42

0.26

4.0

3.3

8.70

7.92

mmol/l

—

Exposure to high and low air pressure and changes in air pressure

0.74

0.26

3.4

2.9

9.30

8.21

mmol/l

—

Congenital deformities of hip

130

1369

0.94

0.25

3.5

3.4

8.10

8.03

mmol/l

0.05

118

1197

Villonodular synovitis (pigmented)

641

1.10

0.25

3.5

3.1

7.89

7.85

mmol/l

0.02

551

Septal defects

582

5563

1.03

0.25

3.7

3.6

7.52

7.86

mmol/l

0.92

504

4835

Malignant neoplasm of anus and anal canal, excluding all cancers (controls excluding all cancers)

110

1161

0.93

0.25

3.7

3.1

6.95

7.16

mmol/l

0.20

967

Benign neoplasm: Mesothelial tissue of other sites/unspecified

1.36

0.25

1.6

2.7

8.30

8.44

mmol/l

—

Other sideroblastic anaemias

305

1.15

0.25

3.5

3.0

7.44

7.13

mmol/l

0.16

244

Myeloproliferative diseases (CML excluded)

771

7859

0.97

0.25

3.0

3.2

7.05

7.21

mmol/l

0.46

636

6518

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

636

6223

1.03

0.24

3.3

8.06

8.18

mmol/l

0.25

554

5355

Cleft lip and cleft lip and palate

574

1.10

0.24

3.1

3.2

7.65

8.69

mmol/l

0.94

508

Pulmonary haemorrhage originating in the perinatal period

0.00

0.24

0.0

3.7

—

11.28

—

Kernicterus

0.00

0.24

0.0

2.2

—

9.33

—

Carcinoma in situ of rectum

781

1.09

0.24

3.1

3.0

7.26

7.66

mmol/l

0.42

646

Melanoma in situ of lower limb, including hip

528

1.11

0.24

2.7

2.9

6.82

6.94

mmol/l

0.09

430

Small plaque parapsoriasis

230

1.18

0.24

4.0

3.0

5.49

8.21

mmol/l

3.76

188

Left ventricular outflow tract obstruction, narrow definition

463

4516

1.03

0.24

3.2

3.6

7.81

8.39

mmol/l

1.68

401

3889

Ulcerative colitis (strict definition, all Crohn cases excluded)

1538

15177

1.02

0.24

3.3

8.39

8.22

mmol/l

0.67

1327

13011

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

723

1.09

0.23

2.9

3.0

7.87

7.60

mmol/l

0.16

602

Typhoid and paratyphoid fevers

393

1.13

0.23

3.2

2.8

6.65

7.70

mmol/l

1.19

343

Malignant melanoma of skin

1193

12104

0.98

0.23

3.4

3.2

7.23

7.41

mmol/l

0.82

990

10075

Fibrosarcoma, excluding all cancers (controls excluding all cancers)

791

1.09

0.23

2.9

3.1

7.74

7.76

mmol/l

0.01

666

Use of metixene

0.00

0.23

0.0

3.7

—

6.73

—

Osteopathy in diseases classified elsewhere

626

1.10

0.23

3.9

3.1

6.99

7.30

mmol/l

0.21

516

Right ventricular outflow tract obstruction

605

1.09

0.23

3.4

4.2

6.00

8.15

mmol/l

3.48

550

Benign neoplasm: Tongue

270

2616

1.04

0.23

3.6

3.1

7.30

7.51

mmol/l

0.31

226

2200

Malignant neoplasm of eye and adnexa

727

0.92

0.23

3.4

3.1

7.88

7.44

mmol/l

0.35

596

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

224

2162

1.05

0.23

3.0

6.33

6.64

mmol/l

0.69

191

1835

Benign neoplasm: Brain, supratentorial

152

1456

1.06

0.23

4.4

3.2

8.10

7.85

mmol/l

0.25

132

1238

Erythema in diseases classified elsewhere

203

1.19

0.23

3.6

2.9

7.28

7.68

mmol/l

0.12

175

Other abnormal products of conception

2947

19823

0.99

0.22

3.3

3.0

7.80

8.24

mmol/l

0.27

2597

17370

Cerebral arteritis

212

1.18

0.22

4.7

2.9

7.71

8.27

mmol/l

0.19

183

Congenital malformations of uterus and cervix

153

1464

1.06

0.22

3.1

3.2

7.46

7.76

mmol/l

0.32

133

1276

Chronic myeloid leukaemia, excluding all cancers (controls excluding all cancers)

851

1.08

0.22

3.5

3.2

8.22

7.80

mmol/l

0.38

713

Benign neoplasm: Bones of skull and face

870

1.08

0.22

2.7

2.9

7.96

7.54

mmol/l

0.31

726

Senility

603

0.91

0.22

3.0

2.8

6.21

6.62

mmol/l

0.28

495

Open bite that required surgery (Lefort1 or BSSRO)

645

0.92

0.22

2.9

3.3

8.08

8.35

mmol/l

0.16

569

Imbalance of constituents of food intake

0.00

0.22

0.0

2.4

—

6.89

—

Mesial bite

733

1.08

0.22

2.8

3.1

8.54

8.58

mmol/l

0.02

646

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

1303

12859

1.02

0.22

3.3

3.1

7.38

7.22

mmol/l

0.68

1083

10593

Injuries to the hip and thigh

5911

53755

1.01

0.21

3.5

3.2

7.05

7.48

mmol/l

10.87

4912

44683

Familial chondrocalcinosis

100

1.30

0.21

4.1

3.0

6.67

7.10

mmol/l

—

Squamous cell neoplasms and carcinoma of cervix

462

1.10

0.21

2.5

2.8

6.47

6.98

mmol/l

0.45

379

Disorders of fatty-acid metabolism

1.23

0.21

3.0

2.3

8.95

8.97

mmol/l

—

Other benign neoplasms of uterus

559

5480

1.03

0.21

2.9

3.0

5.96

5.88

mmol/l

0.19

410

4475

Vascular dementia (other)

463

1.11

0.21

3.8

3.2

6.23

6.60

mmol/l

0.31

384

Cerebral amyloid angiopathy

358

1.13

0.21

3.9

3.3

6.12

7.43

mmol/l

1.20

289

Inhalation and ingestion of food causing obstruction of respiratory tract

776

0.92

0.21

3.0

3.2

6.21

7.73

mmol/l

2.94

638

Liposarcoma

668

1.09

0.21

2.9

3.2

7.21

7.87

mmol/l

0.60

563

Cleft palate

734

1.08

0.21

3.1

3.3

8.71

8.53

mmol/l

0.08

653

Lumbosacral root disorders, not elsewhere classified

116

1108

1.06

0.20

2.7

3.0

7.19

7.35

mmol/l

0.15

111

926

Benign neoplasm of other and unspecified intrathoracic organs

110

1050

1.07

0.20

3.3

3.2

8.06

7.65

mmol/l

0.39

102

865

Other congenital malformations of ear

940

1.07

0.20

3.0

3.4

7.96

8.67

mmol/l

0.75

829

Cleft lip, lip and palate or palate

129

1234

1.06

0.20

3.2

3.4

8.35

8.48

mmol/l

0.08

114

1088

Use of teriflunomide

724

0.93

0.20

3.4

3.0

8.94

8.31

mmol/l

0.47

638

Benign neoplasm: Tonsil

111

1060

1.06

0.20

3.3

3.1

7.95

7.46

mmol/l

0.46

880

Other and unspecified neuropathies

382

0.89

0.20

3.2

7.84

7.80

mmol/l

0.01

307

Iliac crest spur

1.27

0.19

3.5

2.9

6.95

7.47

mmol/l

—

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

278

2855

0.96

0.19

3.7

3.1

6.96

7.50

mmol/l

1.58

243

2379

Intracranial injury with prolonged coma

0.70

0.19

2.0

2.6

8.50

8.14

mmol/l

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

817

1.07

0.19

3.1

7.12

7.42

mmol/l

0.27

670

Crohn disease (strict definition, all UC cases excluded)

452

4616

0.97

0.19

3.2

3.3

8.26

8.09

mmol/l

0.29

394

3970

Lichen planopilaris

254

1.14

0.18

2.9

2.7

7.04

7.48

mmol/l

0.17

208

Ductal carcinoma of pancreas

643

1.08

0.18

2.5

3.1

7.57

7.48

mmol/l

0.06

527

Lung diseases due to external agents

1448

14319

1.01

0.18

3.7

3.2

7.06

7.54

mmol/l

4.02

1165

11829

Normal-pressure hydrocephalus

469

4782

0.97

0.18

3.0

3.2

7.31

6.89

mmol/l

1.40

400

3870

Occupant of special vehicle mainly used on industrial premises injured in transport accident

438

1.10

0.18

3.1

3.3

7.49

8.63

mmol/l

1.06

362

Leukaemia of unspecified cell type

730

0.93

0.18

2.6

3.0

6.53

7.61

mmol/l

1.19

616

Haemorrhagic disorder due to circulating anticoagulants

955

0.94

0.18

3.2

6.29

7.15

mmol/l

1.41

774

Benign neoplasm: Endocrine gland, other/unspecified

328

0.89

0.18

2.8

2.9

5.93

7.60

mmol/l

1.71

273

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

409

4176

0.97

0.18

3.0

3.2

7.40

7.54

mmol/l

0.25

342

3502

Focal epilepsy

2313

23318

0.99

0.18

3.4

3.3

7.65

7.76

mmol/l

0.51

1966

19746

Otosclerosis

815

8033

1.02

0.18

3.1

7.37

7.22

mmol/l

0.46

671

6737

Carcinoma in situ of prostate

605

1.09

0.18

2.9

3.4

9.75

8.58

mmol/l

1.22

505

Malignant neoplasm of bone and articular cartilage of limbs, excluding all cancers (controls excluding all cancers)

897

1.07

0.18

3.5

3.1

7.27

7.78

mmol/l

0.57

758

Benign neoplasm: Prostate

614

1.08

0.18

4.2

3.3

7.80

7.70

mmol/l

0.05

495

Malignant melanoma, excluding all cancers (controls excluding all cancers)

2011

19933

1.01

0.18

3.4

3.2

7.25

7.41

mmol/l

1.01

1661

16576

Seropositive rheumatoid arthritis, wide

3214

31915

1.01

0.18

3.2

3.1

6.77

7.05

mmol/l

3.36

2759

26516

Other benign neoplasm of uterus: Cervix uteri

526

1.09

0.18

2.8

6.96

6.87

mmol/l

0.05

431

Adenocarcinomas of cervix, excluding all cancers (controls excluding all cancers)

359

0.90

0.18

4.0

2.9

6.32

6.95

mmol/l

0.64

291

Unspecified drowning and submersion

1.23

0.18

3.7

3.0

7.81

7.54

mmol/l

—

Presbyopia

580

5900

0.98

0.17

2.8

3.1

7.72

7.80

mmol/l

0.16

494

5035

Aspergillosis

712

1.07

0.17

4.3

3.1

6.88

7.96

mmol/l

1.54

588

Complicated migraine, drug-induced

1.27

0.17

2.8

3.3

8.01

7.37

mmol/l

—

Benign neoplasm: Bronchus and lung

124

1193

1.05

0.17

3.4

3.1

7.56

7.68

mmol/l

0.12

102

987

Melanoma of uvea

911

0.94

0.17

3.7

3.1

7.44

7.54

mmol/l

0.08

741

Other drug-induced osteomalacia in adults

1.15

0.17

3.6

2.8

7.23

9.32

mmol/l

—

Colorectal neuroendocrine tumor and carcinoma, excluding all cancers (controls excluding all cancers)

136

1312

1.05

0.17

2.9

3.1

7.82

7.44

mmol/l

0.41

112

1110

Traumatic spondylopathy

192

0.86

0.17

2.2

2.9

7.11

7.46

mmol/l

0.10

154

Benign neoplasm: Central nervous system, other parts/unspecified

306

0.89

0.16

2.7

3.0

7.21

7.82

mmol/l

0.34

254

Other peripheral vascular diseases

786

7751

1.02

0.16

3.2

3.1

6.85

7.39

mmol/l

3.34

693

6519

Calcaneal spur

114

1096

1.05

0.16

2.7

2.9

7.35

7.19

mmol/l

0.15

100

933

Pneumoconiosis due to other inorganic dusts

265

1.12

0.16

3.4

3.1

6.98

7.11

mmol/l

0.04

214

Pedal cyclist injured in transport accident

2468

24493

1.01

0.16

3.6

3.3

7.64

8.01

mmol/l

3.13

2089

20899

Attention to artificial openings

363

3705

0.97

0.16

3.4

3.2

6.60

7.76

mmol/l

5.87

311

3074

Other/unspecified seropositive rheumatoid arthritis

3174

31534

1.01

0.16

3.2

3.1

6.76

7.05

mmol/l

3.35

2725

26209

Intentional self-harm by other and unspecified firearm discharge

141

1.19

0.16

3.3

9.35

8.99

mmol/l

0.07

127

Other histiocytosis syndromes

103

1.23

0.16

6.4

2.8

5.57

7.76

mmol/l

2.39

Antepartum haemorrhage, not elsewhere classified

642

6322

1.02

0.15

3.0

3.1

8.14

7.71

mmol/l

1.23

570

5532

Benign neoplasm: Spinal cord

137

1325

1.05

0.15

3.3

3.1

7.72

7.84

mmol/l

0.10

119

1113

Injury of blood vessels at hip and thigh level

263

0.89

0.15

3.2

3.1

7.77

7.65

mmol/l

0.05

222

Use of trihexyphenidyl

122

1.19

0.15

2.1

2.9

7.29

7.71

mmol/l

—

108

Endometroid carcinoma of ovary

836

0.94

0.15

2.8

3.0

6.05

6.30

mmol/l

0.23

685

Cyst of spleen

159

0.85

0.15

2.8

2.7

6.65

8.23

mmol/l

0.69

136

Diffuse large B-cell lymphoma

434

4414

0.98

0.15

3.2

7.07

7.43

mmol/l

1.02

360

3643

Benign neoplasm: Cranial nerves

280

2740

1.03

0.15

2.9

3.1

7.59

7.44

mmol/l

0.25

235

2288

Hodgkin lymphoma, hilmo

263

2571

1.03

0.15

3.3

7.78

8.15

mmol/l

0.67

218

2165

Pneumonitis due to solids and liquids

760

7503

1.02

0.14

3.8

3.2

6.87

7.64

mmol/l

4.94

600

6184

Other benign neoplasm of uterus: Other parts/unspecified

418

4251

0.98

0.14

2.9

5.67

5.68

mmol/l

0.02

305

3443

Femoral hernia

449

4417

1.02

0.14

3.1

6.79

7.22

mmol/l

1.51

380

3674

Benign neoplasm: Uterine tubes and ligaments

600

0.93

0.14

3.1

2.9

6.24

6.42

mmol/l

0.18

489

Postmenopausal atrophic vaginitis

2910

17402

1.01

0.14

3.1

2.9

6.23

6.33

mmol/l

0.68

2498

14626

Ulcerative rectosigmoiditis

828

8182

1.02

0.14

3.4

3.3

8.59

8.06

mmol/l

2.40

707

7019

Yaws

104

1.21

0.14

3.4

8.14

7.86

mmol/l

0.05

Urticaria due to cold and heat

668

1.06

0.14

2.8

3.1

7.47

7.85

mmol/l

0.33

571

Malignant neoplasm of penis, excluding all cancers (controls excluding all cancers)

569

0.93

0.14

4.3

3.2

7.84

8.56

mmol/l

0.51

476

Malignant neoplasm of floor of mouth

436

0.92

0.14

2.7

3.1

6.14

7.68

mmol/l

1.57

354

Cyst of iris, ciliary body and anterior chamber

133

1.17

0.14

1.9

3.0

8.38

8.41

mmol/l

—

106

Other disorders of prostate

329

3352

0.98

0.13

3.1

3.2

8.08

8.46

mmol/l

0.96

281

2801

Benign neoplasm: Peripheral nerves and autonomic nervous system

143

1389

1.04

0.13

3.1

7.68

7.51

mmol/l

0.18

121

1158

Labour and delivery complicated by umbilical cord complications

396

4025

0.98

0.12

3.0

3.1

7.26

7.23

mmol/l

0.05

347

3490

Prophylactic surgery

527

0.94

0.12

3.3

2.9

6.65

7.60

mmol/l

0.59

458

malignant neoplasm of female genital organs

1557

15453

1.01

0.12

3.1

3.0

6.16

6.12

mmol/l

0.13

1281

12686

Malignant immunoproliferative diseases

922

0.95

0.12

3.4

3.2

6.71

7.56

mmol/l

1.10

748

Occlusion and stenosis of arteries, not leading to stroke

112

1084

1.04

0.12

3.4

3.1

7.53

7.29

mmol/l

0.21

886

Malignant neoplasm of bone and articular cartilage

800

1.05

0.12

3.0

3.1

7.27

7.71

mmol/l

0.36

673

Non-seminoma of testis, excluding all cancers (controls excluding all cancers)

485

1.07

0.12

3.5

3.9

9.90

9.58

mmol/l

0.14

436

Benign neoplasm: Epididymis

290

1.10

0.12

3.6

3.4

8.85

8.63

mmol/l

0.09

246

Malignant neoplasm of uterus, part unspecified, excluding all cancers (controls excluding all cancers)

362

0.92

0.12

4.0

2.8

5.46

5.89

mmol/l

0.39

293

Peripheral retinal degeneration

289

2839

1.02

0.11

2.7

2.9

7.50

7.59

mmol/l

0.12

257

2399

Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)

136

1325

1.04

0.11

2.8

3.1

6.76

7.63

mmol/l

1.69

113

1100

Benign neoplasm: Cranial nerves

280

2849

0.98

0.11

2.9

3.1

7.59

7.39

mmol/l

0.35

235

2403

Benign neoplasm: Tonsil

111

1143

0.96

0.11

3.3

3.1

7.95

7.59

mmol/l

0.32

950

Benign neoplasm: Short bones of lower limb

870

0.96

0.11

4.6

3.1

7.79

7.89

mmol/l

0.06

729

Myeloproliferative diseases

861

8691

0.99

0.11

3.1

3.2

7.18

7.28

mmol/l

0.29

713

7196

Myopathy due to other toxic agents

1.22

0.11

2.8

2.7

5.02

7.47

mmol/l

—

Pedal cyclist injured in noncollision transport accidents

1121

11303

0.99

0.11

3.4

3.3

7.85

8.07

mmol/l

0.69

961

9668

Phlebitis and thrombophlebitis of femoral vein, drug-induced

1.24

0.11

3.4

3.3

5.36

8.26

mmol/l

—

Other congenital malformations of tongue, mouth and pharynx

103

1057

0.96

0.11

4.2

3.9

7.28

8.60

mmol/l

1.92

950

Chlamydial lymphogranuloma (venereum)

1.20

0.11

4.2

3.0

9.26

10.14

mmol/l

—

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

811

1.04

0.11

3.1

2.9

6.86

8.23

mmol/l

2.40

704

Benign neoplasm: Mesothelial tissue of other sites/unspecified

1.14

0.11

1.6

2.4

8.30

7.87

mmol/l

—

Myelofibrosis

1.14

0.10

1.4

3.2

9.99

8.21

mmol/l

—

Benign neoplasm: Brain, unspecified

533

0.94

0.10

2.9

3.1

7.39

7.56

mmol/l

0.10

452

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

1637

16470

0.99

0.10

3.4

3.2

7.25

7.43

mmol/l

0.98

1373

13734

Acute mastoiditis

714

1.05

0.10

4.3

3.1

7.69

8.25

mmol/l

0.45

618

Carcinoma in situ of breast

439

1.07

0.10

2.7

3.0

6.17

6.82

mmol/l

0.52

362

Carcinoma in situ of uteri, other/unspecified

547

1.06

0.10

2.5

2.9

6.27

6.96

mmol/l

0.46

454

Melanocytic naevi of eyelid, including canthus

833

1.04

0.10

3.5

3.0

6.65

7.46

mmol/l

1.14

690

Leishmaniasis

1.18

0.10

2.5

2.9

8.60

8.53

mmol/l

—

Exposure to excessive heat of man-made origin

624

0.95

0.10

4.3

3.0

6.43

7.84

mmol/l

2.15

510

Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

843

1.04

0.10

3.4

3.7

8.27

8.57

mmol/l

0.20

747

Malignant neoplasm of pyriform sinus

1.10

0.10

2.0

3.3

6.57

8.29

mmol/l

—

Desensitization to allergens

428

4335

0.98

0.10

3.4

3.5

8.05

8.56

mmol/l

1.21

371

3801

Functional disorders of polymorphonuclear neutrophils

1.14

0.09

3.2

2.7

5.35

7.34

mmol/l

—

Cardiomyopathies, Secondary/extrinsic

542

0.95

0.09

3.5

2.9

7.98

8.33

mmol/l

0.21

443

Benign neoplasm of male genital organs

193

1966

0.98

0.09

3.9

3.4

8.08

8.50

mmol/l

0.66

153

1644

Benign neoplasm: Other/unspecified site

151

1478

1.03

0.09

3.3

3.1

6.64

7.50

mmol/l

1.82

130

1237

Malignant neoplasm of vulva

825

1.04

0.09

3.3

2.9

5.83

6.16

mmol/l

0.30

674

Benign neoplasm: Peripheral nerves and autonomic nervous system

143

1461

0.97

0.09

3.1

7.68

7.55

mmol/l

0.13

121

1236

Benign neoplasm of male genital organs

193

1965

0.98

0.09

3.9

3.4

8.08

8.68

mmol/l

1.10

153

1667

Unspecified protein-energy malnutrition

391

1.06

0.09

2.7

3.0

6.08

6.85

mmol/l

0.59

323

Major anomalies of jaw size

236

2398

0.98

0.09

3.4

3.2

8.30

8.28

mmol/l

0.02

207

2068

Lymphangioma, anys site

608

1.05

0.09

3.2

3.0

7.60

8.22

mmol/l

0.48

522

Non-seminoma of testis

490

1.05

0.08

3.5

3.9

9.90

9.47

mmol/l

0.19

434

Congenital malformations of great arteries

173

1667

1.02

0.08

4.0

4.2

6.99

8.05

mmol/l

2.22

158

1480

Malignant neoplasm, wide definition for exclusion

13269

78274

1.00

0.08

3.2

7.47

7.82

mmol/l

15.50

11115

66724

Other benign neoplasm of uterus: Other parts/unspecified

418

4135

1.02

0.08

2.9

3.0

5.67

5.74

mmol/l

0.16

305

3333

Cerebral atherosclerosis

902

1.03

0.08

3.5

3.1

7.42

7.01

mmol/l

0.39

730

Fetal death of unspecified cause

1.15

0.08

5.2

2.3

7.10

8.00

mmol/l

0.23

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

275

0.93

0.08

2.7

5.1

9.17

8.68

mmol/l

0.15

265

Osteonecrosis due to drugs

119

1164

1.03

0.08

4.3

3.1

6.35

7.34

mmol/l

2.21

107

948

Malignant immunoproliferative diseases

867

1.04

0.08

3.4

3.2

6.71

7.34

mmol/l

0.71

708

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

13268

78272

1.00

0.08

3.2

7.47

7.82

mmol/l

15.55

11114

66723

Cholinergic urticaria

422

1.06

0.08

2.9

3.3

8.97

8.10

mmol/l

0.40

364

Transient acantholytic dermatosis [Grover]

167

1.11

0.08

2.6

3.3

5.97

7.62

mmol/l

0.93

140

Actinic reticuloid

0.86

0.08

5.1

3.0

9.61

8.10

mmol/l

—

Noonan syndrome

0.82

0.08

2.3

3.3

9.53

7.88

mmol/l

—

Phakomatoses, not elsewhere classified

964

0.97

0.08

3.1

3.2

8.12

8.07

mmol/l

0.04

838

Café au lait spots

1.05

0.08

1.8

4.8

8.04

8.31

mmol/l

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

521

1.05

0.08

2.9

3.0

6.67

7.50

mmol/l

0.67

436

Benign neoplasm: Female genital organ, unspecified

265

0.93

0.08

3.0

2.7

5.59

7.00

mmol/l

1.78

211

Contact with venomous snakes and lizards

897

1.03

0.08

3.1

8.39

7.75

mmol/l

0.61

754

Melanocytic naevi of upper limb, including shoulder

210

2068

1.02

0.08

3.7

3.1

6.88

7.74

mmol/l

2.17

175

1756

Labyrinthine fistula

275

1.07

0.07

2.3

3.1

8.13

7.91

mmol/l

0.10

237

Congenital and developmental myasthenia

0.85

0.07

2.4

3.2

8.13

8.04

mmol/l

—

Alpha thalassaemia

1.17

0.07

3.5

3.3

7.85

7.41

mmol/l

—

Use of cabergoline

104

1016

1.03

0.07

3.1

8.62

7.91

mmol/l

0.51

865

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

260

2634

0.98

0.07

3.7

3.2

6.84

7.31

mmol/l

0.99

215

2189

Congenital malformations of pulmonary and tricuspid valves

569

0.96

0.07

3.6

4.2

6.37

8.02

mmol/l

1.80

519

Malignant neoplasm of other and unspecified parts of mouth

443

1.05

0.07

2.9

3.2

6.94

7.30

mmol/l

0.25

368

Malignant neoplasm of testis

139

1416

0.98

0.07

3.1

3.8

9.48

9.19

mmol/l

0.23

113

1213

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

454

1.05

0.06

3.3

2.8

6.62

7.10

mmol/l

0.40

373

Complex cardiac defects

446

0.96

0.06

3.4

4.1

6.01

8.08

mmol/l

2.23

400

Spinal enthesopathy

230

2266

1.02

0.06

2.9

3.0

6.91

6.88

mmol/l

0.04

192

1833

Maxillary prognathism

375

1.05

0.06

2.6

3.2

7.96

8.25

mmol/l

0.12

341

Labour and delivery complicated by fetal stress [distress]

1960

13024

1.00

0.06

3.5

3.2

8.04

7.97

mmol/l

0.27

1730

11441

Arthropathy in Crohn disease

821

1.03

0.06

3.3

3.2

7.56

8.04

mmol/l

0.46

705

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

269

2719

0.99

0.06

3.2

7.27

7.50

mmol/l

0.41

225

2257

Chronic lymphocytic leukaemia, helper endpoint

269

2719

0.99

0.06

3.2

7.27

7.50

mmol/l

0.41

225

2257

Isolated patent ductus arteriosus

188

1.08

0.06

3.3

3.1

8.03

8.10

mmol/l

0.02

162

Other degenerative diseases of the basal ganglia

142

1442

0.98

0.06

2.6

3.2

8.09

7.34

mmol/l

1.11

118

1158

Spondylopathies in diseases classified elsewhere

110

1080

1.03

0.06

3.3

3.2

7.12

7.51

mmol/l

0.40

876

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

13260

78268

1.00

0.05

3.2

7.47

7.82

mmol/l

15.39

11106

66719

Malignant neoplasm of other connective and soft tissue

220

2175

1.02

0.05

2.8

3.1

7.10

7.47

mmol/l

0.64

180

1804

Rubella [German measles]

347

3500

0.99

0.05

3.8

3.1

9.73

9.42

mmol/l

0.54

309

3040

Nutritional marasmus

110

0.89

0.05

7.0

2.9

3.58

8.11

mmol/l

—

Venous complications and haemorrhoids in the puerperium

908

0.97

0.05

2.5

3.0

6.45

6.82

mmol/l

0.37

772

Enteropathogenic Escherichia coli infection

258

1.06

0.05

5.4

3.5

8.05

7.78

mmol/l

0.09

212

Progressive vascular leukoencephalopathy

289

2917

0.99

0.05

2.7

3.1

6.47

6.56

mmol/l

0.13

227

2325

Maxillary retrognathism

146

1439

1.02

0.05

3.3

3.6

8.50

8.74

mmol/l

0.21

129

1269

Impacted maxillary molar

417

4138

1.01

0.05

3.8

3.4

8.59

8.72

mmol/l

0.16

379

3652

Other operation for atrial fibrillation

496

1.04

0.05

3.1

3.3

6.50

7.77

mmol/l

1.73

409

Premature separation of placenta [abruptio placentae]

164

1662

0.98

0.05

2.7

3.1

7.39

7.49

mmol/l

0.12

150

1468

Benign neoplasm: Prostate

635

1.03

0.05

4.2

3.3

7.80

8.00

mmol/l

0.13

524

Benign neoplasm: Lymph nodes

209

1.07

0.05

2.8

2.9

7.07

7.97

mmol/l

0.38

170

Scarlet fever

516

1.03

0.05

3.0

2.7

9.13

9.04

mmol/l

0.04

463

Benign neoplasm of brain and other parts of central nervous system

658

6546

1.01

0.05

3.3

3.2

7.72

7.60

mmol/l

0.27

562

5546

Systemic sclerosis, icd10

217

2192

0.99

0.04

3.4

3.0

6.39

6.90

mmol/l

1.06

184

1848

Injury of nerves at hip and thigh level

342

0.95

0.04

4.9

3.1

8.45

8.06

mmol/l

0.10

281

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

694

0.97

0.04

3.3

3.2

7.03

7.53

mmol/l

0.41

565

Retained placenta and membranes, without haemorrhage

1139

11431

1.00

0.04

3.0

3.1

6.76

6.88

mmol/l

0.48

964

9694

Malaria

408

1.04

0.04

4.7

3.0

7.22

8.13

mmol/l

0.69

341

Marginal zone B-cell lymphoma

766

1.03

0.04

3.2

3.0

7.31

7.44

mmol/l

0.10

624

Carcinoma in situ of breast, lobular

723

0.97

0.04

2.8

2.9

6.16

6.45

mmol/l

0.26

596

Other specified/unspecified disorders of ear

240

1.06

0.04

2.2

2.9

6.00

7.51

mmol/l

1.46

205

Benign neoplasm: Brain, unspecified

498

1.03

0.04

2.9

3.0

7.39

7.56

mmol/l

0.10

427

Benign neoplasm: Connective and other soft tissue of thorax

361

0.96

0.04

3.4

2.9

7.09

7.63

mmol/l

0.39

302

conjunctival degenerations and deposits

208

2062

1.01

0.03

3.3

3.1

6.58

7.13

mmol/l

1.18

177

1718

Malignant neoplasm of other endocrine glands and related structures, excluding all cancers (controls excluding all cancers)

419

1.04

0.03

3.3

3.1

7.54

7.57

mmol/l

0.01

350

Congenital malformations of ear causing impairment of hearing

290

0.96

0.03

3.6

3.5

7.77

8.25

mmol/l

0.21

247

Beningn neoplasm: Meninges, unspecified

138

1395

0.99

0.03

2.9

3.1

7.08

6.78

mmol/l

0.28

116

1166

Personality and behavioural disorders due to brain disease, damage and dysfunction

136

1373

0.99

0.03

3.1

3.3

7.41

8.02

mmol/l

0.64

107

1137

Drowning to ice

102

1.11

0.03

2.0

3.0

7.18

7.75

mmol/l

0.18

Benign neoplasm: Bronchus and lung

124

1254

0.98

0.03

3.4

3.1

7.56

7.76

mmol/l

0.21

102

1043

Emphysema

703

7004

1.00

0.03

2.9

3.2

7.48

7.66

mmol/l

0.49

600

5767

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

2018

19790

1.00

0.03

3.1

3.0

6.22

6.17

mmol/l

0.23

1679

16448

Fall involving playground equipment

519

1.03

0.03

4.7

4.8

8.57

8.01

mmol/l

0.24

474

Family history of malignant neoplasm

953

9558

1.00

0.03

2.9

3.0

7.35

7.47

mmol/l

0.32

808

8105

Other dermatomyositis

410

1.03

0.03

3.4

2.9

5.53

7.42

mmol/l

3.14

342

Crowding of teeth, including avohilmo

762

6265

1.00

0.03

4.0

3.5

8.54

8.72

mmol/l

0.36

702

5604

Benign neoplasm: Vagina

124

1227

1.01

0.03

3.8

2.9

6.95

6.47

mmol/l

0.49

106

1027

Unspecified multiple injuries

251

1.05

0.03

5.2

3.4

8.13

8.28

mmol/l

0.04

218

Melanoma in situ of lower limb, including hip

560

1.02

0.02

2.7

2.9

6.82

7.05

mmol/l

0.18

464

Mature T/NK-cell lymphomas, hilmo

122

1208

1.01

0.02

3.0

3.1

7.47

7.61

mmol/l

0.15

989

Nonspecific lymphadenitis

572

5740

1.00

0.02

3.1

7.65

7.83

mmol/l

0.44

498

4913

Congenital malformations of aortic and mitral valves

381

3827

0.99

0.02

3.2

3.6

7.81

8.40

mmol/l

1.68

331

3291

Cleft hard palate NOS

331

1.03

0.02

2.9

3.3

8.56

8.36

mmol/l

0.05

298

Malignant neoplasm of small intestine

201

2023

0.99

0.02

3.2

3.1

7.13

7.47

mmol/l

0.52

166

1668

Leukaemia of unspecified cell type

700

0.98

0.02

2.6

3.0

6.53

7.66

mmol/l

1.28

589

Discontinuity and dislocation of ear ossicles

449

0.97

0.02

3.9

3.1

7.13

7.85

mmol/l

0.64

376

Bicuspidal aortic valve syndrome

339

3404

0.99

0.02

3.1

3.4

7.91

8.45

mmol/l

1.30

295

2907

Injury of nerves at ankle and foot level

561

1.02

0.02

3.6

2.9

8.02

8.13

mmol/l

0.06

469

Systemic sclerosis

220

2212

0.99

0.02

3.3

3.0

6.38

6.93

mmol/l

1.21

187

1872

Acute drug-induced interstitial lung disorder

661

1.02

0.02

2.9

3.1

5.81

7.30

mmol/l

3.30

542

Arthropathy in ulcerative colitis

112

1110

1.01

0.02

3.2

3.1

8.27

7.98

mmol/l

0.27

101

938

Endometriosis of intestine

101

1020

0.99

0.02

2.9

3.3

7.89

7.64

mmol/l

0.22

892

Speech therapy

3177

31797

1.00

0.01

3.3

3.2

7.25

7.34

mmol/l

0.60

2946

26454

Melanocytic naevi of eyelid, including canthus

869

0.99

0.01

3.5

3.0

6.65

7.52

mmol/l

1.27

722

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

548

0.98

0.01

2.9

6.67

7.60

mmol/l

0.79

454

Optic neuritis

359

3578

1.00

0.01

3.8

3.2

7.53

7.79

mmol/l

0.46

304

3070

Benign neoplasm: Lymph nodes

227

0.96

0.01

2.8

3.0

7.07

7.71

mmol/l

0.25

191

Collapsed vertebra, not elsewhere classified

652

1.02

0.01

3.0

6.18

7.02

mmol/l

0.61

530

Unspecified abortion

426

4248

1.00

0.01

3.4

3.0

6.81

7.02

mmol/l

0.48

363

3668

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

305

3041

1.00

0.01

3.2

7.27

7.47

mmol/l

0.32

253

2557

Epidermolysis bullosa

106

0.93

0.01

3.6

3.3

6.93

7.57

mmol/l

—

Inflammation of lacrimal passages (chronic)

141

1403

1.01

0.00

2.8

3.1

6.19

6.94

mmol/l

1.34

119

1165

Hodgkin lymphoma

263

2637

1.00

0.00

3.3

7.78

8.16

mmol/l

0.69

218

2242

Benign neoplasm of other and unspecified sites

312

3113

1.00

0.00

3.2

3.1

7.13

7.52

mmol/l

0.90

266

2654

Adenocarcinomas of cervix

336

0.98

0.00

4.0

2.9

6.32

6.99

mmol/l

0.68

267

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

420

4193

1.00

0.00

3.3

3.1

7.34

7.49

mmol/l

0.32

321

3451

Chronic lymphocytic leukaemia

269

2685

1.00

0.00

3.2

7.27

7.41

mmol/l

0.22

225

2203

Sequelae of tuberculosis

144

1437

1.00

0.00

3.2

3.1

6.30

6.72

mmol/l

0.69

118

1153

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

982

1.00

0.00

4.3

3.0

7.64

7.87

mmol/l

0.19

848

Benign neoplasm: Tongue

270

2697

1.00

0.00

3.6

3.1

7.30

7.54

mmol/l

0.38

226

2293

Ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

684

0.99

0.00

2.5

3.1

7.57

7.72

mmol/l

0.11

561

220

2202

1.00

0.00

3.2

3.1

6.53

7.22

mmol/l

1.37

179

1774

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

861

1.00

0.00

3.1

7.12

7.67

mmol/l

0.60

716

Other benign neoplasm of uterus: Cervix uteri

562

1.00

0.00

2.8

2.9

6.96

6.82

mmol/l

0.08

455

Malignant neoplasm of retroperitoneum and peritoneum

622

1.00

0.00

2.7

2.9

5.83

6.79

mmol/l

1.59

505

Disorder of visual pathways, unspecified

157

1.03

0.00

2.2

4.6

7.59

7.48

mmol/l

0.03

138

Benign neoplasm: Epididymis

309

1.00

0.00

3.6

3.3

8.85

8.89

mmol/l

0.02

266

Benign neoplasm: Endocrine gland, other/unspecified

299

1.00

0.00

2.8

2.9

5.93

7.44

mmol/l

1.48

251

Ankyloglossia

112

1116

1.00

0.00

4.1

8.22

8.68

mmol/l

0.35

1015

Cyst of Bartholin Gland

318

3175

1.00

0.00

2.7

3.0

7.23

6.92

mmol/l

0.50

260

2714

Squamous cell neoplasms and carcinoma of cervix, excluding all cancers (controls excluding all cancers)

497

1.01

0.00

2.5

2.8

6.47

6.90

mmol/l

0.37

414

Other specified/unspecified diseases of inner ear

395

0.98

0.00

3.2

2.9

7.54

7.86

mmol/l

0.23

326

Lymphangioma, anys site

626

1.01

0.00

3.2

3.0

7.60

8.22

mmol/l

0.48

539

Gilbert syndrome

595

1.01

0.00

2.9

8.85

8.67

mmol/l

0.10

505

General- and plastic-surgery devices associated with adverse incidents

205

0.97

0.00

2.8

2.9

6.15

7.49

mmol/l

0.97

171

Mandibular hypoplasia

492

0.99

0.00

2.3

3.3

7.98

8.06

mmol/l

0.04

429

Airway disease due to specific organic dust

211

0.99

0.00

3.9

3.1

7.68

8.10

mmol/l

0.19

178

Carcinoma in situ of bronchus and lung

132

0.98

0.00

3.2

8.04

7.62

mmol/l

—

108

Carcinoma in situ of bronchus and lung

128

1.02

0.00

3.2

3.1

8.04

7.78

mmol/l

—

105

Hereditary angioödema type 1

0.97

0.00

2.9

2.6

6.31

7.44

mmol/l

—

Retained (old) intraocular foreign body

0.87

0.00

4.2

3.5

9.93

8.73

mmol/l

—

Bartonellosis

1.03

0.00

9.0

3.0

6.20

8.25

mmol/l

—

Other hypertrophic osteoarthropathy

0.94

0.00

9.0

2.6

6.12

7.63

mmol/l

—

Labyrinthine dysfunction

1.04

0.00

1.8

3.3

8.67

7.18

mmol/l

—

Explosion and rupture of other specified pressurized devices

0.92

0.00

2.9

3.1

10.74

8.91

mmol/l

—

Degenerative myopia

570

1.00

0.00

2.8

3.1

7.66

7.06

mmol/l

0.44

482

Polyneuropathy due to other toxic agents

1.04

0.00

7.0

2.9

4.52

7.73

mmol/l

—

Malignant neoplasm of parotid gland

670

1.00

0.00

3.4

3.1

7.39

7.61

mmol/l

0.14

554

Other abnormal auditory perceptions

930

1.00

0.00

3.1

3.2

7.83

7.68

mmol/l

0.10

790

Defect, injury or illness of skull

1.00

0.00

6.1

3.2

5.26

8.96

mmol/l

—

Persistent hyperplasia of thymus

1.04

0.00

3.0

2.4

6.87

9.23

mmol/l

—

Other and unspecified disorders of sclera

0.91

0.00

4.1

3.0

6.77

7.82

mmol/l

—

Infantile papular acrodermatitis [Gianotti-Crosti]

0.00

0.0

6.0

—

6.48

—

Calculus of urinary tract in diseases classified elsewhere

1.02

0.00

6.0

3.2

7.76

8.47

mmol/l

—

Infantile muscular atrophy

0.88

0.00

10.2

2.8

4.40

7.92

mmol/l

—

Secondary sideroblastic anaemia due to drugs and toxins

1.03

0.00

4.2

2.7

6.30

6.82

mmol/l

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Creatinine [Moles/volume] in Urine

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS